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Prostaglandin (PG) F2a is the uterine luteolytic hormone in the guinea-pig and
many other non-primate species. In the guinea-pig, oestradiol acting on a
progesterone-primed uterus is the optimum stimulus for PGF2a production i_n vivo,
apparently by the stimulation of phospholipase (PL) A2, the rate limiting step
in PG synthesis.
The output of PGF2a, but not the outputs of PGE2 and PGI2 (measured as its
stable metabolite 6-keto-PGF-]a) , from the guinea-pig uterus superfused Tn vitro
and from guinea-pig endometrium in culture were selectively stimulated between
days 7 and 15 of the oestrous cycle. This output reflects PGF2a synthesis
because PGF2a output from cultured endometrium was inhibited by the non¬
steroidal anti-inflammatory drug, indomethacin.
The output of PGF2a from the day 15 uterus superfused i_n vitro was stimulated by
treatment with the calcium ionophore A23187. pGF2a °utput from day 15
endometrium in culture for three days was inhibited by removing extracellular
Ca2+ and also be treatment with TMB-8 (an intracellular Ca2+ antagonist). Both
extracellular and intracellular Ca2+ were necessary for the stimulation and
maintenance of the high output of PGF2a from the endometrium at the end of the
oestrous cycle. The calmodulin inhibitors trifluoperazine and W-7 also
decreased PGF2a output from cultured day 15 endometrium, implicating calmodulin
as a mediator in this Ca2+-regulated control of PGF2a synthesis.
Cellular and secreted proteins were synthesised by day 7 and day 15 guinea-pig
endometrium in culture. Endometrial protein synthesis was inhibited by
treatment with protein and RNA synthesis inhibitors; these inhibitors also
inhibited endometrial PGF2a output and PGF2a synthesizing capacity (a measure of
tissue PGH synthase levels). The administration of actinomycin D into the
uterine lumen on day 10 _in vivo prevented the stimulation of uterine PGF2a
output and endometrial protein synthesis observed on day 15. These findings
suggest that protein synthesis is involved in the stimulation of endometrial
PGF2a synthesis towards the end of the oestrous cycle. The effects of these
protein and RNA synthesis inhibitors were not due to a rapid inhibitory action
on PGH synthase, and levels of PGH synthase in the endometrium were not the rate
limiting step in PGF2a synthesis by the guinea-pig uterus. Phorbol 12-
myristate, 13~acetate (a stimulator of protein kinase C) and hydrocortisone had
no effect on endometrial PGF2a output demonstrating that a Lipocortln-xike
protein was not involved in the control of endometrial PGF2a synthesis.
Oestradiol (1-100ng/ml) and oxytocin had no effect on PGF2a output from day 7 or
day 15 cultured endometrium. However, progesterone (10-1OOng/ml) and
oestradiol (1000ng/ml) inhibited endometrial PGF2a output and endometrial PGF2a
synthesizing capacity. These ovarian steroids also inhibited the synthesis of
secreted proteins by day 15 guinea-pig endometrium in culture.
It is concluded that in the guinea-pig oestradiol acting on a progesterone-
primed uterus stimulates the synthesis of endometrial protein(s) that with Ca2+
mediates the increased release of precursor for the increase in uterine PGF2a
synthesis towards the end of the oestrous cycle.
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Fresh human semen was studied by Kurzrok and Lieb (1930) who
showed that it would either inhibit or stimulate the motility of
strips of human uterus _in vitro. Subsequently, Goldblatt (1935) and
von Euler (1934 and 1935) showed a marked stimulation of the
contractile activity of smooth muscle by human seminal fluid. Von
Euler (1935) showed similar stimulatory activity in the seminal fluid
of the monkey, sheep, goat and in extracts of sheep seminal vesicles.
All these extracts, which were soluble in lipid solvents and were of
acidic character, caused the contraction of smooth muscle and lowered
the arterial blood pressure in experimental animals. The term
"prostaglandin" was coined by von Euler in 1935 for this unknown
factor which was thought to originate from the prostate gland.
However, the factor originates from the seminal vesicle and it may
have been called "vesiglandin" if this had been realised. In 1939,
von Euler proposed that prostaglandin (PC) was a lipid-soluble, fatty
acid which possibly contained a double bond and a hydroxyl group.
Von Euler's findings that this biological activity was due to a
new group of highly active, lipid-soluble, unsaturated fatty acids was
confirmed by Bergstrom (1949), who also realised the presence of more
than one saturated, hydroxy fatty acid in partially purified
prostaglandin extracts. Bergstrom and Sjovall (1957) then reported
the isolation of a prostaglandin factor (what was to be later termed
PGF) in pure crystalline form. Subsequently, Bergstrom and Sjovall
(1960a,b) were able to elucidate the structures of PGF and PGE using
X-ray crystallography, and these structures of what are now known as
PGFiQ and PGEp were later confirmed using mass spectrometry by
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Bergstrom, Ryhage, Samuelsson and Sjovall (1963). These studies
showed that prostaglandin was not a single compound but a group of
similar substances. Since these initial studies many prostaglandins
have been isolated and identified.
Chemistry and nomenclature of prostaglandins
The prostaglandins are oxygenated, unsaturated hydroxy fatty
acids with 20 carbon atoms (see Figure l.a). They possess a five-
membered ring to which two carbon chains are attached (The prostanoid
skeleton). The 'upper' and 'lower' chains are denoted a and u> and
they contain seven and eight carbon atoms, respectively. In nature,
prostanoic acid is not known to occur.
The correct chemical name for each PG can be derived from the
structure of prostanoic acid, but this produces very long names, so,
for the majority of prostaglandins, a trivial nomenclature is employed
which is briefly explained here (see Figure l.a; Andersen, 1969).
(a) The letter designated to the respective PG describes the
differences in the five-membered ring. However, thromboxanes possess
an additional oxygen atom enclosed in the ring, and PGG2 and PGH2 have
the same ring structure.
(b) The degree of unsaturation of the side chains is indicated by
the subscript number after the letter. Thus, PGE2 contains two double
bonds in the side chains. Prostaglandins of the "1" series
invariably have only one double bond in the transA^"^ position. PGs
of the "3" series have another double bond in the cisA^'l® position.
(c) The isomeric form of the hydroxyl group attached to carbon atom
number 9 in PGs of the F series (i.e. whether it is below or above the
plane of the line) is designated a and respectively.
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Figure l.a
The prostanoid skeleton and the basic structures of the different
groups of prostaglandins.
The "2" series PGs are the major PGs found in most biological
systems, except for primate seminal fluid where "1" and "2" series PGs
are found in equal quantities (Kelly, 1978). PGE2 in acidic
conditions dehydrates to form PGA2. PGA2 can be enzymatically
isomerised into PGC2 followed by PGB2 (Jones, Cammock and Horton,
1972). 19-Hydroxylated derivatives of PGE2, PGF2a, PGA2 and PGB2
have also been found.
Biosynthesis
All naturally occurring PGs and thromboxanes are synthesised
from three essential unsaturated fatty acids containing 20 carbon
atoms, that are membrane bound in cells and are usually esterified in
phospholipids. Arachidonic acid (5,8,11,14-all-cis-eicosatetraenoic
acid) is the most important and is the source of the "2" series PGs.
The other two fatty acid precursors are 8,11,14-all-cis-eicosatrienoic
acid and 5,8,11,14,17-all-cis-eicosapentaenoic acid, and these are the
precursors to the 1 and 3 series PGs, respectively. Arachidonic acid
is also present in trigylcerides and cholesterol esters, as well as
phospholipids, but arachidonic acid bound to phospholipids represents
the main source for PG synthesis and the release of arachidonic acid
is the rate-limiting step in PG synthesis (Kunze and Vogt, 1971;
Samuelsson, 1972; Hong and Levine, 1976; Flower and Blackwell, 1976;
Vogt, 1978; Blackwell and Flower, 1979; Lands, 1979).
Prostaglandin biosynthesis occurs to a greater or lesser degree
everywhere in the body. Essentially, all cell types except red blood
cells possess the ability to synthesise PGs from fatty acids
(Granstrom, 1981). The initial step in the formation of 2-series
prostaglandins from arachidonic acid is the introduction of two
molecules of oxygen at C-ll and C-15 by the enzyme prostaglandin H
synthase (PGH synthase), which requires haem and hydroperoxides for
its activity (Lands, 1979). The continued presence of hydroperoxide
appears to be required to maintain the reaction by a positive feedback
system, and small amounts of hydroperoxide seem to be required to
trigger synthesis (Lands, 1979). This PGH synthase enzyme has two
activities, fatty acid cyclo-oxygenase (which converts arachidonic
acid to PGG2) and prostaglandin hydroperoxidase (which converts PGG2
to PGH2). The cyclo-oxygenase step is readily inhibited by non¬
steroidal anti-inflammatory drugs (e.g. indomethacin and aspirin).
The endoperoxide PGH2 can then be converted into a number of PGs, e.g.
PGE2, PGD2, PGF2q, PGI2 and TXA2; the major ones synthesised depend
upon the type of cell and the synthesizing enzymes it possesses
(Samuelsson, Boldyne, Granstrom, Hamberg, Hammarstrom and Malmsten,
1978). PGI2 is labile (half-life 3-5 min) and is rapidly hydrolysed
to 6-keto - PGFqa. TXA2 is also unstable (half-life of only 30
seconds) and is hydrolysed to TXB2.
Prostaglandins are metabolised at carbon-15 by oxidation of the
secondary alcohol group into a ketone, which requires NAD+ as a co-
factor. These 15-keto-prostaglandins, especially of the F-series,
may retain much of their biological activity of their parent molecule,
but the subsequent reduction of the 13,14-double bond to 13,14-
dihydro-15-keto-prostaglandins decreases the biological activity much
more. These 13,14-dihydro-15-keto-PGs are the main circulating
metabolites of PGF2Q and PGE2, and there may be a 20-fold greater
concentration of the metabolite in the circulation when compared to
the parent molecule. Most tissues possess the ability to metabolise
PGs, but often this is quite low. However, the lungs have a very
high PG metabolising activity, and 95-99% of PGF2Q and PGE2 present in
the circulation is metabolised by one passage through the lungs
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(Ferreira arid Vane, 1967). Furthermore, the metabolism of PGs is a
two stage mechanism, involving an uptake step before the intracellular
metabolism occurs due to NAD+-dependent 15-hydroxyprostaglandin
dehydrogenase. PGF2a and PGE^ exhibit a delay in their transit times
through the pulmonary circulation, and Bito, Baroody and Reitz (1977)
suggested that this is due to internalisation for metabolism.
However, PGI2 and PGD2 are poor substrates for this uptake process.
Therefore, PGF2Q and PGE2 do not act as circulating systemic hormones
while PGI2 and PGD2 could act as circulating hormones. The half-life
of TXA2 is too short for it to be considered as a circulating hormone.
Prostaglandins are not stored in tissues, but are synthesised
and released immediately (Piper and Vane, 1971), with the exception
that PGs are stored in seminal fluid. The concentration of free
arachidonic acid in tissues is low, so before PG biosynthesis can
occur, arachidonic acid must first be released from some bound source.
The primary source of arachidonic acid is phospholipids. Arachidonic
acid is released by phospholipase A2 and intracellular phospholipase A
activities have been found in almost all cells that have been examined
(Van den Bosche, 1980). Prostaglandins and thromboxanes produced by
tissues have many actions in the body, and the significance of
prostaglandin production by the uterus has been investigated for many
years, especially in relation to luteolysis.
Uterine Luteolytic Hormone
The importance of the uterus as an endocrine organ, that could
determine the length of the oestrous cycle, was realised by Loeb in
1923. He showed that hysterectomy of the guinea-pig inhibited corpus
luteal regression, and prolonged the oestrous cycle to between 60 and
120 days. Perceptively, Loeb in 1927 wrote "It is possible that the
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uterus, in particular the mucosa, produces an internal secretion which
exerts a specific abbreviating effect on the life of the corpus
luteum". The theory that a uterine luteolytic hormone exists, which
causes the regression of the corpus luteum, was thereby proposed.
Subsequently, the removal of the uterus has been shown to
prolong luteal function in other species, including the cow (Wiltbank
and Casida, 1956; Anderson, Neal and Melampy, 1962), pig (Spies,
Zimmerman, Self and Casida, 1958), pseudopregnant rat (Bradbury,
1937), rabbit (Asdell and Hammond, 1933) and the sheep (Wiltbank and
Casida, 1956). However, in other species, including the dog (Cheval,
1934), monkey (Burford and Diddle, 1936) and human (Jones and Telinde,
1961; Beavis, Brown and Smith, 1969) hysterectomy does not appear to
affect the life-span of the corpus luteum and so the uterus exerts no
affect on cyclic ovarian function.
In many species, the uterine horn exerts an effect only on the
corpora lutea in the ipsilateral ovary, with no effect on the corpora
lutea in the contra-lateral ovary. In hemi-hysterectomised animals,
the luteolytic factor affects the corpora lutea only in the ovary
adjacent to the retained uterine horn so normal luteal regression
occurs in the ovary contra-lateral to the hemi-hysterectomy. This
effect has been shown in the sheep (Inskeep and Butcher, 1966),
guinea-pig (Bland and Donovan, 1966) and the pseudopregnant rat
(Barley, Butcher and Inskeep, 1966), and the transfer of the
luteolytic factor from the uterus to the ovary on the same side was
thought to be via the vasculature. Bland and Donovan (1966)
suggested that this apparently local activity of the uterine
luteolytic hormone precluded the involvement of the pituitary in the
luteal-ovarian relationship. In the pig, Anderson, Butcher and
Melampy (1961) showed that destruction of the endometrial layer of the
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uterus often prevented luteal regression. Subsequently, Butcher, Chu
and Melampy (1962) chemically destroyed the endometrial layer of the
guinea-pig uterus and this procedure prolonged the oestrous cycle.
It was therefore proposed that the endometrium was the source of the
uterine luteolytic hormone.
The uterine luteolytic hormone, for it to be defined as such,
must cause luteal regression as determined by histological studies
(structural luteolysis). It must also cause functional luteal
regression, indicated by a decline in plasma progesterone levels
(functional luteolysis), subsequent to its release from the uterus.
From the earliest studies up until 1969, there was little
success in isolating and identifying the uterine luteolytic hormone.
However, in 1969, PGF2Q was discovered to exhibit the same action on
the ovary as the uterine luteolytic hormone in the guinea-pig
(Blatchley and Donovan, 1969) , rat (Phariss and Wyngarden, 1969) and
rabbit (Gutknecht, Cornette and Phariss, 1969). Blatchley and
Donovan (1969) showed that the intra-peritoneal injection of PGF2Q
(0.5 mg) administered twice daily for seven days to guinea-pigs
hysterectomised on day 4 or 5 of the cycle resulted in luteal
regression. Phariss and Wyngarden (1969) infused PGF2Q into the
lumen of the pseudopregnant rat uterus on days 5 and 6 of
pseudopregnancy, and the progesterone content of the ovaries of these
animals decreased compared to saline-treated control animals. In
this experiment, PGF2Q caused morphological luteal regression, and
also functional luteal regression which was reflected in the decline
in ovarian progesterone concentrations.
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Subsequently, PGF2Q was shown to have a luteolytic effect in
other non-primate mammals, including the sheep (McCracken, Glew and
Scaramuzzi, 1970), cow (Liehr, Marion and Olsen, 1972; Lauderdale,
1972) and the pig (Gleeson, 1974).
Uterine venous blood concentrations of PGF2Q were demonstrated
to increase towards the end of the oestrous cycle, just before the
occurrence of luteal regression, in the sheep (Bland, Horton and
Poyser, 1971; McCracken, Carlson, Glew, Goding, Baird, Green and
Samuelsson, 1972), pig (Gleeson and Thorburn, 1973; Gleeson, Thorburn
and Cox, 1974), cow (Nancarrow, Buckmaster, Chamley, Cox, Cumming,
Cummins, Drinan, Findldy, Goding, Restall, Schneider and Thorburn,
1973) and guinea-pig (Blatchley, Donovan, Horton and Poyser, 1972).
The uterine venous plasma concentrations of PGF2a increased from about
day 11 of the oestrous cycle, although this timing was not absolute.
Plasma PGF2Q levels had increased significantly by day 13 and in all
these species, luteal regression was generally complete by days 16 to
18. Uterine venous plasma levels of PGF2Q were high throughout this
period of luteal regression.
Bland and Donovan (1966) inserted glass beads into the lumen of
the guinea-pig uterus on days 2 to 4 of the oestrous cycle, and this
advanced the occurrence of luteal regression to between days 9 and 11
of the cycle. Subsequently, Blatchley, Donovan and Poyser (1976)
recorded in these animals with intra-uterine beads an increase in
utero-ovarian venous plasma concentrations of PGF2Q by day 8, and
which peaked on day 12 when utero-ovarian venous plasma progesterone
levels were reduced. This demonstrated that premature luteal
regression induced by intra-uterine beads is associated with the
premature release of PGF2Q from the uterus. A similar effect of
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intra-uterine inserts on increasing uterine PGF2Q production also
occurred in the sheep (Spilman and Duby, 1972), rat and hamster
(Saksena, Lau and Castracane, 1974).
Further evidence to demonstrate that PGF2Q is the uterine
luteolytic hormone includes active immunisation against PGF2Q, where
the antibodies produced probably neutralise PGF2a released from the
uterus into the circulation. Horton and Poyser (1974a) actively
immunised guinea-pigs against PGF2Q and the oestrous cycles of animals
with high anti-PGF2Q titres were more prolonged compared to animals
with lower antibody titres. Immunisation against PGF2a also
prevented luteal regression in sheep (Scaramuzzi, Baird, Wheeler and
Land, 1973).
The prevention of luteal regression by inhibiting uterine PGF2a
luteal synthesis is further evidence that PGF2Q is the uterine
luteolytic hormone. The inhibitor of PG synthesis, indomethacin,
which inhibits the cyclo-oxygenase component of PGH synthase (Vane,
1971) was used in a slow release preparation placed in the lumen of
the guinea-pig uterus (Horton and Poyser, 1973). This local
administration of indomethacin greatly prolonged oestrous cycle
length. Subsequently, Poyser and Horton (1975) demonstrated that
this effect was due to the prevention of luteal regression as shown by
the maintenance of high plasma progesterone levels.
To reiterate the evidence that PGF2Q causes luteal regression:
i. Administration of PGF2Q causes luteal regression and mimics the
luteolysin action of the uterine luteolysis in vivo.
ii. PGF2q is present in the uterine vein in increasing amounts
towards the end of the cycle, preceding luteolysis.
iii. Stimulation of PGF2a output (e.g. by the insertion of intra¬
uterine devices or beads) causes premature luteal regression.
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iv. Immunisation against PGF2Q prolongs the luteal lifespan.
v. Inhibition of PGF2Q synthesis by indomethacin also prolongs the
luteal lifespan.
These results show that PGF2Q is the uterine luteolytic hormone,
but how is the PGF2Q produced by the uterus transported to the ovary
to exert its luteolytic effect ?
The transfer of PGF-?^ from the uterus to the ovary
Bland and Donovan (1969) showed that ligation of the vascular
tissue to the uterus and ovaries in guinea-pigs resulted in
maintenance of the corpora lutea. However, ligation of the oviduct
had no effect on luteal regression (Oxenreider and Day, 1967; Bland
and Donovan, 1969) . These findings implicated the vascular system as
the means of transport of PGF2Q from the uterus to the ovary. In the
sheep, ligation experiments on the uterine vasculature showed that the
luteolytic factor in uterine venous blood must pass into the ovarian
vein for luteolysis to occur (McCracken, Carlson, Glew, Goding, Baird,
Green and Samuelsson, 1972). The ovarian artery runs over the
surface of the utero-ovarian vein. Barrett, Blockey, Brown, Cumming,
Goding, Mole and Obst (1971) showed that separation of the ovarian
artery from the utero-ovarian vein prevented corpus luteum regression,
and they proposed a counter - current mechanism of transfer of PGF2Q
from the vein to the artery. Subsequently, McCracken, Carlson, Glew,
Goding, Baird, Green and Samuelsson (1972) infused [-^H]-PGF2Q into the
sheep uterine vein, before its confluence with the utero-ovarian vein,
on day 14 of the oestrous cycle. Simultaneously, blood samples were
taken from the ovarian artery and the iliac artery, and a small
increase in the amount of the radiolabel was measured in the blood
from the ovarian artery after 20 min, but not in the iliac artery, and
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the peak of radioactivity in the ovarian artery occurred after a
further 20-30 min. This showed a time lag in the transfer of the
[^H]-PGF2q from the utero-ovarian vein to the ovarian artery. From
these studies it was estimated that the amount of PGF2Q transferred by
the counter-current transfer process was in excess of 5%. Horton and
Poyser (1972) pointed out that the efficiency of transfer of PGF2a
must be quite low because if this counter-current mechanism of PGF2a
from vein to artery was too efficient, the levels of PGF2a in the
system would increase and remain high due to the inability of the
local tissues to metabolise prostaglandins. Indeed, if the transfer
process were 100% and the metabolism were nil, PGF2a would pass
through the ovary ad infinitum. The PGF2a that is not retained by
the counter-current mechanism could pass into the systemic circulation
and be inactivated by the lungs (Ferreira and Vane, 1967).
Subsequently, the estimated amounts of radiolabelled PGF2Q transferred
from the uterine vein into the ovarian artery in the sheep were
estimated by Land, Baird and Scaramuzzi (1976) to be 0.1 - 0.56%, and
by Heap, Fleet and Hamon (1985) to be 0.3%. This counter-current
mechanism has also been demonstrated in the cow (Hixon and Hansel,
1974).
The vasculature of the guinea-pig, rat, hamster and pig is so
arranged to allow a counter-current mechanism similar to that proposed
for the sheep (Del Campo and Ginther, 1972 and 1973). However, Egund
and Carter (1974) could not find very close contacts between the
ovarian artery and utero-ovarian vein in the guinea-pig. Furthermore,
the uterine vasculature and the ovarian vasculature are independent in
the rabbit (Hunter and Casida, 1967) and horse (Del Campo and Ginther,
1973), so a counter - current mechanism cannot explain this transfer of
PGF2a from the utero-ovarian vein into the ovarian artery in these two
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species. Therefore, there may be species differences in the mode of
transfer of PGF2Q from uterus to ovary, or an alternative mechanism
may exist. Hansel, Concannon and Lukaszewska (1973) suggested that
part of the luteolytic factor may leave the uterus via the lymphatic
system. Recently, a counter - current transfer system for PGF2a has
been proposed in the pig (Kotwica, 1980) and sheep (Staples, Fleet and
Heap, 1982), between the lymph vessels and the ovarian artery due to
the proximity of these vessels. The concentration of PGF2a in
J
uterine lymph was shown to be low during the first two-thirds of the
oestrous cycle in the non-pregnant sheep, and then to increase after
day 12 (Abdel Rahim, Bland and Poyser, 1983). Heap, Fleet and Hamon
(1985) showed that [^H]-PGF2a infused into a uterine lymph vessel was
recovered from the ovarian blood in the sheep. Heap, Fleet and Hamon
(1985) estimated that the efficiency of [^H]-PGF2Q transfer from a
lymphatic vessel into ovarian blood (0.4%) was similar to that from a
uterine vein (0.3%) into ovarian blood. Clearly, the lymphatic and
vascular system possess the potential to transfer the luteolytic
hormone to the ovarian vasculature of the sheep. In the sheep, Abdel
Rahim, Bland and Poyser (1984) inserted a glass cannula into the
uterine branch of the utero-ovarian vein of the sheep, and isolated
the uterus and ovary from any other tissue contact. Luteal function
was extended, and it was concluded that the transfer of PGF2a solely
from uterine venous blood is not sufficient to cause luteolysis. The
lymphatic system also appears necessary in the transfer of PGF2a to
the ovary in the sheep (Abdel Rahim, Bland and Poyser, 1984). This
alternative method of transfer of PGF2a via the lymphatic vessels may
explain the anatomical differences that do not appear to allow a
counter-current mechanism within the vascular system, for instance in
the horse (Del Campo and Ginther, 1973) and the lymph may contribute
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to the transfer of PGF2a to the ovary in other species that also
process a counter-current vasculature system. Interestingly,
Krzymowski, Czarnocki, Koziorowski, Kotwica and Stefanczyk-Krzymowska
(1986) reported that the vasculature of the pig uterus exhibited a
mechanism of [^H]-PGF2Q uptake by the mesometrium and its back
transfer to the uterus. This mechanism was active when corpora lutea
function was maintained, and strongly suppressed when luteal
regression was occurring.
Transfer of PGF2Q via the uterine lymphatic system as well as
the uterine vascular system to the ovarian artery is the mechanism of
transfer of PGF2Q from the uterus to the ovary in the sheep enabling
the uterus to exert its control on the function of the corpora luteum.
It is also interesting to speculate whether a back-transfer system as
reported in the pig, exists in the guinea-pig, sheep and other
animals, and the degree of control this back transfer system exerts on
luteal function.
The next section examines how the release of the uterine
luteolytic hormone for transfer to the ovary to exert its effect on
the corpus luteum is controlled and stimulated at the appropriate
stage in the cycle.
The mechanism by which PGFpr, causes luteal regression
Prostaglandin F2Q possesses potent vasoconstrictor properties
(DuCharme, Weeks and Montgomery, 1968). It was proposed that PGF2a
may cause reduced blood flow to the ovary, or more specifically to the
corpus luteum, causing luteolysis due to anoxia (Pharriss and
Wyngarden, 1969; Phariss, Cornette and Gutnecht, 1970). Luteal
tissue was shown to have a very high blood flow in sheep (Thorburn and
Hales, 1972), with total ovarian blood flow greatest at times when
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functional corpora lutea are present. Both luteal and ovarian blood
flow rates were shown to decrease around the time of luteal regression
(Niswender, Moor, Akbar, Nett and Diekman, 1975). Niswender,
Reimers, Diekman and Nett (1976) concluded that blood flow to the
corpus luteum may be important in the regulation of luteal function,
including changes occurring during luteal regression. However,
McCracken, Glew and Scaramuzzi (1970) and Baird (1974) could not show
a decline in blood flow preceding the fall in progesterone secretion
during luteal regression in the sheep. Subsequently, Einer-Jensen
and McCracken (1977) observed that progesterone output decreased from
the corpus luteum before the decrease in luteal blood flow. In the
guinea-pig, Hossain, Lee, Clarke and O'Shea (1979) using radioactive
microspheres demonstrated that ovarian and luteal blood flow were high
at least until day 12 of the oestrous cycle. These results were in
agreement with a study by Sjoquist, Bjellin and Carter (1977) in the
guinea-pig. Ovarian and luteal blood flow fall rapidly and to a
large extent during the period when progesterone secretion is
declining towards the end of the oestrous cycle of the guinea-pig,
although there was no evidence to suggest that the fall in luteal
blood flow preceded the fall in plasma progesterone concentrations
(Hossain, Lee, Clarke and O'Shea, 1979). O'Shea, Nightingale and
Chamley (1977) suggested that this reduced luteal blood flow,
occurring later when plasma progesterone levels are already in
decline, may be caused by small luteal capillaries becoming blocked by
cell debris, and not by a constrictor action of PGF2Q. Clearly,
whether PGF2a is or is not involved in the control of luteal blood
flow, vasoconstriction is not the initial stimulus for luteal
regression, but is only a secondary and possibly contributory effect.
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Luteal regression is caused by PGF2Q in the sheep, cow, pig,
guinea-pig, pseudopregnant rat and many other non-primate mammalian
species; in primates PGF2Q causes luteal regression in monkeys, but
not in women (see Horton and Poyser, 1976). However, PGF2a does not
cause luteolysis early in the lifespan of the corpora lutea.
Luteolysis is caused by PGF2Q after day 5 in the cow, sheep, mare, and
rat, after day 10 in the guinea-pig, and after day 12 in the pig.
Clearly, there is a "developmental stage" early in the life of the
corpus luteum which must occur before structural luteal regression can
take place.
The presence of PGF2Q binding sites (receptors) on the luteal
cell membranes of the corpus luteum have been shown in the sheep
(Powell, Hammerstrom and Samuelsson, 1974), cow (Rao, Carmon and
Gorman, 1978), rat (Wright, Luborskymoore and Behrman, 1979) and the
mare (Kimball and Wyngarden, 1977) . In the cow, the binding of PGF2a
to corpora lutea increases during the cycle due to an increase in the
affinity of the binding sites for PGF2Q; maximum affinity occurs
during luteal regression (Rao, Estergreen, Carmon and Mass, 1979).
In the pseudopregnant rat, the binding of PGF2Q to corpora lutea
membranes increases to a maximum on day 7 and then slowly declines
after day 9, which is before luteal regression occurs (Brambaifa and
Schillinger, 1984). In the mare, there is no apparent correlation
between the binding of PGF2Q and the stage of the cycle (Kimball and
Wyngarden, 1977). It seems that the affinity of binding sites
(receptors) for PGF2a, or the number of receptors, or a combination of
both factors may be involved in controlling luteal regression.
Luteinising hormone (LH) binds to its receptor and activates
adenylate cyclase to cause an increase in cyclic adenosine 5'-
monophosphate (cAMP) production, which stimulates luteal progesterone
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formation and release. This LH-induced increase in cAMP production
is prevented by PGF2Q in rat corpora lutea within 15 min (Lahav, Freud
and Lindner, 1976), and in sheep luteal cells (Fletcher and Niswender,
1982). LH binds to its binding sites (receptors) and in turn these
bound receptors join together. These LH receptor aggregates appear
necessary for the activation of adenylate cyclase and cAMP production
(Luborsky, Slater and Behrman, 1984). PGF2a inhibits LH receptor
movement within the membrane, so preventing LH receptor aggregation
and the stimulation of adenylate cyclase (Luborsky, Slater and
Behrman, 1984). Progesterone production is therefore reduced. In
the rat (Behrman, Grinwich, Hichens and MacDonald, 1978), sheep
(Diekman, O'Callaghan, Nett and Niswender, 1978) and pig (Barb,
Kraeling, Rampacek and Pinkert, 1984), PGF2Q appears to reduce LH
binding to its receptor. However, when luteal cells receive a pulse
of LH, binding of LH to these cells increases within 2h ('up
regulation'), due to the appearance in the membrane of receptors that
are not initially available to bind LH. Luborsky, Dorflinger, Wright
and Behrman (1984) proposed that PGF2Q prevents this 'up-regulation'
of LH receptors. Therefore, PGF2Q does not prevent LH binding to its
receptor, but PGF2Q decreases the overall binding of LH, due to it
preventing the appearance of new LH receptors. Eventually, LH
receptors are no longer present in the luteal cell membrane for the
binding of LH. Are the effects of PGF2Q in inhibiting the mobility
of LH-binding sites in the membrane and in preventing LH binding to
its receptor caused by the same action ?
Treatment of rat luteal cells with the calcium ionophore A23187,
which increases the free intracellular Ca^+ concentration, causes the
inhibition of LH-stimulated cAMP production and also inhibits directly
LH-sensitive adenylate cyclase (Dorflinger, Albert, Williams and
Behrman, 1984). PGF2a stimulates the phosphatidylinositol (PI) cycle
in rat luteal membranes (Raymond, Leung and Labrie, 1983), and
inositol 1,4,5-trisphosphate (IP3) produced from phosphatidylinositol
4,5-bisphosphate mobilises intracellular Ca^+ (Berridge, 1984).
Therefore, in luteal cells PGF2Q can release Ca^4" from intracellular
stores by the stimulation of this second messenger system. Protein
phosphorylation is also stimulated by increased turnover of the PI
cycle, due to the stimulation of protein kinase C by diglyceride
(Berridge, 1984). PGF2a-induced luteal regression is associated with
increased membrane rigidification, and this change is calcium,
calmodulin and protein dependent (Riley and Carlson, 1985). It was
suggested that membrane proteins are phosphorylated by a calcium-
dependent, calmodulin-modulated mechanism, causing membrane
rigidification, and that this prevents the movement and appearance of
LH receptors and hence LH binding to its receptor in the luteal
membrane.
In the pig (Lemon and Moir, 1977) cow (Ursely and Leymarie,
1979), and sheep (Fitz, Mayan, Sawyer and Niswender, 1982), luteal
cells are classified into two groups, namely the 'small' and 'large'
cell types. Both groups of cells secrete progesterone, but the large
luteal cell type secretes more progesterone than the small luteal cell
type. However, there are apparently more small luteal cells present
than large luteal cells, so the amount of progesterone secreted by
each cell type is similar (Rodgers, O'Shea and Findlay, 1984).
Progesterone secretion in small luteal cells is dependent on LH and
cAMP. Dibutyryl-cAMP and agents that activate adenylate cyclase, for
instance cholera toxin and forskolin stimulate progesterone production
in small luteal cells (Hoyer, Fitz and Niswender, 1984). However, in
large luteal cells, progesterone secretion is independent of LH and
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cAMP (Niswender, Schwall, Fitz, Farin and Sawyer, 1985). Treatment
of large luteal cells with cholera toxin or forskolin enhances the
occupancy of cAMP-dependent protein kinase by cAMP (Niswender and
Hoyer, 1985) but there is no resultant stimulation of progesterone
production. This may be due to progesterone production by large
luteal cells not being controlled by cAMP. Another possible
explanation may be that progesterone secretion by large luteal cells
cannot be further stimulated (Niswender, Schwall, Fitz, Farin and
Sawyer, 1985). Furthermore, small luteal cells in sheep corpora
lutea have few PGF2Q receptors. The majority of PGF2Q binding sites
are found on large luteal cells (Fitz, Mayan, Sawyer and Niswender,
1982). Also, a greater proportion of small luteal cells are present
early in the luteal lifespan, and large luteal cells increase in
prevalence later in the oestrous cycle. This may explain the lack of
effect of PGF2a early in the oestrous cycle (Fitz and Sawyer, 1982).
Niswender, Schwall, Fitz, Farin and Sawyer (1985) proposed that LH
might stimulate the differentiation of small luteal cells into large
luteal cells. However, O'Shea, Rodgers and Wright (1986) examined the
numbers and size of large and small ovine luteal cells. They
discovered that there were fewer large luteal cells per unit volume on
day 13 than on day 9, but that the mean volume of the large luteal
cells was smaller on day 9 than on day 13. The total numbers of
large luteal cells did not change, so small cells do not appear to
differentiate into large luteal cells.
As the oestrous cycle progresses, the large luteal cells
increase in volume and predominate over the small luteal cells. The
large luteal cells possess PGF2Q receptors and treatment with PGF2a
results both in morphological changes in the large luteal cells,
including extrusion of the cytoplasmic contents, and in functional
changes as the production of progesterone is inhibited (Fitz, Mock,
Mayan and Niswender, 1984). Fitz, Mock, Mayan and Niswender (1984)
proposed that 'PGF2Q induces the large luteal cells to release a toxin
which must accumulate to critical levels before exhibiting its
inhibitory influence on large luteal cell morphology and function' and
presumably this 'toxin' also acts on small luteal cells.
Therefore, PGF2Q causes both functional and structural luteolysis.
PGF2q may also directly inhibit cAMP-induced progesterone
production by the corpus luteum of the rat (Jordan, 1981) and cow
(Pate and Condon, 1984) by inhibiting the enzymes involved in
progesterone synthesis, including cholesterol esterase (which converts
cholesterol esters stored in lipid droplets into free cholesterol) and
cholesterol ester synthetase (Torday, Jefcoate and First, 1980). In
the hysterectomised guinea-pig, PGF2Q causes a 50% inhibition of the
conversion of pregnenolone to progesterone and reduces the activation
of cholesterol esterase (but not of cholesterol ester synthetase) and
of 3/9-hydroxy-steroid-dehydrogenase (Dwyer and Church, 1979a, b).
Furthermore, oestradiol has been suggested by Hixon, Gengenbach and
Hansel (1975) to be required for luteolysis because, when sheep
ovarian follicles are destroyed, PGF2Q induced luteolysis is
prevented.
PGF2Q produced by the uterus is therefore capable of inducing
functional and structural luteolysis in many non-primate species. But
how is PGF2q synthesis by and release from the uterus stimulated in
order to cause luteolysis at the appropriate stage in the oestrous
cycle ?
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The physiological stimulus for PGF?^ synthesis by the uterus
Oestrogen treatment of guinea-pigs on days 4 to 6 of the oestrous
cycle caused premature luteal regression, and shortening of the
oestrous cycle (Choudary and Greenwald, 1968; Bland and Donovan,
1968). Subsequently, by measuring the utero- ovarian plasma
concentrations of PGF2a, Blatchley, Donovan, Horton and Poyser (1972)
showed that oestradiol treatment on days 4 to 6 caused an early
release of PGF2Q from the guinea-pig uterus. They proposed that
endogenous oestradiol released by the developing ovarian follicles
after day 10 of the cycle was the physiological stimulus for uterine
PGF2q synthesis.
In the guinea-pig, oestradiol concentrations in the ovarian
venous plasma increased on day 10 of the oestrous cycle (Joshi, Watson
and Labhsetwar, 1973), just before uterine PGF2Q synthesis is
stimulated as indicated by measuring PGF2Q concentrations in the
utero-ovarian plasma (Blatchley, Donovan, Horton and Poyser, 1972;
Earthy, Bishop and Flack, 1975). In the sheep, maximum plasma
oestradiol concentrations occur between days 10 and 12 of the oestrous
cycle, just before the stimulation of uterine PGF2Q synthesis (Cox,
Thorburn, Currie and Restall, 1974). It appears from this evidence
that oestradiol may be the stimulus for uterine PGF2Q synthesis.
To test this hypothesis, Blatchley and Poyser (1974) treated
ovariectomised guinea-pigs with progesterone and/or oestradiol to
mimic the ovarian steroid concentrations in intact animals, and to
investigate the role of each steroid alone. Progesterone treatment
produced a utero-ovarian venous plasma PGF2Q concentration of 3.7 +
0.5 ng/ml (n = 5), which is similar to concentrations between day 3
and day 10 of the oestrous cycle (Blatchley, Donovan, Horton and
Poyser, 1972; Earthy, Bishop and Flack, 1975). Oestradiol treatment
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produced a utero-ovarian venous plasma concentration of PGF2Q of 12.0
± 5.3 ng/ml, but only two of the six animals exhibited PGF2Q
concentrations that were higher than those receiving the progesterone
treatment. However, animals which were treated with progesterone for
7 days followed by oestradiol and progesterone simultaneously for
three days had increased uterine venous plasma concentrations of PGF2Q
of 34.5 ± 16.7 ng/ml. Therefore, oestradiol acting on a
progesterone-primed uterus was proposed as the optimum combination of
the ovarian steroids for maximum stimulation of PGF2a output from the
guinea-pig uterus (Blatchley and Poyser, 1974). Antonini, Turner and
Pauerstein (1976) showed that PGF2Q output from the guinea-pig uterus
in vivo increased without any change on PGE2 output. Subsequently,
Poyser (1983b) investigated the effect of oestradiol and progesterone
treatment of ovariectomised guinea-pigs on the outputs of PGF2a, PGE2
and 6-keto-PGFqa (the stable metabolite of PGI2) from guinea-pig
uterine horns superfused in vitro. The outputs of all three PGs from
uteri of ovariectomised guinea-pigs were low (0.2 ng/min/uterine
horn). Progesterone treatment had no significant effect on PG
output. Oestradiol treatment significantly stimulated PGF2a output
7-fold, but only increased PGE2 output 1.7-fold and 6-keto-PGFqQ
output 2.9-fold. However, progesterone priming of the uterus
followed by oestradiol treatment caused a further 2-fold increase in
PGF2q output, but with no significant action on the outputs of PGE2
and 6-keto-PGFqQ, when compared to the PG outputs from uteri removed
from oestradiol-treated guinea-pigs (Poyser, 1983b). This study
showed that oestradiol acting on a progesterone-primed uterus caused
the relatively specific stimulation of uterine PGF2Q output that is
seen towards the end of the oestrous cycle of the guinea-pig.
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In ovariectomised sheep, exogenous progesterone treatment for
seven days significantly increased uterine venous plasma PGF2q
concentrations (Scaramuzzi, Baird, Boyle, Land and Wheeler, 1977).
However, progesterone treatment for fourteen days caused a decrease in
PGF2a output from the sheep uterus compared to the output after seven
days of treatment. Ottobre, Lewis, Thayne and Inskeep (1980) showed
that early treatment of sheep with progesterone on days 0 and 1 of the
cycle advanced the time of occurrence of the initial increases in
uterine PGF2q output to day 8 compared to day 12 in control animals.
From these findings, they proposed that a period of progesterone
secretion controls the timing of the initial rises in uterine PGF2a
output. McCracken (1980) infused ewes with progesterone for ten days
starting immediately after oestrus, and recorded a stimulation of
uterine PGF2Q output in peaks of low magnitude on days 9 or 10 of
treatment. Also, Lawson and Cahill (1983) demonstrated that the
preparation of the uterus for pregnancy was advanced by early
progesterone treatment, allowing successful embryo transfer of day 10
embryos on day 6 of progesterone treatment.
The output of PGF2q from the sheep uterus was increased by
oestradiol treatment after several days of exogenous or endogenous
progesterone treatment (Scaramuzzi, Baird, Boyle, Land and Wheeler,
1977; Barcikowski, Carlson, Wilson and McCracken, 1974). In the
sheep uterus autotransplanted in the neck and infused with oestradiol
in vivo, PGF2q output was stimulated after 60-90 min (Barcikowski,
Carlson, Wilson and McCracken, 1974). However, there is still some
controversy concerning the exact role of the ovarian steroids in the
stimulus of uterine PGF2q output from the sheep, because Baird, Land,
Scaramuzzi and Wheeler (1976) and Ottobre, Lewis, Thayne and Inskeep
(1980) found no relationship between the initial rises in PGF2a output
and the increases in oestradiol levels in venous plasma.
Furthermore, when follicles in the sheep ovary were destroyed to
remove the main source of oestradiol, luteal regression was only
delayed (Warren, Hawk and Bolt, 1973) and antisera to oestradiol did
not delay luteal regression in the sheep (Fairclough, Smith and
Peterson, 1976). Therefore, a rise in plasma oestradiol
concentrations may not be necessary for the stimulation of PGF2a by
the sheep uterus to cause luteal regression.
Kindahl, Lindell and Edquist (1981) showed in heifers that
progesterone implants placed on day 12, just after the increase in
uterine PGF2Q output had begun, caused the maintenance of PGF2a output
until the implants were removed. After removal (on day 26), plasma
progesterone concentrations dropped and the animals ovulated two days
later. Therefore, in vivo progesterone appears to play an important
role in the control of the duration of uterine PGF2a synthesis.
Progesterone treatment in vitro inhibited PGF2Q output from both
proliferative and secretory human endometrium in organ culture (Cane
and Villee, 1975; Abel and Baird, 1980), although the results of
Tsang and Ooi (1982) only showed an inhibitory effect of progesterone
on human proliferative endometrium in organ culture. Schatz,
Markiewicz, Barg and Gurpide (1985) showed an inhibitory effect of
progesterone on both human proliferative and secretory endometrium in
organ culture, but the inhibitory effect was more marked on
proliferative endometrium. Oestradiol treatment of human endometrium
in organ culture exhibited a stimulatory effect, that was overcome by
progesterone treatment (Abel and Baird, 1980; Schatz, Markiewicz,
Barg and Gurpide, 1985). Leaver and Seawright (1982) showed
progesterone treatment inhibited PGF2Q output from both day 7 and day
15 guinea-pig endometrium in organ culture (days of low and high PGF2Q
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output, respectively). The inhibitory effect occurred on day 2 of
culture after a preincubation period of one day when no treatment was
administered. Furthermore, oestradiol treatment significantly
stimulated PGF2Q output, an effect that was greater on day 7 than day
15 (Leaver and Seawright, 1982).
However, when the guinea-pig uterus was superfused in vitro and
treated with oestradiol or progesterone, no change in PGF2q. output was
observed (Poyser and Brydon, 1983). This finding was confirmed using
the same preparation by Poyser (1987b). There is evidently some
controversy as to the Ln vitro effects of oestradiol and progesterone
treatment when comparing the actions of these steroids on PG
production by superfused uteri and cultured endometrium of the guinea-
pig. The effect of these hormones must be further examined not only
on PGF2q output, but also on PGE2 and 6-keto-PGF^a outputs.
Nevertheless, the evidence indicates that, i.n vivo, oestradiol acting
on a progesterone-primed uterus is the physiological stimulus for
increasing PGF2q synthesis and release from the guinea-pig uterus.
The infusion of oxytocin into the uterine arterial supply of the
sheep stimulated PGF2a release from the uterus after treatment on day
14 of the oestrous cycle (Roberts, Barcikowski, Wilson, Skarnes and
HcCracken, 1975). Oxytocin has also been shown to stimulate release
of PGF2q in the rat (Campos, Liggins and Seamark, 1980) and the rabbit
(Small, Gavagan and Roberts, 1978). Oxytocin from the ovary is also
necessary for increasing uterine PGF2Q output in the goat (Cooke and
Homeida, 1982; Cooke and Homeida, 1985) and probably the cow (Wathes,
Swann, Birkett, Porter and Pickering, 1983). In the sheep,
immunisation against oxytocin delays luteal regression (Sheldrick,
Mitchell and Flint, 1980), but the endometrium only becomes responsive
to oxytocin after plasma progesterone levels have started to decrease
(Roberts, McCracken, Gavagan and Soloff, 1976; Sheldrick and Flint,
1985) because progesterone seems to prevent the increase in oxytocin
receptor numbers that is induced by oestradiol. Therefore, in the
sheep, oestradiol acting on a progesterone primed uterus causes an
initial increase in endometrial PGF2Q output. The endometrial
responsiveness to oxytocin only occurs after plasma progesterone
concentration have started to decline, so oxytocin is involved in the
maintenance of uterine PGF2Q output in the sheep.
In the guinea-pig, there are conflicting reports concerning the
role of oxytocin in the stimulation of uterine PGF2a output. Leaver
and Seawright (1982) reported that oxytocin stimulated PGF2Q output
from day 15 guinea-pig endometrium in culture. However, Poyser and
Brydon (1983) could find no stimulatory effect of oxytocin on PGF2Q
output from either the day 7 or day 15 guinea-pig uterus superfused in
vitro. Furthermore, Donovan (1961) found no effect of oxytocin on
oestrous cycle length when injected into the guinea-pig. The role of
oxytocin in the control of uterine PGF2Q synthesis and release appears
to exhibit species differences. Also, this report by Leaver and
Seawright (1982) of oxytocin stimulating PGF2a output in the cultured
guinea-pig endometrium must be re-examined.
The pattern of release of PGF?^ output by the uterus
The output of PGF2Q from the uterus occurs in pulsatile surges in
the sheep (McCracken, Carlson, Glew, Goding, Baird, Green and
Samuelsson, 1972; Thorburn, Cox, Currie, Restall and Schneider, 1972),
cow (Nancarrow, Buckmaster, Chamley, Cox, Cumming, Cummins, Drinan,
Findlay, Goding, Restall, Schneider and Thorburn, 1973) and pig
(Gleeson and Thorburn, 1973; Gleeson, Thorburn and Cox, 1974). To
obtain the precise pattern of PGF2Q release, samples of plasma must be
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collected very frequently. Kindahl, Lindell and Edquist (1981)
collected hourly plasma samples from the jugular vein of heifers, and
measured the concentration of the main circulatory metabolite of PGF2Q
(13,14-dihydro-15-keto-PGF2Q). The PGF2a metabolite showed a complex
pattern of pulses of l-5h duration during a 2-3 day period. Plasma
PG metabolite levels increased prior to the decrease in plasma
progesterone levels (Kindahl, Lindell and Edquist, 1981). Therefore,
PGF2q appeared to initiate luteolysis. Kindahl, Lindell and Edquist
(1981) observed a relationship between the plasma concentrations of
the PGF2q metabolite and progesterone, because after each PGF2Q
metabolite peak occurred, the plasma progesterone concentration
decreased in a stepwise pattern. The inhibitory action of PGF2Q on
progesterone production was very rapid (McCracken, Carlson, Glew,
Goding, Baird, Green and Samuelsson, 1972).
Infusions of PGF2a were given directly into the arterial supply
of the ovary autotransplanted to the neck in sheep (Schramm, Bovaird,
Glew, Schramm and McCracken, 1983) . It was discovered that four
separate, hour-long infusions of PGF2Q (0.04 - 0.08^g/ml) given over
19h caused permanent luteal regression in only one of four animals,
but the addition of a fifth and similar infusion of PGF2Q (5 doses in
25h) caused permanent luteal regression in four out of four animals.
A single daily infusion of PGF2a for" four consecutive days caused a
temporary fall in plasma progesterone levels after each daily "pulse"
followed by a recovery. Permanent corpus luteal regression did not
occur with this daily, long term pulsatile administration of PGF2Q.
A relatively short pulse frequency of PGF2Q administration is
therefore required in order to cause luteal regression in sheep.
These ultra-low amounts of PGF2Q administered in a pulsatile manner
were proposed to be comparable with the quantitative estimates of the
amounts of PGF2Q exchanged by the counter-current vascular system in
the sheep (McCracken, Schramm and Okulicz, 1984), and were
approximately one-fortieth of the amounts of PGF2a (2.5/ig/ml)
required to cause luteolysis when given as a continuous infusion for
6-19h into the sheep ovarian artery (McCracken, Barcikowski, Carlson,
Green and Samuelsson, 1973) .
To date, it has proved impossible to examine the pattern of PGF2Q
release in the smaller animals (e.g. guinea-pig and rat) due to the
difficulties in sampling. It is not known whether this pulsatile
pattern of PGF2Q release is a feature of the control of luteolysis in
these smaller animals.
Mechanisms by which steroid hormones control uterine PGF?^ synthesis
1. Oestradiol
The action of oestradiol in stimulating PGF2Q synthesis may be
due to its effect on controlling protein synthesis. Recently, there
has been some controversy as to the mechanism by which oestradiol
binds to its receptor. Prior to 1984, the model proposed by Jensen,
Suzuki, Kawashima, Stumpf, Jungblat and DeSombre (1968) was generally
accepted. In this two-step model, oestradiol diffuses into the
cytoplasm where it binds to the oestrogen receptor. The oestrogen
receptor was thought to be a cytosolic protein because it is recovered
in the supernatant after homogenisation. The oestrogen receptor -
oestradiol complex becomes activated and translocates to the nucleus
where it binds to chromatin and induces specific mRNA synthesis.
Szego (1974) proposed a model where oestradiol is captured by plasma
membrane associated oestrogen receptors and the oestrogen receptor -
oestradiol complexes are then internalised by pinocytosis and
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transferred to the nucleus. However, little conclusive evidence has
been found showing membrane bound oestrogen-receptors using recent
techniques (Nelson, Clarke and Murphy, 1986).
Gorski, Welshons and Sakai (1984) proposed "the nuclear model of
oestrogen receptor action", because immunocytochemical (King and
Green, 1984) and enucleation experiments (Welshons, Lieberman and
Gorski, 1984) suggested that the oestrogen receptor is situated in the
nucleus, and that the binding of oestradiol to the oestrogen receptor
and the activation of the oestrogen receptor - oestradiol complex
occurs within the nucleus. Cytosolic oestrogen receptors were
thought to be an extraction artifact. All the reports agreed that
free oestrogen receptors have a low affinity for the nucleus, and that
their dissociation rates were rapid relative to those of hormone-
receptor complexes. Due to the high concentration of DNA in
mammalian nuclei and due to receptors binding to genomic sites, a
distribution of oestrogen receptors that is predominantly in the
nucleus in intact cells may be expected, even for hormone-free
receptors with a low affinity for the nucleus (Yamamoto, 1985). It
may also be expected that a small fraction of receptors are
transiently cytoplasmic or associated with the membrane and are
available to bind hormone (Yamamoto, 1985). Nelson, Clarke and
Murphy (1984) examined the techniques used and suggested that none of
the models could be discarded until unequivocal evidence is produced
in support of a subcellular location of the oestrogen receptor at all
times.
In the rat, early responses to oestradiol occur within a few
hours of binding to the oestrogen receptor. These include the
synthesis of specific proteins, for instance oestrogen-induced uterine
protein (IP), and the synthesis of a 49 kDa protein within 2h (Kumar,
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O'Connor, Seeger, Beach and Dickerman, 1983). Komm, Rusling and
Lyttle (1986) demonstrated increased production of two proteins (115
and 65 kDa) within 6h of a single injection of oestradiol.
Similarly, oestradiol increased the activity of the enzymes ornithine
carboxylase in the rat uterus (Rourke, Kendra and Katzenellenbogen,
1984), and of hydrolase (Katz, Finlay, Tom and Levitz, 1984) and
arginine esteropeptidase in the mouse uterus (Henrikson, Jazin and
Dickerman, 1987).
French and Casida (1973) demonstrated the importance of protein
synthesis in the control of PGF2a output from the uterus. The
administration of actinomycin D (500/ug) into the uterine lumen of the
sheep on day 11 of the oestrous cycle prevented luteal regression.
Furthermore, when actinomycin D treatment was administered only to one
uterine horn, and transfer via the lumen to the other horn was
prevented, luteal regression occurred only in the ovary ipsilateral to
the non-treated horn. Therefore, the stimulation of DNA-dependent
RNA synthesis, which is inhibited by actinomycin D, was necessary for
the stimulation of the production of the luteolytic hormone from the
sheep uterus. Castracane and Jordan (1976) found that actinomycin D
administered systemically did not prevent PGF2Q release from the rat
uterus. Subsequently, Poyser (1979) demonstrated in the guinea-pig
that the systemic administration of actinomycin D had no effect on
luteal lifespan and by inference, had no effect on uterine PGF2Q
release. However, Poyser (1979) also demonstrated that intra-uterine
administration of actinomycin D (lOpg/uterine horn) on day 10
increased oestrous cycle length in the guinea-pig. Plasma
progesterone concentrations remained high during these extended
cycles, presumably due to an increase in luteal life-span. pgf2q
production by uterine homogenates in vitro was decreased on day 15
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after intra-uterine actinomycin D treatment, and it was proposed that
actinomycin D prevented the increase in uterine PGH synthase levels
that occurs towards the end of the cycle. These effects of
actinomycin D were not overcome by exogenous oestradiol treatment
(Poyser, 1979). However, the studies by Poyser (1979) and by French
and Casida (1973) did not demonstrate, by direct measurement, that
intra-uterine actinomycin D treatment on day 10 or day 11 in vivo
inhibits PGF2Q output from the uterus of the guinea-pig and sheep on
day 15. Therefore, further studies investigating the effects of
protein synthesis inhibitors on PGF2Q output from the uterus need to
be performed.
2. Progesterone and glucocorticoids
PGF2q concentrations in the utero-ovarian venous plasma obtained
from ovariectomised guinea-pigs treated with progesterone were similar
to the values observed in the utero-ovarian plasma of guinea-pigs on
days 3-10 of the oestrous cycle (Blatchley and Poyser, 1974).
However, progesterone was found to potentiate the stimulatory action
of oestradiol on uterine PGF2q, production in ovariectomised guinea-
pigs. Consequently, how does progesterone act to exert this priming
effect ? Also, glucocorticoids have been shown to alter PG
production in a variety of tissues (Hirata, Schiffmann,
Venkatasubramanian, Salomon and Axelrod, 1980) and their mode of
action is also examined here.
In the GH3 cell line derived from rat pituitary tumour and which
exhibit apparently normal steroid receptor systems (in that the cells
respond to glucocorticoid, oestrogen and progesterone), Welshons,
Krummel and Gorski (1985) have found only a low level of receptors for
all three steroids in the cytoplasmic fraction. The majority of the
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unoccupied glucocorticoid and progesterone receptors are primarily
located in the nucleus, like the oestrogen receptors. Philibert and
Raynaud (1974) have reported a progesterone-specific receptor in
immature guinea-pig uteri. An autoradiographic study by Sar and
Stumpf (1974) demonstrated [-^H]-progesterone binding to guinea-pig
uteri. Subsequently, an immunohistochemical study using monoclonal
antibodies, by Perrot-Applanat, Logeat, Groyer-Ricard and Milgrom
(1985) , has demonstrated that the progesterone receptors were confined
to the nucleus of all cell types in the endometrium and myometrium of
mature guinea-pigs. From other evidence however, the main site of
the glucocorticoid receptor however has not been definitely localised
to the nucleus (King, 1987).
Glucocorticoids bind to a specific domain on the glucocorticoid
receptor (Carlstedt-Duke, Okret, Wrange and Gustafsson, 1982) and both
glucocorticoids and progesterone-receptor complexes stimulate
transcription and hence protein synthesis (Parker, 1983). Yamamoto
(1985) proposed that the properties of these two steroid receptors and
oestradiol receptors are similar. However, it is not known whether
progesterone potentiates the stimulatory action of oestradiol on
uterine PGF2a production through an effect mediated by it combining
with its own nuclear receptor.
Glucocorticoid hormones are thought to exert their anti¬
inflammatory actions by increasing the production of proteins that
inhibit phospholipase A2 activity, thus preventing the release of
arachidonic acid for PG, TX and leukotriene synthesis. Inhibition of
(PLM
phospholipase A2 ^by glucocorticoid-stimulated proteins has been
identified in rabbit neutrophils (Hirata, Schiffman,
Venkatasubramanian, Salomon and Axelrod, 1980), rat peritoneal
macrophages (Blackwell, Carnuccio, DiRosa, Flower, Parente and
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Persico, 1980), guinea-pig lung perfusates (Blackwell and Flower,
1979) and rat renomedullary interstitial cells (Rothhut, Russo-Marie,
Wood, DiRosa and Flower, 1983). These antiphospholipase proteins
present in different cell types are immunologically and biochemically
related, if not identical, and are collectively termed lipocortins
(DiRosa, Flower, Hirata, Parente and Russo-Marie, 1984). Three
different peptides have been identified with molecular weights ranging
from 15,000 to 60,000 Daltons and monoclonal antibodies raised against
lipocortin can react with all three types (Hirata, Notsu, Iwara,
Parente, DiRosa and Flower, 1982). Indeed, the amino acid sequence
of human lipocortin has been elucidated (Wallner, Mattaliano, Hession,
Cate, Tizard, Sinclair, Foeller, Chow, Browning, Ramachandran and
Pepinsky, 1986). Furthermore, lipocortin is secreted by human
endometrium in organ culture (Gurpide, Markiewicz, Schatz and Hirata,
1986). The production of lipocortin by cultured human endometrium
was stimulated by treatment with the glucocorticoid, dexamethasone,
which increased lipocortin secretion by both proliferative and
secretory endometrium, although only PGF2a production by secretory
endometrium was inhibited by dexamethasone treatment (Gurpide,
Markiewicz, Schatz and Hirata, 1986; Schatz, Markiewicz and Gurpide,
1986). Consequently, lipocortin may have an attenuating role in the
control of PG synthesis by the guinea-pig uterus.
Touqui, Rothhut, Shaw, Fradin, Vargaftig and Russo-Marie (1986)
demonstrated that in platelets, protein kinase C catalyses
phosphorylation of a lipocortin-1ike protein, causing its
inactivation, and thereby potentiates platelet thromboxane synthesis
in response to appropriate stimuli (Mobley and Tai, 1985) due to the
removal of the inhibitory action of lipocortin on PLA2 activity.
This inactivation by phosphorylation is a feature and characteristic
of lipocortins (DiRosa, Flower, Hirata, Parente and Russo-Marie,
1984). The major biochemical event that activates protein kinase C
is thought to be the transient increase in diacylglycerol, generated
by receptor-mediated phosphoinositide turnover (Kishimoto, Takai,
Mori, Kikkawa and Nishizuku, 1980). The tumour promotor phorbol 12-
myristate-13-acetate (TPA) activates protein kinase C directly,
apparently by mimicking endogenous diacylglycerol (Castagna, Takai,
Kaibuchi, Sano, Kikkawa and Nishizuka, 1982), and indeed protein
kinase C does act as a cellular phorbol ester receptor. TPA has
also been shown to stimulate PLA2 activity in human neutrophils
(Stocker and Richter, 1982), and in human amnion and decidual cells
(Schrey and Read, 1986). Also, Okita, MacDonald and Johnston (1982)
demonstrated that diacylglycerol levels increase 2-fold in human
amnion with the onset of labour. The diacylglycerol may stimulate
protein kinase C to phosphorylate lipocortin, so causing inactivation
of lipocortin and removing its inhibitory influence on PLA2 activity,
and resulting in the increase in PG production measured at parturition
in the amnion, decidua and myometrium (Willman and Collins, 1976).
Lipocortin has been shown to be released from human endometrium
in culture. Therefore, the effects of hydrocortisone (the major
glucocorticoid secreted in the guinea-pig; Fajer and Vogt, 1963) and
of the phorbol ester TPA on PG output from the guinea-pig uterus need
in
to be examined^culture.
Arachidonic acid release from and uptake into the precursor pool for
PG synthesis
The release of arachidonic acid from some bound source is
regarded as the rate-limiting step in PG synthesis by tissues. In the
guinea-pig uterus, 93% of the total arachidonic acid is esterified to
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phospholipids of which 80% is bound to phosphatidylcholine (PC) and
phosphatidylethanolamine (PE) (Leaver and Poyser, 1981). There is a
significant decrease in the amount of arachidonic acid bound to PC,
and an apparent decrease in the amount of arachidonic acid bound to PE
between day 7 and day 15 of the oestrous cycle. Unesterified
arachidonic acid represents only 0.1% of the total arachidonic acid
content of the guinea-pig uterus (Leaver and Poyser, 1981), but even
l^ig unesterified arachidonic acid/g tissue represents a considerable
pool in relation to uterine PG production. However, arachidonic acid
has been reported to be rapidly released after killing and
manipulation of the tissue, in guinea-pig spleen (Flower and
Blackwell, 1976) and in rat cerebral cortex tissue (Marion, Pappius
and Wolfe, 1979), therefore the levels of free arachidonic acid
measured in the guinea-pig uterus may be even lower in vivo.
Ning, Leaver and Poyser (1983) examined the uptake of [ H]
arachidonic acid and [^H]-oleic acid into guinea-pig endometrial
phospholipids. Significantly more []-arachidonic acid but not
significantly more [-^H]-oleic acid was incorporated into phospholipids
(particularly PC and PE) by day 15 than by day 7 guinea-pig
endometrium in culture for 24h (Ning, Leaver and Poyser, 1983). Ning
and Poyser (1984) determined that PC was the major phospholipid
present in the guinea-pig uterus, although more arachidonic acid was
bound to PE. Lesser amounts of phosphatidylinositol (PI) and
phosphatidylserine (PS) were present with sphingomyelin being present
in similar quantities to PE. There were no significant changes in
the amounts of any of these endometrial phospholipids between day 7
and day 15 of the oestrous cycle (Ning and Poyser, 1984). From these
findings, increased incorporation of arachidonic acid into endometrial
phospholipids on day 15 compared to day 7 of the cycle is not due to a
change in uterine phospholipid content. Furthermore, there is no
increase in the turnover of phospholipids because the de novo
synthesis of PC, the synthesis of PC by methylation of PE, and the
synthesis of PI were not different between days 7 and 15 of the cycle
(Ning and Poyser, 1984). Therefore, the incorporation of arachidonic
acid into phospholipid seems to be by the addition to
lysophospholipids rather than by de novo synthesis (see Trotter and
Ferber, 1981), and it is known that arachidonic acid is incorporated
into phospholipids predominantly by this mechanism (Hill and Lands,
1968; Yamashita, Hosaka and Numa, 1973). Clearly, a system exists
by which the guinea-pig endometrium is able to replenish and maintain
phospholipid-bound pools of arachidonic acid precursor by increasing
uptake of arachidonic acid towards the end of the cycle at a time of
increased PGF2Q synthesis, to compensate for the utilization of
arachidonic acid for PG synthesis, the source of which is primarily
from PC and PE.
The action of ovarian steroid hormones on the amounts of PGH synthase
present in the uterus
The amounts of PGF2Q present in uterine tissues is very low and
is inadequate to account for the large amounts of PGF2a synthesised
and released by the uterus towards the end of the oestrous cycle in
the guinea-pig (Poyser, 1972) and sheep (Wilson, Cenedella, Butcher
and Inskeep, 1971). This is further evidence that prostaglandins are
synthesised immediately prior to release and are not stored within the
tissue.
Homogenisation of the guinea-pig uterus releases approximately
5/ig arachidonic acid/lOOmg tissue (Mitchell, Poyser and Wilson, 1977)
and this effect is independent of the day of the oestrous cycle.
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Therefore, release of substrate is not the rate-limiting step for PG
synthesis in these in vitro incubates, and this was exemplified by
Poyser (1972) who demonstrated that the addition of exogenous
arachidonic acid did not increase the amount of PG synthesised by
these uterine homogenates. PGH synthase exhibits a self catalysed
destruction (Lands, LeTellier, Rome and Vanderhoek, 1971) so, as PGs
are formed, the enzyme performing this conversion is inactivated.
Therefore, the amount of PGs produced by homogenate preparations
following incubation for 60 min, represent a direct measure of the
amount of PGH synthase present in the tissue. Poyser (1973)
suggested that the increase in amounts of prostaglandins formed by the
uterus may reflect an increase in the amount of PGH synthase present
in the uterus. Poyser (1972) demonstrated that the amounts of PGF2Q
synthesised by homogenates of guinea-pig uterus increased on day 12 of
the oestrous cycle and then increased further on day 14, and these
increases paralleled the increase in PGF2Q concentrations measured in
utero-ovarian venous plasma (Blatchley, Donovan, Horton and Poyser,
1972) . Four to six times more PGF2Q than PGE2 was synthesised by
guinea-pig uterine homogenates. This increase in the "prostaglandin
synthesizing activity" (or "synthesizing capacity", the term used in
this thesis) in the guinea-pig uterus at the end of the oestrous cycle
was confirmed by Wlodawer, Kindahl and Hamberg (1976), by the
estimation of the amounts of []-arachidonic acid converted into PGs
by guinea-pig uterine microsomes.
The effects of oestrogen and/or progesterone on the PGF2Q uterine
synthesizing capacity of the ovariectomised guinea-pig was
investigated by Naylor and Poyser (1975). They demonstrated that
oestradiol, but not progesterone, was the stimulus to increase uterine
PGF2q synthesizing capacity in the guinea-pig. Wlodawer, Kindahl and
Hamberg (1976), and Thaler-Dao, Ramonatxo, Saintot, Chaintreuil and
Crastes de Paulet (1982) subsequently confirmed this stimulatory
effect of oestradiol on the PGF2Q synthesizing capacity of the guinea-
pig uterus.
The guinea-pig uterus not only synthesises PGF2Q, but also PGE2,
PGI2 (measured as its stable metabolite 6-keto-PGFqa) and thromboxane
A2 (measured as its stable metabolite TXB2). The synthesizing
capacities of these PGs and TX of endometrium, myometrium and whole
uterus were examined, from both intact animals and from ovariectomised
animals treated with oestradiol and/or progesterone in vivo (Poyser,
1983a). In the guinea-pig endometrium, the synthesizing capacities of
PGF2q, PGE2, 6-keto-PGFqQ and TXB2 increased between day 7 and day 15
of the oestrous cycle by 2.3-fold, 2.2-fold, 1.4-fold and 1.2-fold,
respectively. Between day 7 and oestrus, the synthesizing capacities
of PGF2q, PGE2, 6-keto-PGFpQ and TXB2 increased 4.4-fold, 3.0-fold,
1.6-fold and 1.3-fold, respectively. It was demonstrated that
endometrial production of PGs and TX increased after day 11, with a
preferential stimulation of PGF2Q synthesizing capacity. In the
myometrium, little change in the synthesizing capacities of PGs and TX
were observed throughout the oestrous cycle. The major PG synthesised
by homogenates of myometrium was PGI2 (measured as 6-keto-PGFqQ), with
lesser amounts of PGF2Q and very small amounts of PGE2 and TXB2 being
synthesised. The changes in production of PGs and TX by homogenates
of whole guinea-pig uterus generally reflected changes in the PG
synthesizing capacities of the endometrial layer of the uterus,
demonstrating that the endometrium is the tissue that is controlled by
steroid hormones to synthesise the uterine luteolytic hormone (Poyser,
1983a).
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Progesterone treatment of ovariectomised guinea-pigs had no
effect on PG or TX synthesis by homogenates of the endometrium when
compared to control ovariectomised guinea-pigs (Poyser, 1983a).
Oestradiol treatment stimulated the endometrial synthesizing
capacities of PGF2q, PGE2, 6-keto-PGFla and TXB2 by 3.2-fold, 1.6-
fold, 2.2-fold and 2.0-fold, respectively (Poyser, 1983a). When
progesterone and oestradiol were administered together, which is the
optimum stimulus for the output of PGF2q from the uterus, the PGF2q
synthesizing capacity was only stimulated 1.7-fold, and there was no
stimulation of the other products (Poyser, 1983a). Progesterone
treatment appeared to attenuate the stimulatory action of oestradiol
in increasing endometrial PGF2q synthesizing capacity. Since
oestradiol stimulates the synthesis of all PGs and TX by homogenates
of the endometrium and since the supply of arachidonate is not rate
limiting in this in vitro preparation, there has to be an increase in
the concentrations of PGH synthase in the uterus to account for this
general increase in PG production. Oestradiol appears to be the
stimulatory factor required to increase PGF2q synthesizing capacity
(i.e. PGH synthase concentrations) towards the end of the cycle
(Poyser, 1983a). This corresponds to the increase in oestradiol
output from the ovary on day 10 of the oestrous cycle (Joshi, Watson
and Labhsetwar, 1973). However, the optimum stimulus for increasing
PGF2q synthesizing capacity (i.e. only oestradiol) is not the optimum
stimulus for increasing uterine PGF2q output (i.e. oestradiol acting
on a progesterone-primed uterus), so the increase in PGH synthase
levels in the endometrium after day 11 is not the main factor
controlling endometrial PGF2q synthesis and output. Changes in PGH
synthase concentration in the endometrium appear to be only secondary
effects in the selective stimulation of PGF2q synthesis.
Treatment of the guinea-pig uterus on day 10 of the oestrous
cycle in vivo with actinomycin D, a DNA-dependent RNA synthesis
inhibitor, decreased the amount of PGF2Q synthesised by uterine
homogenates on day 15 of the oestrous cycle (Poyser, 1979). Addition
of arachidonic acid to the uterine homogenates did not overcome this
decrease in PGF2a synthesizing capacity, demonstrating that lack of
substrate was not rate - limiting. Treatment with this protein
synthesis inhibitor apparently prevented oestradiol causing the
increase in PGH synthase levels in the uterus towards the end of the
cycle. The treatment of guinea-pigs which had received intra-uterine
actinomycin D on day 10, with exogenous oestradiol on days 11-14 did
not overcome this prevention of the increase in PGF2Q synthesizing
capacity on day 15 of the oestrous cycle. As plasma progesterone
concentrations remain high after actinomycin D treatment, presumably
due to luteal regression being prevented by the inhibition of PGF2Q
synthesis by and release from the uterus, protein synthesis (including
the synthesis of PGH synthase) appears to be a major controlling
factor of uterine PGF2Q production. However, the PGF2Q synthesizing
capacity of the guinea-pig endometrium only increases 2.5-fold between
day 7 and day 15 (Poyser, 1983a) whereas the output of PGF2Q from the
guinea-pig uterus increases 22-fold over this period (Poyser and
Brydon, 1983). This also demonstrates that the PGF2Q synthesizing
capacity of the guinea-pig endometrium is not the primary factor
controlling endometrial PGF2Q production, but is only of secondary
importance. Early in the cycle, the potential for high PGF2Q
synthesis exists within the uterus, if uterine PGH synthase
concentrations were the only controlling factor, but this potential is
not expressed.
39
Clearly other controlling factors are involved in PGF2a
production by the guinea-pig uterus. Studies need to be performed to
investigate further the effect of protein synthesis inhibitors and
ovarian steroid hormones on uterine PG production in the guinea-pig in
order to elucidate some of the other intracellular factors involved in
the control of endometrial PGF2a synthesis.
Phospholipase Enzymes
Cellular phospholipases exist in almost every type of cell and
their functions are as varied as their cellular and tissue
localisation and properties (Waite, 1985). The phospholipases
catalyse the hydrolysis of phospholipids, which may be considered as
derivatives of glycerophosphate in which the two hydroxyls are
esterified to long chain fatty acids and the phosphoryl group forms a
phosphodiester bond with a polar moiety. A "stereospecific
nomenclature" (sn) system is used which is based on the glycerol
backbone and which is numbered as shown in Figure l.b.
All four ester bonds in a phospholipid are susceptible to
enzymatic hydrolysis. Phospholipase Ap cleaves the acyl ester at the
sn-1 position. Phospholipase A2 clea«*s at the sn-2 position.
Phospholipase C cleaves the phosphodiester bond on the gylcerol side,
and phospholipase D cleaves the phosphodiester bond on the polar
groups side (Dennis, 1983; see Fij^t l.b).
Phospholipase A^ : Phospholipase Ap has been discovered in a wide
variety of tissues. The phospholipases Ap that have been studied
most are generally intracellular, and their specificity does not
appear to be absolute. Their distribution and properties have been





















Sites of action of phospholipase A^ , A2, C and D. rA and refer to
the fatty acids on the sn-1 and sn-2 positions of the
stereospecifically numbered phospholipid and X refers to the polar
group - the most common are choline, ethanolainine, serine, inositol
and glycero1.
Phospholipase A| only releases fatty acids from the sn-1 position, its
activity is not important for the release of arachidonic acid, which
is usually found esterified to the sn-2 position of a phospholipid.
Phospholipase A?: Phospholipase A2 was the first phospholipase to be
recognised. It was discovered by the observation that pancreatic
juice or cobra venom would hydrolyse phosphatidylcholine (Wittcoff,
1951) . The enzyme has subsequently been found to occur in a large
variety of snake venoms, and in mammalian exocrine glands where it is
involved in digestion. These extracellular phospholipases A2 are
much more active than intracellular phospholipase A2 and their
properties have been reviewed extensively by Verheij, Slotboom and de
Haas (1981). Phospholipase A2 exist in different forms within cells
depending upon the enzymes' properties which include calcium
dependence, pH optima, localisation in subcellular compartments and
substrate specificity.
Phospholipase A2 hydrolyses the sn-2 fatty acid from the glycerol
backbone, leaving a 1-acyl lysophosphatide. Unsaturated fatty acids
are found predominantly in the 2-position of phospholipids, so
phospholipase A2 is the important enzyme for the release of
arachidonic acid from phospholipids. Rittenhouse-Simmons and Deykin
(1981) demonstrated that the enzyme shows no preference for
phosphatidylethanolamine over phosphatidylcholine. Conditions for
optimal phospholipase A2 activity vary among tissues and they are also
dependent on the types of phospholipase A2 present. For instance, in
human platelet homogenates and membranes, these enzymes' maximum
hydrolyitic ability to release arachidonic acid occurred at pH 9.5
with lOmM calcium ions (Derksen and Cohen, 1975; Jesse and Cohen,
1976).
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Perhaps the most detailed study which has examined phospholipase
enzymes in a single cell type has been carried out in a murine
macrophage cell line. Ross, Deems, Jesaitis, Dennis and Ulevitch
(1985) characterised a number of different phospholipase A2 activities
in the murine macrophage cell line P388Dp. A single Ca^+-dependent
activity with a pH optimum of 8.8 was identified in membrane-rich
fractions, and could be clearly separated from the remaining
activities which were Ca^+-independent and exhibited pH optima of 7.5,
5.1 and 4.2. Subsequently, Ulevitch, Watanabe, Sano, Lister, Deems
and Dennis (1988) purified this Ca^+-dependent phospholipase A2 and
determined its specific activity as 1.7/zM min'^mg"! which is in the
range of the activities of other intracellular phospholipases A2 that
have been previously investigated and which range between 0.2 and 8^iM
min" ■'-mg" ^. In contrast, pure extracellular phospholipases A2 from
mammalian pancreas and snake venom possess specific activities in the
range of 100/iM min" ■'-mg".
Phospholipase A9 (PLA9) activity in the uterus: Downing and Poyser
(1983) examined PLA2 activities on day 7 and day 16 of the oestrous
cycle in the guinea-pig. They showed that PLA2 activity was present
in both microsomal and supernatant fractions of homogenates of guinea-
pig endometrium, after centrifugation at 100,000 g for 60 min,
although 90% of the PLA2 activity was present in the microsomal
fractions and so was presumably membrane-bound. Both of these enzyme
fractions had optimum enzyme activity at pH 8, but the microsomal
fraction demonstrated a requirement for 7mM Ca^+ for maximal enzyme
activity, whereas the supernatant fraction only demonstrated a
requirement for 2mM Ca^+ for maximal activity. The activities of
PLA2 i-n the microsomal fractions on day 7 and day 16 of the oestrous
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cycle were 66.2±7.5 and 96.0110.7 pmol/mg protein/min, respectively.
The activities of PLA2 in the supernatant were 4.210.8 and 7.810.9
pmol/mg protein/min on the respective days. Therefore the activity
of PLA2 in the endometrium increases 1.411.8-fold between the middle
and the end of the oestrous cycle in the guinea-pig. Downing and
Poyser (1983) also estimated the maximal theoretical release rates of
arachidonic acid by microsomal PLA2, from the total amount of protein
present in the endometrium and from the percentage of the total
unsaturated fatty acids in the uterus as arachidonic acid. On days 7
and 15/16, the maximum theoretical rates of release of arachidonic
acid are 15ng/min/uterine horn and 22ng/min/uterine horn,
respectively. Poyser and Brydon (1983) showed that the amounts of
PGF2q released from the guinea-pig uterus superfused in vitro on day 7
and day 15 are 0.11 ng/min/uterine horn and 2. 5ng/min/uterine horn,
respectively. Poyser and Brydon (1983) concluded that the rates of
release of PGF2a from the superfused uterine horns were very similar
to the outputs of PGF2q from the guinea-pig uterus fn vivo (Poyser and
Maule Walker, 1979). The endometrium clearly has a maximum potential
for the release of arachidonic acid for PG production that far exceeds
the observed uterine PG output, so the activity of PLA2 must be
controlled to regulate PG output. Furthermore, Poyser and Brydon
(1983) demonstrated a 22-fold increase in uterine PGF2Q output between
days 7 and 15 of the cycle, but Downing and Poyser (1983) showed
overall PLA2 activity increased only 1.5-fold over this same period.
Total PLA2 activity cannot therefore be the controlling factor in
uterine PGF2Q production by the guinea-pig.
Phospholipase enzymes, notably PLA2, are regulated by steroid
hormones. Uterine PLA2 activity increases 14-fold in
hypophysectomised rats receiving oestradiol-17/3 implants (Dey,
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Hoversland and Johnson, 1982) and Pakrasi, Cheng and Dey (1983)
demonstrated a stimulation of PLA2 activity by oestradiol-17/0 implants
in ovariectomised rats. In the guinea-pig, the increase in
endometrial PLA2 activity between days 7 and 16 of the oestrous cycle
(Downing and Poyser, 1983) occurred after the rise in plasma
oestradiol concentrations on day 10 (Joshi, Watson and Labhsetwar,
1973) which suggests that oestradiol is responsible for this increase.
In human endometrium, Bonney (1985) demonstrated that changes in the
activity of Ca^+-dependent PLA2 were dependent on the stage of the
menstrual cycle. The activity of PLA2 was low in the early
proliferative phase and increased towards mid-cycle to reach a maximum
activity in the early secretory phase. It was proposed that the
preovulatory surge of oestradiol, possibly with progesterone from the
newly formed corpus luteum may be the stimulus for the dramatic rise
in PLA2 activity in the human endometrium. Subsequently PLA2
activity declined in the presence of progesterone to a low level at
menstruation (Bonney, 1985). A further study by Bonney, Qizalbash
and Franks (1987) on the effects of steroids on human PLA2 activity in
explant endometrium has shown that the calcium dependent form of PLA2
is stimulated by pretreatment with progesterone followed by
oestradiol, which is consistent with the progesterone-priming effect.
Dey, Hoversland and Johnson (1982) have also demonstrated in the rat
that oestradiol administered after progesterone-priming stimulates
uterine PLA2 activity.
As discussed earlier, the release of arachidonic acid by PLA2 i-s
regarded as the rate limiting step in uterine PG synthesis and,
without any other influencing factors, the highest PLA2 activity
should determine the availability of the arachidonic acid for PG
production. However, in studies by Bonney (1985), the highest
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activity of PLA2> which is present during the early secretory phase of
the menstrual cycle, occurs before the highest production of PGs by
the endometrium at the end of the cycle (Downie, Poyser and
Wunderlich, 1974; Singh, Baccarini and Zuspan, 1975). Obviously, as
in the guinea-pig, absolute PLA2 activity in the endometrium is not
the sole factor controlling arachidonic acid release, so other factors
mediating uterine PLA2 activity must be involved.
Calcium has been shown to be required for maximal PLA2 activity
in the endometrium jin vitro (Downing and Poyser, 1983; Bonney, 1985),
and has also been discussed as a regulator of PLA2 activity in other
cells (Van den Bosche, 1980). Later, the effect of increasing
intracellular calcium concentrations on PG production by the guinea-
pig uterus is examined.
Lysophospholipase (phospholipase B) : The phospholipase B designation
was used for an enzyme that was thought to cleave at both sn-1 and sn-
2 positions and would hydrolyse a phospholipid as well as its
lysophospholipid product, or did not have clear specificity.
However, these enzymes have been difficult to characterise. There
appears to be little distinction between lysophospholipases and
phospholipase Aq in many cases (Dennis, 1983; Waite, 1985).
Lysophospholipase (lysophospholipid acyl hydrolase) is another fatty
acid releasing enzyme, which removes the fatty acid from the sn-1
carbon position from a lysophospholipid. Arachidonic acid is not
usually found at this site so the role of lysophospholipase is not
important in the control of precursor release for prostaglandin
synthesis.
Phospholipase C: An alternative pathway for the generation of free
arachidonic acid demonstrated in platelets is the conversion of
phosphatidylinositol by phospholipase C (PLC) to 1,2-diacylglycerol
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which is then converted by diacylglycerol lipase to produce free
arachidonic acid (Bell, Kennerley, Stanford and Majerus, 1979). Di
Renzo, Johnston, Okazaki, Okita, MacDonald and Bleasdale (1981) have
reported PLC activity in human uterine decidua, and Bonney and Franks
(1987) have demonstrated PLC activity in human endometrium. Chan
(1983) has reviewed the investigations on human uterine tissues and
found a correlation between uterine PG generation, menstrual PG
release and the severity of dysmenorrhoea in individual cases. In
human endometrium, the stage of the menstrual cycle has no effect on
PLC activity, although an increase in PLC may be involved in some
pathological conditions including menorrhagia and dysfunctional
uterine bleeding, which are associated with increased concentrations
of PGs in the endometrium (Bonney and Franks, 1987).
Phospholipase C metabolises phosphatidylinositol to 1,2-
diacylglycerol, and so it must also be considered that other enzymes
involved in this release of arachidonic acid, for instance
diacylglycerol lipase, may be controlling precursor release. Leaver
and Poyser (1981) demonstrated that phosphatidylinositol contains less
than 10% of the total arachidonic acid in the guinea-pig uterus, and
Ning and Poyser (1984) demonstrated there was no change in the
turnover of phosphatidylinositol between day 7 and day 15 of the
oestrous cycle. Therefore, it appears that the action of
phospholipase C on phosphatidylinositol is not involved in the release
of arachidonic acid for PG synthesis by the guinea-pig uterus.
Furthermore, Poyser (1987a) examined the effects of PLA2 and PLC on PG
synthesis and release by the guinea-pig uterus superfused in vitro,
and demonstrated both PLA2 and PLC stimulated PG output from uteri
removed on day 7 and day 15 of the oestrous cycle. However, the PLC
used was bacterial in origin which preferentially used
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phosphatidylcholine, instead of phosphatidylinositol as substrate. A
phosphatidylcholine - specific PLC is present in some mammalian tissues
(Clark, Shorr and Bromalaski, 1986). There were differences in the
amounts and proportions of the different PGs released by PLA2 an<^ PLC
treatment of guinea-pig uteri. PLA2 appeared to produce a similar
pattern of PG release to the pattern produced by the action of calcium
using the calcium ionophore, A23187, whereas PLC treatment produced a
greater overall stimulation of PG synthesis and, specifically, a much
greater stimulation of PGE2 production. Poyser (1987a) concluded
that the stimulation of endogenous PLA2 by Ca^+, rather than the
stimulation of endogenous PLC, is involved in the release of
arachidonic acid for PG synthesis by the guinea-pig uterus. However,
care must be taken in the interpretation of these data due to the
different properties of intracellular PLA2 and the extracellular PLA2
used in this study, and also to the differences in subtrate
specificity of the PLC used.
The role of calcium in the stimulation of uterine PG synthesis
Membrane bound PLA2 shows a requirement for calcium which was
demonstrated by Kunze, Bohn and Vogt (1974) in homogenates of bovine
seminal vesicles. The synthesis of PGs by bovine seminal vesicles
was stimulated with calcium and this stimulatory effect was inhibited
by EDTA. A small amount of PG was formed even in the presence of
EDTA, but this was thought to reflect the pool of free precursor
present in the homogenate.
The calcium ionophore, A23187 stimulates PG production by several
tissues (Knapp, Oelz, Roberts, Sweetman, Oats and Reep, 1977).
Leaver and Seawright (1982) demonstrated that A23187 stimulates PGF2Q
output from cultured day 7 and day 15 guinea-pig endometrium in a
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similar way to the addition of exogenous arachidonate precursor to the
tissue. It was proposed that calcium influx into the cell regulates
the availability of substrate because of the similarity of this effect
with the addition of exogenous arachidonate to the culture medium.
Subsequently, Poyser and Brydon (1983) demonstrated the role of
calcium in the stimulation of PG synthesis by the guinea-pig uterus.
The outputs of PGF2Q, 6-keto-PGFpQ and, to a lesser extent, PGE2 were
stimulated by the administration of A23187 to both day 7 and day 15
guinea-pig uteri superfused in vitro. PGF2Q output was stimulated 4-
fold and 1.9-fold on days 7 and 15, respectively. Poyser (1983a) has
reported that the main sources of PGF2Q and 6-keto-PGFpQ in the
guinea-pig uterus are the endometrium and the myometrium,
respectively, and these tissues are most likely the sources of these
PGs when the uterus is being superfused and stimulated with A23187
(Poyser,'1983b).
Interestingly however, the high basal output of PGF2Q from day 15
guinea-pig uterus superfused fn vitro was not affected by using
calcium free Krebs' solution (Poyser, 1984a). The output of PGE2 was
also unaffected, whereas PGI2 synthesis was inhibited by superfusing
with Ca^+-free medium. This last result is in agreement with Vesin,
Lieber and Harbon (1982) who demonstrated that PGI2 production by the
guinea-pig myometrium is dependent on extracellular Ca^+. However,
the stimulation of the outputs of PGF2Q, PGE2 and 6-keto-PGFpQ by
A23187 was abolished using Ca^+-free medium which showed that the
action of A23187 is dependent on extracellular Ca^+, and that A23187
is acting as a calcium ionophore and not by some other unspecified
mechanism (Poyser, 1984a). In this series of experiments, the
guinea-pig uteri were only superfused for 2.5 hours with Ca^+-free
medium, and it is possible that there was insufficient time for an
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intracellular source of calcium in the endometrium to be depleted so
therefore a decline in basal PGF2a output was not observed. Using an
intracellular calcium antagonist TMB-8, Poyser (1985b) demonstrated
that the A23187-induced increase in the outputs of PGF2a and 6-keto-
PGFfa from the day 15 superfused guinea-pig uterus were inhibited.
However, the high basal output of PGF2a was unaffected by TMB-8
treatment. TMB-8 was only administered to the superfused guinea-pig
uterus for 40 min, and this may be insufficient time for an inhibitory
action of TMB-8 to sequester intracellular calcium and thus making it
unavailable for stimulation of PGF2Q synthesis and release.
Consequently, the long-term effects of lack of Ca^+ and of TMB-8 on
uterine PG synthesis need to be examined.
However, very high calcium concentrations are required for the
direct stimulation of PLA2, and these concentrations are not reached
in the whole cell. However, it may be speculated that discrete sites
outwith the cell may be able to maintain these raised Ca^+ levels.
Recent evidence has gathered for a further mechanism of controlling
PLA2 by Ca^+ ions, by the modulation of PLA2 by calmodulin. This is
examined in the next section.
The role of calmodulin in mediating PLA9 activity
Calcium has been shown to mediate prostaglandin output from human
dispersed amnion cells (Olson, Opavsky and Challis, 1983), and calcium
stimulates the activity of amnion phospholipases A2 and C (Schultz,
Schwartz, MacDonald and Johnston, 1975; DiRenzo, Johnston, Okazaki,
Okita, MacDonald and Bleasdale, 1981) which directly or indirectly
mobilise arachidonic acid for PG synthesis. However, the optimum
stimulatory concentrations of Ca^+ are in the millimolar range,
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whereas intracellular calcium concentrations are generally in the
micromolar range. Therefore, it may seem unlikely that Ca^+ is
activating PLA2 directly, but acts via a mediator.
Calmodulin is a small acidic protein (M.W. 16,700) consisting of
a single polypeptide chain with four loops, each loop possessing a
domain for binding a calcium ion. Calmodulin plays an important role
in the activation and regulation of many Ca^+-dependent processes in
enkaryotic cells, including the control of several enzyme activities
(Cheung, 1980). Wong and Cheung (1979) using PLA2 from human
platelet membranes and Moskowitz, Andres, Silva, Shapiro, Schook and
Puszkin (1985) using snake venom PLA2 demonstrated that maximal
enzymatic activity of PLA2 was stimulated by calcium which was
mediated via calmodulin, thus demonstrating that PLA2 is a calcium and
a calmodulin dependent enzyme. Wong, Lee, Chao and Cheung (1980)
showed that the addition of exogenous calmodulin stimulated TXB2
production by human platelets.
The binding of calcium to calmodulin creates a hydrophobic domain
on the surface of the calmodulin, which appears necessary for the
interaction of calmodulin with its receptor protein, and this
hydrophobic domain is though to be the binding site of the calmodulin
inhibitor trifluoperazine (TFP; Andersson, Drakenberg, Thulin and
Forsen, 1983). Furthermore, calmodulin has been implicated as a
mediator of prostaglandin synthesis, because TFP prevented the release
of arachidonic acid and the stimulation of PG synthesis by A23187,
vasopressin, NaCl and mannitol in rat renal medulla (Craven and
DuRubertis, 1983), and TFP inhibited the release of arachidonic acid
from phosphatidylcholine by PLA2 after thrombin stimulation of
platelets (Walenga, Opas and Feinstein, 1981). Addition of TFP to
dispersed human amnion cells obtained after caesarian section
inhibited PGE2 output during 3h in culture, and TFP also inhibited
A23187-stimulated PGE2 output from these cells. These studies
indicate that calmodulin controls the activity of PG synthesis in the
human amnion (Olson, Challis, Opavsky, Smeija, Kramar and Skinner,
1985). Poyser (1985a) demonstrated that A23187-stimulated output of
PGF2a from the guinea-pig uterus superfused in vitro was inhibited by
TFP treatment on days 7 and 15 of the oestrous cycle. Another
calmodulin antagonist, W-7, also prevented the A23187- induced
production of PGF2a output from the guinea-pig uterus superfused in
vitro (Poyser, 1985b). These studies implicate a role for calmodulin
in the control of PLA2» and hence PGF2Q synthesis by the guinea-pig
uterus. However, calmodulin inhibitors failed to inhibit basal PGF2a
output when superfused over the guinea-pig uterus for 40 min.
Consequently, the longer term effect of calmodulin inhibitors needs to
be investigated to determine whether calmodulin is involved in the
control of the increase in basal PGF2a output from the guinea-pig
uterus which occurs fn vivo towards the end of the cycle.
SUMMARY
PGF2Q is the uterine luteolytic hormone in the guinea-pig.
Oestradiol acting on a progesterone-primed uterus is the optimum
stimulus for the increase in PGF2Q output from the guinea-pig uterus
towards the end of the oestrous cycle in vivo. The synthesis of
PGF2q is primarily controlled by the activity of PLA2 i-n releasing
arachidonic acid, the substrate for PG production. Calcium and also
calmodulin have been suggested as mediators of PLA2 activity. Also,
steroid hormones act by inducing the production of new proteins, and
proteins have been implicated in the control of PG synthesis.
Consequently, in this thesis, the roles of the following factors
in the control of PGF2Q (and also PGE2 and PGI2) synthesis by 'and
release from the guinea-pig uterus have been studied.
a. Calcium and calmodulin.
b. Protein synthesis.
c. Steroid hormones and oxytocin.
The general techniques used in these experiments presented in
this thesis are used routinely and are described in detail in the next




MATERIALS AND GENERAL METHODS
2.1 INTRODUCTION
The work presented in this thesis has involved the measurement
of PG output from the guinea-pig uterus superfused in vitro, PG output
from guinea-pig endometrial and myometrial tissue maintained in tissue
culture, and PG production by homogenates of guinea-pig endometrial
and myometrial tissue following incubation in vitro. Also the
incorporation of [^H]-leucine into cultured endometrial tissue has
been assessed as a measure of protein synthesis.
PGs were extracted from perfusates and incubates of homogenates
by organic solvents, and were measured by radioimmunoassay (RIA).
PGs released into tissue culture medium were measured directly,
without extraction, by RIA. The experimental work has been divided
into six sections. In this chapter, the general procedures for
superfusing whole uterine horns in vitro, for homogenising and
incubating uterine tissue, for measuring the incorporation of [^H]-
leucine into cellular and secreted proteins by cultured uterine




Absolute ethanol - J. Borough Ltd., London, UK
Acetone - Charles Tennent and Co. Ltd., Glasgow, UK
2-Ethoxyethanol (reagent grade) - Fisons p.I.e., Loughborough,
UK
* Ethyl acetate (reagent grade) - Rathburn Chemicals Ltd.,
Walkerburn, UK
Methanol (Analar) - Rathburn Chemicals Ltd.,
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Walkerburn, UK
* Petroleum spirit, b.pt. - 40-60°C (Analar) - BDH Chemicals
Ltd., Poole, UK
Toluene (reagent grade) - May and Baker Ltd., Dagenham, UK
* redistilled before use.
ii. Radioactive Compounds
L- [4,5-^H]leucine (specific activity 120 Ci/mmol)
[5,6,8,11,12,14,15(n)-]prostaglandin F2a (specific activity
180 Ci/mmol)




[1,2,6,7,16,17-^H]progesterone (specific activity 125 Ci/mmol)
All radioactive compounds were supplied by Amersham
International Ltd., Cardiff, UK.
[^HjPG and [%]progesterone stock solutions were stored at
-20°C. [^H]-leucine stock solutions were stored at 4°C.
PG and progesterone stock solutions were diluted to 5/iCi/ml and
stored at -20°C before using for radioimmunoassay. [^H]PGF2Q
and [^H]PGE2 were diluted with methanol; [^H]6-keto-PGFpQ was
diluted with acetonitrile : water (9 : 1 v/v) , and
[^Hjprogesterone was diluted with toluene.
iii. Other Chemicals
A23187 - Sigma Chemical Co., Poole, UK
Acetonitrile - Sigma Chemical Co., Poole, UK
Actinomycin D - Sigma Chemical Co., Poole, UK
Amphotericin B ('Fungizone') - Flow Labs., Irvine, UK
Arachis oil - BDH Chemicals Ltd., Poole, UK
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Bovine serum albumin (BSA) - Sigma Chemical Co., Poole, UK
2-(4-tert-Butylphenyl)-5-(4-biphenylyl)-1,3,4-oxadiazole (Butyl-
PBD) - Koch-Light Labs., Ltd., Colnbrook, UK
Calcium chloride - BDH Chemicals Ltd., Poole, UK
Cycloheximide - Sigma Chemical Co., Poole, UK
2,5-Diphenyloxazole (PPO) - BDH Chemicals Ltd., Poole, UK
Ethyleneglycol-bis-(/3-aminoethyl ether)N,N'-tetra-acetic acid
(EGTA) - Sigma Chemical Co., Poole, UK
Fluanisone ('Hypnorm') - Crown Chemicals Co. Ltd., Lamberhurst,
UK
Gelatine - BDH Chemicals Ltd., Poole, UK
D-Glucose - BDH Chemicals Ltd., Poole, UK
Glutamine - Flow Labs., Irvine, UK
Heparin - Weddel Pharmaceuticals Ltd., London, UK
Hydrochloric acid (HC1) - Fisons p.I.e., Loughborough, UK
Hydrocortisone - Sigma Chemical Co., Poole, UK
Indomethacin - Merck, Sharp & Dohme Res. Labs., Hoddesdon, UK
Kanamycin - Flow Labs., Irvine, UK
L-Leucine - Sigma Chemical Co., Poole, UK
Magnesium sulphate - BDH Chemicals Ltd., Poole, UK
Medium 199 (modified) with Earle's salts - Flow Labs., Irvine,
UK
Medium 199 (modified) with Earle's salts (calcium depleted)
Flow Labs., Irvine, UK
2-Mercaptoethanol - BDH Chemicals Ltd., Poole, UK
Midazolam ('Hypnovel') - Roche Products Ltd., Welwyn Garden
City, UK
Naloxone ('Narcan') - Du Pont (UK) Ltd., Stevenage, UK
Nifedipine - Bayer (UK) Ltd., Newbury, UK
17/3-Oestradiol - Sigma Chemical Co., Poole, UK
Oestradiol benzoate - Sigma Chemical Co., Poole, UK
Oxytocin - Sigma Chemical Co., Poole, UK
Phorbol 12-myristate 13-acetate (TPA) - Sigma Chemical Co.,
Poole, UK
Potassium chloride - Fisons p.I.e., Loughborough, UK
Potassium dihydrogen orthophosphate - BDH Chemicals Ltd., Poole,
UK
Progesterone - Sigma Chemical Co., Poole, UK
Puromycin - Sigma Chemical Co., Poole, UK
Sodium arachidonate - Sigma Chemical Co., Poole, UK
Sodium azide - BDH Chemicals Ltd., Poole, UK
Sodium chloride - BDH Chemicals Ltd., Poole, UK
Sodium chloride sterile solution (9g/l) - Boots Co. Ltd.,
Nottingham, UK
Sodium dodecyl sulphate (SDS) - Sigma Chemical Co., Poole, UK
Sodium hydrogen phosphate - BDH Chemicals Ltd., Poole, UK
Sodium hydrogen phosphate - BDH Chemicals Ltd., Poole, UK
8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate
hydrochloride (TMB-8) - Aldrich Chemical Co. Ltd., Gillingham,
UK
Trichloroacetic acid - BDH Chemicals Ltd., Poole, UK
Trifluoperazine (TFP) - Smith Kline & French Labs., Welwyn
Garden City, UK
Tris(hydroxymethyl)-methylamine - BDH Chemicals Ltd., Poole, UK
Urea - BDH Chemicals Ltd., Poole, UK
Verapamil - Knoll AG, Ludwigshafen, F.R.G.
N-(6-aminohexy1)-5-chloro-1 -napthalenesulphonamide (W-7)
Beecham-Wulfring, Gronau (Leine), F.R.G.
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Authentic PGs and their metabolites were supplied by Dr. J.
Pike, Upjohn Co., Kalamazoo, U.S.A.
Gases
95% air and 5% CO2
95% O2 and 5% CO2
All gases supplied by British Oxygen Co. Ltd., Guildford, U.K.
Other materials
Petri dishes (vented, 5cm diameter) Sterilin Ltd., Teddington,
UK
Scintillation vials (3ml) Sarstedt Ltd., Leicester, UK
Micropipette tips L.I.P. Ltd., Shipley, UK and Gilson, Villiers-
le-Bel, France
Donkey anti-rabbit serum (DARS) and normal rabbit serum (NRS)
were obtained from the Scottish Antibody Production Unit,
Carstairs Hospital, UK. Stock solutions of antisera were
stored at -20°C. Stock solutions were diluted with the
appropriate diluent and stored at 4°C.
.2 Composition of Solutions




8ml 10% w/v KH2PO4 solution
17.7ml 10% w/v KC1 solution
14.5ml 10% w/v MgSO^ .7H2O solution
12.6ml 1M CaCl2
Krebs' solution was stored at 4°C
Solution for PGF2a radioimmunoassay.




This solution is subsequently called "Tris diluent pH 8"
iii. Solution for PGE2 and progesterone radioimmunoassay.




This solution is subsequently called "phosphate diluent pH 7.5".
iv. Solution for 6-keto-PGFqQ radioimmunoassay.
0.05M Tris buffer pH 6.8
O.lg/1 Sodium azide
1.Og/1 Gelatine
This solution is subsequently called "Tris diluent pH 6.8".
All diluents were stored at 4°C.
v. Scintillation fluid for PG radioimmunoassays and for measurement









All animals used in these studies were virgin female guinea-pigs
weighing between 600-1000g, and they were housed in a 14h light and
lOh dark cycle (lights on between 0500-1900). They were offered a
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standard diet without restriction of RPG pellets (Labsure, Manea, UK),
hay, supplemented vegetables and water supplemented with ascorbic
acid. The guinea-pigs were examined daily and a vaginal smear was
taken when the vaginal membrane was open. The first day of the
oestrous cycle was taken as the day before the post-ovulatory influx
of leucocytes when cornification is at a maximum (Nicol and Snell,
1954). All animals had exhibited at least two normal cycles before
being used.
Each guinea-pig was killed by stunning and incising the neck.
A blood sample was taken from the incised neck when appropriate, in
order to measure the plasma progesterone concentration by
radioimmunoassay (section 2.3.5). Animals on either day 7 or day 15
of the oestrous cycle were used, these being days of low and high
PGF2q output from the uterus respectively (Blatchley, Donovan, Horton
and Poyser, 1972). The uterus was rapidly removed and placed either
in sterile culture medium prior to dissection for tissue culture, or
in cold (4°C) Krebs' solution prior to superfusion or homogenisation.
2.2.2 Extraction of PGs from perfusates and homogenates
PGs were extracted from superfusates and homogenates using the
method described by Poyser (1972). The pH of the perfusate or
homogenate medium was lowered to between pH 3.5 and 4.0 by the
dropwise addition of 1M HC1. The medium was extracted twice with two
volumes of ethyl acetate. These ethyl acetate fractions were
combined and evaporated to dryness under reduced pressure at 45°C on a
rotary evaporator. Superfusate and homogenate residues were
redissolved in 10ml and 5ml ethyl acetate, respectively, and were
stored at -20°C before the amounts of PGs present in the samples were
measured by radioimmunoassay (section 2.3).
59
This extraction procedure gives a high rate of recovery for
PGF2q, PGE2 and 6-keto-PGF^Q. The recoveries (mean ± s.e.m., n = 3)
of the appropriate radioactive PGs at pH 4 were found to be 94 ± 3%
for PGF2q, 92 ± 5% for PGE2 (Poyser and Scott, 1980) and 82 ± 2% for
6-keto-PGFpa (Swan and Poyser, 1983). PG concentrations measured in
perfusates and homogenates have not been corrected for these losses
during recovery.
2.2.3 Superfusion of the guinea-pig uterus in vitro
Superfusion of the guinea-pig uterus was first described by
Poyser and Brydon (1983). By this technique, basal PG outputs can be
measured from a single uterine horn, and also compounds can be added
to the perfusing solution to examine their effects on PG production.
Furthermore, each uterine horn from the same animal can be superfused
simultaneously under the same conditions, with one horn remaining
untreated and acting as a control for the treated horn.
After removal, each horn was weighed after blotting off surface
Krebs' solution, "opened" by cutting longitudinally, and suspended in
an organ chamber attached to an isotonic lever exerting a load of 2g
(see Fig.2.2.3.a). The uterine horn was superfused (5ml/min) with
Krebs' solution at 37°C, pregassed with 95% 02/5% CO2. Samples of
superfusate were collected every 10 min during the specified sampling
period. PGs were extracted from the superfusate with ethyl acetate
(see section 2.2.2) and were measured by radioimmunoassay (see section
2.3) .
2.2.4 Measurement of the synthesizing capacities of PGs by
homogenates of uterine tissue
This technique of homogenisation of the whole uterus of the
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Krebs solution
^ 5mls/minute at 37°C
Figure 2 . 2.3.a
Method for the superfusion of a uterine horn ijr vitro.
guinea-pig to measure the capacity of the tissue to synthesize PGs was
first performed by Poyser (1972). This technique was further refined
by dissecting the endometrium from the myometrium in the guinea-pig
uterus and measuring their synthesizing capacities separately (Poyser,
1983a). The method of homogenising endometrial and myometrial tissue
either immediately after removal from the animal or after superfusion
of the uterus, and of homogenising endometrium after tissue culture
are described here.
i. Homogenisation of endometrium and myometrium to measure PG
synthesizing capacity
The endometrium was carefully dissected away from the myometrium
with a fine pair of scissors. Tissue separation by this technique is
greater than 85% (Leaver and Poyser, 1981). Each tissue type was
weighed after blotting dry, cut finely, and homogenised in 5ml Krebs'
solution using a Fisons or Jencons glass homogeniser (for composition
of Krebs' solution see Section 2.1.2). The homogenate was decanted
into a 50ml conical flask. The homogeniser was then washed with a
further 5ml Krebs' solution, the washings being again homogenised and
then added to the flask (total volume in flask = 10ml). The flask
top was covered with Nescofilm (which was perforated twice; one hole
for the gassing tube and one hole to release the gas) and the flask
was incubated for 60 min at 37°C in a Grant water bath, under
agitation and whilst 95% 02/5% CO2 was being bubbled through the
Krebs' solution. After the incubation period, PGs were extracted
from the incubates with ethyl acetate (section 2.2.2) and were
measured by RIA (section 2.3).
ii. Homogenisation of small amounts of endometrium to measure its PG
synthesizing capacity after tissue culture
The endometrium was blotted dry, weighed and homogenised by the
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same procedure as above (2.2.4.i.) except that two volumes of 2.5ml
Krebs' solution were used for each homogenisation, and the homogenates
were poured into and incubated in a 25ml conical flask. Sodium
arachidonate (2/ig in 10^1 ethanol) was added to each flask. The
homogenates were incubated for 60 min at 37°C whilst being gassed with
95% 02/5% CO2. After the incubation period PGs were extracted from
the incubates with ethyl acetate (section 2.2.2) and were measured by
RIA (section 2.3).
2.2.5 Tissue Culture Technique
Tissue was cultured by a method based on that described by Baker
and Neal (1969) for ovarian tissue, and further refined for the
culture of endometrial tissue by Abel and Baird (1980), Leaver and
Seawright (1982) and Ning, Leaver and Poyser (1983).
i. Tissue culture medium
The medium used in this technique is Medium 199, which has been
modified by including Earle's salts (Morgan, Morton and Parker, 1950).
Earle's balanced salt solution (EBSS) consists of a synthetic mixture
of inorganic salts supplemented with glucose. The functions of this
balanced salt solution are threefold:
(a) as a buffer to maintain pH. Sodium bicarbonate (NaHC03)
(2.2g/l) is present as this buffer.
(b) to maintain osmotic pressure.
(c) as an energy source, provided here by glucose.
The EBSS receives further supplements of amino acids, vitamins,
salts, minerals and extra organic supplements to form Medium 199
(modified); its constituents are shown in table 2.2.5 . i. Glutamine
is an essential factor for stromal viability and good epithelial
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Table 2.2.5 . i
The constituents of Medium 199.
Dorman, Rodgers, Photopulos, Powell and Grisham, 1980), but it is only
stable below 0°C. The culture medium was stored at 4°C and glutamine
was added when required. Furthermore, the medium may be susceptible
to bacterial and fungal growth, so antibiotics are added (Abel and
Baird, 1980; Leaver and Seawright, 1982). Consequently, to 0.51
Medium 199 (modified) under sterile conditions, the following
supplements were added:
glutamine (200mM; 4ml)
amphotericin B ('Fungizone') (250pg/ml; 3ml)
kanamycin (5000pg/ml; 3ml)
After mixing, the medium was dispersed into sterile 25ml storage
bottles and stored at -20°C until required,
ii. Preparation of tissue
Endometrium was dissected away from the myometrium using fine
scissors. Small pieces (l-2mm^) of endometrial or myometrial tissue
were placed on a sterile lens paper lying across a sterile stainless
steel grid in a sterile vented Petri dish (see Figure 2.2.5.a). The
dish contained 4ml supplemented Medium 199 (modified) together with
any other compounds according to the nature of the experiment, as
detailed later in the results section. This arrangement allows the
tissue to be held above the medium but allows medium to be readily
available to the tissue by capillary action through the lens paper.
Between 10 and 25mg endometrial or myometrial tissue were used in
experiments measuring PG output into the medium, and between 30 and
60mg endometrial tissue were used in experiments measuring protein
synthesis by [^H]-leucine incorporation.
The appropriate number of Petri dishes according to the
experiment were inserted into racks, and the racks were then placed in
modified Kilner jars (see figure 2.2.5.a). The air in the jars was
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replaced by a 1:1 mixture of air/C02 (95% : 5%) and O2/CO2 (95% : 5%)
at a pressure of 0.7kgcm"^ (10 lb in"*). The jars were then
incubated at 37°C for the specified time. When the medium in the
dishes was removed and replaced with fresh medium, the jars were
regassed and then replaced in the incubator. Fresh medium was
prewarmed to 37°C before being used for replacing the original medium.
Organ culture methods require the tissue to be placed at the
gas/liquid interface to maximize gas exchange (Trowell, 1959). High
oxygen levels are used to overcome problems of diffusion related to
the size of the tissue pieces. The small amount of CO2 is necessary
to maintain pH. Atmospheric CO2 will regulate dissolved CO2 directly
according to the temperature, and the CO2 combines with H2O to produce
H2CO3 which dissociates:
H20 + C02 H2C03 ~* H+ + HCO3
HCO3 has a fairly low dissociation constant with the available
cations, so it tends to reassociate leaving the medium acid. The net
result of increasing CO2 is to depress the pH and by increasing the
bicarbonate concentration the equation is pushed to the left until an
equilibrium is reached at pH 7.4. Without CO2 present, at this
incubation temperature, the pH increases, the sodium phenol red
indicator changes from red to purple and cell functions may be
inhibited. In the experiments performed in this thesis, the indicator
always maintained its red colour,
iii. Tissue viability
Previous studies performed in this laboratory have carried out
extensive histological studies to compare visually the viability of
cultured and non-cultured guinea-pig endometrium. There were no
obvious differences between tissue before and after 72h of culture
(Leaver and Seawright, 1982; Ning, Leaver and Poyser, 1983; Ning and
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Poyser, 1984). Therefore, this tissue culture procedure is adequate
for normal maintainance and survival of the endometrium for up to 72h
of culture, the longest period used in the studies to be described in
this thesis.
2.3 RADIOIMMUNOASSAY METHODS
2.3.1 Measurement of PGs by radioimmunoassay (general method)
Introduction
The procedure for preparing radioimmunoassays to measure PGF2Q,
PGE2 and 6-keto-PGF]^Q is essentially the same. This general method
will be described, with the specific details of each PG assay being
noted.
Antisera used and assay protocol
Antisera for PGF2Q, PGE2 and 6-keto-PGFpQ were all raised in
rabbits using, respectively, a PGF2a-bovine serum albumin conjugate
(Dighe, Emslie, Henderson, Rutherford and Simon, 1975), a PGE2-
thyroglobulin conjugate (Dighe, Smith, Ungar and Whelpdale, 1978) and
a 6-keto-PGFpQ-thyroglobulin conjugate (Dighe, Jones and Poyser,
1978) .
The amount of [^H]PG used in each assay gave between 15,000-
20,000 counts per tube when scintillation counted for 4 min ([-^H]PGF2a
and [^H]6-keto-PGFqQ) or for 10 min ([^H]PGE2). The [^H]PG solution
was prepared by evaporating off the solvent carrier in a stream of air
and then redissolving the [^H]PG in sufficient of the appropriate
diluent, such that a 50pl aliquot of this solution provided the
required number of counts.
The antiserum dilution selected was that which bound 60% of the
[^H]PG in the absence of any non-radioactive PG (zero standard). A
1:100 stock solution of antiserum in the appropriate diluent was used
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to prepare the final dilution required.
Standard PG solutions were made up in diluent from a PG stock
solution of lyug/ml in methanol; 200/il of this stock solution were
taken, and the methanol was evaporated off under a stream of air.
The PG was redissolved in 20ml of the appropriate diluent to give a
final PG concentration of lOng/ml. Nine (for PGE2 and 6-keto-PGFpQ
assays) or ten (for PGF2Q assays) standard solutions were prepared
from this solution, ranging from 0.02 - 5.12ng PG/ml for PGE2 and 6-
keto-PGFpa standard solutions, and ranging from 0.01 - 5.12ng/ml for
PGF2Q standard solutions. From each of these standard solutions,
0.5ml was dispensed in triplicate into 3ml plastic insert
scintillation vials, the order ofthe tubes being as detailed in Table
2.3.1.1.
Counting standards and non-specific binding standards were also
prepared and dispensed in quadruplicate as specified in Table 2.3.1.i.
The four counting standards when averaged gave an estimate of the
number of radioactive counts within each tube. The non-specific
binding standards estimate [^H]PG binding to sites other than the
specific PG binding sites, which include the vial, non-specific sites
on the antiserum, and other compounds used in the assay. The non¬
specific binding was always less than 10% in every assay.
The assay procedure is outlined in the flow diagram (Figure
2.3.1.a). Tissue culture samples and extracted samples in ethyl
acetate were dispensed in duplicate into tubes using Eppendorf
pipettes with disposable tips. Different volumes of the same sample
(diluted if necessary) were prepared to ensure parallelism of results
among volumes. It also ensured that the amount of PG measured was
within the detection limits of the assay. Samples in ethyl acetate
were taken to dryness at 45°C, under a stream of air. Diluent was
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Table 2.3.1,1 The order and contents of the tubes containing
the non-specific binding standards, counting
standards, and PG standards when preparing a PG
radioimmunoassay.
i TUBE NUMBER ng PG/TUBE COMMENTS |
| 1-4 5 ng | non-specific binding
| standards
5-8 - | counting standards,
j 50/il of the appropriate |
j [^H]PG solution per tube|
9-11 0.01 0.005 PG standard curve j
12-14 0.02 0.01 i it ll It I
15-17 0.04 for PGE2 0.02
I 11 ll 11 I
; 18-20 0.08 and 0.04 I " " " |
| 21-23 0.16 6-keto- 0.08 for | it ll 11 I
24-26 0.32 PGFla 0.16 PGF2q
I 11 11 ll j
! 27-29 0.64 assay 0.32 assay
I ll II ll I
| 30-32 1.28 0.64 j ll 11 " j
33-35 2.56 1.28 11 11 11 J
| 36-38 2.56 I 11 II tt I
For assays measuring the amount of PG in tissue culture samples,
100/il culture medium were added to each PGF2Q assay standard tube
(total volume 600pl) or 200/il medium were added to each PGE2 and 6-
keto-PGF^a assay standard tube (total volume 700pl). This ensures
that the standard solutions and samples of tissue culture medium were
comparable in their constituents.
Extracted samples: Tissue culture medium samples:
dispense samples into tubes
I
evaporate off ethyl acetate to
dryness in a stream of air at
45°C
dispense samples into tubes
\
add appropriate volume of diluent
to maintain constant volume
(600/il PGF2a; 700^1 PGE2 and 6-
keto-PGFpa) throughout assay
add 50^1 appropriate [^H]PG
add 50/^1 appropriate diluted PG antiserum
I
"whirlimix" and incubate at room temperature for lh (PGF2q assays) or
for 2h (PGE2 and 6-keto-PGF^Q assays)
add 50/j1 NRS (1:100 dilution; not PGE2 assay)
add 50/il DARS (1:10 dilution)
1
"whirlimix" and incubate overnight at 4°C
I




add 3ml scintillation fluid and apply caps to vials
J
"whirlimix" to resuspend pellet
I
count each tube in liquid scintillation counter for 4 min
(PGF2q and 6-keto-PGF1q) or for 10 min (PGE2)
Figure 2.3 .1. a
General protocol for PG radioimmunoassays.
then added to the dispensed samples; 500/xl were added to extracted,
dried residue samples, and an appropriate volume was added to the
tissue culture medium samples to maintain constancy in the total
volume (i.e. 600^x1 PGF2Q; 700^x1 PGE2 and 6-keto-PGF^Q) throughout all
the tubes within an assay (see Table 2.3.1.i.).
Tubes containing the samples and the standard solutions were
then treated in the same way. To each tube were added 50/xl of the
appropriate [^H]PG solution and 50^x1 of the appropriate diluted PG
antiserum. The tubes were "whirlimixed" and were then incubated at
room temperature for lh for PGF2q. assays or for 2h for PGE2 and 6-
keto-PGF^a assays. Normal rabbit serum (NRS; 50/xl; 1:100 dilution)
and donkey anti-rabbit serum (DARS; 50/xl; 1:10 dilution) were then
added to each tube and the tubes "whirlimixed" again. NRS was added
to ensure that, at high dilutions of the antiserum, there was
sufficient gamma-globulin present for adequate precipitation
subsequently. DARS was added to separate free PG from antibody-bound
PG. However, it was not necessary to add NRS to the PGE2 assay since
a low dilution of PGE2 antiserum was used. The tubes were incubated
overnight at 4°C.
The following day, the tubes were centrifuged at 1300g for 30
min at 4°C. The supernatant was poured off and discarded, and 3ml
scintillation fluid (section 2.1.2.v.) were dispensed into each tube.
A cap was then inserted into the top of each tube, and the tubes were
"whirlimixed" to resuspend the pellet. The tubes were scintillation
counted for 4 min for PGF2a and 6-keto-PGFpQ assays or for 10 min for
PGE2 assays using a Packard liquid scintillation counter.
Data from the counter were passed directly into an IBM-personal
computer programmed with the Packard Data Aquisition and Analysis
System (PC-DAAS). The Spline Curve-Fit programme was used which
processes the standards according to a Modified Smooth Spline
Algorithm. This programme subtracted the amount of non-specific
binding from all standards then calculated the co-ordinates for the
curve of best-fit. Using this standard curve, the computer
calculated the amount of PG in each sample tube. Sample tubes that
lay outside the linear part of the curve were reassayed using
different volumes or different dilutions of the sample.




standard deviation of sample duplicate
mean value of sample duplicate
x 100
of variation total number of duplicates
Two tubes containing a known standard amount of the appropriate
PG (0.16ng/tube) were included at the end of each assay, and the
average amounts of PG measured in these assays were used to calculate
the inter-assay coefficient of variation, using the formula:
inter-assay standard deviation of average standard amount
coefficient =
^ -|qq
of variation mean of average standard amount
Cross - reactivities for each of the PG antisera have been
determined previously in this laboratory. The method used entails
the setting up of a standard curve for the PG together with standard
curves for the different prostaglandins and PG metabolites. The
concentration of the different PG or PG metabolite which produced a
50% fall in binding from the binding produced by a zero standard
solution of the PG to which the antibodies were raised was obtained
and the percentage cross-reactivity was calculated using the formula:
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concentration of the PG (to which the
antisera was raised) giving a 50% fall
in zero standard binding
% cross - reactivity = x 100
concentration of different PG or PG
metabolite giving a 50% fall in zero
standard binding
/
2.3.2 Measurement of PGF?^ by radioimmunoassay
A standard curve for PGF2Q was set up as detailed in Table
2.3.l.i. The general assay protocol was followed as given in section
2.3.1, using the variations for the PGF2Q radioimmunoassay as outlined
there. The reagents used were:
Tris diluent pH 8
[^H]PGF2q (50/xl of a 0.125 /j.Ci/ml solution)
PGF2q antiserum (rabbit 6, 6th bleed), 50/xl of a 1:1200 dilution
(i.e. 1:1200)
Results
The mean (± s.e.m.) values of the standard curves from six
consecutive PGF2Q assays are shown in Figure 2.3.2.a.
Intra-assay coefficient of variation = 5.6%
Inter-assay coefficient of variation = 8.2%
Table 2.3.2.i. shows the cross-reactivities of the PGF2Q
antiserum (rabbit 6, 6th bleed) with other prostaglandins and their
metabolites as determined previously (Dighe, Emslie, Henderson,
Rutherford and Simon, 1975; Poyser and Scott, 1980; Lytton and
Poyser, 1982).
Conclusion
The PGF2a antiserum cross-reacts with PGF];a to a significant
extent. Previous work by Poyser (1983a) analysing PGs produced by
the guinea-pig uterus by gas chromatography-mass spectrometry (GC-MS)
showed that very little PGF]^a was synthesised in comparison with
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ng PGF-2CX
Figure 2.3 . 2.a
Standard curve for PGF2Q radioimmunoassay (mean ± s.e.m.,
= 6).
Table 2.3.2.i Cross-reactivities with various prostanoids and
their metabolites of the PGF2a antiserum (rabbit
6, 6th bleed), measured at 30% binding of tracer.
| PROSTANOID j % CROSS-REACTIVITY AT 30% j
| binding OF TRACER j
1 pgf2q ! 100 i
i pgf1q 28.0 |
I pge2 1 0.2 !
! PGEl | 0.5 j
i pga2 I <0.1 !
I pgb2 I <0.1 j
i pgd2 ! 0.4 1
| 15-keto-PGF2a 1 0.5 |
| 13,14-dihydro-15-keto-PGF2a I 0.2 |
| 6-keto-PGF]^Q i 0.5 |
| 15-keto-PGE2 ! <o.i |
| 13 ,14-dihydro-15-keto-PGE2 ! o.i j
i txb2 0.6
PGF2q- Therefore, in these studies it is highly probable that the
PGF2q antiserum was measuring predominantly the PG to which it had
been raised.
2.3.3 Measurement of PGE9 by radioimmunoassay
A standard curve for PGE2 was prepared as detailed in Table
2.3.1.i. The general assay procedure was followed (Section 2.3.1)
using the variations for the PGE2 as outlined previously. The
reagents used were:
Phosphate diluent pH 7.5
[^H]PGE2 (50/ul of a 0.063/iCi/ml solution)
PGE2 antiserum (rabbit 5, 6th bleed), 50/il of a 1:300 dilution
Results
Figure 2.3.3.a shows the combined results (mean ± s.e.m.) of the
standard curves from six consecutive PGE2 radioimmunoassays.
Intra-assay coefficient of variation = 7.8%
Inter-assay coefficient of variation = 8.6%
Table 2.3.3.i shows the cross-reactivities of the PGE2 antiserum
(rabbit 5, 6th bleed) with other prostanoids and their metabolites as
determined previously (Poyser and Scott, 1980; Lytton and Poyser,
1982) .
Conclusions
The PGE2 antibody showed a high cross - reactivity with PGE^ and
PGB2 and some cross - reactivity with PGA2. Previous work which
involved analysing the PGs produced by the guinea-pig uterus by GC-MS
showed that PGE;[, PGA2 and PGB2 were not synthesised in any detectable
quantities (Poyser, 1983a), so the measurements made using this PGE2
antiserum are very probably of PGE2.
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ng PGE-2
Figure 2,3 . 3 . a
Standard curve for PGE2 radioimmunoassay (mean ± s.e.m., n = 6)
Table 2.3.3.i Cross-reactivities with various prostanoids and
their metabolites of the PGE2 antiserum (rabbit
5, 6th bleed), measured at 30% binding of tracer
| PROSTANOID
1 1
| % CROSS-REACTIVITY AT 30% j






I pge! | 94.0 j
j j
i pga2 I 13.6
j j
i pgb2 I 72.7
|






j 6-keto-PGF]^a 0.3 i
!
! 15-keto-PGF2q 1 0.1 j
] |









i txb2 i 0.2
1 1
2.3.4 Measurement of 6-keto-PGF-i^ by radioimmunoassay
A standard curve for 6-keto-PGFpQ was prepared as detailed in
Table 2.3.1.i. The general assay protocol was followed (section
2.3.1) using the specific changes for this assay as described. The
reagents used were:
Tris diluent pH 6.8
[ %] 6-keto-PGFpQ (50^1 of a 0.2 /jCi/ml solution)
6-keto-PGFpa antiserum (rabbit NP 1, 6th bleed) 50pl 1:1400
dilution.
Results
The mean (+ s.e.m.) values of the standard curves of six
consecutive 6-keto-PGFpQ assays are shown in Figure 2.3.4.a.
Intra-assay coefficient of variation = 5.9%
Inter-assay coefficient of variation = 6.6%
Table 2.3.4. i shows the cross-reactivities of the 6-keto-PGFpQ,
antiserum used with other prostanoids as determined previously
(Poyser, 1980; Poyser and Scott, 1980).
2.3.5 Measurement of progesterone by radioimmunoassay
Introduction
This assay was used to measure the progesterone concentration in
samples of plasma removed from guinea-pigs. After stunning the
guinea-pig and incising the neck, a blood sample (5ml) was taken from
the incised neck into a syringe containing heparin (lOOOU/ml; 0.1ml).
The blood sample was then centrifuged (2500g) and the plasma was
removed and stored at -20°C. Progesterone was extracted just prior
to assaying the samples. The protocol of the progesterone
radioimmunoassay was similar to that of the PG radioimmunoassay, so it
will only be described in brief. This radioimmunoassay was adapted
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Figure 2.3.4.a
Standard curve for 6-keto-PGFla radioimmunoassay (mean ± s.e.m.,
n = 6) .
Table 2.3.4.i Cross - reactivities with various prostanoids and
their metabolites of the 6-keto-PGFpQ antiserum
(rabbit 1, 6th bleed), measured at 30% binding of
tracer.
| PROSTANOID j % CROSS-REACTIVITY AT 30%
| BINDING OF TRACER I
6-keto-PGF]_Q 100 I
1 pga2 1 <0.1 i
! pgb2 <0.1
! pgd2 j <0.1 |
I PGE]_ 1 1.1 !
I pge2 1 4.2
1 PGF1q 0.4 j
| PGF2q <0.1 [
15-keto-PGF2a i <0.1 !
1 13,14-dihydro-15-keto-PGF2a | o.i !
15-keto-PGE2 I 0.1 !
13,14-dihydro-15-keto-PGE2 j o.i !
I txb2 I <o.i j
from the method described previously by Poyser and Horton (1975).
Extraction of progesterone from plasma samples
Progesterone was extracted from samples by the method described
by Dighe and Hunter (1974) . The samples were dispensed out in two
volumes in duplicate into glass test tubes and 2ml redistilled
petroleum spirit (b.pt. 40-60°C) were added. The tubes were shaken
vigorously for 3 min in a Baird and Tatlock multivortex shaker. the
lower aqueous layer was frozen in a bath of acetone containing dry
ice. The upper layer was decanted into a small glass test tube.
This extraction process was then repeated. The petroleum spirit
extract was blown to dryness with a jet of air, at 60°C.
Antiserum used
Antiserum for progesterone was raised in rabbits by immunising
them with progesterone-lla-hemisuccinate-bovine serum albumin, as
described by Poyser (1983a) using the method of Dighe and Hunter
(1974).
Reagents
Phosphate diluent pH 7.5
[^H]progesterone (50pl of a 0.036 pCi/ml solution)
progesterone antiserum (Rabbit NP 3, 2nd bleed) 50pl of a 1:600
dilution.
Method
From a stock solution of lpg/ml progesterone in methanol the
standard solutions were prepared. Initially, 200pl of this stock
solution were taken, and the methanol was blown off and 20ml phosphate
diluent pH 7.5 were added. Nine standard solutions ranging from
0.02ng/ml to 5.12ng/ml were prepared from this solution (lOng/ml).
Each standard solution was dispensed into glass test tubes in
triplicate (1ml each standard solution per tube), with counting
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standards, non-specific binding standards and zero standards all in
quadruplicate, as detailed in Table 2.3.5.i. The % binding of tracer
by the zero standards indicates the maximum binding of the tracer by
the added antiserum in the absence of non-radioactive progesterone.
The remainder of the protocol for preparing the assay is detailed in
Figure 2.3.5.a., and is similar to the PG radioimmunoassay protocol
(section 2.3.1).
However, this progesterone radioimmunoassay differs from the PG
radioimmunoassays because supernatant containing free []progesterone
was counted in the assay tubes by the scintillation counter rather
than counting the bound [%]progesterone in the pellet fraction. The
vials were counted for 10 min in a Nuclear Chicago Liquid
Scintillation counter. The results for the standard curve were
processed by a Commodore 4032 computer programmed to subtract
background counts and then calculate the percentage of bound
[ -^Hjprogesterone from the amount of free [-^Hjprogesterone present in
the supernatant, according to the formula:
sample counts - background counts
% bound = 100 - x 100
average counting standards - background
counts
The standard curve was plotted and the line of best fit was
drawn by hand. The percentage of []progesterone bound was
calculated for the extracted plasma samples, and compared with the
standard curve. The amount of progesterone per sample was then
measured from the standard curve.
Results
Figure 2.3.5.b shows the mean (± s.e.m.) results of the standard
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Table 2,3.5.i The order and contents of the tubes containing
the non-specific binding standards, counting
standards, zero standards and progesterone


































dispense samples into tubes
I
extract progesterone using petroleum spirit (b.pt. 40-60°C)
1
blow to dryness (60°C) in stream of air
i
add 1ml phosphate diluent pH 7.5
\
add 50pl [ ^H]progesterone (0 . 036/iCi/ml)
add 50/tzl progesterone antiserum (1:600 dilution)
I
"whirlimix" and incubate for lhr at room temperature
I
add 50/il NRS (1:140)
add 50/il DARS (1:10)
I
"whirlimix" and incubate overnight at 4°C
I
centrifuge at 1300g for 30 min at 4°C
1
decant supernatant into scintillation vials
I




count each tube in a liquid scintillation counter for 10 min
Figure 2.3.5.a
Protocol for setting up a progesterone radioimmunoassay
Figure 2.3 . 5,b
Standard curve for progesterone radioimmunoassay (mean ± s.e.m.,
n = 6) .
Table 2 . 3■5.ii Cross - reactivities with various compounds of the
progesterone antiserum (rabbit NP 13, 2nd bleed),
measured at 30% binding of tracer.
| COMPOUND
1 1
| % CROSS-REACTIVITY AT 30% |
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curves of six consecutive progesterone assays.
Intra-assay coefficient of variation = 10.8%
Inter-assay coefficient of variation = 10.1%
Table 2.3.5.ii shows the cross-reactivities of the progesterone
antiserum (Rabbit NP 13, 2nd bleed) at 50% binding of the tracer as
determined by the method of Dighe and Hunter (1974). The cross
reactivities have been reported previously by Poyser (1983a; 1984b).
Conelusion
The progesterone antiserum showed a high cross - reactivity with
lla-hydroxyprogesterone and 11/3-hydroxyprogesterone. However, these
are synthetic steroids and are not present in vivo. The values for
plasma progesterone concentrations obtained by this assay and which
are reported later (see section 3.5) were in the expected range
(Challis, Heap and Illingworth, 1971; Poyser and Horton, 1975).
Plasma progesterone concentrations declined before oestrus (see
section 3.5). Therefore the antiserum was regarded as suitable to
measure guinea-pig plasma progesterone levels.
2.4 MEASUREMENT OF ENDOMETRIAL PROTEIN SYNTHESIS
Introduction
This technique was used to investigate protein synthesis by
pieces of the guinea-pig endometrium maintained in tissue culture, by
measuring [^H]-leucine incorporation into both cellular and secreted
proteins.
The technique used to measure synthesis of cellular proteins was
adapted from the method of Findlay, Ackland, Burton, Davis, Maule
Walker, Walters and Heap (1981). Synthesis of secretory proteins was
measured by an adaptation of the method described by Strinden and
Shapiro (1983). Endometrium was prepared for tissue culture as
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explained in section 2.2.5, with 30-60mg tissue being placed in each
dish. The medium of each dish contained 10/iCi [ H]-leucine
(2.5^iCi/ml), and the tissue was incubated for up to 24h under
conditions previously described (section 2.2.5). Further supplements
to the medium and incubation times are given later (see sections 3.4,
3.5 and 3.6). The methods for measuring [^H]-leucine incorporation
into cellular and secreted proteins are outlined in Figure 2.4.a.
2.4.1 Measurement of leucine incorporated into cellular proteins
The tissue was weighed after blotting dry, placed in a 3ml
scintillation tube and washed three times with 1ml Medium 199 at 4°C.
Lysis buffer (1ml; 8M urea, 1% v/v sodium dodecyl sulphate and 5% v/v
mercaptoethanol) was added, the cap was inserted into the top of the
tube, and the tube was shaken and then incubated at 4°C overnight.
Tissue protein was extracted by freezing on solid CO2, then allowing
to thaw at room temperature while "whirlimixing". This freeze-thaw
process was carried out three times. After centrifugation at 1400g
for 15 min, 200/ul supernatant were added in quadruplicate to 300pl
saline (0.9g/ml) containing bovine serum albumin (BSA; 0.1% w/v) and
L-leucine (0.1% w/v). Protein was precipitated by adding 500^1 10%
w/v trichloroacetic acid (TCA), and the tubes were "whirlimixed" and
then incubated for 30 min at 4°C. The tubes were centrifuged at
1400g for 15 min and washed once with 500/il 5% w/v TCA, "whirlimixed"
to resuspend the precipitate and centrifuged at 1400g for 15 min.
The supernatant was discarded and the precipitate was dissolved by
incubating with 100/zl formic acid for 30 min at room temperature.
Scintillation fluid (3ml; see section 2.1.2.v) was added, caps were
inserted into the tops of tubes, and the tubes were counted in a
Packard liquid scintillation counter for 10 min.
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2.4.2 Measurement of f^H]-leucine incorporation into secreted
proteins
The culture medium was centrifuged in glass tubes at lOOOg for
10 min. Four 200pl aliquots of the supernatant were placed in 3ml
scintillation vials and BSA solution (in saline) was added (lOpl of a
0.2g BSA/lOml saline solution; 0.1% w/v solution). Protein was
precipitated with 300pl 10% w/v TCA, and the tubes were "whirlimixed"
and incubated for 30 min at 4°C. The tubes were centrifuged at 1400g
for 15 min at 4°C and then the supernatant was discarded. The
precipitate was washed with 300^1 5% w/v TCA, "whirlimixed" and
centrifuged again. This wash process to remove any free [^H]-leucine
was carried out 3 times. Finally, the supernatant was discarded, the
precipitate was incubated for 30 min with 100^1 formic acid to
dissolve the pellet, 3ml scintillation fluid (see section 2.1.2.v)
were added to each tube, caps were inserted into the tops of each
tube, and then the tubes were counted in a Packard liquid
scintillation counter for 10 min.
Four counting standard tubes were prepared consisting of 50pl
culture medium containing [^H]-leucine (2.5pCi/ml; retained after
dispensing the medium into the Petri dishes) , lOOpl formic acid and
3ml scintillation fluid. Also, four background counting tubes were
prepared containing lOOpl formic acid and 3ml scintillation fluid.
These tubes were counted for 10 min in the liquid scintillation
counter with the sample tubes.
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Cellular proteins: Secreted proteins:
measure wet weight of tissue
1
wash 3 times with culture medium
add 1ml lysis buffer, shake and
leave overnight
extract tissue protein by
freezing on solid CO2 and thawing
and "whirlimixing" 3 times
centrifuge (14(30g for 15 min)
take 200/xl supernatant and add
300^1 saline (containing BSA and
L-leucine supplements) and 500/jI
10% w/v TCA |
"whirlimix" and leave for 30 min
at 4°C I
centrifuge (1400g for 15 min)
t
discard supernatant and wash
pellet once with 500//1 5% w/v TCA
and "whirlimix"
I
centrifuge (1400g for 15 min)
i
discard supernatant
centrifuge medium (lOOg for 10
min) |
take 200^1 supernatant and add
10^1 BSA solution (0.1% w/v
solution)
Then add 300^1 10% w/v TCA.
"whirlimix" and leave for 30 min
at 4°C
centrifuge (1400g for 15 min)
I
discard supernatant, add 300^1 5%
w/v TCA and "whirlimix"
t
centrifuge (^1400g for 15 min)
wash, "whirlimix" and centrifuge
2 more times
discard supernatant
dissolve pellet in 100^1 formic acid
and leave for 30 min
t
add 3ml scintillation fluid
t
liquid scintillation count for 10 min
Figure 2.4.a
The methods used for measuring [^H]-leucine incorporation into
cellular and secreted proteins.
SECTION 3
RESULTS
3.1 PROSTAGLANDIN OUTPUT FROM THE GUINEA-PIG ENDOMETRIUM IN CULTURE
INTRODUCTION
PGF2a is the uterine luteolytic hormone in the guinea-pig. The
output of PGF2q from the uterus increased from day 11 to the end of
the oestrous cycle when measured in the utero-ovarian vein (Blatchley,
Donovan, Horton and Poyser, 1972). Poyser and Brydon (1983) have
shown that PGF2a output, when measured from the superfused guinea-pig
uterus in vitro, increases 21.9-fold between day 7 and day 15 of the
cycle, and Poyser (1983a) showed that the primary site of PGF2q
synthesis is the endometrium. Leaver and Seawright (1982) examined
the output of PGF2q from guinea-pig endometrium cultured for three
days and showed that PGF2q output was greater on day 15 than on day 7
and that output declined with time.
The culturing of guinea-pig endometrium, removed on day 7 and
day 15 of the oestrous cycle, has been one of the major experimental
techniques used in the studies presented in this thesis. The aims of
this experiment are:
(a) to examine and compare the outputs of PGF2Q, and also of PGE2
and 6-keto-PGFqQ which have not previously been measured, from guinea-
pig endometrium removed on day 7 and day 15 of the oestrous cycle and
cultured for three days.
(b) to conduct a more detailed analysis of the outputs of these
three PGs from guinea-pig endometrium removed on day 7 and day 15 of
the oestrous cycle and sampled at 6 hourly intervals over the initial
24h period of culture.
(c) to establish the outputs of these PGs from guinea-pig
endometrium removed on day 7 and day 15 of the oestrous cycle and
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culture for three days and for 24h in order to allow comparison with
various treatments in the following experimental results sections 3.2,
3.3, 3.4, 3.5 and 3.6.
METHODS
Virgin female guinea-pigs were used on day 7 and day 15 of the
oestrous cycle. The animals were killed and their uteri were removed
in preparation for tissue culture (section 2.2.1). The endometrium
was dissected from the myometrium, and between 10 and 20 mg
endometrium in small pieces, were placed in each petri-dish for
culturing as explained in section 2.2.5. Four dishes containing
endometrium from each uterus were prepared with two dishes being
cultured in each of two modified Kilner jars which were gassed and
incubated as explained in section 2.2.5. The frequency of changing
the medium is explained in the specific experimental methods below.
All samples of culture medium were stored at -20°C before
radioimmunoassay, without extraction, for PGF2Q, PGE2 and 6-keto-PGF]^a
(see section 2.3).
Experiment 1: Basal PG output from day 7 and day 15 guinea-pig
endometrium cultured for three days
Uteri were removed from five day 7 and five day 15 guinea-pigs.
Endometrium from each uterus was removed and cultured for 72h as
explained above. The medium was changed every 24h and the jars were
regassed before being replaced in the incubator.
Experiment 2: Basal PG output from day 7 and day 15 guinea-pig
endometrium cultured for 24h
Uteri from five day 7 and five day 15 guinea-pigs were used.
Endometrium from each uterus was cultured for 24h, as explained above.
The medium was changed every 6h, and the jars containing the dishes
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were regassed after every change before being returned to the
incubator.
Statistical tests
Student's 't' test (or the modified 't' test if the variances
were unequal as shown by the variance ratio F-test) was used to
compare day 7 and day 15 outputs for the same PG at the same time.
Duncan's multiple-range test was used in Experiment 2 to analyse
changes in the outputs of PGs into the culture medium with time.
RESULTS
Experiment 1: Basal PG output from day 7 and day 15 guinea-pig
endometrium cultured for three days
The outputs from day 7 and day 15 guinea-pig endometrium of
PGF2q, PGE2 and 6-keto-PGF]^Q significantly (P < 0.05) declined from
day 1 to day 3 of culture (Figure 3.1.a). The ratios of the mean PG
outputs from day 15 compared to day 7 endometrium on days 1, 2 and 3
of culture, for PGF2Q were 7.2:1.0, 3.3:1.0 and 2.1:1.0, respectively,
for PGE2 were 3.3:1.0, 2.4:1.0 and 1.3:1.0, respectively, and for 6-
keto-PGFia were 1.2:1.0, 1.3:1.0 and 1.2:1.0, respectively. The
output of PGF2q was significantly (P < 0.05) higher from day 15
endometrium than from day 7 endometrium on all three days of culture.
The output of PGE2 was significantly (P < 0.05) higher from day 15
than from day 7 endometrium during days 1 and 2 of culture, and the
output of 6-keto-PGF]^Q was significantly (P < 0.05) higher from day 15
than from day 7 endometrium only during day 2 of culture. The ratios
of the mean outputs of PGF2Q, 6-keto-PGF^Q and PGE2 on days 1, 2 and 3
of culture for day 7 cultured endometrium were 7.3:11.0:1.0,
9.8:4.8:1.0 and 6.7:4.3:1.0, respectively, and for day 15 cultured
tissue they were 13.9:3.4:1.0, 13.4:2.6:1.0 and 8.2:3.2:1.0,
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Mean (± s.e.m.; n = 10) outputs of PGF2Q, PGE2 and 5-keto-PGF^Q from
guinea-pig endometrium removed on day 7 (open columns) or on day 15
(hatched columns) of the oestrous cycle and cultured for three days,
with sampling every 24h.
| output significantly (P < 0.05) lower compared to day 15 output
for the same PG on the same day of culture.
respectively. The outputs of PGF2Q and 6-keto-PGF^a were similar
from day 7 endometrium with a lesser amount of PGE2 being released.
However, PGF2Q was the major PG produced from day 15 endometrium, with
lesser quantities of 6-keto-PGFpQ and even smaller amounts of PGE2
being released.
Experiment 2: Basal PG output from day 7 and day 15 guinea-pip,
endometrium cultured for 24h
The output of PGF2a from day 7 endometrium significantly (P <
0.05) increased during the first 18h of culture, then declined
slightly during the final sample period of 18 to 24h (Figure 3.1.b).
The output of PGF2q from day 15 endometrium significantly (P < 0.05)
declined during 24h in culture (Figure 3.1.b). PGE2 output from day
7 endometrium did not change significantly throughout the culture
period, whereas PGE2 output from day 15 endometrium significantly (P <
0.05) declined over 24h in culture (Figure 3.1.b). The output of 6-
keto-PGFpa from both day 7 and day 15 guinea-pig endometrium
significantly (P < 0.05) declined during the 24h period of culture
(Figure 3.1.b). The ratios of the mean PG outputs from day 15
compared to day 7 tissue, between Oh and 6h, 6h and 12h, 12h and 18h
and 18h and 24h of culture, for PGF2Q were 26.5:1.0, 9.8:1.0, 3.0:1.0
and 2.5:1.0, respectively, for PGE2 were 4.5:1.0, 4.9:1.0, 1.8:1.0 and
1.8:1.0, respectively, and for 6-keto-PGFpQ were 0.9:1.0, 1.5:1.0,
1.1:1.0 and 0.9:1.0, respectively. The outputs of PGF2Q and PGE2
from day 15 endometrium were significantly (P < 0.05) higher than
from day 7 endometrium during all the sample periods over 24h. The
output of 6-keto-PGFiq from day 15 endometrium was significantly (P <
0.05) higher than from day 7 endometrium only between 6h and 12h.
The ratios of the mean outputs of PGF2Q, 6-keto-PGF]^Q and PGE2 between
0 and 6h, 6h and 12h, 12h and 18h, and 18h and 24h of culture from
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endometrium of day 7 animals were 2.3:14.7:1.0, 8.0:9.9:1.0,
9.7:3.5:1.0 and 8.2:3.1:1.0, respectively. For day 15 endometrium
these ratios were 13.3:2.8:1.0, 15.9:3.1:1.0, 15.8:2.2:1.0 and
11.8:1.6:1.0, respectively. During the first two sample periods, 6-
keto-PGFpa output from day 7 endometrium was significantly (P < 0.05)
greater than PGF2a output. However, for the period between 12h and
24h, PGF2a output was significantly (P < 0.05) greater than 6-keto-
PGFla output. The output of PGE2 was lower than the outputs of PGF2Q
and 6-keto-PGFpa. More PGF2Q than PGE2 and 6-keto-PGFpQ was released
from day 15 endometrium. The amount of 6-keto-PGFpa released was
more than the amount of PGE2 released from day 15 endometrium.
CONCLUSIONS
The basal outputs of PGF2Q and, to a lesser degree, PGE2 from
guinea-pig endometrium cultured for three days or for 24h were higher
from tissue removed on day 15 than from tissue removed on day 7 of the
oestrous cycle. The output of 6-keto-PGFpQ from endometrium was
similar on both day 7 and 15 for three days and for 24h of culture.
From both day 7 and day 15 endometrium cultured, for three days, the
output of all three PGs declined with time. During the first 24h of
culture, the outputs of all three PGs from day 15 endometrium and the
output of 6-keto-PGFpQ from day 7 tissue also declined. However,
PGF2a output from day 7 tissue cultured for 24h increased to a peak
between 12h and 18h. The output of PGE2 from day 7 endometrium did
not significantly change from the output during the first 6h of
culture throughout the culture period.
DISCUSSION
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Figure 3.1.b
Mean (± s.e.m.; n = 10) outputs of PGF2Q, PGE2 and 6-keto-PGFpQ from
guinea-pig endometrium removed on day 7 (open columns) or on day 15
(hatched columns) of the oestrous cycle and cultured for 24h, with
sampling every 6h.
f output significantly (P < 0.05) lower compared to day 15 output
for same PG during the same sample period,
superscripts: columns with the same superscript are not significantly
(P < 0.05) different for the same PG from tissue removed on the same
day of the oestrous cycle.
cultured guinea-pig endometrium is in agreement with the increase in
PGF2a concentrations in the utero-ovarian venous plasma of the guinea-
pig at the end of the oestrous cycle (Blatchley, Donovan, Horton and
Poyser, 1972; Earthy, Bishop and Flack, 1975; Antonini, Turner and
Pauerstein, 1976). A study on the superfused guinea-pig uterus by
Poyser and Brydon (1983) showed that PGF2a output increased 21.9-fold
between days 7 and 15 of the oestrous cycle, while PGE2 and 6-keto-
PGFia outputs only increased 2.9- and 1.2-fold, respectively. The
increases in PG outputs between day 7 and day 15 during the first 6h
of culture were 26.5,-fold for PGF2Q and 4.5-fold for PGE2, while the
output of 6-keto-PGFpQ was slightly less from day 15 than from day 7
endometrium. During this first six hours of culture there appears to
be a large degree of comparability in the PG outputs with the much
shorter superfusion experiments.
The decline in PG output from the endometrium in culture for
several days has been previously reported for human endometrium (Abel
and Baird, 1980; Tsang and Ooi, 1982) and for guinea-pig endometrium
cultured for three days (Leaver and Seawright, 1982). However, there
was an increase in PGF2Q output between 12h and 18h of culture from
day 7 endometrium. This increase may have been due to removing the
endometrium from the influence of progesterone that is present in
vivo. Plasma progesterone concentrations are high at this stage of
the cycle in the guinea-pig (Joshi, Watson and Labhsetwar, 1973) and
also in the sheep (Ottobre, Lewis, Thayne and Inskeep, 1980).
Vincent and Inskeep (1986) have shown that after ovariectomy of sheep
on day 12 of the oestrous cycle, PGF2Q concentrations in the utero-
ovarian vein rise rapidly on day 13 but, if progesterone was replaced,
the PGF2a concentrations were not different from intact ewes. Thus,
progesterone has an inhibitory effect on endometrial PGF2a synthesis
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in the sheep. A similar action in the guinea-pig could explain why
removing the endometrium on day 7 from intact guinea-pigs and placing
it in culture (away from the inhibitory action of progesterone)
results in the increase in endometrial PGF2Q output.
This experiment has shown the outputs of PGF2a, PGE2 and 6-keto-
PGFfa from guinea-pig endometrium maintained in culture for three
days, and also in more detail, the profile of the outputs of these PGs
during the initial 24h period of culture. These outputs of PGs from
untreated (control) endometrium maintained in culture can be compared
with endometrium subjected to a variety of different treatments that
are presented in the following results sections (sections 3.2, 3.3,
3.5 and 3.6).
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3.2 THE EFFECT OF INDOMETHACIN ON PROSTAGLANDIN PRODUCTION BY THE
GUINEA-PIG ENDOMETRIUM IN CULTURE
INTRODUCTION
Indomethaciri is a non-steroidal anti-inflammatory drug that
inhibits PG synthesis by inhibiting the cyclo-oxygenase component of
the PGH synthase enzyme, which converts arachidonic acid to PGH2 (Rome
and Lands, 1975). Indomethacin has been shown to increase the length
of the oestrous cycle in the guinea-pig (Marley, 1972; Horton and
Poyser, 1973) an effect that was proposed to be caused by the
inhibition of PGF2a synthesis by the guinea-pig uterus (Poyser and
Horton, 1975). Subsequently, Poyser (1985a) showed that indomethacin
inhibits basal PGF2a output from the superfused guinea-pig uterus in
vitro when added to the superfusing solution.
This study has investigated PG synthesis in the guinea-pig
endometrium by examining the effect of indomethacin on PG output from
and PG synthesizing capacity of the guinea-pig endometrium in culture
for up to 24h. As PGs are synthesised immediately before release and
are not stored (Ramwell, Leovey and Sintetos, 1977), the main aim of
this study was to show that PG synthesis occurred during tissue
culture.
METHODS
Guinea-pigs on day 7 and day 15 of the oestrous cycle were
killed, and their uteri were removed in preparation for tissue culture
as described previously (section 2.2.1). Endometrium was dissected
from each uterus and small pieces of endometrium were placed in 24
Petri dishes, each dish containing 12-20mg tissue (see section 2.2.5).
The dishes were divided into six groups of four dishes and were
treated as follows; two groups were treated with 2/zg indomethacin/ml
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(added in 10^1 ethanol) , two groups were treated with lO^ig
indomethacin/ml (added in 10/il ethanol) and the final two groups were
treated with 10/il ethanol (controls). The dishes were distributed
among three Kilner jars, so that in each jar there were two different
groups of dishes of each treatment (i.e. 8 dishes/jar). The jars were
gassed and then incubated for 24h, sampling every 6h, in the
conditions specified in section 2.2.5.
Immediately after the jars were placed in the incubator, two
amounts of the remaining endometrium, each weighing approximately 12-
20mg, were accurately weighed, homogenised and incubated for 60 min
with 2/jg sodium arachidonate (dispensed in 10/il ethanol) according to
the method and conditions described in section 2.2.4.ii. These two
homogenates of endometrium measured the "Oh" control PG synthesizing
capacity of the tissue. After incubation, PGs were extracted from
the incubates and redissolved in 5ml ethyl acetate as described in
section 2.2.2.
After 6h, 12h and 18h of culture, one dish was removed from each
group of dishes at each time. The medium from the remaining dishes
was collected, replaced with fresh medium, and the same dose of
indomethacin or ethanol was added. These dishes were then replaced
in the jars, which were regassed and returned to the incubator in the
conditions previously specified. After 24h of culture, the remaining
six dishes were removed.
The culture medium from the removed dishes was collected. The
tissue was then weighed, homogenised and incubated with 2pg sodium
arachidonate. After 60 min incubation, the PGs were extracted, as
described for "Oh" controls above. These homogenates measured the
endometrial PG synthesizing capacities after 6h, 12h, 18h and 24h of
culture. All samples of a culture medium and ethyl acetate extracts
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of incubate samples were stored at -20°C before the amounts of PGF2Q,
PGE2 and 6-keto-PGF^a present were measured by radioimmunoassay (see
section 2.3).
Statistical tests
PG outputs from or synthesizing capacities of treated tissues
were compared with their respective control values for the same PG at
the same time using Student's 't'test. Duncan's multiple - range test
was used to compare PG production by "Oh" control endometrial
homogenates with PG production by control or treated endometrial
homogenates, after different periods in culture; this test was also
used to analyse changes in the outputs of PGs released into the
culture medium with time.
RESULTS
The output of PGF2q from control day 7 guinea-pig endometrium
was greatest during the first 6h of culture (Figure 3.2.a). The
output of PGF2q declined significantly (P < 0.05) between 6h and 12h,
then increased between 12h and 18h, and this level was maintained up
to 24h (Figure 3.2.a). Control outputs of PGE2 and 6-keto-PGFpa from
day 7 endometrium declined significantly (P < 0.05) during the 24h
period of culture, from an initial highest output during the first 6h
of culture (Figure 3.2.a).
Indomethacin treatment of day 7 guinea-pig endometrium at both
concentrations (2 and 10/ig/ml) significantly (P < 0.05) inhibited the
increase in PGF2Q output exhibited by control tissues between 12h and
18h, and this inhibition was maintained for the remainder of the
culture period (Figure 3.2.a). Both 2 and 10/ig/ml concentrations of
indomethacin significantly (P < 0.05) inhibited PGE2 output from day 7
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Mean (± s.e.m.; n = 6) PG outputs (ng/mg tissue/6h) from guinea-pig
endometrium removed on day 7 of the oestrous cycle and cultured for up
to 24h, changing the culture medium every 6h in the absence (controls
(C) ; open columns) or presence of 2^g/ml (hatched columns) or 10^ig/ml
indomethacin (crossed columns).
| significantly (P < 0.05) lower than control (C) PG output at the
same time for the same PG.
Different superscripts on control (C) columns for the same PG indicate
they are significantly (P < 0.05) different.
0.05) inhibited 6-keto-PGFpQ output from day 7 endometrium throughout
*
the 24h period of culture, when compared to control outputs at the
same time (Figure 3.2.a).
The outputs of PGF2Q, PGE2 and 6-keto-PGFpQ from control
endometrium obtained from day 15 guinea-pigs were significantly (P <
0.05) higher during the first 6h of culture than during the next three
culture periods (Figure 3.2.b). The outputs of all PGs declined
steadily over the 24h period of culture. Indomethacin at both
concentrations of 2 and 10/ig/ml significantly (P < 0.05) inhibited the
outputs of all three PGs during every 6h sample period throughout the
24h culture, when compared to controls at the same time for the same
PG (Figure 3.2.b).
The amounts of PGF2a synthesised by control day 7 guinea-pig
endometrium homogenised after culture increased steadily with time
and, at 24h, production was significantly (P < 0.05) higher than at Oh
(Figure 3.2.c). The amounts of PGE2 and 6-keto-PGFpa synthesised by
day 7 endometrium homogenised after culture did not significantly
change with time (Figure 3.2.c). Indomethacin treatment at both
concentrations of 2 and 10/ag/ml significantly (P < 0.05) inhibited
PGF2q, PGE2 and 6-keto-PGFpQ production by day 7 endometrium
homogenised after 6h, 12h, 18h and 24h of culture, when compared both
to their respective Oh control values and to their respective control
values at the same time, except lO^ig indomethacin/ml treatment did not
significantly inhibit the PGE2 synthesising capacity after 6h, 12h and
18h to a value lower than the Oh control value (Figure 3.2.c).
Cultured, control endometrium from day-15 guinea-pigs after
homogenisation and incubation showed no significant change in the
amounts of any PG produced at any time when compared to Oh control
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Mean (± s.e.ra.; n - 6) PG outputs (ng/mg tissue/6h) from guinea-pig
endometrium removed on day 15 of the oestrous cycle and cultured for
up to 24h, changing the culture medium every 6h in the absence
(controls (C); open columns) or presence of 2/xg/ml (hatched columns)
or 10/jg/ml indomethacin (crossed columns) .
f significantly (P < 0.05) lower than control (C) PG output at the
same time for the same PG.
Different superscripts on control (C) columns for the same PG indicate




















































































Mean (± s.e.m.; n = 6) production of PGs (ng/mg tissue/h) synthesised
by homogenates of day 7 guinea-pig endometrium either without culture
and without treatment (control (C) ; open columns) at Oh or a ter ,
12h, 18h and 24h of culture in the absence (control (C) ; open
columns) and in the presence of 2^g/ml (hatched columns) or lO^g/m
indomethacin (crossed columns).
f significantly (P < 0.05) lower than control PG production at the
same time, for the same PG.
* significantly (P < 0.05) lower than control PG production at Oh
for the same PG. ,.
Different superscripts on control (C) columns for the same PC, in icate
they are significantly (P < 0.05) different.














































































Mean (± s.e.ra.; n = 6) production of PGs (ng/mg tissue/h) synthesised
by homogenates of day 15 guinea-pig endometrium either without culture
and without treatment (control (C); open columns) at Oh, or after 6h,
12h, 18h and 24h of culture in the absence (control (C) ; open
columns) and in the presence of 2/ug/ml (hatched columns) or 10^ig/ml
indomethacin (crossed columns).
f significantly (P < 0.05) lower than control PG production at the
same time for the same PG.
* significantly (P < 0.05) lower than control PG production at Oh
for the same PG.
Different superscripts on control (C) columns for the same PG indicate
they are significanLly (P < 0.05) different.
both concentrations (2 and 10/ug/ml) significantly (P < 0.05) inhibited
PGF2q, PGE2 and 6-keto-PGFpQ production by day 15 endometrium
homogenised after 6h, 12h, 18h and 24h of culture, when compared both
to their respective control values measured at the same time and to
their respective Oh control values (Figure 3.2.d).
The amounts of PGF2a and 6-keto-PGFpQ produced by control
endometrial homogenates were significantly (P < 0.05) higher on day 15
than on day 7 at all sample times (Figure 3.2.C and 3.2.d). The
amounts of PGE2 produced by day 15 control endometrial homogenates at
every sample time were not significantly different from day 7
endometrial homogenates. Similar amounts of 6-keto-PGFpa and PGE2,
with slightly less PGF2a, were synthesized by homogenates of day 7
tissue (Figures 3.2.c and 3.2.d).
CONCLUSIONS
The basal outputs of PGF2Q, PGE2 and 6-keto-PGFpa from day 7 and
day 15 guinea-pig endometrium in culture for up to 24h presented here
are similar to the PG outputs and profiles of PG outputs presented in
section 3.1 (see Figure 3.1.b).
Treatment with indomethacin prevented the increase in PGF2a
output from day 7 endometrium which occurs after 12h in culture, and
also inhibited PGF2Q output from day 15 endometrium throughout the
culture period. Indomethacin treatment inhibited PGE2 output from
both day 7 and day 15 cultured endometrium throughout the 24h culture
period, although this effect on output was not significant between 6h
and 24h for day 7 endometrium due to the very low output of PGE2.
Indomethacin treatment inhibited 6-keto-PGFpQ output from both day 7
and day 15 guinea-pig endometrium throughout the 24h culture period.
Indomethacin appeared to exert a non-specific inhibitory action on all
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PG outputs from guinea-pig endometrium in culture for 24h, which is in
agreement with indomethacin inhibiting the cyclo-oxygenase component
of PGH synthase.
Indomethacin significantly inhibited PG synthesis by homogenates
of day 7 and day 15 endometrium at the end of each culture period
(i.e. the PG synthesizing capacity; this term refers to PG production
by homogenised and therefore broken cell preparations) . This
inhibitory effect of indomethacin treatment on PG synthesizing
capacity appears to be an irreversible blockade (or a very slow
reversible blockade), because no further indomethacin was added to the
incubating medium used for the homogenates, and therefore the block
was not reversed by this dilution of the tissue and cell contents
after homogenization.
DISCUSSION
It can be seen from these results that there is little
correlation between the basal PG outputs and the PG synthesizing
capacities for cultured endometrium when making a comparison between
the same and also different days of the oestrous cycle. The output
of PGF2q from the first 6h of culture from day 15 endometrium was
10.8-fold higher than from day 7 endometrium, although the
synthesizing capacity was only 3.8-fold higher. The PGF2Q
synthesizing capacity did not increase to the same extent as PGF2Q
output between day 7 and day 15. Also, the output of PGF2Q from day-
15 endometrium significantly declined by up to 80% during the 24h
period of culture, but there was no significant change in the PGF2Q
synthesizing capacity throughout the 24h culture period. This
decrease in PG output without a change in the synthesizing capacity is
seen elsewhere; PGE2 and 6-keto-PGF^Q outputs from both day 7 and day
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15 tissue significantly decreased from a maximal output during the
first 6h of culture, although there was no significant change in their
synthesizing capacities. From this evidence, PG output from either
day 7 or day 15 guinea-pig endometrium in culture does not appear to
be controlled by their PG synthesizing capacity.
Prostaglandin H synthase has two enzymic activities; a cyclo-
oxygenase activity that converts arachidonic acid into the
hydroperoxide, PGG2, and a peroxide activity that reduces PGG2 to PGH2
(Miyamoto, Ogino, Yamamoto and Hayaishi, 1976). Subsequent steps in
PG biosynthesis lead very rapidly (1-2 min) to the formation of PGs
and thromboxanes including PGF2Q, PGE2 and PGI2 from PGH2 (Hamberg,
Svensson, Wakabayashi and Samuelsson, 1974) . Indomethacin is a
selective inhibitor of the cyclo-oxygenase step and this effect was
found to be almost irreversible (Miyamoto, Ogino, Yamamoto and
Hayaishi, 1976; Mizumo, Yamamoto and Lands, 1982). Non-steroidal
drugs have been shown to have different potencies at inhibiting PG
synthesis in different tissues (Shen, 1977). Hahn, Carraher and
McGuire (1982) have shown that indomethacin is a highly potent
inhibitor of PGF2Q-induced contractions of the guinea-pig uterus.
Interestingly, Tolman, Fuller and Rosenthale (1985) demonstrated that
the non-steroidal anti-inflammatory drug, suprofen was a more potent
inhibitor of PGF2Q and PGE2 production than of 6-keto-PGF^a production
by guinea-pig uterine homogenate preparations. Unlike suprofen,
indomethacin treatment of guinea-pig endometrium was non-selective in
its PG inhibitory action.
Indomethacin administered by a slow releasing preparation placed
in the uterine lumen of the guinea-pig has been shown to increase the
oestrous cycle length (Marley, 1972; Poyser and Horton, 1973).
However, oral or parenteral administration of indomethacin has little
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effect on increasing oestrous cycle length (cycle length was only
increased by up to 3 days) whereas local intra-uterine administration
of indomethacin prolonged oestrous cycle length, in some cases to over
50 days, a similar effect to that produced by hysterectomy (Marley,
1973; Poyser and Horton, 1973). Subsequently, Poyser and Horton
(1975) showed that in the guinea-pig an intra-uterine preparation of
indomethacin lengthened the oestrous cycle (in one animal to 72 days)
and plasma progesterone concentrations were higher throughout this
extended cycle, indicating that functional corpora lutea were
maintained. Indomethacin treatment has also been shown to prolong
luteal function in the rabbit (0'Grady, Caldwell, Auletta and Speroff,
1972) and the rat (Chatterjee, 1973). Treatment with indomethacin
(5.6/xM) of the day 15 guinea-pig uterus superfused _in vitro inhibited
the outputs of PGF2a, PGE2 and 6-keto-PGFla (Poyser, 1985a). The
outputs of all PGs from guinea-pig uterus were inhibited by
indomethacin after a short delay (10-20 mins), and the inhibition
produced by indomethacin appeared to be non-specific because the
outputs of all three PGs were inhibited at a similar rate and to a
similar extent (Poyser, 1985a). The results presented here are
compatible with the previous studies that indomethacin inhibits the
outputs of all PGs from the guinea-pig endometrium to a similar
extent.
Concentrations of PGH synthase may reach nM concentrations in
vivo. For instance, levels of 10^ molecules of PGH synthase per
platelet have been measured (Roth and Machuga, 1982). With a
platelet count of 2.5 x 10-* per mm-*, human blood PGH synthase
concentration may reach 4.2nM, and if all of this enzyme were
activated at once, a theoretical pulse of 0.7/jM PGG2 would result
(Kulmacz, 1987). However, the amount of substrate and the amount of
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initiator (i.e. fatty acid peroxides) for the cyclo-oxygenase are the
limiting factors for PG synthesis in vivo, and therefore only a small
amount of the total PGH synthase enzyme available would be
synthesizing PGs at any one time (Marshall, Kulmacz and Lands, 1987).
The measurement of PG synthesis by broken cell homogenates
(termed synthesizing capacity here) is not a direct measure of the
potential for PG production by the intact tissue because, as stated
above, the PGH synthase released by homogenisation in vitro is not all
activated at the same time ijq vivo. Concentrations of free
arachidonic acid released after homogenisation of the guinea-pig
uterus but before incubation of the homogenates are high (2/xg free
arachidonic acid/lOOmg tissue; Mitchell, Poyser and Wilson, 1977).
Furthermore, after incubation for 60 min, concentrations of free
arachidonic acid increased further during the incubation period to
about 5pg free arachidonic acid/lOOmg tissue. Mitchell, Poyser and
Wilson (1977) also showed there was no difference in the amounts of
free arachidonic acid released by homogenates of day 7 and day 15
guinea-pig uterus, both before and after incubation. However, more
prostaglandins were produced by day 15 than by day 7 uterine
homogenates. It was calculated that about 1% of the available
arachidonic acid from day 7 uterine tissue, and about 2-3% of the
available arachidonic acid from day 15 tissue was converted to
prostaglandins after incubation of homogenates of these tissues
(Mitchell, Poyser and Wilson, 1977). Dimov, Christensen and Green
(1983) also demonstrated that homogenisation of a variety of human
reproductive tissues caused the release of substantial quantities (pg
quantities of arachidonic acid released/g tissue) into the medium
during incubation. Furthermore, in the present study exogenous
sodium arachidonate was added to the incubates of homogenates to
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ensure sufficient arachidonic acid substrate was available for
conversion by PGH synthase to PGH2, and then to the measured PGs.
Clearly, the limitation of prostaglandin synthesis in homogenates of
guinea-pig uterus is not due to a lack of precursor, as occurs in
vivo.
The activity of PGH synthase exhibits self-catalysed
inactivation (Miyamoto, Ogino, Yamamoto and Hayaishi, 1976; Ohki,
Ogino, Yamamoto and Hayaishi, 1979). This means that as arachidonic
acid is converted by PGH synthase to PGH2, the enzyme is inactivated
and eventually (in less than 60 min) the reaction stops due to the
lack of active enzyme rather than lack of substrate (Lands, LeTellier,
Rome and Vanderhoek, 1972). Therefore, the amount of PGH synthase
present determines the amount of PGH2 and hence the amount of measured
PGs formed. Tissue levels of PGs in guinea-pig endometrium have been
determined by Poyser (unpublished results). After removal from the
guinea-pig the endometrium was placed immediately in ethanol, which
prevents PG production (Jouvenaz, Nugteren, Beerthius and Van Dorp,
1970; Green, 1979), and the tissue was homogenised. The PGs were
extracted from the homogenates and were measured by radioimmunoassay.
Tissue levels (all expressed as ng PG/mg tissue )of PGF2Q in day 7 and
day 15 tissue were 0.024 ± 0.005 and 0.81 ± 0.15, respectively; the
levels of PGE2 were 0.058 ± 0.011 and 0.055 ± 0.008, respectively;
and the levels of 6-keto-PGF^Q were 0.038 ± 0.006 and 0.043 ± 0.006,
respectively. The tissue levels of all the PGs were very low in both
day 7 and day 15 endometrium. Therefore, the amounts of PGs present
in incubates of homogenates produce a direct measure of the amount of
PGH synthase present in the incubates available for PG synthesis.
However, in the intact tissue, the supply of substrate in the rate-
limiting step in PG synthesis by and release from the guinea-pig
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endometrium. Since indomethacin treatment reduced the amounts of PGs
present in the medium following culture, PG synthesis must have been
occurring in the endometrium during culture.
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3.3 CALCIUM AND ITS ROLE IN PROSTAGLANDIN PRODUCTION BY THE GUINEA-
PIG ENDOMETRIUM
INTRODUCTION
Prostaglandin F2Q output from the superfused guinea-pig uterus
removed on day 15 of the oestrous cycle is stimulated by the calcium
ionophore A23187 (Poyser and Brydon, 1983). This stimulation was
abolished by using calcium-free superfusing medium (Poyser, 1984a),
indicating that the response to A23187 is mediated by extracellular
Ca^+ entering the cell. A23187 has only a weak stimulatory effect on
PGE2 output. Phospholipase (PL) A2 also stimulates PGF2Q and, to a
much smaller extent, PGE2 output from guinea-pig uterus when
superfused _in vitro. Since the profile of PG output stimulated by
A23187 and PLA2 are similar, these results suggest that the increase
in PG synthesis activated by A23187 is due to an increase in
intracellular calcium, and the consequent stimulation of endogenous
PLA2 (Poyser, 1987a). PLA2 is a calcium-requiring enzyme, and it has
been proposed that oestradiol acts upon a progesterone-primed uterus
to produce a rise in the endometrial intracellular calcium
concentration, which stimulates PLA2 to release arachidonic acid from
phospholipids for PGF2Q production at the end of the cycle (Downing
and Poyser, 1983) .
This study has further investigated the involvement of calcium
in PG synthesis in the guinea-pig uterus, by measuring PG outputs from
guinea-pig endometrium in tissue culture by addressing the following
questions:-
(a) How much does the high output of PGF2Q from endometrium removed
on day 15 of the oestrous cycle depend on intracellular and
extracellular calcium ?
(b) If extracellular calcium is involved, does the calcium enter the
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cell by voltage-dependent calcium channels ?
(c) Does calmodulin, a calcium-binding protein (Cheung, 1980) that
has been implicated in the stimulation of PLA2 (Moskowitz, Andres,
Silva, Shapiro, Schook and Puszkin, 1985), have a role in increasing
PGF2q output from day 15 endometrium ?
(d) Are the mechanisms controlling PGF2a synthesis also controlling
PGE2 and 6-keto-PGF^Q synthesis ?
(e) Lipocortin inhibits the activity of PLA2 (Blackwell and Flower,
1983) and lipocortin has been demonstrated to be released from human
endometrium in culture (Gurpide, Markiewicz, Schatz and Hirata, 1986).
In platelets, a lipocortin-like protein is inactivated by
phosphorylation by the enzyme protein kinase C (Touqui, Rothhurt,
Shaw, Fradin, Vargaftig, and Russo-Marie, 1986). Is protein kinase C
and hence a lipocortin-like protein involved in the control of PG
synthesis in guinea-pig endometrium ?
METHODS
Guinea-pigs were killed and their uteri removed in preparation
for tissue culture (section 2.2.1). Endometrium was dissected away
from the myometrium and small pieces were placed in Petri dishes for
tissue culture according to the method described in section 2.2.5.
Each Petri dish contained 10-15mg tissue. Eighteen Petri dishes were
prepared from the endometrium of each uterus. Four of these dishes
were left untreated (controls), the remaining fourteen dishes
contained the treatments administered in duplicate, as specified in
the individual experimental methods below. These dishes were then
divided equally, with nine dishes being placed into two modified
Kilner jars. Each group of nine dishes contained two control dishes
and one dish from each of the duplicate treatments. The endometrium
96
was cultured for 72h in the conditions specified in section 2.2.5.
The culture medium was changed every 24h, and the dishes were replaced
in the jars, regassed and incubated as above. The samples of culture
medium were stored at -20°C before the amounts of PGF2Q, PGE2 and 6-
keto-PGFpQ present were measured by radioimmunoassay (see section
2.3) .
1. Experimental treatments using Ca^+-containing medium
Endometrium was used from guinea-pigs killed on day 15 of the
oestrous cycle (day 15 endometrium). All eighteen dishes from each
uterus contained Ca2+-containing Medium 199 with supplements as
described in section 2.2.5. The following compounds were utilised,
in duplicate for each treatment: ethyleneglycol-bis-(/3-aminoethyl
ether acid (EGTA; a calcium chelator; 2mM), 8-(N,N'-diethylamino)-
octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8; an intracellular
Ca^+ antagonist; 30 and lOO^M; Chiou and Malagodi, 1975),
trifluoperazine (TFP; a calmodulin antagonist; 100 and 200/iM; Levin
and Weiss, 1977), N-(6-aminohexyl)- 5-chloro-1-naphthalenesulphonamide
(W-7; a calmodulin antagonist; 150 and 300/zM; Hidaka, Asano,
Iwadare, Mutsumoto, Totsuka and Aoki, 1978), nifedipine (1, 10 and
lOOpM; dispensed in 20/ul ethanol) and verapamil (1, 10, 50 and 100/iM;
dispensed in 20/il saline) (both voltage-dependent Ca^+-channel
blockers; Janis and Scriabine, 1985) and phorbol 12-myristate 13-
acetate (TPA; a stimulator of protein kinase C; 1, 5 and 25ng/ml
dispensed in 20/nl ethanol; Castagna, Takai, Kaibuchi, Sano, Kikkawa
and Nishuzuka, 1982).
Also, endometrium removed from guinea-pigs on day 7 of the
oestrous cycle (day 7 endometrium) was cultured in four untreated day
7 control dishes and in six dishes containing one of the duplicate
concentrations of TPA used (1, 5, 25ng/ml). The dishes were divided
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equally as before between two Kilner jars, each containing two day 7
control dishes and one of each duplicate treatment. The dishes were
incubated for 72h, with sampling every 24h, using the same procedure
as for day 15 tissue.
All experiments that required the preparation and dispensing of
nifedipine and verapamil were performed under light from a sodium lamp
due to the instability of these compounds in UV light.
2. Experimental treatments using Ca^+-depleted medium
Day 15 guinea-pig endometrium was prepared for tissue culture in
eighteen dishes as before. Four of these dishes were prepared
containing Ca^+-containing medium (Ca^+-containing medium controls),
while the remaining dishes were prepared containing Ca^"1"-depleted
medium. Four of these remaining fourteen dishes received no further
treatment (Ca^+-depleted medium controls). The remaining ten dishes
were treated, in duplicate, with EGTA (2mM) , TMB-8 (100/iM), W-7
(150pM) , nifedipine (100/uM) and verapamil (100/jM). The dishes were
divided equally between two Kilner jars as before, each jar containing
two of each of the two groups of controls (i.e. Ca^+-containing and
Ca2+-depleted medium controls) and one of each of the duplicate
treatments. The jars were incubated for 72h, and sampled every 24h,
using the protocol specified above.
Presentation of results and statistical tests
From one uterus, there was insufficient endometrial tissue to
prepare sufficient petri dishes to allow the different compounds at
all the concentrations used to be compared with one set of control
dishes. Therefore, to allow comparison between different sets of
dishes using different controls, data are expressed as a percentage of
the day 1 control value of that set of dishes for the same PG. The
control value was obtained by taking the average of the two control
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values for each Kilner jar. Treatment with different concentrations
of a compound were performed in the same set of dishes using the same
control values.
Results were analysed using the one- or two-tailed Student's 't'
test as appropriate. The outputs from treated endometrium in Ca^+-
containing medium were compared to their respective control outputs
for the same PG during the same time period. The outputs of PGs from
treated endometrium cultured in Ca2+-depleted medium were compared to
their respective Ca^+-depleted control output values for the same PG
during the same time period.
RESULTS
1. Using Ca2+-containing medium
Basal outputs of PGF2Q, PGE2 and 6-keto-PGFpQ from day 7 and day
15 guinea-pig endometrium cultured in Ca^+-containing medium for three
days have already been described in section 3.1.
Effects of various treatments on PG output
The effects of EGTA, TMB-8, TFP, W-7, nifedipine and verapamil
on the outputs of PGF2a, PGE2 and 6-keto-PGF^Q from day 15 guinea-pig
endometrium in culture are shown in Figures 3.3.a, 3.3.b, 3.3.c,
3.3.d, 3.3.e and 3.3.f, respectively.
The outputs of PGF2Q, PGE2 and 6-keto-PGFpQ were significantly
(P < 0.05) reduced on day 1 of culture by EGTA (2mM) (Figure 3.3.a).
EGTA also significantly (P < 0.05) reduced PGF2Q output on day 2 of
culture and significantly (P < 0.05) increased 6-keto-PGF^a output on
day 3 of culture (Figure 3.3.a).
The output of PGF2Q was significantly (P < 0.05) inhibited on
all three days of culture by both concentrations (30 and 100/iM) of
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Figure 3.3.a
Mean (± s.e.m.; n = 10) outputs (expressed as % of day 1 control (C)
output for the same PG) of PGF2Q, PGE2 and 6-keto-PGF^q, from guinea-
pig endometrium removed on day 15 of the oestrous cycle and cultured
for three days in Ca^+-containing medium, with sampling every 24h, in
the absence (controls (C) ; open columns) and presence (hatched
columns) of 2mM EGTA.
f significantly (P < 0.05) different compared to the control value














































Mean (± s.e.m.; n = 10) outputs (expressed as I of day 1 control (C)
output for the same PG) of PGF2Q, PGE2 and 6-keto-PGFpa from guinea-
pig endometrium removed on day 15 of the oestrous cycle and cultured
for three days in Ca^+-containing medium, with sampling every 24h, in
the absence (controls (C) ; open columns) and presence of 30^iM
(hatched columns) and 100/zM (crossed columns) TMB-8.
f significantly (P < 0.05) different compared to the control value
for the same PG on the same day of culture.
reduced by 30/iM TMB-8 on day 2 of culture, and lOOpM TMB-8
significantly (P < 0.05) increased the outputs of PGE2 and 6-keto-
PGFpQ on day 3 of culture (Figure 3.3.b).
Trifluoperazine (TFP; 200/iM) significantly (P < 0.05) reduced
PGF2q output on day 1 of culture, 100/^M TFP significantly (P < 0.05)
reduced PGF2a output on day 2 of culture, and TFP (100 and 200yuM)
significantly (P < 0.05) reduced PGF2Q output on day 3 of culture
(Figure 3.3.c). The outputs of PGE2 and 6-keto-PGFpa were
significantly (P < 0.05) increased by TFP (100 and 200/^M) on all three
days of culture, with the exception of 100^zM TFP treatment on 6-keto-
PGFpa output on day 3 of culture which showed no significant change
when compared to the corresponding control output (Figure 3.3.c).
The output of PGF2a was significantly (P < 0.05) inhibited by W-
7 (150 and 300/xM) treatment on days 1, 2 and 3 of culture (Figure
3 . 3 . d) . Treatment with W-7 (150 and 300^zM) significantly (P < 0.05)
increased PGE2 output on all three days of culture, except for
treatment with 150/jM W-7 on day 1 of culture. The output of 6-keto-
PGF1q was significantly (P < 0.05) increased by W-7 (150 and 300/iM) on
day 2 of culture and by 150/iM W-7 on day 3 of culture (Figure 3.3.d).
Nifedipine (1 and 10/^M) had no significant effect on the outputs
of PGF2Q, PGE2 and 6-ke to - PGFpQ, on any day of culture, except for 1/iM
nifedipine which significantly (P < 0.05) increased PGF2Q output on
day 2 of culture (Figure 3.3.e). Nifedipine (100/iM) significantly (P
< 0.05) reduced PGF2Q output on all three days of culture, PGE2 output
on day 1 and day 2 of culture and 6-keto-PGFpQ output on day 1 of
culture (Figure 3.3.e).
Verapamil (l^iM) had no effect on the outputs of PGF2a, PGE2 and
6-keto-PGFpa on any day of culture (Figure 3.3.f). Verapamil (10/xM
and IOO^iM) significantly (P < 0.05) reduced PGF2a output on day 1 of
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Figure 3.3.c
Mean (± s.e.m.; n = 10) outputs (expressed as I of day 1 control (C)
output for the same PG) of PGF2Q, PGE2 and 6-keto-PGF^Q from guinea-
pig endometrium removed on day 15 of the oestrous cycle and cultured
for three days in Ca^+-containing medium, with sampling every 24h, in
the absence (controls (C) ; open columns) and presence of 100/^M
(hatched columns) and 200/iM (crossed columns) TFP.
f significantly (P < 0.05) different compared to the control value
















































Mean (± s.e.m.; n = 10) outputs (expressed as % of day 1 control (C)
output for the same PG) of PGF2Q, PGE2 and 6-keto-PGFpQ from guinea-
pig endometrium removed on day 15 of the oestrous cycle and cultured
for three days in Ca2+-containing medium, with sampling every 24h, in
the absence (controls (C) ; open columns) and presence of 150/iM
(hatched columns) and 300yuM (crossed columns) W-7.
f significantly (P < 0.05) different compared to the control value
for the same PG on the same day of culture.
















































ean (± s.e.m.; n = 10) outputs (expressed as % of day 1 control (C)
utput for the same PG) of PGF2Q, PGE2 and 6-keto-PGF^a from guinea-
ig endometrium removed on day 15 of the oestrous cycle and cultured
or three days in Ca^+-containing medium, with sampling every 24h, in
he absence (controls (C); open columns) and presence of l^M (hatched
olumns), 10/nM (crossed columns) and 100/iM (squared columns)
ifedipine.
significantly (P < 0.05) different compared to the control value
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Mean (± s.e.m.; n = 10) outputs (expressed as % of day 1 control (C)
output for the same PG) of PGF2Q, PGE2 and 6-keto-PGFpQ from guinea-
pig endometrium removed on day 15 of the oestrous cycle and cultured
for three days in Ca2+-containing medium, with sampling every 24h, in
the absence (controls (C); open columns) and presence of lpM (hatched
columns), lOpM (crossed columns), 50pM (squared columns) and lOOpM
(circled columns) verapamil.
f significantly (P < 0.05) different compared to the control value
for the same PG on the same day of culture.
culture and 10/iM verapamil significantly (P < 0.05) reduced PGF2Q
output during day 2 of culture. The outputs of PGE2 and 6-keto-PGFpQ
were not significantly changed by verapamil (10/iM and 50/iM) on days 1,
2 and 3 of culture, except 50/iM verapamil significantly (P < 0.05)
increased 6-keto-PGFpa output on day 3 of culture. Verapamil (100/iM)
significantly (P < 0.05) increased PGE2 and 6-keto-PGFpQ outputs on
days 2 and 3 of culture (Figure 3.3.f).
TPA (1, 5 and 25ng/ml) had no significant effect on the outputs
of PGF2a, PGE2 and 6-keto-PGFpa when compared to the respective
control values, from either day 7 (Figure 3.3.g) or day 15 (Figure
3.3.h) cultured guinea-pig endometrium on any day of culture.
2. Using Ca^+-depleted medium
Basal PG outputs from day 15 guinea-pig endometrium in culture
The basal outputs of PGF2Q, PGE2 and 6-keto-PGFpQ from day 15
guinea-pig endometrium cultured for three days in Ca^+-depleted medium
and in Ca^+-containing medium are compared in Figure 3.3.i. The
outputs of PGF2a and PGE2 on day 1 and day 2 of culture were
significantly (P < 0.05) reduced in Ca^+-depleted medium. The
combined outputs of PGF2a and PGE2 from endometrium cultured in Ca^+-
depleted medium decreased by 48% and 39% on days 1 and 2,
respectively. The output of 6-keto-PGFpQ was significantly (P <
0.05) reduced by 14% on day 1 of culture in Ca^"1"-depleted medium
(Figure 3 . 3 . i) .
Effect of various treatments on PG output
The effects of EGTA, TMB-8, W-7, nifedipine and verapamil on the
outputs of PGF2a, PGE2 and 6-keto-PGFpQ from day 15 guinea-pig
endometrium cultured for three days in Ca^"1"-depleted medium are
illustrated in Figures 3.3.j, 3.3.k, 3.3.1 and 3.3.m, respectively.
EGTA (2mM) significantly (P < 0.05) reduced PGF2a output on days
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Mean (± s.e.m.; n = 10) outputs (expressed as % of day 1 control (C)
output for the same PG) of PGF2Q, PGE2 and 6-keto-PGF]^Q from guinea-
pig endometrium removed on day 7 of the oestrous cycle and cultured
for three days in Ca^"1"-containing medium, sampling every 24h, in the
absence (controls (C); open columns) and presence of lng/ml (hatched
columns), 5ng/ml (crossed columns) and 25ng/ml (squared columns) TPA.

















































































Mean (± s.e.m.; n = 10) outputs (expressed as % of day 1 control (C)
output for the same PG) of PGF2a, PGE2 and 6-keto-PGFpa from guinea-
pig endometrium removed on day 15 of the oestrous cycle and cultured
for three days in Ca^+-containing medium, sampling every 24h, in the
absence (controls (C); open columns) and presence of lng/ml (hatched
columns), 5ng/ml (crossed columns) and 25ng/ml (squared columns) TPA.
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Figure 3.3 , i
Mean (± s.e.m.; n = 10) outputs of PGF2Q, PGE2 and 6-keto-PGFjQ from
guinea-pig endometrium removed on day 15 of the oestrous cycle and
cultured for three days in Ca^+-containing medium (open bars), or in
Ca^+-depleted medium (hatched bars), with sampling every 24h.
f significantly (P < 0.05) lower compared to the output from
endometrium cultured in Ca^+-containing medium for the same PG on the
same day of culture.
1 and 2 of culture and 6-keto-PGF]^Q output on day 1 of culture (Figure
3.3.j). EGTA (2mM) significantly (P < 0.05) increased 6-keto-PGF^a
output on days 2 and 3 of culture (Figure 3.3.j).
The output of PGF2q was significantly (P < 0.05) reduced on days
1 and 2, and the output of PGE2 was significantly (P < 0.05) increased
on day 1 and day 2 of culture by 100/^M TMB-8 treatment (Figure 3.3.k).
The output of 6-keto-PGFpQ was significantly (P < 0.05) increased by
100/iM TMB-8 on day 2 and day 3 of culture (Figure 3.3.k).
The output of PGF2a was significantly (P < 0.05) inhibited on
day 1 of culture by 150^iM W-7 (Figure 3.3.1). W-7 significantly (P <
0.05) increased the output of PGE2 on all three days of culture, and
significantly (P < 0.05) increased the output of 6-keto-PGFpa on days
2 and 3 of culture (Figure 3.3.1).
Nifedipine (100/iM) significantly (P < 0.05) inhibited PGF2a,
O 1
PGE2 and 6-keto-PGFpQ outputs from endometrium cultured in Cac -
depleted medium during day 1 of culture, significantly (P < 0.05)
inhibited PGF2Q and PGE2 outputs during day 2 of culture, and
significantly (P < 0.05) inhibited PGE2 output during day 3 of culture
(Figure 3.3.m). Verapamil (100/iM) significantly (P < 0.05) inhibited
PGF2q output during day 1 of culture and significantly (P < 0.05)
increased PGE2 and 6-keto-PGFpQ outputs on days 2 and 3 of culture
(Figure 3.3.m).
CONCLUSIONS
The output of PGF2Q, which is high from guinea-pig endometrium
on day 15 of the oestrous cycle and cultured in Ca^+-containing
medium, was reduced when cultured in Ca^+-depleted medium.
Endometrial PGF2Q output from day 15 cultured endometrium was also
reduced when cultured in Ca^+-containing medium and treated with EGTA
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Mean (± s.e.m.; n = 10) outputs (expressed as I of day 1 control (C)
output for the same PG) of PGF2q> PGE2 and 6-keto-PGFla from guinea-
pig endometrium removed on day 15 of the oestrous cycle and cu ture
for three days in Ca2+-depleted medium, with sampling every 24h in
the absence (controls (C) ; open columns) and presence (hatched
columns) of 2mM EGTA.
f significantly (P < 0.05) different compared to the control value
for the same PG on the same day of culture.
Day 1 Day 2 Day 3
Figure 3.3.k
Mean (± s.e.m.; n = 10) outputs (expressed as % of day 1 control (C)
output for the same PG) of PGF2a, PGE2 and 6-keto-PGFla from guinea-
pig endometrium removed on day 15 of the oestrous cycle and cu ture
for three days in Ca2+-depleted medium, with sampling every 24h, in
the absence (controls (C) ; open columns) and presence (hatched
columns) of lOOjiM TMB-8.
f significantly (P < 0.05) different compared to the control value
for the same PG on the same day of culture.
Day 1 Day 2 Day 3
Figure 3.3.1
Mean (± s.e.m.; n = 10) outputs (expressed as % of day 1 control (C)
output for the same PG) of PGF2q, PGE2 and 6-keto-PGFla from guinea-
pig endometrium removed on day 15 of the oestrous cycle and cultured
for three days in Ca2 + -depleted medium, with sampling every 24h, in
the absence (controls (C) ; open columns) and presence (hatched
columns) of 150/iM W-7.
f significantly (P < 0.05) different compared to the control value




























































Mean (± s.e.m.; n = 10) outputs (expressed as % of day 1 control (C)
output for the same PG) of PGF2q., PGE2 and 6-keto-PGF^Q from guinea-
pig endometrium removed on day 15 of the oestrous cycle and cultured
for three days in Ca^+-depleted medium, with sampling every 24h, in
the absence (controls (C); open columns) and presence of 100/xM
nifedipine (hatched columns) and 100/iM verapamil (crossed columns),
f significantly (P < 0.05) different compared to the control value
for the same PG on the same day of culture.
(which chelates Ca^+), and with the intracellular Ca^+ antagonist,
TMB-8. Treatment with EGTA and TMB-8 also caused a further small
reduction in PGF2Q output from endometrium cultured in Ca^+-depleted
medium. These findings show that the high output of PGF2a from day
15 endometrium in culture is dependent on the presence of Ca^+, and
that the Ca^+ required is primarily extracellular in source.
The high output of PGF2Q from day 15 cultured endometrium was
reduced by treatment with the calmodulin inhibitors W-7 and, to a
lesser degree, TFP when cultured in Ca^+-containing medium, and also
by W-7 treatment in Ca^+-depleted medium. This suggests that
calmodulin is necessary for maintenance of the high output of PGF2a
from day 15 guinea-pig endometrium in culture.
At low concentrations of nifedipine (1 and lO^tM) and of
verapamil (l^M) (concentrations which normally block voltage - dependent
calcium channels), there was no change in PGF2a output from cultured
day 15 endometrium. However, at higher concentrations of nifedipine
(100/iM) and verapamil (10 and lOOpM) there was some inhibitory effect
on PGF2Q output. This inhibitory action on PGF2Q output was also
present in Ca2+-depleted medium, suggesting that the effect was due to
an intracellular action of the compounds and was not due to the
blocking of voltage-dependent calcium channels.
The removal of extracellular Ca^+ inhibited the outputs of PGE2
and 6-keto-PGFqQ, but these outputs were inhibited to a lesser degree
than the inhibition of PGF2a output. However, TMB-8, TFP, W-7,
verapamil and, to a lesser extent, EGTA all stimulated PGE2 and 6-
keto-PGFpQ outputs, and therefore have apparently opposing actions on
the production of different PGs. Nifedipine at the highest
concentration used (100/jM) did not exhibit this opposing action on the
production of different PGs, but exhibited an inhibitory effect on all
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PGs.
The outputs of PGF2a, PGE2 and 6-keto-PGFpQ were not changed by
treatment with TPA; these findings indicate that protein kinase C is
not involved in the stimulation of endometrial PGF2a synthesis.
DISCUSSION
9-4-
Endometrial PGF2a output was inhibited by culturing in CaiT-
depleted medium, and also in Ca2+-containing medium with the addition
of EGTA. This suggests that extracellular calcium is necessary for
the stimulation of PGF2Q output. Treatment with TMB-8, an
intracellular calcium antagonist, also exhibited an inhibitory action
of PGF2a output. This action of TMB-8 may either be due to an
inhibitory effect on extracellular calcium that enters the cell, by
making it unavailable for its PGF2Q stimulating activity, or an effect
on intracellular calcium already present in the cell. As TMB-8
caused a further slight inhibition of PGF2Q output in Ca2+-depleted
medium, TMB-8 may be acting by a combination of both mechanisms.
Scharff and Foder (1984) reported that the effects of TMB-8 are not
totally specific on intracellular calcium stores. At high
concentrations, TMB-8 decreased calmodulin sensitivity of red blood
cell Ca2+-ATPase, a model which is devoid of intracellular Ca^+
stores, and calmodulin has also been implicated in the control of
PGF2q output from the guinea-pig uterus. Also TMB-8 altered
phosphatidylinositol labelling, an effect usually related directly to
effects on the plasma membrane (Uchida, Filburn and Sacktor, 1984),
suggesting TMB-8 may inhibit membrane bound PLA2 directly. Donowitz,
Cusolito and Sharp (1986) showed a maximal effect of TMB-8 (50/iM) in
increasing active Na+ and CI" absorption by rabbit ileum. They
reported that the effects of TMB-8 at this order of concentration
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appeared to be consistent with an action to trap calcium within
intracellular stores, and TMB-8 did not appear to change Ca^+ entry.
The concentrations of TMB-8 used are similar to those examined in this
thesis, and it appears that other effects of TMB-8 on PGF2a output
(e.g. action via calmodulin and via direct membrane effect) may not be
significant.
EGTA treatment also caused a further slight inhibition of PGF2a
output from endometrium cultured in Ca^+-depleted medium. Therefore,
EGTA may possess both an intracellular and extracellular effect, or
its action may be due to a chelation of any residual calcium in the
extracellular medium, and any calcium that is released from the tissue
during culture. However, structural changes occur in HeLa and human
fibroblast cells, which manifest themselves as an increase in the
number of microvilli and the appearance of surface blebs when treated
with EDTA (Moskalewski and Thyberg, 1981). EDTA is a close chemical
analogue of EGTA so a contributing factor in the inhibitory effect of
EGTA in both Ca2+-containing and Ca^+-depleted medium may be due to
non-specific structural changes in the endometrial cells.
The high basal output of PGF2Q from day 15 guinea-pig
endometrium was inhibited by the calmodulin inhibitors W-7 and, to a
lesser extent, TFP, suggesting that calmodulin is involved in the
stimulation of PLA2 activity and hence PG synthesis. However,
whether the interaction of calmodulin with PLA2 i-s necessary to
stimulate PLA2 activity is controversial. Withnall and Brown (1982)
reported that several drugs that act as calmodulin antagonists,
including TFP, inhibit pancreatic PLA2 activity directly. They
proposed that calmodulin was not involved in the stimulation of
pancreatic PLA2■ However, a study by Gerritsen, Nganele and
Rodrigues (1987) reported that TFP inhibited the activity of porcine
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pancreatic PLA2• Ballou and Cheung (1983) also reported that
calmodulin demonstrated no stimulatory activity on purified platelet
PLA2 • Also, calmodulin exhibited no stimulatory effect on membrane -
bound or purified PLA2 from mitochondria when an endogenous substrate
was used (t ^C]-ethanolamine- labelled mitochondria); Calmodulin
exhibited only a small (20%) stimulatory action on PLA2 using an
endogenous substrate (deWinter, Korpancova and Van den Bosche, 1984).
Watanabe, Hashimoto, Teramoto, Kuma, Naito and Oka (1986) showed that
platelet PLA2 was stimulated by acidic phospholipids (such as
phosphatidic acid and phosphatidylserine) but not by calmodulin, in a
calcium-dependent manner. The calmodulin inhibitors TFP and W-7
inhibited this stimulation of PLA2 by an inhibition of calcium binding
to the acidic phospholipids.
The affinity j^of phenothiazines, of which TFP is a derivative, is
related to their hydrophobicity, and they possess greater affinity in
the presence of Ca^+, an effect which is probably due to modified
exposure of hydrophobic areas in the Ca^+-bound conformation of
calmodulin. A calcium-induced conformational change of calmodulin
has been detected by -'-H-NMR spectroscopy (Ikura, Hiraoki, Hikichi,
Mikuni, Yazawa and Yagi, 1983). The interaction of TFP with
calmodulin was investigated by Dalgarno, Klevit, Levine, Scott,
Williams, Gergely, Grabarek, Leavis, Grand and Drabikowski (1984), and
it was determined that the TFP-induced inhibition of the biological
activity of calmodulin is apparently due to conformational
restrictions caused by the binding of TFP. They proposed that TFP
restricts the conformations of calmodulin in which (,a) Ca^"r is
released and (b) calmodulin interacts with its partner protein/enzyme.
Sutoo, Akiyama, Fujii and Matsushita (1986) demonstrated that the
conformational changes of calmodulin produced by W-7, when calmodulin
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was fully bound with Ca^+, were similar to TFP, but they suggested
that W-7 may also possess a further binding site. From this
evidence, both TFP and W-7 bind to calmodulin and inhibit its
biological effect. Phospholipase A2 enzymes have been demonstrated
to be regulated by several mechanisms, and not every PLA2 has been
demonstrated to require calmodulin. Extracellular pancreatic PLA2
has a much higher enzymic activity than cellular PLA2> anc* also
platelet PLA2 may he controlled by other mechanisms.
Nifedipine and verapamil at concentrations that normally block
voltage-dependent calcium channels (Godfraind, Miller and Wibo, 1986)
had no effect on basal PGF2Q output from cultured day 15 endometrium.
However, nifedipine (100/iM) had a marked inhibitory effect and
verapamil (10-100/uM) also exhibited an inhibitory action on basal
PGF2a output, but this effect was smaller and was only significant
sometimes. This inhibitory effect of verapamil and nifedipine on
PGF2a output was also present in Ca^+-depleted medium, indicating that
it is not due to a voltage - dependent calcium channel blocking action
and that extracellular calcium is not involved. In a NMR study
examining interactions with calmodulin, the verapamil derivative,
D600, bound to and inhibited the action of calmodulin (Andersson,
Drakenberg, Thulin and Forsen, 1983). Nifedipine (10-440pM) also
partially inhibited calmodulin activated cAMP phosphodiesterase
activity (Minocherhomjee and Roufogalis, 1984). Calmodulin activates
calmodulin-deficient phosphodiesterase and Schlondorff and Satriano
(1985) demonstrated that this activation was inhibited by the
verapamil derivative, D600 (lOO^m). This inhibitory effect was
overcome by increasing the calmodulin concentration. Nifedipine (15-
30/iM) also inhibited phosphodiesterase activity but this inhibitory
effect was not overcome by adding calmodulin. This suggests that
verapamil, but not nifedipine acts via the inhibition of calmodulin.
This may be further and indirect evidence that implicates calmodulin
as a mediator of endometrial Ca2+-stimulated PGF2a synthesis.
Furthermore, Chang, Blazek and Carlson (1987) proposed that nifedipine
may ■ inhibit P'LA.2 activity directly, when using semi-purified
preparations of PLA2 obtained from platelets and mouse peritoneal
macrophages, an action that is independent of its channel blocking
activity. However, they appeared not to have considered the report
of Hope, Welton and Swislocki (1986) that PLA2 preparations may be
contaminated with calmodulin. Therefore, this may not be a direct
inhibitory effect of nifedipine on PLA2 but rather via an action on
calmodulin. Godfraind, Miller and Wibo (1986) concluded that
dihydropyridine derivatives (e.g. nifedipine) have a very low affinity
for calmodulin and only at high concentrations, as used in this
present study was there any interaction with calmodulin. Erdreich
and Rahamimoff (1987) proposed that verapamil at high concentrations
(up to 200/iM) binds non-specifically to phospholipid layers and this
effect may cause intracellular effects on membrane-bound proteins.
Therefore, verapamil (at the highest concentration used in this study)
may inhibit PLA2, a membrane bound protein, by a direct effect via the
membrane.
Paradoxically, TMB-8, TFP, W-7, verapamil, and also but to a
lesser extent, EGTA stimulated the outputs of PGE2 and 6-keto-PGFpQ
from day 15 cultured endometrium. In previous studies (Poyser,
1985a,b), TMB-8, TFP and W-7 caused a small stimulation of the basal
outputs of PGF2Q, PGE2 and 6-keto-PGFpQ from the guinea-pig uterus
superfused in vitro. TMB-8, TFP and W-7 appear to possess opposing
actions on PG synthesis and release, although the inhibitory action on
PGF2q is predominant in the tissue culture studies. Verapamil and
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EGTA also exhibit similar opposing stimulatory and inhibitory effects
on PG output, whereas nifedipine was the only compound investigated in
this study which exhibited solely an inhibitory action on the
synthesis of all PGs. Nifedipine may therefore possess a direct
inhibitory effect on PLA2 (Chang, Blazek and Carlson, 1987). A
similar stimulatory effect on the synthesis of PGE2 and 6-keto-PGFpa
by calcium channel blockers (including verapamil) has also been
reported in cultured rat cardiac myocytes (Escoubet, Griffaton, Samuel
and Lechat, 1986). This effect was suggested to be independent of
calcium channel blocking activity. Interestingly, TFP exhibited a
greater stimulatory action on PGE2 and 6-keto-PGFpQ outputs than the
other compounds investigated, which may explain its lesser inhibitory
action on PGF2Q output from cultured day 15 guinea-pig endometrium.
Indeed, TFP has been demonstrated to stimulate arachidonic acid
release from phosphatidylcholine and phosphatidylethanolamine in
guinea-pig macrophages, and this is presumably available for PG
synthesis (Takenawa, Homma and Nagai, 1982).
Lipocortin inhibits PLA2 activity (Blackwell and Flower, 1983),
and a lipocortin-like protein in platelets is phosphorylated by
protein kinase C, which causes inactivation of its PLA2 inhibitory
action (Touqui, Rothhut, Shaw, Fradin, Vargaftig and Russo-Marie,
1986) . However PG outputs were unaltered by TPA treatment of day 7
and 15 guinea-pig endometrium in culture, so PLA2 activity in this
tissue is not normally controlled by protein kinase C-inactivated,
lipocortin-like protein. Kojima, Kojima and Rasmussen (1985)
investigated the effect of TMB-8 on isolated adrenal glomerulosa cells
and they showed that TMB-8 inhibited the activity of protein kinase C
directly. However, in this study TPA has no effect on PG production
by the guinea-pig endometrium in culture and so this secondary effect
109
of TMB-8 on protein kinase C is not significant.
Overall, the results in this section have shown that Ca^+ is
required for the high output of PGF2a from cultured, day 15 guinea-pig
endometrium, and also, but to a lesser extent, for the outputs of PGE2
and 6-keto-PGF^a. The primary source of this Ca^+ is extracellular
in origin but the Ca^+ does not enter the cells by voltage-dependent
Ca^+ channels. Calmodulin has also been implicated in the control of
PGF2q output, but the control of PLA2 by a lipocortin-like protein
appears not to be involved.
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3.4 SYNTHESIS OF CELLULAR AND SECRETED PROTEINS BY GUINEA-PIG
ENDOMETRIUM IN CULTURE
INTRODUCTION
Oestradiol acting on a progesterone-primed uterus appears to be
the stimulus for the increase in PGF2Q output towards the end of the
oestrous cycle in the guinea-pig (Blatchley and Poyser, 1974; Poyser,
1983b). These ovarian steroids have well-documented stimulatory
effects upon tissue metabolism, differentiation and growth in the
female reproductive tract. The primary pathway by which oestradiol
and progesterone exert their effects is by stimulating the production
of specific RNAs that carry the information required for the synthesis
of new proteins which produce the physiological changes (Bremner and
West, 1975). Both oestradiol and progesterone have been shown to
stimulate protein synthesis in endometrium, in culture, from the cow
(Bartol, Roberts, Bazer and Thatcher, 1985), human (Strinden and
Shapiro, 1983), rabbit (Rajkumar, Bigsby, Lieberman and Gershenson,
1983), rat (Komm, Keeping, Sabogal and Lyttle, 1985), and sheep
(Miller, Murphy and Stone, 1975), and also in the foetal guinea-pig
uterus (Sumida and Pasqualini, 1981). Poyser (1979) has shown that
the intra-uterine injection of actinomycin D, an inhibitor of DNA-
dependent RNA synthesis inhibits PGF2Q production by homogenates of
the guinea-pig uterus. It was proposed that changes in protein
synthesis (controlled by ovarian steroids) could control PG production
by the guinea-pig uterus.
This study has investigated the incorporation of [^H]-leucine
into cellular and secreted proteins synthesised by the guinea-pig
endometrium removed on day 7 and day 15 of the oestrous cycle and
cultured for up to 24h. The aims of the experiment are:-
(a) to examine whether de novo protein synthesis occurs in
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endometrium in culture.
(b) if protein synthesis does occur, to investigate the rates of
synthesis of cellular and secreted proteins by day 7 and day 15
cultured endometrium, and whether these rates change over 24h.
(c) if protein synthesis does occur, to determine a suitable period
of culture during which the effects of protein synthesis inhibitors
and steroids on protein synthesis can be investigated (see sections
3.5 and 3.6, respectively).
METHODS
Five day 7 and five day 15 guinea-pigs were killed and their
uteri removed in preparation for tissue culture (section 2.2.1). For
each uterus, endometrium was separated from the myometrium and six
Petri dishes were prepared for tissue culture, each dish containing
between 30 and 60mg endometrium (section 2.2.5). Each dish also
contained lOj/Ci [^Hj-leucine (2.5^Ci/ml) according to section 2.4
(i.e. the method for the measurement of protein synthesis). These
dishes were placed in a modified Kilner jar which was gassed and
incubated according to section 2.2.5. Immediately after the jar was
placed in the incubator, 30-60mg of the remaining endometrium was
placed in another Petri dish (which also contained 10/^Ci [^H]-leucine)
according to the tissue culture method above. The endometrium in the
dish was washed with the [ ]-leucine - containing medium using a
Pasteur pipette and was incubated for 2 min at room temperature. The
endometrium was removed and weighed accurately. Then the procedure
for measuring [^H]-leucine incorporation into cellular and secreted
proteins was followed for this tissue and the medium in the dish
(section 2.4). This endometrium and culture medium measured the non¬
specific binding of [^H]-leucine that was retained in the multiple
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stage process to measure [^H]-leucine incorporation into cellular and
secreted proteins, respectively.
After lh, 2h, 4h, 8h, 12h and 24h, one dish was removed from the
Kilner jar at each time, and the remaining dishes were replaced in the
jar which was then regassed and incubated as specified above (except
at 24h). The amounts of [^H]-leucine incorporated into endometrial
cellular and secreted proteins was measured as described in section
2.4 from each of the dishes as they were removed.
Analysis of results
All results were expressed as cpm/mg tissue/10^ standard counts.
For each set of dishes, the respective non-specific binding counts
(measured after 2 min) for cellular and secreted proteins were
subtracted from their corresponding incorporated counts measured
between lh and 24h. The line of best fit for [^H]-leucine
incorporation into total secreted and cellular proteins on day 7 and
day 15 was calculated by linear regression analysis (r > 0.98 in all
cases). Student's 't' test was used to compare the amounts of [^H]-
leucine incorporated into cellular and secreted proteins by cultured
endometrium removed on day 7 and day 15 of the oestrous cycle after
each period in culture.
RESULTS
The incorporation of [^H]-leucine into newly synthesised
cellular and secreted proteins by guinea-pig endometrium removed on
day 7 and day 15 of the oestrous cycle and cultured for up to 24h is
shown in Figure 3.4.a. The incorporation of [^H]-leucine into
cellular and secreted proteins during the 24h culture period was
linear by both day 7 and day 15 endometrium. There were no











Time course of [^H]-leucine incorporation into cellular and secreted
proteins by day 7 and day 15 guinea-pig endometrium in culture for up
to 24h (mean ± s.e.m.; n = 5) .
* significantly (P < 0.05) higher than [^H]-leucine incorporation into
proteins secreted by day 7 endometrium after the same period in
culture.
into cellular proteins by day 7 and day 15 endometrium at any time
during the culture period. However, after 4h and for the remainder
of the 24h culture period, significantly (P < 0.05) more [^H]-leucine
was incorporated into secreted proteins by day 15 endometrium than by
day 7 endometrium.
CONCLUSIONS
Radiolabelled leucine was incorporated into cellular and
secreted proteins by the guinea-pig endometrium in culture, which
showed that de novo protein synthesis occurred in this preparation.
Fresh protein synthesis of both total cellular and secreted proteins
occurred at a constant rate during the 24h period in culture, which is
shown by the linear plots of [3H]-leucine incorporation. There was
no difference in the rates of synthesis of cellular proteins between
day 7 and day 15 endometrium during 24h in culture. However, there
was a significantly (P < 0.05) higher rate of synthesis of secreted
proteins by the day 15 endometrium. After 24h of culture, the amount
of secreted protein synthesised by day 15 endometrium was 2.8-fold
greater than by day 7 endometrium. From these data, the optimum
period for culturing endometrium and treating with various factors to
investigate changes in the rate of protein synthesis is 24h. The
rate of [^H]-leucine incorporation into both cellular and secreted
proteins by day 7 and day 15 endometrium is constant during 24h in
culture (demonstrated by linear plot), and by using longer periods of
culture, it is easier to determine changes in the rates of protein
synthesis.
DISCUSSION
This study has shown that fresh protein is synthesised by the
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guinea-pig endometrium in culture, and that the rates of synthesis of
cellular and secreted protein are linear during the 24h culture
period. This is in agreement with Strinden and Shapiro (1983) who
showed a linear incorporation of [^H]-leucine into cellular and
secreted proteins synthesised by the human proliferative endometrium
in organ culture for at least lOh and then up to 20h. Bartol,
Roberts, Bazer and Thatcher (1985) have shown that the bovine
endometrium in culture can be maintained successfully for periods of
at least 24h for recovery of proteins synthesised and released into
the medium. This is in agreement with the findings presented here,
where the rates of protein synthesis were constant for 24h. Bartol,
Roberts, Bazer and Thatcher (1985) also suggested that endometrial
tissues in this short term explant culture reflect the same metabolic
state of the tissues wJiicJ) existed fn vivo prior to removal. This
is also compatible with PG production from guinea-pig endometrium in
culture for 24h presented in section 3.1, where PGF2Q production is
high from day 15 and low from day 7 tissue, reflecting the ija vivo
state at the time of removal.
It is conceivable that the newly synthesised secreted proteins
measured are cellular proteins released into the medium by cell lysis.
However, Strinden and Shapiro (1983) showed that the majority of
proteins secreted from the human proliferative endometrium are
glycoproteins, which are not like the cellular proteins synthesised.
Komm, Rusling and Lyttle (1986) investigating immature rat uterus in
organ culture also showed that proteins, which were newly synthesised
and then released into the medium, were different from newly
synthesised cellular proteins. This indicates cell lysis is not a
major contributory factor in the release of radiolabelled proteins
into the culture medium.
115
There were no differences in the rates of cellular protein
synthesis between day 7 and day 15 endometrium in culture but there
was a greater rate of synthesis of secreted proteins from day 15 when
compared to day 7 endometrium in culture. However, this technique is
unable to distinguish between an increase in the general rate of
synthesis of all secreted proteins and an increase in the production
of specific secreted proteins. Furthermore, synthesis of specific
proteins may be stimulated or inhibited at different stages of the
cycle which may not change the measured rate of overall protein
synthesis, but the actual proteins being synthesised would be very
different. Proteins synthesised by the endometrium during the
menstrual cycle of the human (Bell, Patel, Kirwan and Drife, 1986) and
the oestrous cycle of the cow (Bartol, Roberts, Bazer and Thatcher,
1985) vary at different stages of the cycle.
The results presented in this study show that de novo protein
synthesis occurred in the guinea-pig endometrium and that this
preparation could be maintained for 24h in culture to measure total
cellular and secreted protein synthesis. There was no difference in
the total amounts of cellular proteins synthesised by day 7 and day 15
culture endometrium, but more secreted proteins were synthesised by
day 15 cultured endometrium.
116
3.5 THE ROLE OF PROTEIN SYNTHESIS IN THE CONTROL OF PG PRODUCTION
BY THE GUINEA-PIG UTERUS
INTRODUCTION
Oestradiol acting on a progesterone-primed uterus is probably
the physiological stimulus that causes the relatively specific
increase in PGF2a output from the guinea-pig uterus towards the end of
the oestrous cycle (Poyser, 1983b). Many of the actions of
oestradiol are mediated by an increase in protein synthesis (Brenner
and West, 1975). Previous studies in the sheep (French and Casida,
1973) and in the guinea-pig (Poyser, 1979) have shown that the intra¬
uterine administration of actinomycin D, an inhibitor of DNA-dependent
RNA synthesis, increases oestrous cycle length. In the study in the
guinea-pig, Poyser (1979) showed that the in vitro PGF2Q and PGE2
synthesizing capacities of homogenates of the uterus were reduced by
intra-uterine actinomycin D treatment. This was reflected _in vivo by
increased peripheral plasma progesterone concentrations, presumably
due to an inhibition of the production of the luteolytic factor
(PGF2Q), therefore prolonging luteal function.
Recently, there has been much interest shown in the production
of proteins both by the uterus and by the conceptus in early
pregnancy, and the ability of these proteins to control PG synthesis.
The lipocortins, PLA2 inhibitory proteins, have been shown to be
produced by the human endometrium in culture (Gurpide, Markiewicz,
Schatz and Hirata, 1986). Proteins with an inhibitory action on
prostaglandin production have been shown to be produced by the embryo
in early pregnancy in the cow (Knickerbocker, Thatcher, Bazer, Drost,
Barron, Fincher and Roberts, 1986) and in the sheep (Fincher, Bazer,
Hansen, Thatcher and Roberts, 1986).
Inhibitors of protein and RNA synthesis have been used to
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investigate whether protein and RNA synthesis are necessary for a
variety of physiological functions. If an inhibitor of protein or
RNA synthesis alters such a function, it is inferred that the
production of a protein(s) is required in controlling this
physiological function, and other metabolic functions are not affected
(Fagan and Goldberg, 1986). It is possible, therefore, that a
protein is the mediator in the action of oestradiol in the stimulation
of PGF2q synthesis.
The next series of experiments have examined the role of protein
synthesis in the control of PG synthesis in the guinea-pig uterus.
The effects of the in vivo and iui vitro treatment with protein and RNA
synthesis inhibitors on PG outputs from, PG synthesising capacities
of, and protein synthesis by cultured and superfused, guinea-pig
uterine tissues have been investigated. The aims of this series of
experiments are: -
(a) to investigate whether protein synthesis is inhibited in the
endometrium by inhibitors of protein- and RNA-synthesis by measuring
the incorporation of [^H]-leucine into proteins synthesised by the
endometrium in culture.
(b) to investigate the actions of protein and RNA synthesis
inhibitors on PG outputs from and synthesising capacities of day 7 and
day 15 endometrium in culture.
(c) to investigate whether protein and RNA synthesis inhibitors have
a rapid (i.e. less than lh) inhibitory effect on PG synthesis by the
guinea-pig uterus. A rapid inhibitory effect on PG production has
been previously reported in skeletal muscle preparations (Turinsky,
1985; Fagan and Goldberg, 1986).
(d) to investigate the effects of the intra-uterine injection of
actinomycin D on day 10 of the oestrous cycle on PG production and
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protein synthesis by the guinea-pig uterus on day 15 of the oestrous
cycle.
3.5.1 THE EFFECTS OF PROTEIN AND RNA SYNTHESIS INHIBITORS ON PG
PRODUCTION AND FRESH PROTEIN SYNTHESIS BY THE GUINEA-PIG
ENDOMETRIUM IN CULTURE
INTRODUCTION
This experiment has investigated the role of actinomycin D (a
DNA-dependent RNA synthesis inhibitor), cycloheximide (an inhibitor of
the elongation step of protein transcription), and puromycin (an
inhibitor of the synthesis of proteins by releasing nascent
polypeptide chains before their synthesis is complete) on the PG
outputs from and PG synthesising capacities (measured in homogenates)
of cultured guinea-pig endometrium. The synthesis of cellular and
secreted proteins has already been shown to occur in cultured guinea-
pig endometrium in section 3.4. This section has also examined the
actions of actinomycin D, cycloheximide and puromycin on this protein
synthesis by endometrium in culture.
METHODS
Guinea-pigs on day 7 and day 15 of the oestrous cycle were
killed and their uteri were removed in preparation for tissue culture,
as described in section 2.2.1. Endometrium was dissected from the
myometrium and small pieces were placed in Petri dishes as detailed in
the tissue culture method (section 2.2.5). In Experiments 1 and 2,
each dish contained 12-20mg endometrium and, in Experiment 3,
additional dishes contained 30-60mg endometrium. The dishes were
incubated in modified Kilner jars in the conditions described
previously (section 2.2.5). All the tissue culture samples and ethyl
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acetate extracts of the homogenate samples from Experiments 1 and 2
were stored at -20°C before the amounts of PGF2Q, PGE2 and 6-keto-
PGF1q were measured by radioimmunoassay (section 2.3).
The details of each experiment are explained below. All
protein synthesis inhibitors were administered in 50//1 sterile saline.
Experiment 1: Effects of protein synthesis inhibitors on PG outputs
from guinea-pig endometrium cultures for 24h
The uteri from five day 7 and five day 15 guinea-pigs were
removed and endometrium from each uterus was used to prepare eighteen
Petri dishes for tissue culture (see above). The dishes were treated
as follows: four dishes remained untreated (controls) and the
remaining fourteen dishes were divided into seven pairs and these
pairs were treated with one of the following concentrations of protein
or RNA synthesis inhibitors; actinomycin D (1, 10 and 50/ig/ml) ;
cycloheximide (10 and 50/xg/ml) ; puromycin (10 and 50/ig/ml). These
dishes were divided equally between two modified Kilner jars, so that
there were two control dishes and one of each of the seven duplicate
treatments in each jar (i.e. nine dishes/jar). These jars were
gassed and incubated as specified above for 24h. The medium was
removed every 6h, and the dishes were replenished with fresh medium
and the same treatment. The dishes were replaced in the jars which
were gassed and incubated as above.
Experiment 2: Effects of protein synthesis inhibitors on PG outputs
from and PG synthesisinp; capacities of guinea-pig, endometrium in
culture for up to 12h
The uteri from five day 7 and five day 15 guinea-pigs were
removed and endometrium from each uterus was used to prepare sixteen
Petri dishes for tissue culture (see above). These dishes were
divided into four groups of four, and each group was treated as
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follows. One group of dishes was left untreated (controls), and the
remaining groups of dishes were treated with one of the following:
actinomycin D (50/ig/ml); cycloheximide (10/jg/ml) ; puromycin
(50/jg/ml). The dishes were divided equally between two modified
Kilner jars, so each jar contained two dishes from each group (i.e. 8
dishes/jar), and the jars were gassed and incubated as specified above
for up to 12h.
Immediately after the jars were placed in the incubator, two
amounts of the remaining endometrium, each weighing approximately 12-
20mg, were weighed accurately, homogenised and incubated for 60 min
with 2/ig sodium arachidonate (prepared in lOpl ethanol) as described
previously (section 2.2.4.ii). These two homogenates measured the
control PG synthesizing capacities of the endometrium at Oh. PGs
were extracted from the incubates and were then redissolved in 5ml
ethyl acetate as described in section 2.2.2.
After 6h of incubation, one control dish and one dish containing
each treatment was removed from each jar (i.e. four dishes removed
from each jar and eight dishes were therefore removed in total). The
medium was harvested from the remaining dishes and replaced with fresh
medium containing the same concentration of protein synthesis
inhibitors. These dishes were replaced in the jars, which were
gassed and incubated as before for a further 6h. After a total of
12h of incubation, these dishes were also removed.
Immediately after the dishes were removed from the jars at 6h
and 12h, the endometrium was weighed, homogenised and incubated for 60
min with 2/xg sodium arachidonate as for the measurement of the Oh
control endometrial PG synthesizing capacities as described above.
The PGs were extracted and stored in 5ml ethyl acetate as above.
These homogenates measured the PG synthesizing capacities of
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endometrial homogenates after 6h and 12h of culture. The culture
medium was collected for measurement of PG output.
Experiment 3: Effects of protein synthesis inhibitors on endometrial
protein synthesis
The uteri were removed from five day 7 and five day 15 guinea-
pigs and endometrium from each uterus was placed in four Petri dishes
for tissue culture (as explained above). Each dish contained 30-60mg
endometrium and 10/iCi [^H] -leucine (2.5/iCi/ml) as specified in the
procedure for measuring protein synthesis (section 2.4). The dishes
were placed in a modified Kilner jar, which was gassed and incubated
for 24h in the conditions given in section 2.2.5.
As soon as the jar was placed in the incubator, between 30 and
60mg of the remaining endometrium was placed in another Petri dish
containing [3^]-leucine (2.5pCi/ml) as in the method for the
preparation for tissue culture as above. The tissue was washed with
the []-leucine - containing culture medium in the dish. After 2 min
incubation at room temperature, the endometrium was removed and
weighed. The procedures detailing the measurement of [^H]-leucine
incorporation into cellular and secreted proteins by endometrial
tissue were then followed, as detailed in section 2.4. The results
from this dish measured the non-specific binding of [3H]-leucine
during the procedures used to measure [^H]-leucine incorporation into
cellular and secreted proteins.
The other dishes were removed from the jar after 24h of culture.
The incorporation of [3H]-leucine into cellular and secreted proteins
was measured by analysing the endometrium and culture medium,
respectively, as detailed in section 2.4.
Statistical analysis and calculations
All statistical comparisons were made using Student's ' t' test
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(or a modified 't' test if the variances were unequal as shown by the
variance ratio F-test). In Experiment 3, the amounts of [^H]-leucine
which were bound non-specifically, and retained during the measurement
of cellular and secreted proteins were subtracted from the values for
the amounts of [3H]-leucine which were incorporated into the same type
of protein synthesised during the 24h in culture. Also in Experiment
3, results were compared using the paired 't' test.
RESULTS
Experiment 1: Effects of protein synthesis inhibitors on PG outputs
from guinea-pig endometrium cultured for 24h
The basal, control outputs of PGF2Q, PGE2 and 6-keto-PGFpa from
day 7 and day 15 guinea-pig endometrium cultured for 24h, with
sampling every 6h, have been previously reported in detail in section
3.1 (see figure 3.1.b). The outputs of PGF2Q and PGE2 from day 7
guinea-pig endometrium in culture were not significantly changed by
actinomycin D treatment (1, 10 and 50^g/ml) during the first 6h of
culture or by actinomycin D (lpg/ml) treatment throughout the culture
period when compared to the respective control output value at the
same time (Figure 3.5.1.a). The output of PGF2Q was significantly (P
< 0.05) inhibited by 10 and 50/ig actinomycin D/ml treatment, during
the three remaining sample periods between 6h and 24h of culture.
The output of PGE2 was significantly (P < 0.05) inhibited by
actinomycin D (50pg/ml) treatment between 6h and 12h of culture, and
by actinomycin D (10 and 50/jg/ml) treatment between 12h and 18h, and
18h and 24h of culture (Figure 3.5.1.a). Actinomycin D treatment
exhibited no significant effect on 6-keto-PGFqa output during 24h of
culture of day 7 guinea-pig endometrium (Figure 3.5.1.a).
The output of PGF2a from day 15 endometrium cultured for 24h was
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Figure 3.5.1. a
Mean (± s.e.m.; n = 10) outputs of PGF2Q, PGE2 and 6-keto-PGF^q, from
day 7 guinea-pig endometrium cultured for 24h (sampling every 6h) and
not treated (control (C); open columns) or treated with 1/ig/ml
(hatched columns), 10/ig/ml (crossed columns) and 50/xg/ml (squared
columns) actinomycin D.
f significantly (P < 0.05) lower than corresponding control value
for the same PG during the same time period.
not significantly changed by actinoraycin D (1 and 10/ig/ml) treatment
throughout the culture period, except for 10/ig actinomycin D/ml,
treatment which significantly (P < 0.05) inhibited PGF2a output
between 18h and 24h of culture (Figure 3.5.1.b). Actinomycin D
(50/jg/ml) treatment significantly (P < 0.05) inhibited PGF2Q output
from day 15 endometrium during all four sample periods between 0 and
24h of culture. The output of PGE2 from day 15 endometrium was not
significantly altered by actinomycin D (1 and 10/ig/ml) treatment, but
PGE2 output was significantly (P < 0.05) inhibited by 50/ig actinomycin
D/ml treatment during all four sample periods in the 24h period of
culture (Figure 3.5.1.b). Actinomycin D (1 and 10/ig/ml) treatment
had no significant effect on 6-keto-PGFpa output throughout the 24h of
culture, except for 10/ig actinomycin D/ml treatment which
significantly (P < 0.05) inhibited 6-keto-PGF^Q output from day 15
endometrium between 12h and 18h of culture (Figure 3.5.1.b).
Actinomycin D (50/ig/ml) treatment significantly (P < 0.05) inhibited
6-keto - PGF;lq output between 0 and 6h, 6h and 12h and 12h and 18h of
culture (Figure 3.5.1.b).
Cycloheximide (10 and 50/ig/ml) treatment had no significant
effect on PGF2q. output from day 7 guinea-pig endometrium during the
first 6h of culture (Figure 3.5.1.c). However, in the following
three sample periods between 6h and 24h, cycloheximide treatment at
both concentrations significantly (P < 0.05) inhibited the increase in
PGF2a output as exhibited by the control values, and indeed further
inhibited PGF2Q output when compared to the 0-6h control PGF2a output.
Paradoxically the output of PGE2 was significantly (P < 0.05)
stimulated by 50/ig cycloheximide/ml treatment, but not by 10/ig
cycloheximide/ml treatment, during the first 6h of culture (Figure
3.5.l.c). Cycloheximide treatment (both concentrations) had no
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Figure 3 . 5 .1 ,b
Mean (± s.e.m.; n = 10) outputs of PGF2Q> PGE2 and 6-keto-PGF^Q from
day 15 guinea-pig endometrium cultured for 24h (sampling every 6h) and
not treated (control (C) ; open columns) or treated with l^ig/ml
(hatched columns) , 10^ig/ml (crossed columns) and 50|ig/ml (squared
columns) actinomycin D.
f significantly (P < 0.05) lower than corresponding control value
for the same PG during the same time period.
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Mean (± s.e.m.; n — 10) outputs of PGF2Q, PGE2 and 6-keto-PGF^a from
day 7, guinea-pig endometrium cultured for 24h (sampling every 6h) and
not treated (control (C) ; open columns) or treated with 10/ig/ml
(hatched columns) and 50/jg/ml (crossed columns) cycloheximide .
f significantly (P < 0.05) lower than corresponding control value
for the same PG during the same time period.
* significantly (P < 0.05) higher than corresponding control value
for the same PG during the same time period.
significant effect on PGE2 output from day 7 endometrium during the
remainder of the 24h period in culture, except 10/ig cycloheximide/ml
treatment significantly (P < 0.05) inhibited PGE2 output between 12h
and 18h of culture. Treatment with cycloheximide (10 and 50/ig/ml)
had no significant action on 6-keto-PGFpQ output during the first 6h
of culture of day 7 endometrium (Figure 3.5.1.c). However,
cycloheximide treatment at both concentrations significantly (P <
0.05) reduced 6-keto-PGFpQ output from day 7 endometrium between 6h
and 12h, 12h and 18h and 18h and 24h of culture (Figure 3.5.1.C).
The output of PGF2a from day 15 endometrium was significantly (P
< 0.05) inhibited by cycloheximide (10 and 50/ig/ml) treatment
throughout the 24h period in culture (Figure 3.5.1.d). The outputs
of PGE2 and 6-keto - PGF^q, from day 15 endometrium were not altered by
cycloheximide treatment during the first 6h of culture (Figure
3.5.l.d). However, PGE2 and 6-keto-PGFpQ outputs were significantly
(P < 0.05) inhibited by both concentrations of cycloheximide used
between 6h and 12h, and 12h and 18h of culture. Cycloheximide
treatment had no effect on PGE2 output between 18h and 24h of culture,
whereas cycloheximide (50pg/ml but not lO^g/ml) significantly (P <
0.05) inhibited 6-keto-PGF]^Q output from day 15 endometrium between
18h and 24h of culture (Figure 3.5.l.d).
The outputs of PGF2Q, PGE2 and 6 - ke to - PGF;lq from day 7 guinea-
pig endometrium were not affected by puromycin (10 and 50/ig/ml)
treatment during the first 6h of culture (Figure 3.5.1.e). The
outputs of PGF2q between 6h and 12h, 12h and 18h and 18h and 24h were
significantly (P < 0.05) lower than the respective control outputs of
PGF2q at the same times, and were also significantly (P < 0.05) lower
than the control PGF2q output between 0 and 6h, following treatment










































































Mean (± s.e.m.; n = 10) outputs of PGF2Q, PGE2 and 5-keto-PGF^a from
day 15 guinea-pig endometrium cultured for 24h (sampling every 6h) and
not treated (control (C); open columns) or treated with 10pg/ml
(hatched columns) and 50/ig/ml (crossed columns) cycloheximide.
f significantly (P < 0.05) lower than corresponding control value
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Mean (± s.e.m.; n = 10) outputs of PGF2Q, PGE2 and 6-keto-PGFpQ from
day 7 guinea-pig endometrium cultured for 24h (sampling every 6h) and
not treated (control (C) ; open columns) or treated with 10/2g/ml
(hatched columns) and 50/ig/ml (crossed columns) puromycin.
| significantly (P < 0.05) lower than corresponding control value
for the same PG during the same time period.
day 7 endometrium was significantly (P < 0.05) inhibited by 10/ug
puromycin/ml treatment between 6h and 12h of culture, and by 10 and
50/ig puromycin/ml treatment between 12h and 18h, and 18h and 24h of
culture. Treatment with puromycin (lOyng/ml), but not puromycin
(50^ig/ml) significantly (P < 0.05) reduced 6-keto-PGFpa output from
day 7 endometrium during the three time periods between 6h and 24h of
culture (Figure 3.5.1.e).
The output of PGF2q from day 15 endometrium was significantly (P
< 0.05) inhibited by puromycin (50pg/ml) treatment, but not by
puromycin (10/ug/ml) treatment during the first 6h of culture (Figure
3.5.1.f). The outputs of PGE2 and 6-keto-PGFpQ from day 15
endometrium were not altered by puromycin treatment during the first
6h of culture (Figure 3.5.1.f). Puromycin (10 and 50^g/ml) treatment
significantly (P < 0.05) inhibited the outputs of PGF2Q, PGE2 and 6-
keto-PGFpa from day 15 guinea-pig endometrium during the three periods
of culture between 6h and 24h (Figure 3.5.1.f).
Experiment 2: Effects of protein synthesis inhibitors on PG outputs
from and PG synthesizing capacities of guinea-pig endometrium in
culture for up to 12h
Day 7: The control (untreated) outputs of PGE2 and 6-keto-PGF]^Q, but
not PGF2Q, from day 7 endometrium significantly (P < 0.05) decreased
from 0-6h to 6h-12h of culture (Figure 3.5.1.g). Treatment with
actinomycin D (50/ig/ml) and puromycin (50/ig/ml) had no significant
effect on PGF2a, PGE2 or 6-keto-PGF^Q outputs from day 7 endometrium
during the first 6h of culture (Figure 3.5.1.g). However,
cycloheximide (10/ig/ml) treatment significantly (P < 0.05) inhibited
PGF2Q output, but not PGE2 or 6-keto-PGFpa outputs, from day 7
endometrium between 0 and 6h of culture (Figure 3.5.1.g). Treatment
with actinomycin D, cycloheximide and puromycin significantly (P <
126










































































Mean (± s.e.m.; n = 10) outputs of PGF2Q, PGE2 and 6-keto-PGFpa from
day 15 guinea-pig endometrium cultured for 24h (sampling every 6h) and
not treated (control (C) ; open columns) or treated with lO^ig/ml
(hatched columns) and 50/jg/ml (crossed columns) puromycin.
f significantly (P < 0.05) lower than corresponding control value
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Mean (± s.e.m.; n = 6) outputs of PGF2Q, PGE2 and 6-keto-PGFi^ from
day 7 guinea-pig endometrium cultured for 12h (sampling every 6I1) and
not treated (control (C); open columns) or treated with actinomycin D
(50/zg/ml; hatched columns), cycloheximide (10^g/ml; crossed columns)
and puromycin (50/ig/ml; squared columns).
f significantly (P < 0.05) lower than corresponding control output
value for the same PG during the same time period.
* significantly (P < 0.05) lower than 0-6h control output value for
the same PG.
0.05) inhibited PGF2Q and 6-keto-PGFpQ outputs, but not PGE2 output
from day 7 endometrium in culture between 6h and 12h (Figure 3.5.l.g).
The PGF2a synthesizing capacity of untreated (control) day 7
endometrial homogenates was significantly (P < 0.05) higher than the
Oh control value after 12h, but not after 6h, of culture (Figure
3.5.l.h). The amount of 6-keto-PGFpa synthesised by control day 7
endometrial homogenates was significantly (P < 0.05) higher after both
6h and 12h of culture, and the amount of PGE2 synthesised was
significantly (P < 0.05) higher after 12h, when compared to the
corresponding Oh control value (Figure 3.5.l.h). Actinomycin D,
cycloheximide and puromycin treatment significantly (P < 0.05)
inhibited the synthesizing capacities of day 7 endometrial homogenates
of all three PGs after 6h and 12h of culture when compared to their
corresponding control value at the same time, except actinomycin D
treatment had no significant inhibitory effect on the 6-keto-PGFpQ
synthesizing capacity after 12h of culture. Actinomycin D treatment
prevented the increase in PGF2Q synthesizing capacity from the Oh
control value after 12h of culture of day 7 endometrial homogenates
(Figure 3.5.l.h). Cycloheximide and puromycin treatment not only
prevented the increase in PGF2Q synthesizing capacity of day 7
endometrial homogenates observed in control values after 12h of
culture, but also further significantly (P < 0.05) inhibited PGF2Q
synthesising capacity after 12h of culture when compared to the Oh
control value. Actinomycin D and puromycin treatment prevented the
increase in PGE2 synthesizing capacity of day 7 endometrium after 12h
of culture, whereas treatment with cycloheximide not only prevenced
this increase in PGE2 synthesizing capacity, but also significantly (P
< 0.05) inhibited PGE2 synthesizing capacity after 12h of culture when
compared to the Oh control value. All three protein or RNA synthesis
127












































































C 50 10 50
H9 /ml
Mean (± s.e.m. ; n = 6) outputs of PGF2q> PGE2 and 6-keto-PGFpQ
synthesized by homogenates of day 7 guinea-pig endometrium either not
cultured and homogenised immediately (01) or cultured for 6h or 12h
before homogenisation and either not treated (control (C) ; open
columns) or treated with actinomycin D (50/jg/ml; hatched columns),
cycloheximide (10/xg/ml; crossed columns) and puromycin (50^ig/ml,
squared columns).
| significantly (P < 0.05) lower than the control (C) PG production
at the same time for the same PG.
^ significantly (P < 0.05) higher than the Oh control (C) PG
production for the same PG.
* significantly (P < 0.05) lower than the Oh control (C) PG
production for the same PG.
inhibitors used inhibited the 6-keto-PGFpQ synthesizing capacity of
day 7 endometrium after 6h of culture, but the synthesizing capacities
were still significantly (P < 0.05) higher than the Oh control value.
Actinomycin D treatment significantly (P < 0.05) inhibited the 6-keto-
PGFpa synthesizing capacity of day 7 endometrium after 12h of culture
although this synthesising capacity was still significantly (P < 0.05)
higher than the Oh control value. However, puromycin and
cycloheximide treatment inhibited the 6-keto-PGFpa synthesizing
capacity of day 7 endometrium homogenised after 12h of culture to
values that were not significantly different from the Oh control value
(Figure 3.5.1.h).
Day 15: The control outputs of 6 -keto- PGFpQ, but not the control
outputs of PGF2a or PGE2 from cultured day 15 endometrium declined
significantly (P < 0.05) between the 0-6h and 6h-12h periods of
culture (Figure 3.5.1.i). All three protein or RNA synthesis
inhibitors significantly (P < 0.05) reduced PGF2Q output from day 15
endometrium during both 6h culture periods (i.e. between 0 and 6h and
6h and 12h) compared to the control PGF2Q output values during the.
same periods (Figure 3.5.1. i). Puromycin treatment, but not
actinomycin D or cycloheximide treatment significantly (P < 0.05)
inhibited PGE2 output from day 15 endometrium during the first culture
period, and all three protein or RNA synthesis inhibitors
significantly (P < 0.05) reduced PGE2 output between 6h and 12h of
culture when compared to the control PGE2 output value recorded during
this period (Figure 3 . 5.1.i). The output of 6-keto-PGFpQ from day 15
cultured endometrium was significantly (P < 0.05) inhibited by
cycloheximide, but not by actinomycin D or puromycin during the first
6h period of culture, and was significantly (P < 0.05) inhibited by
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from
He 11 v-i. c c ., n = 6) outputs of PGF2Q, PGEj and 6-keto-PGF^a
day 15 guinea-pig endometrium cultured for 12h (sampling e\ery 6h) and
not treated (control (C); open columns) or treated with actinomycin D
(50/ig/ml; hatched columns), cycloheximide (10/ig/ml; crossed columns)
and puromycin (50/ig/ml; squared columns).
f significantly (P < 0.05) lower than corresponding control output
value for the same PG during the same time period.
* significantly (P < 0.05) lower than 0-6h control output value for
the same PG.
second 6h period of culture compared to the corresponding control PG
output value at the same time (Figure 3.5.1.i.).
The synthesizing capacities of PGF2Q, PGE2 and 6-keto-PGF^Q of
untreated (control) day 15 endometrium after 6h of culture were
significantly (P < 0.05) higher than their respective Oh control
values (Figure 3.5.1.j). This significantly (P < 0.05) higher level
compared to Oh synthesizing capacity values was maintained after 12h
of culture for all three PGs. The day 15 endometrial synthesizing
capacities of all three PGs were significantly (P < 0.05) reduced by
treatment with actinomycin D, cycloheximide and puromycin after both
6h and 12h of culture, when compared to their corresponding control
value at the same time, except that actinomycin D treatment did not
significantly alter the 6-keto-PGF^Q synthesizing capacity after 6h of
culture compared to the corresponding control value (Figure 3.5.1.j).
After actinomycin D treatment both the PGF2Q synthesizing capacity
after 6h and the 6-keto - PGF;lq synthesising capacity after 6h and 12h
were still significantly (P < 0.05) higher than Oh control values.
The PGF2q synthesizing capacity of day 15 endometrium treated with
actinomycin D was reduced to a value after 12h of culture that was not
different from the Oh control value. Treatment with cycloheximide
prevented the increase in PGF2Q synthesising capacity exhibited by
control day 15 endometrium after 6h of culture, and further,
significantly (P < 0.05) reduced the PGF2Q synthesizing capacity of
day 15 endometrium cultured for 12h when compared to the Oh control
value. The increase in control, PGE2 synthesizing capacity after 6h
and 12h of culture was not only prevented but was further and
significantly (P < 0.05) inhibited following treatment with
cycloheximide when compared to the Oh control value. The increases
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pg/ml
Mean (± s.e.m. ; n = 6) outputs of PGF2Q, PGE2 and 6-keto-PGF^Q.
synthesized by homogenates of day 15 guinea-pig endometrium either not
cultured and homogenised immediately (0) , or cultured for 6h or 12h
before homogenisation and either not treated (control (C); open
columns) or treated with actinomycin D (50gg/ml; hatched columns),
cycloheximide (10/ig/ml; crossed columns) and puromycin (50/ig/ml;
squared columns).
t significantly (P < 0.05) lower than the control (C) PG production
at the same time for the same PG.
^ significantly (P < 0.05) higher than the Oh control (C) PG
production for the same PG.
* significantly (P < 0.05) lower than the Oh control (C) PG
production for the same PG.
control day 15 endometrium during 12h of culture were prevented by
puromycin treatment after both 6h and 12h of culture. In addition,
puromycin treatment further reduced the endometrial synthesizing
capacities of PGF2Q and PGE2 to values which were significantly (P <
0.05) lower than the Oh control value for the same PG (Figure
3 . 5 .1. j ) .
Experiment 3
Figure 3.5.1.k shows the incorporation of [^H]-leucine into
cellular and secreted proteins synthesised by day 7 and day 15
endometrium cultured for 24h, and not treated (control) or treated
with protein and RNA synthesis inhibitors. In the control dishes
there were significantly (P < 0.05) greater amounts of [^H]-leucine
incorporated into secreted proteins synthesised by day 15 endometrium
than by day 7 endometrium in culture for 24h. There was no
significant difference between the amounts of [^H]-leucine
incorporated into the cellular proteins by day 7 and day 15 cultured
endometrium. These results are in agreement with the results
obtained for the incorporation of [^H]-leucine into cellular and
secreted proteins synthesised by day 7 and day 15 endometrium cultured
for 24h and which are presented previously in section 3.4.
Treatment with actinomycin D (50/ig/ml), cycloheximide (lOpg/ml)
and puromycin (50/xg/ml) significantly (P < 0.05) inhibited the amounts
of [^H]-leucine incorporated into cellular and secreted proteins by
day 7 and day 15 endometrium in culture for 24h (Figure 3.5.k).
CONCLUSIONS
Actinomycin D, cycloheximide and puromycin had an inhibitory
effect on the syntheses of cellular and secreted proteins by both day



















































Figure 3 . 5 .1, k
Mean (± s.e..m.; n = 5) of [^H]-leucine incorporation (measured as
cpm/mg tissue/10^ standard counts) into cellular and secreted proteins
synthesised by day 7 and day 15 guinea-pig endometrium in culture for
24h, not treated (controls; open columns) or treated wich actinomycin
D (50^ig/ml; hatched columns), cycloheximide (10/ig/ml; crossed
columns) and puromycin (50/ig/ml; squared columns).
f significantly (P < 0.05) higher than the control value for day 7
secreted proteins (by the paired 't' test).
* significantly (P < 0.05) lower than [ -^H]-leucine incorporation into
control proteins of the same type synthesised by endometrium from
guinea-pigs on the same day of the cycle (by the paired 't' test).
and RNA synthesis inhibitors used are adequate to inhibit protein
synthesis, and it may be inferred that any effects on PG synthesis are
due to this inhibition of protein synthesis.
Treatment with actinomycin D (10 and 50/ig/ml, but not 1/ig/ml)
had an inhibitory effect on PGF2Q and PGE2, but not 6-keto-PGF^a
outputs from cultured day 7 guinea-pig endometrium, but this
inhibitory effect was not immediate since it only became apparent
during the second (i.e. 6h to 12h) period of culture. Only the
highest concentration of actinomycin D inhibited the outputs of all
three PGs from cultured day 15 endometrium. However, inhibition by
actinomycin D was apparent during the first (i.e. 0 to 6h) period of
culture.
Cycloheximide treatment had a major inhibitory effect on PGF2Q
output, and a lesser inhibitory effect on PGE2 and 6-keto-PGFpQ
I
outputs from day 15 guinea-pig endometrium in culture. The outputs
of PGE2 and 6-keto-PGFpQ exhibited a 6h delay before inhibition of
output was observed. However, the output of PGF2Q was inhibited
during the first (i.e. 0 to 6h) period of culture.
Puromycin treatment had a major inhibitory action on the outputs
of PGF2Q, PGE2 and, to a lesser extent, 6-keto-PGF|Q from both day 7
and day 15 cultured endometrium. The output of PGF2a was not
inhibited by puromycin treatment of day 7 endometrium during the first
6h of culture, but puromycin (50/^g/ml) treatment of day 15 endometrium
was inhibitory during the first 6h of culture. This inhibitory
effect on the outputs of PGE2 and 6 - ke to - PGF^a, from both day 7 and
day 15 endometrium was not present during the first (0 to 6h) culture
period.
The endometrial synthesizing capacities of PGF2Q, PGE2 and 6-
keto-PGF]^Q were reduced by treatment with cycloheximide, puromycin
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and, to a slightly lesser extent, actinomycin D. However, there were
discrepancies between the inhibitory actions of protein or RNA
synthesis inhibitors on the synthesizing capacities of PGF2Q, PGE2 and
6-keto-PGFpQ, after 6h of culture, and the measured output for the
same PG during the first 6h of culture. For example, the
synthesizing capacities of PGF2Q, PGE2 and 6-keto-PGF^a in homogenates
of endometrium from both day 7 and day 15 guinea-pigs were inhibited
after 6h of culture by actinomycin D, cycloheximide and puromycin
(except actinomycin D treatment which had no inhibitory effect on the
6-keto-PGFpQ, synthesizing capacity of day 15 endometrium). However,
none of these protein synthesis inhibitors had any effect on; (i) PG
output from day 7 endometrium during the first 6h (i.e. 0 - 6h) of
culture (except for cycloheximide which significantly inhibited PGF2Q
output in Experiment 2, and reduced PGF2a output, but not
significantly in Experiment 1), (ii) PGE2 output from day 15
endometrium during the first 6h period of culture, except for
puromycin (iii) 6-keto-PGF]^Q output from day 15 endometrium except for
cycloheximide. These discrepancies provide further evidence that the
synthesizing capacity (and hence the concentration of PGH synthase) is
not the rate-limiting step which controls PG synthesis by the guinea-
pig endometrium. Previous evidence was presented in section 3.2
showing differences between PG outputs and PG synthesizing capacities.
However, care must be taken in the interpretation of these results
because most of the PGs released during the 0 - 6h period of culture
may have been released early in this period of culture, whereas the
respective synthesizing capacities may only be inhibited during the
later stages of the culture period, to produce an observed decrease in
PG synthesizing capacity. Therefore, the output and the PG
synthesizing capacity may both decrease towards the end of the first
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6h of culture, but this change in the output cannot be observed due to
the high output occurring early in the period masking the effect.
This means that this evidence does not necessarily preclude output
being linked to PG synthesizing capacity (and hence PGH synthase
concentration).
3.5.2 THE EFFECTS OF ACTINOMYCIN D, CYCLOHEXIMIDE AND PUROMYCIN ON PG
OUTPUTS FROM AND PG SYNTHESIZING CAPACITIES OF GUINEA-PIG UTERUS
SUPERFUSED IN VITRO
INTRODUCTION
Prostaglandin output from skeletal muscle has been shown to be
very rapidly inhibited by protein and RNA synthesis inhibitors. In
rat soleus muscle preparations, Turinsky and Loegering (1985) using
cycloheximide, and Turinsky (1985) using puromycin and emitine showed
that PGE2 output is inhibited within lh of treatment. Fagan and
Goldberg (1986) using the rat extensor digitorum longus muscle
preparation have shown a very rapid inhibitory effect (within 10 min)
on PGE2 and PGI2 synthesis after treatment with cycloheximide,
puromycin and actinomycin D. It has been suggested from these
results that this inhibitory effect of protein and RNA synthesis
inhibitors on PG output is due to a rapid inhibition of PGH synthase
production, and that this enzyme exhibits a very rapid turnover of
synthesis and breakdown so controlling PG production (Fagan and
Goldberg, 1986) .
The aims of this study were to investigate the short term
actions (up to lh) of the protein inhibitors cycloheximide and
puromycin, and of the inhibitor of DNA-dependent RNA synthesis,
actinomycin D, on the PG outputs from and PG synthesizing capacities
of the guinea-pig uterus superfused i_n vitro.
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METHODS
Thirty guinea-pigs were used and each had exhibited at least two
oestrous cycles of normal length prior to use. The animals were
killed and the uteri removed in preparation for superfusion as
described in section 2.2.1.
The uteri from five day 7 and five day 15 animals were divided
into their two uterine horns. Each horn was weighed, then "opened"
and prepared for superfusion as explained in section 2.2.3. Both
uterine horns were superfused independently (5ml Krebs' solution/min)
in the conditions previously detailed (section 2.2.3). Each horn was
initially superfused for a "settling" period of 60 min, then
superfusate samples were collected every 10 min for the next 80 min
(i.e. 8 samples/uterine horn; samples 1 to 8). Between 90 and 110
min (i.e. samples 4 and 5) the normal Krebs' solution superfusing one
horn (test horn; T) was replaced with Krebs' solution containing
actinomycin D (50/jg/ml). The other horn remained untreated and acted
as a control (C). Following collection, the pH of each superfusate
sample was lowered to 4.0 and the PGs were extracted and then
redissolved in 10ml ethyl acetate (section 2.2.2). Immediately after
the period of superfusion, the endometrium and the myometrium were
separated by dissection, weighed accurately, homogenised and incubated
for 60 min as explained in section 2.2.4.i. These homogenates
measured the PG synthesizing capacities of their respective tissues.
PGs were extracted from the incubates and redissolved in 5ml ethyl
acetate (section 2.2.2). All ethyl acetate extracts of incubate and
superfusate samples were stored at -20°C before the amounts of PGF2Q,
PGE2 and 6-keto-PGF]^Q present were measured by radioimmunoassay
(section 2.3).
This procedure was repeated with uteri from five day 7 and five
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day 15 guinea-pigs, except the Krebs' solution superfusing the test
horns during samples 4 and 5 contained cycloheximide (50/^g/ml). The
procedure was also repeated (as above) with puromycin (50//g/ml) added
to the Krebs' solution superfusing the test horn during samples 4 and
5.
Statistical Tests
Duncan's multiple range test was used to test for significant
changes in the output of a PG during the superfusion period.
Student's 't'-test was used to compare PG synthesising capacities with
their respective control values, for the same PG from the same tissue
removed on the same day of the cycle.
RESULTS
Actinomycin D treatment (50^g/ml) significantly (P < 0.05)
stimulated PGF2Q output from day 7 superfused uterine horns during the
first 10 min (sample 4) of treatment (Figure 3.5.2.a). However,
actinomycin D treatment had no significant effect on PGF2a output from
day 15 superfused uterine horns (Figure 3.5.2.b). PGE2 output from
day 7 superfused uterine horns was not significantly changed by
actinomycin D treatment (Figure 3.5.2.a), whereas PGE2 output from day
15 superfused uterine horns was significantly (P < 0.05) stimulated
between 10 and 20 min (sample 5) of treatment with actinomycin D
(Figure 3.5.2.b). The output of 6-keto-PGF^Q from both day 7 and day
15 superfused uterine horns was significantly (P < 0.05) stimulated
during the 20 min treatment period (samples 4 and 5) by actinomycin D
(Figures 3.5.2.a and 3.5.2.b, respectively).
Cycloheximide treatment (50pg/ml) significantly (P < 0.05)
stimulated PGF2Q output from day 7 superfused uterine horns during




Figure 3.5.2 . a
Mean (± s.e.m.; n = 5) outputs (ng/min/lOOmg tissue) of PGF2Q, PGE2
and 6-keto-PGFpa from day 7 guinea-pig uterine horns superfused for
140 min, in the absence (control (C) ; broken line •— — —■ ) or
presence (treatment (T) ; • —• ) of actinomycin D (50/ig/ml)
between 90 min and 110 min.




Figure 3 . 5 . 2 . b
Mean (± s.e.m.; n = 5) outputs (ng/min/lOOmg tissue) of PGF2a, PGE2
and 6-keto-PGFpQ from day 15 guinea-pig uterine horns superfused for
140 min, in the absence (control (C) ; broken line •— — —■ ) or
presence (treatment (T); &- • ) of actinomycin D (50^g/ml)
between 90 min and 110 min.
f significantly (P < 0.05) higher than control values for the same PG
prior to treatment.
exhibited no effect on PGF2Q output from day 15 superfused uterine
horns (Figure 3.5.2.d). The output of PGE2 was significantly (P <
0.05) stimulated by cycloheximide during the treatment period, from
both day 7 and day 15 superfused uterine horns and also during the 10
min sample period after treatment (sample 6) from day 15 superfused
uterine horns (Figures 3.5.2.C and 3.5.2.d, respectively). Treatment
with cycloheximide significantly (P < 0.05) stimulated 6-keto-PGFpa
output from day 7 superfused uterine horns during the 20 min treatment
period (Figure 3.5.2.c), and during the first 10 min of treatment from
day 15 superfused uterine horns (Figure 3.5.2.d).
No significant change occurred in outputs of PGF2Q and PGE2 from
day 7 (Figure 3.5.2.e) and day 15 (Figure 3.5.2.f) superfused uterine
horns treated with puromycin. However, puromycin treatment
significantly (P < 0.05) stimulated 6-keto-PGF^Q output from day 7
uterine horns during the first 10 min (sample 4) of treatment, and
stimulated 6-keto-PGF]^a output from day 15 superfused uterine horns
throughout the 20 min treatment period (samples 4 and 5; Figures
3.5.2.e and 3.5.2.f, respectively).
The PGF2q, PGE2 and 6-keto-PGF^a synthesizing capacities of
endometrium and myometrium measured from uteri after 140 min of
superfusion were not significantly altered by superfusing the uteri
with actinomycin D (50^g/ml; Figure 3.5.2.g), cycloheximide (50^g/ml;
Figure 3.5.2.h) and puromycin (50/^g/ml; Figure 3.5.2i) between 90 and
110 min of the superfusion period, when compared to their respective
untreated control values for the same PG synthesising capacity
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Figure 3 . 5.2.c
Mean (± s.e.m.; n = 5) outputs (ng/min/lOOmg tissue) of PGF2a, PGE2
and 6-keto-PGF]^Q from day 7 guinea-pig uterine horns superfused for
140 min, in the absence (control (C) ; broken line •— —■ ) 01
presence (treatment (T); • -• ) of cycloheximide (50pg/ml)
between 90 min and 110 min.




Figure 3 . 5 . 2 , d
Mean (± s.e.m. ; n = 5) outputs (ng/min/lOOmg tissue) of PGF2q,, PGE2
and 6-keto-PGFpQ from day 15 guinea-pig uterine horns superfused for
140 min, in the absence (control (C); broken line ■— — —■ ) or
presence (treatment (T) ; # -• ) of cycloheximide (50/^g/ml)
between 90 min and 110 min.
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Figure 3.5 , 2.e
Mean (± s.e.m.; n = 5) outputs (ng/min/lOOmg tissue) of PGF2a, PGE2
and 6-keto-PGF]^Q from day 7 guinea-pig uterine horns superfused for
140 min, in the absence (control (C) ; broken line ■— — —■■ ) or
presence (treatment (T); m • ) of puromycin (50^g/ml) between
90 min and 110 min.
f significantly (P < 0.05) higher than control values for the same PG
prior to treatment.
70 80 90 100 110 140 130 120
minutes
Figure 3,5 . 2 . f
Mean (± s.e.m. ; n = 5) outputs (ng/min/lOOmg tissue) of PGF2a, PGE2
and 6-keto-PGF^Q from day 15 guinea-pig uterine horns superfused for
140 min, in the absence (control (C); broken line •— ■ ) or
presence (treatment (T) ; • • ) of puromycin (50/ig/ml) between
90 min and 110 min.
f significantly (P < 0.05) higher than control values for the same





Day 7 Day 1 5
6-keto-PGF- 1(X
*





























C T C T C T C T
Figure 3.5.2.R
Mean (± s.e.m.; n = 5) amounts (ng/min/lOOmg tissue) of PGF2a, PGE2
and 6-keto-PGF^Q, synthesised by homogenates of endometrium an
myometrium dissected from day 7 and day 15 guinea-pig uteri a ter
superfusion for 140 min, and not treated (controls (C); open columns)
or treated, (columns containing symbols) between 90 min and 110 min o
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Figure 3.5.2.h
Mean (± s.e.m.; n = 5) amounts (ng/min/lOOmg tissue) of PGF2Q, PGE2
and 6-keto-PGF^Q synthesised by homogenates of endometrium and
myometrium dissected from day 7 and day 15 guinea-pig uteri after
superfusion for 140 min, and not treated (controls (C); open columns)
or treated (columns containing symbols) between 90 min and 110 min of
superfusion with cycloheximide (50yug/ml) .
PGF-2CX









































Figure 3 . 5,2.i
Mean (± s.e.m.; n = 5) amounts (ng/min/lOOmg tissue) of PGF2a, PGE2
and 6-keto-PGFlQ, synthesised by homogenates of endometrium and
myometrium dissected from day 7 and day 15 guinea-pig uteri a ter
superfusion for 140 min, and not treated (Controls (C); open columns)
or treated (columns containing symbols) between 90 min and 110 min o
superfusion with puromycin (50/jg/ml) .
CONCLUSIONS
Actinomycin D, puromycin and cycloheximide had no inhibitory
action on the outputs of PGF2Q, PGE2 and 6-keto-PGFpQ from either day
7 or day 15 uteri superfused i_n vitro for a short period of time.
Furthermore, these protein or RNA synthesis inhibitors had no effect
on the PG synthesising capacities of the myometrium and endometrium
when measured approximately lh after treatment. These results
indicate that, in the guinea-pig uterus, there is no rapid inhibitory
action of protein or RNA synthesis inhibitors on the synthesis of PGH
synthase.
Paradoxically, actinomycin D treatment stimulated PGF2a and 6-
keto-PGFpQ output from the day 7 uterus and PGE2 and 6-keto-PGF]^a
outputs from the day 15 uterus. Cycloheximide treatment stimulated
the outputs of all three PGs from both day 7 and day 15 uteri. The
greatest stimulation was exhibited by cycloheximide treatment on PGE2
output, which showed a 5.3-fold increase from day 7, and 5.8-fold
increase from day 15 superfused uteri. Puromycin treatment stimulated
6-keto-PGFpQ from both day 7 and day 15 uteri.
The mechanisms by which actinomycin D, cycloheximide and
puromycin stimulate uterine PG synthesis need to be elucidated.
However, it is clear that the protein and RNA synthesis inhibitors do
not exert rapidly occurring inhibitory effects on PG output which has
been reported in other tissues. Furthermore, the protein and RNA
synthesis inhibitors do not exhibit a rapidly occurring, inhibitory
action on endometrial or myometrial PG synthesizing capacity (a
measure of tissue PGH synthase levels), an effect which in other
tissues has been suggested to inhibit PG output.
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3.5.3 THE EFFECT OF ACTINOMYCIN D TREATMENT IN VIVO ON PROSTAGLANDIN
PRODUCTION BY THE GUINEA-PIG UTERUS
INTRODUCTION
A previous study by Poyser (1979) showed that actinoraycin D,
when injected into the lumen of the uterus, prevented the increase in
PGF2q synthesizing capacity of the uterus that normally occurs towards
the end of the oestrous cycle. This treatment also prevented luteal
regression, as shown by the maintenance of high plasma progesterone
concentrations, and increased the length of the oestrous cycle. In
this study by Poyser (1979) it was proposed that PGF2Q output from the
guinea-pig uterus on day 15 had been inhibited by intra-uterine
actinomycin D treatment on day 10. The present study has further
investigated the effect of actinomycin D treatment in vivo on PG
production by the guinea-pig uterus, and examined some possible
regulatory mechanisms by which PG production may be controlled.
METHODS
Virgin, female guinea-pigs were used which had exhibited at
least two oestrous cycles of normal length (section 2.2.1). After
receiving the appropriate treatment, as detailed below none of the
animals used exhibited any adverse effects from any of the treatments
administered. All the animals were killed on day 15 of the oestrous
cycle; a blood sample was collected from each of the animals and the
uteri were removed (section 2.2.1). Plasma was separated from each
blood sample by centrifugation, and was stored at -20°C before the
amount of progesterone present was measured by radioimmunoassay




Each uterus from five day 15 guinea-pigs was divided into its
two uterine horns. One uterine horn was quickly dissected to
separate the endometrium from the myometrium. Each tissue was
weighed, homogenised and incubated for 60 min in the conditions as
specified in section 2.2.4.i. These homogenates measured the "0 min"
PG synthesizing capacities of their respective tissues. The other
uterine horn was weighed, "opened" and prepared for superfusion
(section 2.2.3). This horn was superfused with Krebs' solution
(5ml/min) for 70 min, according to the method and conditions explained
in section 2.2.3, and superfusate samples were taken every 10 min
throughout the period of superfusion (i.e. 7 samples). Immediately
after the period of superfusion, the endometrial layer was dissected
from the myometrial layer and each tissue type was weighed,
homogenised and incubated for 60 min as detailed for the "0 min"
homogenate above. These homogenates measured the PG synthesizing
capacities of their respective tissues at "70 min".
PGs were extracted from superfusate and incubate samples as
explained in section 2.2.2, and the extracts were stored at -20°C
before the amounts of PGF2Q, PGE2 and 6-keto-PGFqQ present were
measured by radioimmunoassay (section 2.3).
Experiment 2
Ten day 10 guinea-pigs were anaesthetized by the intra¬
peritoneal injection of fentanyl citrate (0.47mg/kg) and fluanisone
(15mg/kg; 'Hypnorm'), plus midazolam (3mg/kg; 'Hypnovel'). An
incision was made in the abdomen of each guinea-pig, and then a thread
was passed behind the junction of the two uterine horns. By pulling
on this thread the junction of the two horns was easily exposed.
Sterile saline solution (0.5ml; 9g NaCl/1) was injected into the
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lumen of each uterine horn of five of the animals. The remaining
five animals received an injection into each uterine horn of sterile
saline (0.5ml) containing 20^/g actinomycin D. The thread was then
pulled free. The body wall and the skin of each guinea-pig were then
stitched. Each animal then received a subcutaneous injection of
naloxone (0.4mg; 'Narcan') which hastened the rate of recovery from
the anaesthetic.
The uterus from each guinea-pig was removed on day 15, and the
uterine horns were divided and treated according to a similar
procedure as in Experiment 1. The two tissues from one uterine horn
were homogenised and incubated for 60 min in order to measure the "0
min" PG synthesizing capacity. The other horn was superfused for 70
min as in Experiment 1. However, only two superfusate samples were
taken from the superfused horn. The first sample was collected
during the initial 10 min of superfusion (0-10 min), and the second
sample was collected during the last 10 min of the 70 min superfusion
period (60-70 min). After superfusion, the uterus was removed and
the endometrium and myometrium were dissected apart, and were then
weighed, homogenised and incubated for 60 min as explained in section
2.2.4.i. These homogenates measured the PG synthesizing capacities
of the two tissues after "70 min". The PGs in the incubate and
superfusate samples were extracted and stored at -20°C before the
amounts of PGs present in the samples were measured by
radioimmunoassay as in Experiment 1.
This procedure was repeated on a further ten guinea-pigs, with
additionally each animal receiving a subcutaneous injection of lOyug




Ten day 10 guinea-pigs were anaesthetized and either saline
(0.5ml) or saline (0.5ml) containing 20pg actinomycin D was injected
into each uterine horn (five animals receiving each treatment), as
explained in Experiment 2. On day 15, the uterus from each animal
was removed and separated into its two horns, which were weighed,
"opened" and prepared for superfusion as in Experiment 1. Both horns
were superfused separately with Krebs' solution as described in
section 2.2.3. After an initial settling period of 60 min,
superfusate samples were collected every 10 min for the next 90 min
from each horn (i.e. 9 samples/horn). One of these uterine horns
from each animal was superfused with Krebs' solution containing A23187
(lpg/ml) during the collection of samples 4, 5 and 6 (test horn).
The other horn remained untreated throughout the superfusion period
(control horn). Immediately after the end of the superfusion, each
horn was separated by dissection into its endometrium and myometrium,
which were then weighed, homogenised and incubated for 60 min as in
Experiment 1. These homogenates measured the PG synthesizing
capacities for both tissues after 150 min of superfusion, with or
without A23187 treatment. PGs in these incubate and superfusate
samples were extracted and stored at -20°C before the amounts of PGs
present in the samples were measured by radioimmunoassay as in
Experiment 1.
This procedure was repeated on a further ten guinea-pigs, with
additionally each animal receiving a subcutaneous injection of 10/ig
oestradiol benzoate in 0.5ml arachis oil daily on days 11-14 of the.
oestrous cycle.
Experiment 4
Ten day 10 guinea-pigs were anaesthetized and each uterine horn
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was injected with either saline (0.5ml) or saline (0.5ml) containing
20pg actinomycin D, as in Experiment 2, with five animals receiving
each treatment. The uterus from each guinea-pig was removed on day
15 in preparation for tissue culture (section 2.2.1). The
endometrium was separated from the myometrium and small pieces of
endometrium were placed in three Petri dishes according to the tissue
culture method (section 2.2.5). Two of these dishes contained 12-
20mg of endometrium. The third dish contained 30-60mg of endometrium
and 10/LtCi [^H]-leucine (2.5/iCi/ml) was added to the medium, according
to the method to investigate protein synthesis as described in section
2.4. Two further dishes were prepared for culture, each containing
small pieces of myometrium weighing 15-25mg in total. These five
dishes were placed in a modified Kilner jar, which was gassed and
incubated for 24h as detailed in section 2.2.5.
Immediately after the jar was placed in the incubator, 30-60mg
of the remaining endometrium were placed in a Petri dish containing
10/iCi [-^H]-leucine (2 . 5/iCi/ml) , according to the tissue culture method
(section 2.2.5). This tissue was washed with the []-leucine-
containing medium and incubated for 2 min at room temperature. The
tissue was then weighed. The tissue and medium were subjected to the
methods, detailed in section 2.4, to quantify [^H]-leucine
incorporation into cellular and secreted proteins in order to measure
the non-specific binding of the [^H]-leucine that occurred during
these procedures.
After 24h, the Kilner jar was removed from the incubator. The
endometrium in the dish containing [^H]-leucine was weighed, and the
amounts of [^H]-leucine incorporated into cellular and secreted
proteins by the endometrium were measured by the procedures detailed
in section 2.4.
142
The endometrium and myometrium from the remaining four dishes
were weighed; the samples of culture medium were removed and stored
at -20°C before the amounts of PGF2a, PGE2 and 6-keto-PGFpa present
were measured by radioimmunoassay (section 2.3).
Statistical tests and calculations
Duncan's multiple range test was used to test for significant
changes in the output of a PG during the period of superfusion. All
other comparisons were made using Student's 't' test, (which was used
in a modified form if the variances were unequal as shown by the
variance ratio F test), or by using the paired 't' test as
appropriate.
The amounts of [^H]-leucine which were bound non-specifically
during the methods used for investigating cellular and secreted
protein synthesis were subtracted from the respective results
measuring [^H]-leucine incorporation into cellular and secreted
proteins obtained after 24h of culture.
RESULTS
Experiment 1
The outputs of PGF2Q, PGE2 and 6-keto-PGFpQ from guinea-pig
uterine horns superfused in vitro for 70 min were high for the first
ten minute sample period (Figure 3.5.2.a). The outputs of all three
PGs then significantly (P < 0.05) decreased between 10 and 20 min to a
level of output that was 50-80% lower than the output from the first
sample period. There was no significant change in the output from
the uterine horns from this second sample throughout the remainder of
the 70 min superfusion period, for any PG. The synthesizing
capacities of PGF2a and PGE2, but not of 6-keto-PGF^a, in homogenates
of endometrium significantly (P < 0.05) decreased between 0 min and 70
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Figure 3 , 5 . 3 . a
Mean (± s.e.m.; n = 5) outputs of PGF2Q, PGE2 and 6-keto-PGFqQ from
day 15 guinea-pig uterine horns superfused fn vitro.
f significantly (P < 0.05) higher than the subsequent PG output value
































Mean (± s.e.m.; n = 5) amounts (ng/lOOmg tissue) of PGF2q, PGE2 and
6-keto-PGFiQ synthesised by homogenates of endometrium and myometrium
from day 15 guinea-pigs immediately after killing and removing the
uterus from the animal (Time 0) or after 70 min superfusion.
_
t significantly (P < 0.05) lower than corresponding value at 0 min
for the same PG and tissue.
min (Figure 3.5.3.b). The synthesizing capacities of all three PGs
in homogenates of myometrium did not alter between the two time
periods. In this group of day 15 guinea-pigs, mean (± s.e.m.; n =
5) plasma progesterone concentrations were 0.27 ± 0.05ng/ml.
Experiment 2
The outputs of PGF2Q, PGE2 and 6-keto-PGFpQ from all uterine
horns, not treated or treated with actinomycin D and not treated or
treated with oestradiol benzoate between day 11 and day 14, were
significantly (P < 0.05) lower at 70 min than at 10 min (Figures
3.5.3.C and 3.5.3.d). The outputs of PGF2a and PGE2, but not of 6-
keto-PGFpa, were significantly ( P < 0.05) reduced from uterine horns
treated with actinomycin D when compared to control horns after both
10 min and 70 min of superfusion (Figure 3.5.3.c). Similarly, the
outputs of PGF2a and PGE2, but not of 6-keto-PGFpa, were also
significantly (P < 0.05) lower at both times from actinomycin D-
treated horns than from control horns from guinea-pigs that were also
administered oestradiol benzoate on days 11-14 (Figures 3.5.3.d).
The exception to this was that the output of PGE2 from actinomycin D-
treated uterine horns was significantly (P < 0.05) reduced after 70
min, but not after 10 min of superfusion (Figure 3.5.3.d).
The synthesizing capacities of PGF2Q, PGE2 and 6-keto-PGFpa in
endometrium from guinea-pigs treated with intra-uterine saline
(controls), but not from animals treated with intra-uterine
actinomycin D, were significantly (P < 0.05) decreased between 0 min
and after 70 min of superfusion (Figure 3.5.3.e). The endometrial
synthesizing capacities of PGF2Q, PGE2 and 6-keto-PGF]^Q of oestradiol-
treated guinea-pigs were not significantly altered between 0 min and
70 min, irrespective of whether the uterine horns were treated with




































































C.Acf.Dt1 tO.ct DC.Act DC.ActDC ActD
107107 TIME(mins)
Figure3-5.3.d Mean(+s.e.m.;n=5)amountsofPGF2a(c lu nswi hd t ),PGEp(c lumnswithcrosses)and6-keto-PGF-|(columns withdiamonds)releasedfromsuperfu edterineh ns(ng/min/1OOmgtissue)superfusedfor10inan7min,an(± s.e.m.;n=5)plasmaprogesteroneconcentr tions( /ml),a dea±. .m.;=5uterinehweights( gx100)ofday15guinea-pigsreceivingond y 10intra-uteri einj ctioni achho fith rN Clsolution(0.5ml;9 NaCl/1;controls( ))rNaClsolutioncontainingactinomycD(20act nomycinD hor ;hatchedc lumns)treatedwithsubcutaneousinje i nof10yg/mloestradiolbenz ated i yys11-1^. tsignificantly(P<0.05)lowerthacorr spondingcontroloutputfthes meGtsametim .1significantly(P<0.05)lowerthancorr spondingut ut10mif rthes mePGf ot ut ri ensrec ivingthesametre t ent. significantly(P<0.05)lowerthacorr spond!ngcontrolute i ehwe ght.
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capacities of PGF2Q, PGE2 and 6-keto-PGF^Q in the myometrium were not
changed between 0 min and 70 min irrespective of whether the guinea-
pigs received intra-uterine saline or intra-uterine actinomycin D on
day 10, and were treated or not treated with oestradiol benzoate on
days 11-14 (Figures 3.5.3.e and 3.5.3.f).
The amounts of PGF2Q, but not of PGE2 and 6 - keto-PGF]^Q,
synthesised by homogenates of endometrium were significantly (P <
0.05) reduced in animals receiving intra-uterine actinomycin D
treatment, when compared to saline - treated controls (Figure 3.5.3.e).
However, in oestradiol-treated guinea-pigs, the endometrial
synthesizing capacities of PGF2a, PGE2 and 6-keto - PGF;lq were all
significantly (P < 0.05) reduced by actinomycin D treatment when
compared to saline-treated control animals (Figure 3.5.3.f). Intra¬
uterine actinomycin D treatment did not change PG synthesizing
capacities in homogenates of myometrium from guinea-pigs not treated
or treated with oestradiol benzoate between days 11-14 (Figures
3.5.3.e and 3.5.3.f).
In guinea-pigs that received intra-uterine actinomycin D, with
or without oestradiol benzoate treatment, plasma progesterone
concentrations on day 15 were significantly (P < 0.05) higher compared
to the low plasma progesterone concentrations in intra-uterine saline
treated (control) animals (Figures 3.5.3.C and 3.5.3.d). Intra¬
uterine actinomycin D administration significantly (P < 0.05)
inhibited the increase in uterine horn weights induced by treatment
with oestradiol benzoate (Figure 3.5.3.d).
Experiment 3
The basal output of PGF2Q from day 15 guinea-pig uterine horns
superfused fn vitro was significantly (P < 0.05) inhibited by the
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Figure 3 , 5,3.e
Mean (± s.e.m.; n = 5) amounts of PGF2Q (columns with dots), PGE2
(columns with crosses) and 6-keto-PGFpQ (columns with diamonds)
synthesised (ng/lOOmg tissue) by homogenates of endometrium and
myometrium from day 15 guinea-pigs receiving on day-10 an intra¬
uterine injection into each horn of either saline (control (C)) or
saline containing 20/jg actinomycin D (hatched columns) and either not
superfused (0 min) or superfused for 70 min.
f significantly (P < 0.05) lower than corresponding control value
for the same PG at the same time and from the same tissue.
A significantly (P < 0.05) lower than corresponding value at 0 min
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Figure 3.5,3.f
Mean (± s.e.m.; n = 5) amounts of PGF2Q (columns with dots), PGE2
(columns with crosses) and 6-keto-PGF^a (columns with diamonds)
synthesised (ng/lOOmg tissue) by homogenates of endometrium and
myometrium from day 15 guinea-pigs receiving on day-10 an intra¬
uterine injection into each horn of either saline (control (C)) or
saline containing 20/tg actinomycin D (hatched columns) and either not
superfused (0 min) or superfused for 70 min, and treated with a
subcutaneous injection of 10^g oestradiol benzoate daily on days 11-
14.
f significantly (P < 0.05) lower than corresponding control value
for the same PG at the same time and from the same tissue.
without oestradiol treatment on days 11-14 (Figures 3.5.3.g and
3.5.3.h). The outputs of PGE2 and 6-keto-PGFpQ were also
significantly (P < 0.05) inhibited by intra-uterine treatment with
actinomycin D on day 10, irrespective of whether the guinea-pigs were
not treated or treated with oestradiol benzoate (Figures 3.5.3.g and
3.5.3.h). The outputs of PGF2Q and 6-ke to - PGF]^Q, and to a lesser
extent PGE2, were significantly (P < 0.05) stimulated by A23187
treatment and this stimulation was independent of the treatment in
vivo (Figures 3.5.3.g and 3.5.3.h). A23187 treatment caused an
approximately 3-fold stimulation of PGF2a output above basal outputs
from the uterus of guinea-pigs treated in vivo with saline or
actinomycin D and not receiving or receiving oestradiol benzoate
between days 11-14 (Figures 3.5.3.g and 3.5.3.h).
The amounts of PGF2Q, PGE2 and 6-keto-PGFpQ synthesised by
homogenates of endometrium and myometrium after 150 min superfusion
were not changed by treatment with A23187 (Figures 3.5.3.i and
3 . 5.3.j). The synthesizing capacity of PGF2Q but not of PGE2 or 6-
keto-PGFpQ, was significantly (P < 0.05) reduced in both the
endometrium and myometrium of actinomycin D-treated uterine horns from
guinea-pigs receiving oestradiol benzoate (Figure 3.5.3.i). The
synthesizing capacities of PGF2Q, PGE2 and 6-keto-PGFpa in endometrium
from oestradiol-treated guinea-pigs were significantly (P < 0.05)
reduced by actinomycin D treatment (Figure 3.5.3.j). Treatment with
intra-uterine actinomycin D had no effect on PG synthesizing
capacities of the myometrium from guinea-pigs receiving oestradiol
benzoate on days 11-14 (Figure 3.5 . 3 . j ) .
Mean (± s.e.m.; n = 5) plasma progesterone concentrations in
actinomycin D-treated and saline - treated guinea-pigs, not receiving
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Figure 3 . 5 . 3.i
Mean (± s.e.m.; n = 5) amounts of PGF2Q (columns with dots), PGE2
(columns with crosses) and 6 - ke to - PGF^q. (columns with diamonds)
synthesized (ng/lOOmg tissue) by homogenates of endometrium and
myometrium from uterine horns superfused for 150 min from day 15
guinea-pigs receiving on day-10 an intra-uterine injection of either
saline (control; C) or saline containing 20/ug actinomycin D (hatched
columns; Act.D) and during 150 min superfusion of the uterine horns
in vitro not treated (-) or treated (+) with A23187.
f significantly (P < 0.05) lower than corresponding control values
for the same PG from the same tissue receiving similar treatment
in vivo and in vitro.
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Figure 3 . 5 , 3 . j
Mean (± s.e.m.; n = 5) amounts of PGF2Q (columns with dots), PGE2
(columns with crosses) and 6-keto-PGF^Q (columns with diamonds)
synthesised (ng/lOOmg tissue) by homogenates of endometrium and
myometrium from uterine horns superfused for 150 min from day 15
guinea-pigs receiving on day-10 an intra-uterine injection of either
saline (control; C) or saline containing 20/ig actinomycin D (hatched
columns; Act. D) and treated with a subcutaneous injection of lO^zg
oestradiol benzoate daily on days 11-14 and during 150 min superfusion
of the uterine horns in vitro not treated (-) or treated ( + ) with
A23187.
f significantly (P < 0.05) lower than corresponding control values
for the same PG from the same tissue receiving similar treatment
in vivo and in vitro.
respectively. In guinea-pigs receiving oestradiol benzoate on days
11-14 and treated with intra-uterine actinomycin D or saline, the mean
(± s.e.m.; n = 5) plasma progesterone concentrations were 3.31 ± 0.80
and 0.11 + 0.02ng/ml, respectively. Actinomycin D treatment
significantly (P < 0.05) inhibited the increase in uterine horn
weights induced by oestradiol benzoate treatment. The mean (±
s.e.m.; n = 10) weights of the oestradiol-treated and intra-uterine
saline - treated, and oestradiol-treated and intra-uterine actinomycin
D-treated uterine horns were 910 ± 43 and 596 ± 24mg, respectively.
Experiment 4
The amounts of [^H]-leucine incorporated into cellular and
secreted proteins by day 15 endometrium obtained from uteri which had
been treated with intra-uterine saline on day 10 (i.e. controls) were
not significantly different from the values obtained for untreated day
15 endometrium presented in section 3.4 (Figure 3.4.a). The intra¬
uterine injection of actinomycin D on day 10 significantly (P < 0.05)
inhibited the amounts of [^H]-leucine incorporated into cellular and
secreted proteins by endometrium removed on day 15 and cultured for
24h (Figure 3.5.3.k).
The output of PGF2q from day 15 endometrium removed from uteri
which had received intra-uterine actinomycin D treatment on day 10 and
cultured for 24h was significantly (P < 0.05) reduced when compared to
the control PGF2Q output from endometrium removed from intra-uterine
saline - treated uteri and cultured for 24h (Figure 3.5.3.1). The
outputs of PGE2 and 6-keto-PGF]^Q from day 15 cultured endometrium from
uteri receiving intra-uterine actinomycin D treatment in vivo on day
10 were not significantly altered compared to their corresponding
control endometrial PG output values for uteri receiving intra-uterine











































Mean (± s.e.m.; n = 5) amounts of [^H]-leucine incorporated into
cellular and secreted proteins by day 15 endometrium cultured for 24h
after receiving either intra-uterine saline (controls; open columns)
or intra-uterine saline containing actinomycin D (20/rg actinomycin
D/horn; hatched columns on day 10 of the oestrous cycle.
* significantly (P < 0.05) lower incorporation of [ H]-leucine into
the same category of protein when compared to the endometrial

































sal. act. D sal. act. D sal. act. D
Figure 3.5,3.1
Mean (± s.e.m.; n = 5) outputs of PGF2Q, PGE2 and 6-keto-PGF]^Q from
day 15 guinea-pig endometrium and myometrium cultured for 24h,
receiving either intra-uterine saline (controls; sal.; open columns)
or intra-uterine saline containing actinomycin D (20/xg actinomycin
D/horn; act.D; hatched columns) on day 10 of the oestrous cycle,
f significantly (P < 0.05) lower than corresponding control (animal
receiving saline treatment) PG output from the same tissue type.
* significantly (P < 0.05) higher than corresponding control (animal
receiving saline treatment) PG output from the same tissue type.
from myometrium from intra-uterine actinomycin-D treated uteri and
cultured for 24h were not significantly changed compared to their
respective control myometrial PG outputs from uteri receiving intra¬
uterine saline treatment (Figure 3.5.3.1). However, 6-keto-PGF^Q
output from myometrium removed from uteri receiving intra-uterine
actinomycin D treatment and cultured for 24h was significantly (P <
0.05) stimulated 1.7-fold when compared to the corresponding control
6-keto - PGF;lq output from cultured myometrium from uteri treated with
intra-uterine saline (Figure 3.5.3.1).
Mean (± s.e.m.; n = 5) plasma progesterone concentrations in
actinomycin D-treated and saline-treated guinea-pigs in this
experiment were 3.99 ± 0.49 and 0.59 ± O.lOng/ml, respectively.
CONCLUSIONS
The syntheses of cellular and secreted proteins by cultured day
15 guinea-pig endometrium were inhibited by the intra-uterine
administration of actinomycin D on day 10. The output of PGF2Q from
the superfused day 15 guinea-pig uterus was decreased by 80-85% by the
intra-uterine administration of actinomycin D. Plasma progesterone
concentrations were high in day 15 guinea-pigs receiving intra-uterine
actinomycin D on day 10 when compared to control day 15 guinea-pigs
receiving intra-uterine saline on day 10. The high plasma
progesterone levels indicated that luteal regression had been
prevented due to the inhibition of uterine PGF2a synthesis by
actinomycin D treatment. Administration of oestradiol benzoate on
days 11-14 did not overcome the inhibitory action of actinomycin D
treatment (on day 10) on day 15 uterine PGF2Q output. The inhibition
of PGF2q output by actinomycin D treatment which was not overcome by
oestradiol benzoate administration, was also reflected in the
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maintenance of high plasma progesterone concentrations on day 15,
indicating that the lifespan of the corpora lutea had been extended.
The inhibitory action of actinomycin D treatment in vivo on day 15
guinea-pig uterine PGF2Q output appeared selective to the endometrial
layer of the uterus because, in actinomycin D-treated guinea-pigs,
PGF2Q output was inhibited from the endometrium but not from the
myometrium when the tissues were cultured for 24h. The output of
PGF2q from day 15 endometrium cultured for 24h was 4.4-fold higher
from saline-treated compared to actinomycin D-treated guinea-pigs.
The outputs of PGE2 and 6-keto-PGFpQ from the superfused guinea-
pig uterus removed on day 15 after receiving intra-uterine saline
(i.e. control) on day 10 were much lower than the output of PGF2Q from
the same superfused uterus. Treatment with intra-uterine actinomycin
D reduced the output of PGE2, but not of 6-keto-PGFpa, from the day 15
superfused guinea-pig uterus, and this inhibitory action was not
overcome by oestradiol benzoate treatment. The output of PGE2 from
cultured endometrium taken from actinomycin D-treated uteri was
inhibited by approximately 50% compared to PGE2 output from saline-
treated uteri, although this effect was not significant due to the
very low PGE2 outputs measured and hence the relatively larger
standard errors observed. The output of PGE2 from myometrium in
culture was not significantly altered by actinomycin D treatment in
vivo. The output of 6-keto-PGFpa from cultured endometrium from
actinomycin D-treated horns was not changed significantly compared to
saline-treated horns. Paradoxically, actinomycin D treatment ijr vivo
stimulated 6-keto-PGFpQ output from myometrium in culture.
The endometrial PGF2Q synthesizing capacity in guinea-pigs
receiving intra-uterine saline (i.e. controls) and not receiving
oestradiol benzoate decreased by 40% between 0 and 70 min, and
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decreased by a further 50% between 70 min and 150 min. The PGE2 and
6-keto-PGFpQ endometrial synthesizing capacities of control guinea-
pigs decreased between 0 min and 70 min but did not decline further
between 70 min and 150 min. Interestingly, oestradiol treatment
prevented the decrease in endometrial PG synthesizing capacity with
time. The initial outputs of PGF2Q, PGE2 and 6-keto-PGFpQ were high
during the first 10 min of superfusion, but subsequently, basal
outputs of PGF2q, PGE2 and 6-keto-PGF-[a remained steady throughout the
subsequent period of superfusion (up to 150 min).
Treatment with intra-uterine actinomycin D specifically
inhibited endometrial PGF2Q synthesizing capacity, but had no effect
on myometrial PGF2Q synthesizing capacity, or endometrial or
myometrial PGE2 and 6-keto-PGF]^a synthesizing capacities. Oestradiol
benzoate treatment did not overcome the inhibitory effect of
actinomycin D treatment in vivo on endometrial PGF2Q synthesizing
capacity, and in fact endometrial, but not myometrial, PGF2Q, PGE2 and
6-keto-PGF^Q synthesizing capacities were inhibited in actinomycin D-
treated guinea-pigs also receiving oestradiol benzoate.
Uterine PGF2Q output from all uterine horns, irrespective of
whether they were not treated or treated with actinomycin D ijri vivo,
and not treated or treated with oestradiol benzoate, was stimulated
approximately 3-fold by A23187 treatment. Actinomycin D treatment
therefore did not exert any inhibitory effect on this stimulatory
action on PG output by A23187. The outputs of 6-keto-PGF]^Q and, to a




The basal output of PGF2Q from the superfused guinea-pig uterus
in vitro was low when removed on day 7 of the oestrous cycle.
However, by day 15, PGF2Q output had increased approximately 20-fold
when compared to PGF2Q output on day 7. The output of PGF2Q from the
day 7 and day 15 uterus superfused in vitro are similar to those
measured by Poyser and Brydon (1983), who demonstrated a 22-fold
increase in output between days 7 and 15 of the cycle. Also, the
output of PGF2q from day 15 endometrium in culture for 24h was 10-15
fold greater than PGF2Q output from day 7 cultured endometrium.
The basal outputs of PGE2 and 6-keto-PGF]^Q from the day 7
guinea-pig uterus superfused in vitro were similar to day 7 PGF2a
output values. There was little change in PGE2 and 6-keto-PGFpa
outputs on day 15 compared to day 7 of the oestrous cycle from uteri
superfused in vitro, and these findings also agree with the results
for day 7 and day 15 cultured endometrium. These findings
demonstrate a selective stimulation of PGF2Q output from the guinea-
pig endometrium towards the end of the cycle. The injection of
intra-uterine saline on day 10 appeared to have no effect on uterine
PGF2q, PGE2 and 6-keto-PGF]^Q outputs from the day 15 uterus superfused
in vitro. Also, the outputs of all three PGs from endometrium
cultured for 24h removed from animals treated with intra-uterine
saline were similar to the corresponding PG outputs over the same time
period in culture from day 15 endometrium not treated i^n vivo on day
10. This demonstrates that the invasive procedure to inject the
uterine horns on day 10 had no effect on uterine PG synthesis on day
15.
Actinomycin D, cycloheximide and puromycin inhibited the
synthesis of cellular and secreted proteins by day 7 and day 15
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guinea-pig endometrium in culture. Furthermore, intra-uterine
actinomycin D treatment in vivo on day 10 inhibited the synthesis of
cellular and secreted proteins by endometrium removed on day 15 of the
oestrous cycle and cultured for 24h. Actinomcyin D treatment ija vivo
on day 10 also inhibited the uterotrophic effect of exogenous
oestradiol administered on days 11-14 and also inhibited, but not
significantly, the uterotrophic effect of endogenous oestradiol.
The intra-uterine injection of actinomycin D on day 10 caused an
80-85% reduction in PGF2Q output from the day 15, superfused guinea-
pig uterus. Actinomycin D treatment in vivo on day 10 also inhibited
PGF2q output from endometrium removed on day 15 of the cycle and then
cultured for 24h. Plasma progesterone levels in the animals
receiving actinomycin D were high on day 15 when compared to the
saline-treated, control animals. Clearly, intra-uterine actinomycin
D treatment ini vivo on day 10 by its inhibitory action on endometrial
protein synthesis, inhibits the selective stimulation of PGF2Q that
occurs towards the end of the cycle as demonstrated by the low PGF2a
output measured on day 15, so removing the luteolytic effect of the
uterus, ija vivo.
Actinomycin D, cycloheximide and puromycin had an inhibitory
effect on both cellular and secreted protein syntheses. However,
there were several examples of an inhibition of endometrial PG
synthesizing capacity by these compounds occurring before an
inhibition of PG output, which demonstrates that although protein and
RNA synthesis inhibitors have an inhibitory action on the
replenishment of PGH synthase levels in the endometrium by fresh
protein synthesis, this is not the rate limiting step in controlling
endometrial PG synthesis. Furthermore, in both animals treated with
actinomycin D and saline in vivo, the Ca^+ ionophore A23187 stimulated
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PG synthesis approximately three-fold, irrespective of treatment.
This shows that the Ca^4"-induced stimulation of PG synthesis is not
limited by uterine PGH synthase concentrations, and this finding is in
agreement with results already discussed in section 3.2.
Furthermore, protein and RNA synthesis inhibitors superfused over both
day 7 and day 15 guinea-pig uteri ini vitro had no inhibitory effect on
endometrial and myometrial PGH synthase concentrations (measured as
PG synthesizing capacity) after a short period (about Ih) . This
demonstrates that PGH synthase levels in the guinea-pig uterus are not
rapidly reduced, unlike findings by Fagan and Goldberg (1986) in rat
extensor digitorum longus muscle (a skeletal muscle preparation),
where PGH synthase levels in the muscle rapidly (in less than 60 min)
declined during treatment with protein synthesis inhibitors. Fagan
and Goldberg (1986) proposed that PGH synthase was rapidly used,
resulting in inactivation and then rapidly replenished by protein
synthesis, and hence was the rate limiting step in PG synthesis in
this preparation. Tissue PGH synthase levels are very high in the
guinea-pig uterus (see discussion section 3.2). Therefore, from
these data, the amount of substrate available for conversion by PGH
synthase appears to be the rate limiting step in endometrial PG
synthesis in the guinea-pig.
Unexpectedly, protein and RNA synthesis inhibitors also
stimulated PG outputs from the guinea-pig uterus. Cycloheximide
significantly increased PGE2 output from day 7 cultured endometrium
during the first 6h culture period. Furthermore, actinomycin D
stimulated PGF2Q and 6-keto-PGFpQ outputs from day 7, and PGE2 and 6-
keto-PGF]^Q outputs from day 15 guinea-pig uterus superfused rn vitro.
Puromycin stimulated 6-keto-PGF]^Q output from both day 7 and day 15
superfused uterine horns. Cycloheximide stimulated the outputs of
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PGF2q, PGE2 and 6-keto-PGFpQ from day 7, and PGE2 and 6-keto-PGF2Q
outputs from day 15 superfused uterine horns. Cycloheximide
particularly stimulated PGE2 output from both day 7 and day 15 uteri.
Paradoxically, protein synthesis inhibitors, such as
cycloheximide, increase the levels of certain proteins or their
corresponding mRNAs. Ringold. Diekmann, Vannice, Trahey and
McCormick (1984) in Chinese hamster ovary cells transfected with a
plasmid carrying the human /3-interferon gene found that cycloheximide,
in the absence of any other inducer, stimulated the production of
interferon RNA. Sorrentini, Battistini, Curatola and Di Francesco
(1985) examined the effect of cycloheximide (0.1 - 50/ig/ml) on a
number of murine and human cell lines and found a pattern of protein
synthesis consisting of enhanced and induced protein species in two
main classes of 20-40 and 70-120kD. Using Balb/c 3T3 cells,
Hamilton, Nilsen-Hamilton and Adams (1985) demonstrated a 2 to 5-fold
increase in production of 'superinducible proteins' (six proteins
ranging from 12.5-62kDa). Superinduction occurred at concentrations
of cycloheximide (lpg/ml) which inhibited protein synthesis by at
least 85%, and the greatest amounts of these proteins were observed
after 6-8h. From these findings it may be speculated that the
protein and RNA synthesis inhibitors, particularly cycloheximide, are
stimulating a protein that stimulates uterine PG synthesis, especially
PGE2 output during the first 6h of culture from day 7 endometrium.
Alternatively, it may be argued that the effects of protein and RNA
synthesis inhibitors on PG outputs from superfused uterine horns are
very rapid, with insufficient time for a stimulatory protein to be
induced. The effect of the inhibitors may be therefore a non¬
specific effect, for instance on the membrane causing the release of
more substrate which produces a transitory increase in PG output. As
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the stimulation of PGE2 output by cycloheximide is the largest
observed, the apparent stimulation of PGE2 observed in culture may be
due to this non-specific unspecified effect causing a stimulation of
PGE2 output early in the initial 6h culture period, which may mask the
inhibitory action of cycloheximide on PGE2 output later in the first
sample period, as observed in subsequent sample periods.
Steroids have been shown to act via the stimulation of protein
synthesis in the uterus (Brenner and West, 1975). Oestradiol acting
on a progesterone-primed uterus is the optimum stimulus for the
increase in PGF2Q output that occurs towards the end of the oestrous
cycle in the guinea-pig (Poyser, 1983b). In this section, protein
and RNA synthesis inhibitors have been demonstrated to inhibit both
protein synthesis and PG synthesis. These findings indicate that the
stimulatory effect of steroid hormones on uterine PG synthesis is due
to their effect on increasing protein synthesis in the uterus.
Therefore, the next series of experiments (section 3.6) addresses this
question, and examines the role of oestradiol, progesterone, and other
hormones that may have an action on both PG production and on protein
synthesis by the guinea-pig endometrium.
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3.6 EFFECTS OF OESTRADIOL, PROGESTERONE, HYDROCORTISONE AND OXYTOCIN
ON PROSTAGLANDIN PRODUCTION BY THE GUINEA-PIG ENDOMETRIUM IN
CULTURE
INTRODUCTION
In ovariectomised guinea-pigs, the action of oestradiol on a
progesterone-primed uterus causes a large stimulation of PGF2a output
(Blatchley and Poyser, 1974). In intact animals, oestradiol output
from the guinea-pig ovary has been shown to increase after day 10 of
the cycle (Joshi, Watson and Labhsetwar, 1973) and, after day 11,
PGF2q output increases from the uterus (Blatchley, Donovan, Horton and
Poyser, 1972; Earthy, Bishop and Flack, 1975; Antonini, Turner and
Pauerstein, 1976). Therefore, it has been proposed that these
ovarian steroid hormones are the physiological stimulus for
endometrial PGF2Q production (Poyser, 1983b). However, progesterone
has been shown to inhibit basal and oestradiol stimulated PGF2Q output
from the human endometrium and the guinea-pig endometrium maintained
in tissue culture (Cane and Villee, 1975; Abel and Baird, 1980;
Leaver and Seawright, 1982), and also from human endometrial cells
maintained in culture (Schatz, Markiewicz, Barg and Gurpide, 1985).
In vivo, plasma progesterone concentrations are required to fall in
several mammalian species before maximal PGF2Q output can occur
(Horton and Poyser, 1976).
Glucocorticoid hormones exert part of their anti-inflammatory
action by increasing the production of lipocortins, which inhibit
phospholipase (PL) A2 activity and so reduce the amount of arachidonic
acid released from phospholipids and which is available for
prostaglandin, thromboxane and leukotriene production (Blackwell and
Flower, 1983). Recently, lipocortins have been implicated in the
control of PG synthesis by the human endometrium (Gurpide, Markiewicz,
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Schatz and Hirata, 1986), since there was a clear relationship between
increased lipocortin and decreased PG levels found in the culture
medium.
This study has examined the effects of steroid hormones and of
oxytocin on PG synthesis by the guinea-pig uterus by measuring PG
outputs from and PG synthesizing capacities of guinea-pig endometrium
in tissue culture. The effects of ovarian steroids on fresh protein
synthesis are also examined.
The aims of this study are:
(a) to investigate whether hydrocortisone, the main glucocorticoid
hormone secreted in the guinea-pig (Fajer and Vogt, 1963), has an
inhibitory effect on PGF2a output from guinea-pig endometrium.
(b) to investigate whether the inhibitory effect of progesterone on
endometrial PGF2Q production is due to a glucocorticoid-like action.
(c) to confirm a previous report by Leaver and Seawright (1982) that
oestradiol and oxytocin stimulate PGFpa output from cultured guinea-
pig endometrium.
(d) to examine the effects of oestradiol, progesterone,
hydrocortisone and oxytocin on the outputs of PGE2 and 6-keto-PGFpa
from guinea-pig endometrium.
(e) to investigate the actions of oestradiol and progesterone on the
amounts of PGFpa, PGE2 and 6-keto-PGFpQ produced by guinea-pig
endometrial homogenates after culture.
(f) to examine whether the effects of oestradiol and progesterone on
endometrial PGF2a production are related to hormone - induced changes in
protein synthesis.
METHODS
Female guinea-pigs were used on either day 7 or day 15 of the
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oestrous cycle and their uteri were removed in preparation for tissue
culture as detailed in section 2.2.1. Endometrium was separated from
the myometrium and small pieces of endometrium were placed in petri
dishes according to the method for tissue culture (section 2.2.5).
In Experiments 1, 2 and 3, each dish contained between 12 and 20mg
endometrium, and in Experiment 4, between 30 and 60mg endometrium.
The dishes were placed in modified Kilner jars, which were gassed and
incubated under the conditions detailed in section 2.2.5. Details of
the individual experimental procedures are given below. All culture
medium and ethyl acetate samples were stored at -20°C before the
amounts of PGF2a, PGE2 and 6-keto-PGFpQ present were measured by
radioimmunoassay (see sections 2.3.1, 2.3.2, 2.3.3. and 2.3.4).
Experiment 1
Day 7 and day 15 guinea-pigs were used (5 animals per day).
Endometrium removed from the uterus of each animal was placed into
eighteen Petri dishes in preparation for tissue culture as explained
above. These dishes were divided equally between two Kilner jars
(i.e. nine dishes/jar), which were gassed and incubated for 24h as
detailed above.
After 24h, the culture medium was changed. Two of the Petri
dishes in each jar were left untreated (controls), and each hormone
concentration was added to one of the remaining dishes from each jar
(i.e. each treatment was performed in duplicate with one of each of
the duplicate treatments being placed in each jar). The treatments
are specified below. The dishes were replaced in the jars, which
were gassed and incubated (as above) for a further 24h.
After 48h of culture the medium was changed again, but no
further treatment was administered. The dishes were replaced in the
jars, which were gassed and incubated (as above) for a further 24h.
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After 72h of culture, the culture medium was collected and the
endometrium in each dish was weighed.
Treatments: Endometrium on day 7 and day 15 of the oestrous
cycle was treated on day 2 (between 24h and 48h) with oestradiol-17/3
(10,100 and l,000ng/ml), progesterone (10 and lOOng/ml) and oxytocin
(10"5 and 10"4U/ml).
Experiment 2
The procedure for this experiment was very similar to that of
Experiment 1. Uteri were removed from five day 7 and five day 15
guinea-pigs. Endometrium from each uterus was placed into eighteen
Petri dishes in preparation for tissue culture. The dishes were
divided equally between two Kilner jars. Each jar contained two
control dishes and one dish of each treatment performed in duplicate
as specified below. The jars were gassed and incubated for 24h.
The medium was changed every 24h, as in Experiment 1. However,
endometrium in these Petri dishes was treated on all three days of
culture (the hormone treatment was added at time Oh and after each
change of medium at 24h and 48h) as specified below:
Treatments: Day 7 endometrium was treated on all three days of
culture with oestradiol-17/3 (1, 10, 100 and lOOOng/ml) . Day 15
endometrium was treated on all three days of culture with oestradiol-
17/3 (1, 10, 100 and lOOOng/ml), progesterone (1, 10, 100 and
lOOOng/ml), hydrocortisone (1, 10, 100 and lOOOng/ml) or oxytocin
(10"6, 10'5 and 10"4U/ml).
Experiment 3
Uteri from six guinea-pigs on day 7 and from six guinea-pigs on
day 15 of the oestrous cycle were removed in preparation for tissue
culture as above. Endometrium was dissected from each uterus and was
placed into twenty Petri dishes, according to the tissue culture
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methods as before. These dishes were divided into five groups of
four dishes and each group was treated with one of the following:
oestradiol-17/3 (lOng/ml); oestradiol-17/3 (lOOOng/ml) ; progesterone
(lOng/ml); progesterone (lOOng/ml); the final group remained
untreated (controls). The groups of dishes were distributed between
three Kilner jars, so that in two jars there were four groups (i.e.
two groups/jar), with the final group in the third jar. The jars
were gassed and incubated as specified above.
Immediately after the jars were placed in the incubator, between
12-20mg of the remaining endometrium was weighed accurately,
homogenised and incubated for 60 min with 2^ig sodium arachidonate
(added in 10/jl ethanol) according to the procedure and conditions
explained in section 2.2.4.ii. This homogenate measured the "Oh"
control PG synthesizing capacity of the endometrium. After
incubation, PGs were extracted from the incubate and redissolved in
5ml ethyl acetate as explained in section 2.2.2.
After 6h, 12h and 18h of culture, one dish was removed from each
group of dishes at each time. The medium from the remaining dishes
was collected and replaced with both fresh medium and the appropriate
steroid treatment. The dishes were replaced in the jars, which were
gassed and incubated as specified above. After 24h of culture, the
remaining five dishes were removed.
Immediately after removal, the culture medium from the dishes
was collected. The tissue was weighed, homogenised and incubated for
60 min with 2/ig sodium arachidonate (section 2.2.4.ii), and the PGs
were then extracted (section 2.2.2) as explained for "Oh" controls
above. These homogenates measured endometrial PG synthesizing
capacities after 6h, 12h, 18h and 24h of culture.
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Experiment 4
Five day 7 and five day 15 guinea-pigs were killed and their
uteri removed (as above). Endometrium was dissected from each uterus
and was placed in five Petri dishes in preparation for tissue culture
as specified above (30-60mg tissue/dish). Each dish also contained
10 [id [^H]-Leucine (2.5^Ci/ml), consistent with the method for
measuring protein synthesis (section 2.4). These dishes were placed
in a modified Kilner jar, which was gassed and incubated for 24h as
detailed above. Immediately after the jar was placed in the
incubator, 30-60mg of the remaining endometrium was placed in another
Petri dish, according to the tissue culture method, which contained
lOpCi [^H]-leucine (2.5^iCi/ml) in the medium. The culture medium was
washed over the endometrium using a Pasteur pipette and the dish was
incubated for 2 min at room temperature. The endometrium was then
weighed accurately. The endometrium and culture medium from this
dish measured the non-specific binding of [^H]-leucine that occurred
during the procedures used to measure [^H]-leucine incorporation into
freshly synthesised cellular and secreted proteins, respectively
(section 2.4). After 24h of culture, the incubated dishes were
removed, and the incorporation of [^H]-leucine into cellular and
secreted proteins was measured by analysing the endometrium and
culture medium, respectively, as specified in section 2.4.
Presentation of results, calculations and statistical analysis
The outputs of PGF2Q, PGE2 and 6-keto-PGFpa from guinea-pig
endometrium in Experiments 1 and 2 are expressed as a percentage of
their respective day 1 control output value for the same set of
dishes. The control output values in Experiment 1 are the day 1
values obtained from every dish for each PG. The control output
values in Experiment 2 are the mean of the two values obtained for the
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untreated dishes in each jar for each PG. There was insufficient
endometrium to test all the hormones at all the concentrations using
endometrium removed from the same guinea-pig. By exhibiting the
results in this form, the effects of different hormone treatments on
the outputs of PGs from endometrium removed from different animals can
be compared.
Changes with time in PG outputs from and PG synthesizing
capacities of endometrium in Experiment 3 were examined using Duncan's
multiple range test. Other comparisons were made using Student's 't'
test (or the modified 't' test if variances were unequal by the
variance F-test) in Experiments 1, 2, 3 and 4, as appropriate.
In Experiment 4, the non-specific binding of [^H]-leucine at
time Oh that occurred in the endometrium and culture medium was
subtracted from the amount of [^H]-leucine incorporated into cellular
and secreted proteins, respectively, after 24h in culture.
RESULTS
Basal outputs of PGF2Q, PGE2 and 6-keto-PGFpQ from endometrium
removed on day 7 and day 15 of the oestrous cycle and cultured for
three days are shown in Figure 3.1. a in Section 3.1. Briefly, when
day 7 endometrium is cultured for three days, PGF2Q and 6-keto-PGFpQ
outputs are similar, while PGE2 output is lower. When day 15
endometrium is cultured for three davs, PGF2Q is the main PG released,
with lesser amounts of PGE2 and 6-keto-PGFpQ being released. Outputs
of all PGs from both day 7 and day 15 endometrium declined during the
three day culture period (see section 3.1).
Experiment 1
Oestradiol (10, 100 and lOOOng/ml) treatment of day 7 and day 15
endometrium on day 2 of culture had no stimulatory action on the
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outputs of PGF2a, PGE2 and 6-keto-PGFpQ either on day 2 (during
treatment) or on day 3 (after treatment; Figures 3.6.a and 3.6.b).
In fact, oestradiol (lOOOng/ml) treatment on day 2 of culture
significantly (P < 0.05) inhibited PGF2a, PGE2 and 6-keto-PGFpQ
outputs from day 7, and PGF2Q and PGE2 outputs from day 15 endometrium
on day 3 of culture (Figure 3.6.a and 3.6.b). Progesterone
(lOOng/ml) treatment on day 2 of culture significantly (P < 0.05)
inhibited PGF2Q and PGE2 outputs on day 2 of culture from day 7
endometrium, and significantly (P < 0.05) inhibited the output of PGE2
on day 2, and the output of PGF2Q on day 3 of culture from day 15
endometrium. Also, progesterone (lOng/ml) treatment significantly (P
< 0.05) inhibited PGF2Q output from day 7 endometrium on day 2 of
culture. The output of 6-keto-PGF]^a was not changed by progesterone
treatment from either day 7 or day 15 endometrium (Figures 3.6.a and
3.6.b respectively). Oxytocin (10"^ and 10"^U/ml) treatment had no
effect on the output of any PG from either day 7 or day 15 endometrium
on either day 2 or day 3 of culture (Figures 3.6.a and 3.6.b,
respectively).
Experiment 2
Oestradiol treatment (1, 10 and lOOng/ml) had no effect on PGF2a
and PGE2 outputs on any day of culture, from either day 7 or day 15
endometrium (Figures 3.6.c and 3.6.d, respectively). Addition of
oestradiol (lOOOng/ml) significantly (P < 0.05) inhibited PGF2Q output
on all three days of culture from day 7 and day 15 endometrium.
Oestradiol (lOOOng/ml) treatment also significantly (P < 0.05) reduced
PGE2 outputs on days 1 and 2 of culture from day 7 endometrium, and on
days 2 and 3 from day 15 endometrium in culture. Oestradiol-treated
endometrium from either day 7 or day 15 of the oestrous cycle
exhibited no significant change in 6-keto-PGF^Q output on any day of
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Day 1 Day 2 °ay 3
ng/ml U/ml ng/ml U/ml
Figure 3.6.a
Mean (± s.e.m.; n = 10) outputs of PGF2Q, PGE2 and 6-keto-PGF^a
(expressed as a percentage of day 1 PG output value) from day 7
guinea-pig endometrium in culture for three days, sampling every 24h
and not treated (controls (0) ; open columns) or treated with
oestradiol (10, 100 and lOOOng/ml; hatched columns), progesterone (10
and lOOng/ml; columns with crosses) and oxytocin (10"-5 and
10"^U/ml; columns with squares) on day 2 of culture,
f significantly (P < 0.05) lower than the corresponding control
value for the same PG on the same day of culture.
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Mean (± s.e.m. ; n = 10) outputs of PGF2Q, PGE2 and 6-keto-PGFja
(expressed as a percentage of day 1 PG output value) from day 15
guinea-pig endometrium in culture for three days, sampling every day,
and not treated (controls (0); open columns) or treated with
oestradiol (10, 100 and lOOOng/ml; hatched columns), progesterone (10
and lOOng/ml; columns with crosses) and oxytocin (10"5 and
10"uJ/ml; columns with squares) on day 2 of culture,
f significantly (P < 0.05) lower than the corresponding control
value for the same PG on the same day of culture.
Day 1 Day 2 Day 3
Figure 3.6. c
Mean (± s.e.m. ; n = 10) outputs of PGFjq, PGE2 and 6-keto-PGF^Q
(expressed as a percentage of day 1 control (0) value) from day 7
cultured guinea-pig endometrium and not treated (control (0) ; open
columns) or treated with lng/ml (hatched columns), lOng/ml (columns
with crosses), lOOng/ml (columns with squares) and lOOOng/ml (columns
with circles) oestradiol on all three days of culture,
f significantly (P < 0.05) lower than the corresponding control (0)
value for the same PG on the same day of culture,
n.d. be low the detection level for PGE2•
Day 1 Day 2 Day 3
ng/ml ng/ml ng/ml
Figure 3.6.d
Mean (± s.e.m.; n = 10) outputs of PGF2a, PGE2 and 6 - ke to - PGFpQ
(expressed as a percentage of day 1 control (0) value) from day 15
cultured guinea-pig endometrium and not treated (control (0); open
columns) or treated with lng/ml (hatched columns), lOng/ml (columns
with crosses), lOOng/ml (columns with squares) and lOOOng/ml (columns
with circles) oestradiol on all three days of culture,
f significantly (P < 0.05) lower than the corresponding control (0)
value for the same PG on the same day of culture.
culture compared to the control values on the same day of culture
(Figures 3.6.c and 3.6.d).
Treatment of day 15 endometrium with oxytocin (10"^, 10"^ and
10"^ U/ml) had no significant effect on the outputs of PGF2Q, PGE2 or
6-keto-PGF]^a on any day of culture (Figure 3.6.e).
Progesterone (1, 10, 100 and lOOOng/ml) treatment significantly
(P < 0.05) inhibited PGF2Q output from day 15 endometrium on days 1
and 2 of culture, except progesterone (lng/ml) treatment had no
significant effect on day 1 of culture (Figure 3.6.f). Progesterone
(lOOOng/ml) treatment significantly (P < 0.05) inhibited PGF2a output
from day 15 endometrium on day 3 of culture, but lower concentrations
of progesterone exhibited no action on PGF2Q output on day 3 of
culture (Figure 3.6.f). The output of PGE2 was not changed by
progesterone treatment, except PGE2 output was significantly (P <
0.05) inhibited by progesterone (lOOng/ml) on day 2, and by
progesterone (lOOOng/ml) on days 1 and 2 of culture. Progesterone
treatment had no significant effect on 6-keto-PGFpQ output from day 15
endometrium on any day of culture (Figure 3.6.f).
Hydrocortisone (1, 10, 100 and lOOOng/ml) treatment had no
significant effect on the outputs of ,PGF2Q. PGE2 and 6-keto-PGF^Q from
day 15 endometrium in culture for three days (Figure 3.6.g).
Experiment 3
The effects of oestradiol and progesterone on PG output from and
PG synthesizing capacity of guinea-pig endometrium maintained in
culture for up to 24h, are shown in Figures 3.6.h to 3.6.0. The
control (C) results have been presented twice in both sets of steroid
results for clarity, and they will be examined first in this results
section.
Control values: The output of PGF2a from day 7 endometrium between 0
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Mean (± s.e.m.; n = 10) outputs of PGF2Q, PGE2 and 6-keto-PGFia
(expressed as a percentage of day 1 control (0) value) from day 15
cultured guinea-pig endometrium and not treated (control (0), open
columns) or treated with lO'^U/ml (hatched columns), 10" U/ml (columns
with crosses) and 10"4U/ml (columns with squares) oxytocin on all
three days of culture.
Day 1 Day 2 Day 3
ng/ml ng/ml ng/ml
Figure 3.6.f
Mean (± s.e.m.; n = 10) outputs of PGF2Q, PGE2 and 6-keto-PGF]_q
(expressed as a percentage of day 1 control (0) value) from day 15
cultured guinea-pig endometrium and not treated (control (0) ; open
columns) or treated with lng/ml (hatched columns), lOng/ml (columns
with crosses), lOOng/ml (columns with squares) and lOOOng/ml (columns
with circles) progesterone on all three days of culture,
t significantly (P < 0.05) lower than the corresponding control (0)
value for the same PG on the same day of culture.
Day 1 Day 2 Day 3
Figure 3.6.g
Mean (± s.e.m. ; n = 10) outputs of PGF2Q, PGE2 and 6-keto-PGF]^a
(expressed as a percentage of day 1 control (0) value) from day 15
cultured guinea-pig endometrium and not treated (control (0); open
columns) or treated with lng/ml (hatched columns), lOng/ml (columns
with crosses), lOOng/ml (columns with squares) and lOOOng/ml (columns
with circles) hydrocortisone on all three days of culture,
f significantly (P < 0.05) lower than the corresponding control (0)
value for the same PG on the same day of culture.
and 6h decreased slightly, but not significantly, to the lowest output
which was recorded between 6h and 12h (Figures 3.6.h and 3.6.1). The
PGF2a output then increased between 12h and 18h and was significantly
(P < 0.05) greater than the PGF2Q output between 6h and 12h. This
significantly (P < 0.05) higher output of PGF2a was maintained until
the end of the 24h culture period. The output of PGE2 declined
significantly (P < 0.05) from its highest level between 0 and 6h to a
lower level of output between 6h and 12h, and this significantly (P <
0.05) lower output of PGE2 remained constant for the remainder of the
culture period (Figures 3.6.h and 3.6.1). The output of 6-keto-PGF]^a
from day 7 endometrium declined significantly (P < 0.05) throughout
the culture period (Figures 3.6.g and 3.6.1).
The amounts of PGF2a and PGE2 synthesised by homogenates of day
7 endometrium following culture for up to 24h significantly (P < 0.05)
increased from the Oh control value up to the 18h sample time for
PGF2q, and up to the 12h sample time for PGE2 (Figures 3.6. i and
3.6.m). These increased levels in PG synthesizing capacities were
maintained up to the end of the culture period. The synthesizing
capacity of 6-keto-PGF^Q of day 7 endometrium did not change
significantly from the Oh control value at any of the sample times
after culture (Figures 3.6. i and 3.6.m).
The outputs of PGF2q,, PGE2 and 6-keto-PGF]ia from day 15
endometrium cultured for up to 24h all significantly (P < 0.05)
declined during the culture period (Figures 3.6.j and 3.6.111). The
amounts of PGF2a, PGE2 and 6 - keto - PGF]^Q synthesised by homogenates of
day 15 endometrium cultured for up to 24h significantly (P < 0.05)
increased after 6h of culture, when compared to Oh values (Figure
3.6.k and 3.6.0). The synthesizing capacities of PGF2Q and 6-keto-
PGFiQ were significantly (P < 0.05) at their highest values after 6h
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and 12h of culture, and then they declined from this level after 18h
and 24h of culture. However, after 24h of culture, the synthesizing
capacities of PGF2Q and 6-keto-PGFpQ were still significantly (P <
0.05) higher than their respective Oh control synthesizing capacities.
The synthesizing capacity of PGE2 was significantly (P < 0.05) higher
after 6h of culture when compared to the Oh control value; this
increased synthesizing capacity for PGE2 did not change significantly
for the remaining sampling periods (Figures 3.6.k and 3.6.0).
Oestradiol treatment: The outputs of PGF2Q, PGE2 and 6-keto-PGFpQ
from day 7 endometrium were not changed by oestradiol (lOng/ml;
Figure 3.6.h). However, the output of PGF2Q after treatment with
oestradiol (lOOOng/ml) was significantly (P < 0.05) inhibited between
12h and 18h, and 18h and 24h of culture. Furthermore, the rise in
control values seen during these periods were prevented by oestradiol
(lOOOng/ml; Figure 3.6.h). The outputs of PGE2 and 6-keto-PGFpa
were not affected by treatment with oestradiol (lOOOng/ml; Figure
3.6.h).
The PGF2q synthesizing capacity of day 7 endometrium treated
with oestradiol (both concentrations) was significantly (P < 0.05)
higher after 12h, 18h and 24h of culture when compared to Oh control
values (Figure 3.6.i). These increases are the same as exhibited by
control (non-treated) endometrium over the same time periods.
Furthermore, treatment of endometrium with 10ng oestradiol/ml
significantly (P < 0.05) increased the PGF2q synthesizing capacity
after 18h of culture compared to the control value at the same time.
Treatment of endometrium with oestradiol (lOOOng/ml) after 18h of
culture significantly (P < 0.05) prevented to some extent the increase
in PGF2q synthesizing capacity exhibited by the control value at the
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Figure 3.6.h
Mean (± s.e.m.; n - 6) outputs of FGF2a, PGE2 and 6-keto-PGFlQ (ng/mg
tissue/6h) from guinea-pig endometrium removed on day o e
oestrous cycle and cultured for up to 24h, changing the culture medium
every 6h, not treated (controls (C); open columns), or treated witn
lOng oestradio1/ml (hatched columns), or lOOOng oestradiol/m (crosse
columns).
f significantly (P 0.05) lower than the control (C) PG outpu
the same time for the same PG.
Control (C) columns with different superscripts for the same






















































































































ng/ml ng/ml i ng/ml
Mean (± s.e.m.; n = 6) amounts of PGF2a, PGE'2 and 6 - keto - PGF;lq (ng/mg
tissue/h) synthesised by homogenates of day 7 guinea-pig endometrium
at Oh and after 6h, 12h, 18h and 24h of culture, not treated (control
(C); open columns), or treated with 10ng oestiadiol/m1 vHatched
columns) or lOOOng oestradiol/ml (crossed columns) during the culture
period.
f significantly (P < 0.05) lower than the control (C) PG production
at the same time for the same PG.
^ significantly (P < 0.05) higher than the Oh control (C) PG
production for the same PG.
* significantly (P < 0.05) higher than control (C) PG production at
the same time for the same PG.
Control (C) columns with different superscripts for the same PG
indicate the values are significantly (P < 0.05) different.
significantly (P < 0.05) higher than the Oh control. The PGE2
synthesizing capacity of day 7 guinea-pig endometrium was
significantly (P < 0.05) higher after 18h and 24h of culture than at
Oh following treatment with lOng oestradiol/ml (Figure 3.6.i). This
increase in PGE2 synthesizing capacity following oestradiol (lOng/ml)
treatment was similar to the control value profile of PGE2
synthesizing capacity, except that control values increased to a
significantly (P < 0.05) higher level than Oh controls after 12h of
culture, a sample period earlier than the lOng oestradiol/ml treated
endometrial value (Figure 3.6.i). After 18h of culture, lOng
oestradiol/ml treatment significantly (P < 0.05) increased PGE2
synthesizing capacity to a value greater than the control value at the
same time. Oestradiol (lOOOng/ml) treatment prevented the increase
in PGE2 synthesizing capacity observed during culture, so the PGE2
synthesizing capacity did not change from the Oh control value. The
profile of the amounts of 6-keto-PGFpQ produced by homogenates of day
7 endometrium following 6h to 24h in culture when treated with
oestradiol was similar to the control profile of 6-keto-PGF^a
production by homogenates (Figure 3.6.i). However, the 6-keto-PGFpQ
synthesizing capacity of day 7 endometrium treated with oestradiol
(lOng/ml) was significantly (P < 0.05) higher after 6h, 12h and 18h of
culture compared to the control value at Oh, although these values
were not significantly different from the control values at the same
respective times. Oestradiol (lOOOng/ml) did not change the 6-keto-
PGFpa synthesizing capacity of day 7 endometrium during culture when
compared to the Oh control value and to the control values at the same
respective times (Figure 3.6.i).
Treatment with oestradiol (lOng/ml) had no effect on the outputs
of PGF2Q, PGE2 and 6-keto-PGF^Q from day 15 endometrium during 24h in
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culture (Figure 3.6.j). Oestradiol (lOOOng/ml) treatment did not
change PGE2 and 6-keto-PGFpa outputs during 24h of culture, and PGF2Q
output between Oh and 6h and 6h and 12h of culture. However,
oestradiol (lOOOng/ml) treatment significantly (P < 0.05) reduced
PGF2q output from day 15 endometrium between 12h and 18h, and 18h and
24h of culture (Figure 3.6.j).
The PGF2a synthesizing capacity of day 15 guinea-pig endometrium
after 6h of culture was significantly (P < 0.05) higher than at Oh
following treatment with lOOOng oestradiol/ml, and was also increased,
but not significantly, following treatment with 10ng oestradiol/ml
(Figure 3.6.k). After 12h, the PGF2Q synthesizing capacity of
oestradiol-treated, day 15 endometrium was significantly (P < 0.05)
higher than at Oh, although lOOOng oestradiol/ml treatment
significantly (P < 0.05) reduced PGF2Q synthesizing capacity compared
to the 12h control value. After 18h, the PGF2Q synthesizing capacity
of day 15 endometrium treated with oestradiol (lOng/ml) was
significantly (P < 0.05) higher than the Oh control value. Treatment
with oestradiol (lOOOng/ml) significantly (P < 0.05) reduced PGF2Q
synthesizing capacity after 18h and 24h of culture compared to the
respective control value at the same time. Treatment with lOng
oestradiol/ml prevented the increase in PGE2 synthesizing capacity of
day 15 endometrium after 6h and 24h of culture, but had no significant
effect after 12h and 18h of culture (Figure 3.6.k). Oestradiol
(lOOOng/ml) treatment significantly (P < 0.05) prevented the rise in
PGE2 synthesizing capacity of day 15 endometrium after 6h, 18h and 24h
of culture, but not after 12h of culture, and significantly (P < 0.05)
reduced PGE2 synthesizing capacity at every sample period compared to
the respective control value at the same time (Figure 3.6.k).


























































































C 10 1000' C 10 1000' C 101000
ng/ml ng/ml ng/ml
Figure 3.6.j
Mean (± s.e.ra.; n = 6) outputs of PGF2q,, PGE2 and 6 - ke to - PGF]^Q (ng/mg
tissue/6h) front guinea pig endometrium removed on day 15 of the
oestrous cycle and cultured for up to 24h, changing the culture medium
every 6h, not treated (controls (C);
lOng oestradiol/ml (hatched columns),
columns).
f significantly (P < 0.05) lower than the control (C) PG output at
the same time for the same PG.
Control (C) columns with different superscripts for the same PG
indicate the values are significantly (P < 0.05) different.
open columns), or treated with
or lOOOng oestradiol/ml (crossed
0 hours 6 hours 12 hours 18 hours 24 hours
A A A A A
ng/ml ng/ml ng/ml ng/ml
Figure 3.6 . k
Mean (± s.e.m.; n - 6) amounts of PGF2Q, PGE2 and 6-keto-PGF]^Q (ng/mg
tissue/h) synthesised by homogenates of day 15 guinea-pig endometrium
at Oh and after 6h, 12h, 18h and 24h of culture, not treated (control
(C) ; open columns), or treated with 10ng oestradiol/ml (hatched
columns) or lOOOng oestradiol/ml (crossed columns) during the culture
period.
t significantly (P < 0.05) lower than the control (C) PG production
at the same time for the same PG.
^ significantly (P < 0.05) higher than the Oh control (C) PG
production for the same PG.
Control (C) columns with different superscripts for the same PG
indicate the values are significantly (P < 0.05) different.
increase in 6-keto-PGFpQ synthesizing capacity of day 15 endometrium
observed during the 24h period of culture (Figure 3.6.k). However,
oestradiol (lOOOng/ml) treatment prevented this increase in 6-keto-
PGFia synthesizing capacity after 18h and 24h, but not after 6h of
culture, and furthermore, this treatment significantly (P < 0.05)
reduced 6-keto-PGFpQ synthesizing capacity after 12h of culture when
compared to the control value at the same time (Figure 3.6.k).
Progesterone treatment: Progesterone (10 and lOOng/ml) treatment
significantly (P < 0.05) inhibited PGF2Q output from day 7 endometrium
between 12h and 18h, and 18h and 24h of culture when compared to the
corresponding control values at the same times (Figure 3.6.1). This
inhibitory action of progesterone prevented the rise in PGF2Q output
observed between 12h and 24h in control values over the same time
period. Progesterone (both concentrations) treatment had no
significant effect on PGE2 and 6-keto-PGF]^Q outputs when compared to
the respective control values at the same times (Figure 3.6.1).
Treatment with both concentrations of progesterone (10 and
lOOng/ml) reduced and delayed the increase in PGF2a synthesizing
capacity of homogenates of day 7 endometrium during culture for 24h,
when compared to control values at the same times (Figure 3.6.m).
Unlike the control PGF2Q synthesizing capacity value after 12h, 18h
and 24h of culture, the PGF2Q synthesizing capacity of day 7
endometrium treated with progesterone was not significantly higher
than the Oh control value at any sample time. In fact, progesterone
treatment significantly (P < 0.05) lowered PGF2Q synthesizing capacity
(except for lOOng progesterone/ml treatment after 24h of culture; when
compared to the respective control value at the same time.
Progesterone treatment prevented the significant (P < 0.05) rise in
PGE2 synthesizing capacity of day 7 endometrium during 24h of culture.
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Mean (± s.e.m.; n = 6) outpuCs of PGF2Q, PGE2 and 6-keto-PGF^Q (ng/rag
tissue/6h) from guinea-pig endometrium removed on day 7 of the
oestrous cycle and cultured for up to 24h, changing the culture medium
every 6h, not treated (controls (C); open columns), or treated with
lOng progesterone/ml (hatched columns), or lOOng progesterone/ml
(crossed columns).
f significantly (P < 0.05) lower than the control (C) PG output at
the same time for the same PG.
Control (C) columns with different superscripts for the same PG
indicate the values are significantly (P < 0.05) different.
0 hours 6 hours 12 hours 18 hours 24 hours
Figure 3.6.m
Mean (± s.e.m.; n = 6) amounts of PGF2Q, PGE2 and 6-keto-PGFpQ (ng/mg
tissue/h) synthesised by homogenates of day 7 guinea-pig endometrium
at Oh and after 6h, 12h, 18h and 24h of culture, not treated (control
(C); open columns), or treated with 10ng progesterone/ml (hatched
columns) or lOOng progesterone/ml (crossed columns) during the culture
period..
| significantly (P < 0.05) lower than the control (C) PG production
at the same time for the same PG.
^ significantly (P < 0.05) higher than the Oh control (C) PG
production for the same PG.
Control (C) columns with different superscripts for the same PG
indicate the values are significantly (P < 0.05) different.
The PGE2 synthesizing capacity of day 7 endometrium was significantly
(P < 0.05) lower than the corresponding control value at the same
time, after 12h of culture when treated with progesterone (10 and
lOOng/ml) and after 18h of culture when treated with 10ng
progesterone/ml (Figure 3.6.m). The 6-keto-PGF2Q synthesizing
capacity of day 7 endometrium was not significantly changed by
progesterone treatment throughout the 24h culture period (Figure
3.6.m).
The output of PGF2q from day 15 endometrium cultured for 24h was
significantly (P < 0.05) inhibited by progesterone (10 and lOOng/ml)
treatment, between 12h and 18h, and 18h and 24h when compared to the
control values during the same time period (Figure 3.6.n). The
outputs of PGE2 and 6-keto-PGFpQ were not altered by progesterone
treatment, except PGE2 output was significantly (P < 0.05) inhibited
by lOng progesterone/ml between 12h and 18h, and 6-keto-PGFpQ output
was significantly (P < 0.05) inhibited by lOOng progesterone/ml
between 18h and 24h of culture (Figure 3.6.n).
The rise in PGF2Q synthesizing capacity during the 24h culture
of day 15 endometrium demonstrated by the control values was prevented
by progesterone treatment at both concentrations used (10 and
lOOng/ml; Figure 3.6.0). During 24h of culture, the amounts of
PGF2q produced by homogenates of day 15 endometrium following
treatment with progesterone were not significantly higher than the Oh
control value. After 6h, the PGF2a synthesizing capacity of day 15
endometrium treated with progesterone (10 and lOOng/ml) was neither
significantly higher than the Oh control value nor significantly lower
than the 6h control value, but was between both control values.
However, after 12h, 18h and 24h of culture, the PGF2a synthesizing
capacities of day 15 endometrium treated with both concentrations of
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6 hours 12 hours 18 hours 24 hours
ng/ml ng/ml ng/ml ng/ml
Figure 3.6.n
Mean (± s.e.m.; n = 6) outputs of PGF2Q, PGE2 and 6-keto-PGFpQ (ng/mg
tissue/6h) from guinea-pig endometrium removed on day 15 of the
oestrous cycle and cultured for up to 24h, changing the culture medium
every 6h, not treated (controls (C); open columns), or treated with
lOng progesterone/ml (hatched columns), or lOOng progesterone/ml
(crossed columns).
f significantly (P < 0.05) lower than the control (C) PG output at
the same time for the same PG.
Control (C) columns with different superscripts for the same PG
indicate the values are significantly (P < 0.05) different.











































































































































































ng/ml ng/ml rig/ml ng/ml
Figure 3.6.o
Mean (± s.e.m.; n = 6) amounts of PGF2Q, PGE2 and 6-keto-PGF]^Q (ng/mg
tissue/h) synthesised by homogenates of day 15 guinea-pig endometrium
at Oh and after 6h, 12h, 18h and 24h of culture, not treated (control
(C); open columns), or treated with lOng progesterone/ml (hatched
columns) or lOOng progesterone/ml (crossed columns) during the culture
period.
f significantly (P < 0.05) lower than the control (C) PG production
at the same time for the same PG.
^ significantly (P < 0.05) higher than the Oh control (C) PG
production for the same PG.
Control (C) columns with different superscripts for the same PG
indicate the values are significantly (P < 0.05) different.
progesterone were significantly (P < 0.05) lower than their respective
control value at the same times. Progesterone treatment (both
concentrations used) also prevented the rise in PGE2 synthesizing
capacity of day 15 endometrium that occurred during culture (Figure
3.6.o). The PGE2 synthesizing capacity of day 15 endometrium after
6h, 12h, 18h and 24h of culture was significantly (P < 0.05) inhibited
by progesterone treatment (10 and lOOng/ml) when compared to their
respective control values at the same times, except after 6h of
culture for the lOOng progesterone/ml treatment. The 6-keto-PGFpQ
synthesizing capacity of day 15 endometrial homogenates was less
affected by progesterone treatment than the synthesizing capacities of
PGF2q and PGE2 (Figure 3.6.0). After 6h and 12h of culture, the 6-
keto-PGFpQ synthesizing capacity of day 15 endometrium treated with
both concentrations of progesterone was significantly (P < 0.05)
higher than the Oh control value. However, the treatment of day 15
endometrium with 10ng progesterone/ml for 6h, and with lOOng
progesterone/ml for 12h significantly (P < 0.05) reduced the 6-keto-
PGFpQ synthesizing capacity compared to the corresponding control
values at the same time. After 18h and 24h of culture, the 6-keto-
PGFpQ synthesizing capacity of progesterone - treated, day 15
endometrium was not significantly higher (unlike control values at
these times) than the Oh control value, except for the value for day
15 endometrium treated with lOOng progesterone/ml for 18h of culture
which was significantly (P < 0.05) raised. Also, the 6-keto-PGFpa
synthesizing capacity of day 15 endometrium treated with lOOng
progesterone/ml for 24h of culture was significantly (P < 0.05) lower
than the corresponding 24h control value (Figure 3.6.0).
Experiment 4
The incorporation of [^Hj-leucine into cellular and secreted
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proteins synthesised by day 7 and day 15 guinea-pig endometrium in
culture for 24h, and not treated (control) or treated with oestradiol
and progesterone, is shown in Figure 3.6.p. There was no significant
difference between the amounts of [^H]-leucine incorporated into total
cellular proteins synthesised by day 7 and day 15 endometrium cultured
for 24h. The incorporation of [^H]-leucine into secreted proteins
however, was significantly (P < 0.05) higher by day 15 than by day 7
endometrium. These untreated (control) results are comparable with
the previously presented profiles of incorporation of [^H]-leucine
into cellular and secreted proteins after 24h of culture (see section
3.4 and Figure 3.4.a).
Oestradiol and progesterone treatment had no significant effect
on the incorporation of [^H]-leucine into cellular proteins by day 7
and day 15 endometrium in culture for 24h. However, lOOOng
oestradiol/ml, but not lOng oestradiol/ml, significantly (P < 0.05)
inhibited the incorporation of [-^H]-leucine into secreted proteins by
both day 7 and day 15 cultured endometrium. Furthermore,
progesterone (10 and lOOng/ml) treatment of day 15 endometrium, but
not of day 7 endometrium, significantly (P < 0.05) reduced the
incorporation of [^H]-leucine into secreted proteins during 24h in
culture (Figure 3.6.p).
CONCLUSIONS
The untreated, control, basal outputs of PGF2Q, PGE2 and 6-keto-
PGFiQ from day 7 and day 15 guinea-pig endometrium cultured for three
days and for 24h were comparable to the control PG outputs during
these periods of culture, presented earlier in Section 3.1. The
output of PGF2q was higher from day 15 than from day 7 endometrium.
PGF2q output declined from both day 7 and day 15 endometrium when
172
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n = 5) amounts of [^H]-leucine (measured as cpm/mg
standard counts) incorporated into cellular and secreted
proteins synthesised by day 7 and day 15 guinea-pig endometrium in
culture for 24h, not treated (controls; open columns) or treated with
oestradiol (10 and lOOOng/ml; hatched columns) or progesterone (10
and lOOng/ml; crossed columns).
* significantly (P < 0.05) lower than (^Hj-leucine incorporation into
control secreted proteins by endometrium removed on the same day of
the cycle (by the paired 't' test).
cultured for three days, and PGF2a output declined from day 15 but not
from day 7 endometrium when cultured for 24h. This decline in output
during either of the culture periods was not overcome by oestradiol
treatment. Day 7 endometrium exhibited an increase in PGF2Q output
during the final 12h of the 24h culture period. Oestradiol treatment
had no stimulatory effect on this output either. Furthermore,
treatment of cultured guinea-pig endometrium with oxytocin had no
stimulatory action on PGF2Q output.
Indeed, oestradiol, at the highest concentration (lOOOng/ml)
used was found to inhibit PGF2Q output. The highest concentration of
oestradiol (lOOOng/ml) also inhibited PGE2, but not 6-keto-PGF^a
output from both day 7 and day 15 endometrium in culture. This high
dose of oestradiol also had an inhibitory effect on the PGF2Q and PGE2
synthesizing capacities of day 7 and day 15 guinea-pig endometrium in
culture and had a slight inhibitory action on the 6-keto - PGF^q.
synthesizing capacity of day 15 endometrium.
Progesterone treatment inhibited PGF2Q and PGE2, but not 6-keto-
PGFpa basal outputs from both day 7 and day 15 guinea-pig endometrium
in culture, during both three days and 24h of culture. Progesterone
also had a marked inhibitory action on PGF2a and PGE2 synthesizing
capacities of both day 7 and day 15 endometrium, but very little
effect on the day 15, and no effect on the day 7 6-keto-PGFpQ
synthesizing capacity.
Hydrocortisone, which is the main glucocorticoid hormone
secreted in the guinea-pig (Fajer and Vogt, 1963), had no effect on
any PG output from day 15 endometrium on any day of culture.
Furthermore, progesterone exhibited an inhibitory action on PG
production, whereas hydrocortisone had no effect. Therefore, it is
unlikely that the inhibitory action of progesterone occurs via a
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glucocorticoid-like effect.
Oestradiol, at the highest concentration used (lOOOng/ml) had an
inhibitory action on the synthesis of secreted proteins, but not on
cellular proteins, synthesised by both day 7 and day 15 guinea-pig
endometrium cultured for 24h. Progesterone treatment (10 and
lOOng/ml) had an inhibitory effect on the synthesis of secreted, but
not cellular proteins, by day 15 but not by day 7 endometrium in
culture for 24h.
DISCUSSION
In Experiments 1, 2 and 3 the output of PGF2Q during the first
24h of culture was approximately 10-fold greater from day 15
endometrium than from day 7 endometrium. This increase is consistent
with the jin vivo stimulatory action of oestradiol, released in
increasing amounts from the ovary after day 11 (Joshi, Watson and
Labhsetwar, 1973), acting on a progesterone-primed uterus causing this
increase in PGF2a output between day 7 and day 15 of the oestrous
cycle.
Oestradiol and oxytocin did not stimulate PGF2Q output from the
guinea-pig endometrium in culture. These findings are contrary to a
previous study by Leaver and Seawright (1982), who reported that both
hormones stimulated PGF2Q output from cultured guinea-pig endometrium.
However, this lack of effect on PG production by oxytocin is
consistent with work by Poyser and Brydon (1983) who showed there was
no effect on PG outputs from the guinea-pig uterus during a 30 min
superfusion with oxytocin. Poyser and Brydon (1983) and Poyser
(1987b) demonstrated that treatment with oestradiol of both day 7 and
day 15 guinea-pig uterine horns superfused in vitro also had no effect
on the outputs of PGF2Q, PGE2, 6-keto-PGF^Q and TXB2.
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Illingworth and Perry (1973) reported that large, non-
physiological doses of oestradiol administered to guinea-pigs on day 9
of the cycle prevented luteolysis due, at least in part, to an anti-
luteolytic effect. In the present study, oestradiol at the highest
concentration used (lOOOng/ml) inhibited PGF2Q output and also PGE2
output from the cultured guinea-pig endometrium, and this inhibitory
action on the synthesis of the uterine luteolytic hormone fn vitro may
explain the anti-luteolytic effect of oestradiol observed in vivo.
There were several discrepancies in the results from Experiment
2 when comparing PG outputs with the corresponding PG synthesizing
capacity which suggests that the PG synthesizing capacity is not the
factor controlling basal PG output. The profiles of control basal
PGF2q output and of PGF2Q synthesizing capacity of day 7 endometrium
in culture for 24h exhibited some differences. The basal output of
PGF2q during the 24h period declined between 0-6h and 6h-12h, then
increased to the end of the culture period, whereas PGF2a synthesizing
capacity increased from Oh and plateaued at a level that was
significantly higher than the Oh level. Furthermore, the profiles of
the basal outputs of PGE2 and 6-keto-PGF^a from control day 7
endometrium declined during the 24h in culture which differed from
their respective synthesizing capacity profiles: the synthesizing
capacity of PGE2 increased during the culture period from the Oh
value, and 6-keto-PGF^Q synthesizing capacity was maintained during
the culture period at a constant level. The basal outputs of PGF2Q,
PGE2 and 6-keto-PGF]^Q from day 15 endometrium all declined throughout
the 24h culture period. However, the synthesizing capacity of all
three PGs increased between Oh and 6h, and then the PGF2a and 6-keto-
PGFiQ, but not the PGE2 synthesizing capacities declined only
slightly, so showing very different profiles of PG synthesizing
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capacity for cultured endometrium compared to the respective profiles
of PG output. Treatment of day 7 endometrium with oestradiol
(lOOOng/ml) prevented the increase in PGF2Q output between 12h and
18h, and 18h and 24h of culture, whereas PGF2Q synthesizing capacity
after 18h and 24h was significantly higher than the Oh control value
(although the PGF2Q synthesizing capacity after 18h was significantly
lower than the corresponding control value at the same time) . The
synthesizing capacities of PGF2Q and PGE2 from day 7 endometrium
treated with lOng oestradiol/ml were significantly higher after 18h of
culture than their respective controls at the same time, but the
outputs of PGF2q and PGE2 between 12h and 18h after oestradiol
(lOng/ml) treatment were not changed from their control values.
Oestradiol treatment (lOOOng/ml) significantly decreased PGE2
synthesizing capacity from day 15 endometrium at every sample time,
but the output of PGE2 was unaffected throughout the 24h culture
period. Treatment of day 7 endometrium with progesterone (10 and
lOOng/ml) prevented the increase in basal PGF2a output, but did not
prevent the increase in PGF2Q synthesizing capacity (although the
synthesizing capacity values were still lower than control values).
Progesterone treatment (10 and lOOng/ml) significantly inhibited both
PGF2a output and synthesizing capacity from cultured day 15
endometrium, but the progesterone inhibitory action on PGF2Q
synthesizing capacity occurred after 12h of culture, whereas the
inhibition of PGF2Q output was observed in the subsequent sample
periods between 12h and 24h of culture. This evidence (also see
section 3.2 and 3.5 for further similar evidence) has shown that the
synthesizing capacity (and hence endometrial PGH synthase
concentrations) is not the controlling step in PG synthesis by the
guinea-pig endometrium.
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Treatment with glucocorticoids in some tissues, including the
human endometrium in tissue culture (Gurpide, Markiewicz, Schatz and
Hirata, 1986), increase the production of proteins called lipocortins,
that inhibit PLA2 activity. As hydrocortisone treatment had no
effect on PG production from the guinea-pig endometrium in culture,
this suggests lipocortins are not involved in the control of PLA2
activity, which is the rate - limiting step in the control of PG
synthesis (Vogt, 1978). As progesterone exhibits an inhibitory
effect on PG production, the progesterone action is not likely to be
due to a glucocorticoid-like action. This finding is in agreement
with Schatz, Markiewicz and Gurpide (1986) who demonstrated that both
the glucocorticoid (dexamethasone) and progesterone inhibit PGF2a
output from cultured human endometrium. However, dexamethasone
increased the amount of lipocortin released by the endometrium into
the culture medium, whereas progesterone decreased lipocortin
production. Therefore, progesterone and dexamethasone do not inhibit
the output of PGF2q from human endometrium in culture by the same
mechanism.
To summarise the findings from this results section, oestradiol
and oxytocin did not possess a stimulatory action on PGF2Q output from
COlfvurj fe
cultured guinea-pig endometrium^a previous report . In fact
oestradiol at the highest dose administered inhibited both PGF2Q
output and synthesizing capacity. Hydrocortisone had no effect on PG
output, providing further evidence that lipocortin is not involved in
the control of PLA2 activity and hence PG synthesis. Progesterone
inhibited PGF2Q production, but this effect appears not to be a
glucocorticoid-like action. Discrepancies between the PG output and
the corresponding PG synthesizing capacity provide further evidence
that tissue PGH synthase levels are not the controlling step in PG
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synthesis by guinea-pig endometrium. Both progesterone and
oestradiol inhibited the synthesis of secreted proteins by the day 15
guinea-pig endometrium when PGF2Q output was high. Therefore a
*
protein may be involved in the stimulation of endometrial PGF2Q




The basal output of PGF2Q was higher from the Day 15 guinea-pig
uterus than from the day 7 guinea-pig uterus, as demonstrated by the
superfusion experiments (Section 3.5). The site of production of the
uterine luteolytic hormone is the endometrium (Poyser, 1983a) and, in
culture, endometrium removed from day 15 guinea-pigs produced more
PGF2q than endometrium removed from day 7 animals. These findings
agree with previous studies which examined PGF2Q output from cultured
guinea-pig endometrium (Leaver and Seawright, 1982) and from guinea-
pig uterine horns superfused in vitro (Poyser, 1983b; Poyser and
Brydon, 1983), and reflect the higher PGF2Q concentrations observed in
the guinea-pig uterine venous plasma that occur towards the end of the
oestrous cycle (Blatchley, Donovan, Horton and Poyser, 1972).
The outputs of PGE2 and 6-keto-PGFpa from day 15 guinea-pig uteri
superfused in vitro and from day 15 cultured endometrium were much
lower than the output of PGF2a, as previously reported (Poyser and
Brydon, 1983). The outputs of PGE2 and 6-keto-PGFpQ from day 7
superfused guinea-pig uteri and from day 7 cultured endometrium were
similar to their respective outputs from day 15 tissue, and were also
similar to the output of PGF2Q from the day 7 superfused uterus and
cultured endometrium, and these results agree with previous reports
(Poyser, 1983b; Poyser and Brydon, 1983).
The amounts of PGs measured as "output" from uterine tissues is
not only dependent upon PG synthesis but is also dependent upon the
catabolism of PGs. The amounts of PGs measured in incubates of
homogenates of uterine tissues (as a measure of tissue PGH synthase
levels; synthesizing capacity) is also dependent on the catabolism of
PGs in the incubates. The initial reaction in PG catabolism is
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catalysed by NAD+-dependent 15-hydroxyprostaglandin dehydrogenase.
In the pig lung, no measurable metabolism to the 15-keto-PG product
occurred when NAD+ was absent (Anggard and Samuelsson, 1966).
Subsequent catabolism by A-^-PG reductase, which requires NADPH as a
co-factor, produces the 13,14-dihydro-15-keto-PG product.
The antisera used to measure PGF2Q, PGE2 and 6-keto-PGFpa by
radioimmunoassay in these studies have very low cross-reactivities
with the 15-keto-PG and 13,14-dihydro-15-keto-PG metabolites (see
Tables 2.3.2.i, 2. 3. 3. i and 2.3.4.i for the cross - reactivities of PG
antibodies raised to PGF2a, PGE2 and 6-keto-PGF]^a, respectively).
Clearly, the radioimmunoassay antisera used do not cross-react with
the PG metabolites, but uterine tissue must be examined to determine
whether measured PGs reflect total PG production or only a fraction of
the total PG production because of PG catabolism.
Injected PGs are rapidly metabolised during a single passage
through the lungs (Ferreira and Vane, 1967), and metabolising enzymes
have also been identified in the testis (Nakano and Prancan, 1971),
liver (Dawson, Ramwell and Shaw, 1968), kidney (Nissen and Andersen,
1968) and placenta (Jarabak, 1974). In human uterine homogenates,
Nakano, Montague and Darrow (1971) found that the metabolism of PGEp
was low. Subsequently however, Casey, Hemsell, MacDonald and
Johnston (1980) reported that the specific activity of NAD+-dependent
15-hydroxyprostaglandin dehydrogenase, measured using PGE2 as
substrate, was 55-fold greater in endometrium during the secretory
phase when compared to the menstrual and premenstrual stages, and that
the activity during the secretory phase was 3.5-fold greater than
during the proliferative phase. Prostaglandin dehydrogenase activity
was primarily found in the cytosolic fractions of glandular but not
stromal epithelia (Casey, Hemsell, MacDonald and Johnston, 1980).
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However, without the addition of NAD+, or with the addition of the
reduced form of the co-factor (NADH), homogenates of human uterine
tissue did not exhibit any measurable catabolism (Abel and Kelly,
1983).
In the guinea-pig, Maule Walker and Poyser (1978) demonstrated
that exogenous PGE2 and PGF2a were almost completely metabolised when
added to homogenates of day 15 guinea-pig lung when incubated in
Tyrode's solution containing NAD+. This finding is in agreement with
in vivo observations by Piper, Vane and Wyllie (1970) who demonstrated
the lungs appeared to be the principle site of PG metabolism in the
guinea-pig. Metabolism after the addition of exogenous PGF2Q and
PGE2 to day 15 guinea-pig uterine homogenates was relatively low (up
to 14% metabolism) with NAD+ present in the incubates (Maule Walker
and Poyser, 1978). Without NAD+ present, no detectable metabolism (<
5%) of PGF2q occurred in guinea-pig uterine homogenates (Poyser,
1979). These findings show that there is no significant metabolism
of PGs by guinea-pig uterine tissue, and PG outputs and PG
synthesizing capacities reflect the total PG release from and PG
synthesis by the uterus.
Where is the specific site of PGF2Q synthesis ? In the human
uterus, both glandular and stromal cells synthesise PGs (Schatz and
Gurpide, 1983), but there is some disagreement as to which cell type
is the main source. In non-pregnant endometrium maintained in organ
culture for 10-21 days, Gal, Casey, Johnston and MacDonald (1982)
reported that stromal cells released more PGs than glandular cells.
However, in this study over such a long time period, it must bo
questioned whether these stromal and glandular cells reflect their
true state rn vivo. However, Lumsden, Brown and Baird (1983) found
that homogenates of glands from either secretory or proliferative
181
endometrium converted more [^C]-arachidonic acid to PGF2a and PGE2
than stromal cells, and that the glandular cells released more PGs
than the stromal cells.
Oestradiol (10~®M) stimulated PGF production 4-fold during a 24h
incubation of human glandular tissue, whereas stromal cell PGF
production was either unaffected or inhibited (Skinner, Liggins,
Wilson and Neale, 1984). Schatz, Markiewicz and Gurpide (1986)
demonstrated that the basal output of PGF2Q was similar from both
endometrial epithelial (glandular) and stromal cells, but oestradiol
only stimulated PGF2Q output from epithelial cells. The response of
epithelial cells to oestradiol of increased PGF2Q synthesis was
further stimulated by A23187 administration, but A23187 had no effect
on PGF2a output from stromal cells (Schatz, Markiewicz and Gurpide,
1987). It was concluded that both cell types from the human
endometrium may contribute significantly to basal PGF2a output, but
that glandular epithelial cells, not stromal cells, are the primary
targets for the stimulatory effect of oestradiol on PGF2Q output by
secretory endometrium (Schatz, Markiewicz and Gurpide, 1987).
The immunocytochemical localisation of PGH synthase has suggested
that this enzyme is limited to the epithelial component of secretory
endometrium (Rees, Parry, Anderson and Turnbull, 1982), although some
PGH synthase must exist is stromal cells for PG production. Within
the cell, Rollins and Smith (1980), in an electron microscope study of
mouse Swiss 3T3 cells, determined that monoclonal antibodies raised
against PGH synthase bound to the endoplasmic reticulum and membranes
adjoining the outer nuclear membrane, but not to plasma or
mitochondrial membranes. Subsequently, DeWitt, Rollins, Day, Gauger
and Smith (1981) localised PGH synthase to the cytoplasmic surface of
the endoplasmic reticulum of sheep vesicular gland microsomes. In
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platelets, Carey, Menashi and Crawford (1982) also localised the site
of PGH synthase to the endoplasmic reticulum. Also in platelets, the
endoplasmic reticulum has been determined as the site of PLA2 i-n the
cell (Lagarde, Menashi and Crawford, 1981). The organisation and
relationships of PLA2, PGH synthase and also the specific PG
synthesizing enzymes within the endoplasmic reticulum is not known.
PGF2q synthesis by the guinea-pig endometrium is specifically
stimulated towards the end of the cycle, and there is also a selective
stimulation of PGF2Q synthesizing capacity at the end of the cycle,
particularly at oestrus when progesterone concentrations are lowest
(Poyser, 1983a,b). This may suggest that discrete sites for the
release of arachidonic acid by PLA2 > f°r PGH synthase and for the
PGF2q synthesizing apparatus are selectively organised to be in very
close proximity towards the end of the cycle in order to allow the
selective synthesis of PGF2Q. Alternatively, if the enzymes for PG
synthesis are not linked in this way for the synthesis of only one PG
at discrete sites, as more arachidonic acid is released by PLA2 after
day 11 of the oestrous cycle, this extra precursor must be channelled
by some mechanism specifically to the PGF2q. synthesizing enzymes.
The next part of the general discussion examines the mechanisms
by which PGF2q., and also PGE2 and PGI2, synthesis and release is
controlled in the guinea-pig uterus, and how uterine PGF2Q production
is stimulated towards the end of the oestrous cycle.
Extracellular calcium has been shown in the studies presented in
this thesis to be required for PGF2Q synthesis by the cultured guinea-
pig endometrium. However, endometrial PGF2Q synthesis may be
dependent upon the release of Ca^+ from intracellular stores, and the
extracellular calcium may be required to replenish these stores rather
than extracellular calcium acting directly to stimulate PGF2Q
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synthesis. Indeed, Poyser (1984a) showed that the basal output of
PGF2a from day 15 guinea-pig uterus was not altered by superfusing in
vitro with Ca2+-free Krebs' solution for 150 min. It appears from
these studies by Poyser (1984a) and the results presented here that
the inhibitory effect of the removal of extracellular calcium on
endometrial PGF2Q synthesis occurs after several hours. This may be
anticipated with the PGF2Q output from the guinea-pig uterus being
stimulated over several days in vivo towards the end of the oestrous
cycle. Olson, Opavsky and Challis (1983) have reported that calcium,
normally of extracellular source, is required for PGE2 production by
dispersed human amnion cells, and this effect occurred during a 3h
incubation. Intracellular Ca^+ may recycle to maintain high PGF2Q
output for short periods as demonstrated when using Ca^+-free Krebs'
superfusing solution which had no effect on uterine PGF2a output
during a 2. 5h superfusion (Poyser, 1984a). Alternatively, the
stimulatory effect of calcium on PGF2Q synthesis may be long-lasting
and slow in onset, and this is in agreement with Poyser (1983b) who
demonstrated that from the guinea-pig uterus superfused ijr vitro,
basal PGF2Q output was not inhibited by treatment for 40 min with TMB-
8 (an intracellular Ca^+ antagonist). However, the stimulation of
PGF2a ouput from the superfused guinea-pig uterus fn vitro by calcium
(by using the Ca^+ ionophore A23187) was eliminated using Ca2+-free
Krebs' solution (Poyser, 1984a) and was reduced by TMB-8 treatment.
These findings demonstrate that Ca^4" is required for the further
stimulation of PGF2a output above basal levels and that the response
to this Ca^+ is fast (i.e. within minutes) in onset.
The removal of extracellular calcium from cultured day 15
endometrium had less of an inhibitory effect on basal PGE2 and 6-keto-
PGFiq outputs than on basal PGF2Q output. This may be due to the
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outputs of PGE2 and 6-keto-PGFqQ being much lower than PGF2Q output,
and thus possibly having different controlling systems regulating
their synthesis compared to the Ca^+-depehdent PGF2Q regulatory
mechanism in the guinea-pig endometrium.
The high basal output of PGF2a from cultured day 15 guinea-pig
endometrium was inhibited by the calmodulin inhibitors W-7 and, to a
lesser extent, TFP. These results suggest that calmodulin is
involved in the stimulation of PLA2 activity and hence PGF2a
synthesis. These findings are consistent with the inhibitory effects
of TFP and W-7 on the A23187-stimulated increases in PGF2Q output from
the guinea-pig uterus superfused in vitro (Poyser, 1985a,b).
Similarly, PGE2 production by dispersed human amnion cells, removed by
caesarian section prior to the onset of spontaneous labour, also show
a similar requirement for calcium and calmodulin (Olson, Challis,
Opavsky, Smeija, Kramar and Skinner, 1985; Olson, Kramar and Smeija,
1987) .
How is the intracellular calcium concentration controlled ?
Michell (1975) noted that accelerated phosphatidylinositol (PI)
turnover was linked with cellular processes that are associated with
Ca^+ mobilisation. It was proposed that PI turnover might in some
way trigger Ca^+ mobilisation. Michell, Kirk, Jones, Downes and
Creba (1981) suggested that the increased rate of turnover of
phosphoinositides was a response of cells that reflected the
transduction of signals across the cell membrane. Subsequently, the
hydrolysis of phosphatidyl 4,5-bisphosphate by a phosphodiesterase to
inositol 1,4,5-trisphosphate has been shown to be an important
secondary messenger system in many cells which transduce the signal
from an appropriate cell surface receptor, when an agonist binds to
it, to release calcium from internal stores (Berridge, 1984; Berridge
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and Irvine, 1984; Berridge, 1987). This system is adapted to
control short-term cellular responses. However, Ning and Poyser
(1984) have demonstrated that there is no increase in turnover of
phosphatidylinositol and phosphatidyl 4,5-bisphosphate in the guinea-
pig endometrium on day 15 compared to day 7 of the oestrous cycle.
Therefore, this signal mechanism is not involved in the control of
intracellular calcium that controls PLA2 activity and hence PG
synthesis by the guinea-pig endometrium. This is not unexpected as
the stimulus for PG synthesis towards the end of the cycle is
oestradiol acting on a progesterone-primed uterus, and steroids
usually exert their effect via an intracellular action by combining
with a nuclear receptor and stimulating protein synthesis rather than
by binding to an extracellular membrane receptor (see General
Introduction).
The control of cAMP has also be postulated as a possible
mechanism by which PG synthesis is controlled in the uterus.
McCracken, Schramm and Okulicz (1984) developed a hypothesis to
explain events leading to luteolysis in sheep. They proposed that
oestradiol induces synthesis of oxytocin receptors which are inserted
into the membranes of endometrial cells, and that oxytocin binding, by
causing the stimulation of the adenylate cyclase system to generate
cyclic adenosine monophosphate (cAMP), stimulates of PLA2 activity and
the release of arachidonic acid and, hence, increases PGF2Q
production. The action of many hormones are mediated within the
target cell by activation of adenylate cyclase and cAMP production
(Birnbaumer, 1977). The effect of forskolin, which stimulates
adenylate cyclase, was examined on PG output from and cAMP production
by the guinea-pig uterus (Poyser, 1987a). Forskolin stimulated cAMP
production by the endometrium and myometrium, but had no effect on
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uterine PG output. Therefore, cAMP is not involved in the
stimulation of endometrial PGF2a synthesis and release. Also, as
oxytocin treatment has no effect on PG output from cultured guinea-pig
endometrium, as determined in these studies, and has no effect on PG
output from the guinea-pig uterus superfused i_n vitro (Poyser and
Brydon, 1983), the mechanism controlling PGF2a output from the sheep
uterus involving oxytocin, as suggested by McCracken, Schramm and
Okulicz (1984), does not control PGF2Q synthesis by the guinea-pig
uterus.
Fragments of human secretory endometrium in organ culture are
stimulated by oestradiol to produce PGF2Q (Abel and Baird, 1980;
Tsang and Ooi, 1982; Schatz, Markiewicz and Gurpide, 1984;
Markiewicz, Schatz, Barg and Gurpide, 1984; Schatz, Markiewicz, Barg
and Gurpide, 1985). Oestradiol also stimulates PGF2a production by
human epithelial cells in monolayer culture, derived from glands of
proliferative and secretory endometrium (Schatz and Gurpide, 1983;
Schatz, Markiewicz and Gurpide, 1984; Schatz, Markiewicz, Barg and
Gurpide, 1985).
In the studies presented in this thesis, oestradiol had no
stimulatory effect on the outputs of PGF2Q, PGE2 or 6-keto-PGFpQ from
the day 7 or day 15 guinea-pig endometrium in culture. These
findings are contrary to a report by Leaver and Seawright (1982) who
showed that oestradiol had a stimulatory effect on PGF2Q output from
both day 7 and day 15 cultured guinea-pig endometrium. The findings
presented here, but not the findings of Leaver and Seawright, are in
agreement with Poyser and Brydon (1983) who showed that oestradiol
(10/ug/ml) had no significant effect on PGF2Q, PGE2 and 6-keto-PGF^Q
outputs from either the day 7 or day 15 guinea-pig uterus superfused
in vitro and treated with oestradiol for 3h. Poyser (1987b)
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confirmed that oestradiol (1 and 10^g/ml) had no significant
stimulatory effect on PG outputs from the superfused day 7 and day 15
guinea-pig uterus. Wilson, Liggins, Aimer, and Watkins (1986) were
also unable to demonstrate a stimulatory action of oestradiol in
dispersed human endometrial cells, which conflicts with previous
observations using human endometrial preparations, but agrees with the
findings presented here. Oestradiol (10/ig/ml) actually inhibited the
increases in PGF2Q, PGE2 and 6-keto-PGF^Q outputs from the day 7 and
day 15 superfused guinea-pig uterus induced by the addition of
arachidonic acid to the superfusing medium. Furthermore, oestradiol
(10/ig/ml) caused an inhibition of PG output from the superfused
guinea-pig uterus induced by A23187 treatment (Poyser, 1987b).
Oestradiol appears to have an inhibitory effect on the conversion of
arachidonic acid into PGs and this may be a factor involved in the
lack of stimulation of endometrial PG output. In the studies in this
thesis, oestradiol (lOOOng/ml) reduced PG output from guinea-pig
endometrium in culture and this inhibition of endometrial PG output
may also be due to an inhibition of the conversion of arachidonic acid
to PGs. The inhibitory effects of high doses of oestradiol on PG
synthesis and release from cultured guinea-pig endometrium in these
studies are in agreement with findings in vivo. Large, non-
physiological doses of oestradiol inhibit luteolysis in the guinea-pig
(Illingworth and Perry, 1973), whereas smaller physiological doses of
oestradiol administered at an early stage of the cycle induce
premature luteolysis due to stimulation of PGF2a output from the
uterus (Blatchley, Donovan, Horton and Poyser, 1972).
Oestradiol does not act as a cyclo-oxygenase inhibitor, because
10/ug/ml oestradiol stimulated PG production by homogenates of day 7
guinea-pig uteri (Naylor and Poyser, 1975). This stimulatory effect
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of oestradiol on PG synthesis by broken cell preparations has also
been observed in rat uterine homogenates where PGF2Q production was
stimulated by the addition of oestradiol to the incubates (Jouanen,
Saintot, Thaler-Dao and Crastes de Paulet, 1985). Furthermore,
oestradiol did not inhibit basal PG output from the superfused guinea-
pig uterus unlike the cyclo-oxygenase inhibitor, indomethacin (Poyser,
1985a). Oestradiol may therefore prevent the access of endogenous
arachidonic acid after its release to the PGH synthase enzyme for PG
synthesis. This may be a direct, non-genomic effect of oestradiol.
Oestradiol has been reported to induce other non-genomic effects
including changes in water permeability and membrane stabilisation
(Duval, Durant and Homo-Delarche, 1983).
Calmodulin synthesis in the guinea-pig uterus may also be
controlled by ovarian steroids. Flandroy, Cheung and Steiner (1983)
showed that oestradiol increases calmodulin levels in the rat uterus,
and oestradiol and progesterone increase calmodulin concentrations in
the rabbit myometrium (Matsui, Higashi, Fukunaga, Miyazaki, Maeyama
and Miyamoto, 1983). A similar increase in uterine calmodulin
concentrations in the guinea-pig may be required to enable the maximum
stimulation of PGF2Q synthesis to occur towards the end of the cycle.
This suggestion requires further investigation.
Progesterone treatment inhibited PGF2a and PGE2 outputs from both
day 7 and day 15 guinea-pig uterus, cultured for 24h or three days.
This inhibitory action of progesterone on PG synthesis and release has
been previously reported to occur in day 7 arid day 15 cultured guinea-
pig endometrium (Leaver and Seawright, 1982), and in cultured human
endometrium (Cane and Villee, 1975; Skinner, Liggins, Wilson and
Neale, 1984; Wilson, Liggins, Aimer and Watkins, 1986). Although
this inhibitory action of progesterone occurs during the menstrual
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cycle, Tsang and Ooi (1982) demonstrated that progesterone inhibited
PGF production in proliferative but not in secretory endometrium,
whereas Abel and Baird (1980) using physiological doses of
progesterone found a decrease in PG output from both secretory and
proliferative endometrium in culture. Wilson, Liggins, Aimer and
Watkins (1986) demonstrated that the inhibitory effect of progesterone
on endometrial PGF2Q production increased with the day of the cycle in
women. However, Schatz, Markiewicz and Gurpide (1985) demonstrated
that, although progesterone treatment inhibited PGF2Q output from both
proliferative and secretory endometrium in organ culture, this
inhibition was more pronounced in proliferative tissue. Clearly
differences exist between these reports, and these may be due to
different incubation and culture conditions. Nevertheless, the
effect of progesterone on guinea-pig endometrium in culture on the
inhibition of PG output appears to be similar to human endometrium,
and it confirms a previous report in the guinea-pig by Leaver and
Seawright (1982). Wilson, Liggins, Aimer and Watkins (1986) showed
that progesterone inhibited the release of arachidonic acid (and hence
inhibited PG synthesis and release) from dispersed endometrial
epithelial cells. Therefore they proposed that, as the inhibitory
effect occurred within 15 min and was not significantly greater after
24h than lh, this inhibitory response to progesterone does not depend
upon protein synthesis or classical receptor interaction. However,
in the short term (up to 3h) , progesterone (10/ug/ml) had no effect on
the basal outputs of PGF2Q, PGE2 and 6-keto-PGFpQ, from the guinea-pig
uterus superfused in vitro (Poyser and Brydon, 1983; Poyser, 1987b).
In the ovariectomised mouse, a single injection of oestradiol
induces cellular proliferation of the endometrial epithelium, while
having little effect on DNA synthetic activity of the endometrial
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stroma (Martin, 1980). However, animals treated with progesterone
for two days before administration of oestradiol show a dramatic
proliferative response in the stroma, but no DNA synthetic activity in
the epithelium (Martin, 1980) . Studies in both the rat and mouse
have shown that progesterone antagonises the synthesis of the
oestrogen receptor (Hsueh, Peck and Clark, 1975), inhibits nuclear
retention of the oestradiol-oestrogen receptor complex (Okulicz, Evans
and Leavitt, 1981), and inhibits oestradiol uptake specifically by the
endometrial epithelium (Prasad, Sar and Stumpf, 1976). Therefore,
progesterone may interfere with the interaction of oestradiol and its
receptor, or with the oestradiol-oestrogen receptor complex and the
nucleus, and these actions may contribute to the inhibitory effect of
progesterone on the stimulation of PG synthesis by oestradiol in vivo.
Indeed, in the guinea-pig uterus, endometrial PGF2Q synthesizing
capacity was stimulated 3.2-fold by oestradiol, but when progesterone
is also administered, PGF2a synthesizing capacity was only stimulated
1.7-fold (Poyser, 1983a). Also, endometrial PGF2Q synthesizing
capacity is highest at the end of the cycle when plasma oestradiol
levels are highest and plasma progesterone levels are lowest (Poyser,
1983a).
In the studies in this thesis, treatment with progesterone and
with a high dose of oestradiol (lOOOng/ml) inhibited PGF2a and PGE2
outputs, but not 6-keto-PGF]^a output, from both the day 7 and day 15
guinea-pig endometrium in culture (although lOOng progesterone/ml
ii-
inhibited 6-keto-PGF]^Q output from day 15 endometrium between 18h and
24h of culture). Furthermore, administration of progesterone and
oestradiol (lOOOng/ml) to day 7 and day 15 guinea-pig endometrium in
culture inhibited the synthesizing capacities of PGF2a and PGE2.
However, these treatments had only a slight inhibitory action on the
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6-keto-PGFpQ synthesizing capacity of day 15, but not of day 7
cultured guinea-pig endometrium. Also, treatment with progesterone
and oestradiol (lOOOng/ml) inhibited the synthesis of secreted
proteins, but not of cellular proteins, by day 15 guinea-pig
endometrium. Oestradiol (lOOOng/ml) also inhibited secreted protein
synthesis by day 7 endometrium. Clearly, from these results both
progesterone and high doses of oestradiol have almost identical
effects on PG and protein syntheses by both day 7 and day 15 guinea-
pig endometrium in culture. This progesterone-like activity of
oestradiol could also explain the anti-luteolytic action of high doses
(non-physiological) of oestradiol reported by Illingworth and Perry
(1973) in the guinea-pig.
Recently, a new family of proteins of 35-36 kDa has been
reported, and these proteins have been isolated from several tissues
and assigned different names. These include the calpactins I and II
from bovine intestine, proteins I and II from pig intestine,
lipocortins I and II from various tissues including human endometrium
and placenta, calelectrin from bovine liver, calcimedin from chicken
liver, cytosynalin from bovine brain, p36 from chicken embryo
fibroblasts or lymphocytes, p35 from A-431 cells and chromobindins 6
and 7 from adrenal medulla (Martin, Derancourt, Capony, Watrin and
Cavadore, 1988). There is much homology within this group; p. 36,
protein I, calpactin I and lipocortin II appear to be similar.
Furthermore, p35, calpactin II and lipocortin I are also thought to be
related (Haigler, Schlaepfer and Burgess, 1987; Martin, Derancourt,
Capony, Watrin and Cavadore, 1988). Glenney and Tack (1985) showed
that lipocortin II (p36) are cleared by limited proteolysis into two
products of 3kDa and 33kDa, and the 3kDa N-terminal part contains the
site of phosphorylation by C-kinase (Gould, Woodgett, Isacke and
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Hunter, 1986). The complete sequences of p36 and p35 and the deduced
protein sequences have shown that their proteins contain multiple
domains with repeated sequences of about 70 amino acid residues.
Martin, Derancourt, Capony, Watkin and Cavadore (1988) isolated
two 36kDa proteins from smooth muscle bovine aorta; one was a monomer
and the other one was complexed with a lOkDa subunit protein. These
were thought to be identical or at least very similar to p36 and
calpactin I. The 36kDa and lOkDa were bound very strongly and this
complex bound very strongly to calmodulin in a calcium-dependent
manner; this binding property to calmodulin was not found in the
uncomplexed 36kDa manner. Gerke and Weber (1985) reported that p36 +
plO protein complex induced formation of F-actin bundles, whereas
Martin, Derancourt, Capony, Watrin and Cavadore (1988) discovered the
O.
36kDa + lOkDa protein complex broke F-actin filaments in a Caz -
dependent manner, and that there was no obvious reason for this
difference. However, from these data, it was suggested that the
36kDa + lOkDa protein complex may modulate some Ca^+-regulated effects
mediated by calmodulin. So, the action of these two homologous
proteins on PLA2 would appear to be primarily inhibitory, via
inhibiting calmodulin, and hence PG synthesis should be reduced.
What are the implications of these findings for PG synthesis by the
uterus ?
In cultured human endometrium, the glucocorticoid hormone,
dexamethasone, stimulates the production of lipocortins by both
proliferative and secretory endometrium (Gurpide, Markiewicz, Schatz
and Hirata, 1986). However, Schatz, Markiewicz and Gurpide (1986)
reported that dexamethasone treatment only inhibited PGF2Q production
by secretory endometrium. Kelly and Smith (1987) found only a small
inhibitory effect of dexamethasone on PGF2Q production by
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proliferative endometrium. Treatment with hydrocortisone, the main
glucocorticoid hormone secreted by the guinea-pig (Fajer and Vogt,
1963) had no effect on the outputs PGF2Q, PGE2 and 6-keto-PGFpQ from
the cultured day 15 guinea-pig endometrium. Furthermore,
hydrocortisone (lOpg/ml) treatment of the day 15 guinea-pig uterus
superfused in vitro for 3h had no effects on either the basal or
A23187-stimulated outputs of PGF2a, PGE2 or 6-keto-PGFxa (Poyser,
1987b). TPA activates protein kinase C which in turn phorphorylates
lipocortin, thus inactivating it and. removing its inhibitory influence
on PLA2 activity and, hence, on PG synthesis (Nishizuka, 1986). The
administration of TPA to day 7 and day 15 cultured guinea-pig
endometrium had no significant effect on the outputs of PGF2Q, PGE2
and 6-keto-PGF^Q. Also, TPA had no effect on either basal or A23187-
stimulated PG outputs from the day 7 and day 15 guinea-pig uterus
superfused in vitro (Poyser 1987a). The results of Poyser (1987a, b)
are consistent with the findings in these studies that hydrocortisone
and protein kinase C have no effect on PG output from the guinea-pig
endometrium. Therefore, by inference, lipocortin and related
proteins are not a controlling factor in PG synthesis and release from
the guinea-pig endometrium.
In the studies presented in this thesis, the protein and RNA
synthesis inhibitors actinomycin D, cycloheximide and puromycin have
been demonstrated to inhibit PGF2Q, PGE2 and 6-keto-PGFpa release from
cultured day 7 and day 15 guinea-pig endometrium at concentrations
greater than lug/ml. Smith and Kelly (1987) have also examined the
effect of actinomycin D on PGF and PGE production by glandular and
stromal cells from human endometrium in the secretory phase. They
showed that actinomycin D (lOOng/ml) had no effect on basal or
oestradiol- stimulated PGF output and PGE output from either glandular
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or stromal cells. Paradoxically, Smith and Kelly (1987) observed a
stimulation of PGF and PGE outputs with actinomycin D treatment.
They suggested from these findings that basal release of PGF and PGE
from secretory glandular epithelial cells from the human endometrium
is suppressed and that inhibition of protein synthesis reverses this
effect. However, Smith and Kelly (1987) did not demonstrate that
this dose of actinomycin D (lOOng/ml) inhibited protein synthesis,
unlike the higher doses used in this study which did inhibit both
secreted and cellular protein synthesis and also uterine PG
production.
Treatment with intra-uterine actinomycin D in vivo on day 10
inhibited the basal outputs of PGF2Q and PGE2 but not 6-keto-PGFpQ,
from the guinea-pig uterus when measured in vitro on day 15.
Castracane and Jordan (1976) treated ovariectomised rats after
progesterone priming with a single dose of oestradiol-17/9 and observed
a stimulation of uterine PGF and PGE output. However, the systemic
treatment of these rats with actinomycin D or cycloheximide failed to
inhibit the oestrogen-stimulated uterine PG synthesis. They proposed
that the action of oestradiol on the stimulation of uterine PG
production was not due to stimulation of protein synthesis. However,
in a previous study Poyser (1979) demonstrated that systemic treatment
of guinea-pigs with actinomycin D (20/ug) failed to inhibit uterine PG
synthesizing capacity or extend the oestrous cycle, whereas intra¬
uterine actinomycin D treatment (10pg/uterine horn,; i.e. the same
dose) reduced PG synthesizing capacity, prevented luteal regression
and extended the cycle length. These studies have demonstrated that
the effect of intra-uterine actinomycin D treatment is to inhibit PG
synthesis by and release from the guinea-pig uterus. Therefore, the
study by Castracane and Jordan (1976) should be repeated, but the
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protein synthesis inhibitors need to be administered directly into the
uterus and not systemically in order to examine their effect on
uterine PG synthesis. Overall, the studies presented in this thesis
indicate that increased protein synthesis is necessary for the
stimulation of endometrial PGF2Q synthesis in the guinea-pig.
Recently, proteins have been implicated in the control of PG
production in several different cell types, because inhibitors of
protein synthesis have been demonstrated to inhibit PG synthesis.
These include: PGE2 synthesis by transformed fibroblasts in reponse
to serum, thrombin and bradykinin is inhibited by actinomycin D and
cycloheximide (Pong, Hong and Levine, 1977); PGE2 synthesis by
skeletal muscle is inhibited by puromycin and emitine (Turinsky,
1985); PGI2 synthesis by endothelial cells, stimulated by bradykinin
and leukotrienes, is inhibited by cycloheximide and actinomycin D
(Clark, Littlejohn, Mong and Crooke, 1986); PGI2 and PGE2 synthesis
by macrophages stimulated by TPA and zymosan is inhibited by
actinomycin D (Bonney, Wightman, Dahlgren, Davies, Kuehl and Humes,
1980); and PGE2 synthesis by the brain, stimulated by endogenous
pyrogen, is inhibited by anisomycin (Townsend, Cranston and Hellon,
1984).
There has been several reports of proteins that exert a
stimulatory effect on PG synthesis. Subbiah, Yunker, Yamamoto,
Kottke and Bale (1985) demonstrated that PG synthesis in cultured skin
fibroblasts was stimulated by human breast milk. Subsequently,
Bydlowski, Yunker, Campaigne, Kotogal and Subbiah (1986) showed that
human breast milk contained a protein of less than lOkDa which had a
potent stimulatory effect on PGI2 synthesis (measured as 6-keto-PGFpQ)
from rabbit aorta. A protein or protein-associated substance of less
than lOkDa in human fetal urine induced a 10- to 600-fold increase in
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PGE2 synthesis from human amnion cells in monolayer culture (Casey,
MacDonald and Mitchell, 1983). Melittin is a phospholipase A2
stimulatory peptide (2,800Da) isolated from bee venom (Haberman,
1972). Bee, wasp and hornet venom peptides have a well characterised
ability to stimulate PLA2 activity (Mollay and Kreil, 1974;
Blackwell, Carnuccio, DiRosa, Flower, Parente and Persico, 1980).
Melittin has also been demonstrated to cause an increase in
intracellular Ca^+ concentrations in cultured human fibroblasts, an
effect which is inhibited by TMB-8. This suggests that melittin may
exert its PLA2 stimulatory action by releasing calcium from
intracellular stores (Mix, Dinerstein and Villereal, 1984).
Subsequently, Clark, Conway, Shorr and Crooke (1987) prepared
antibodies against melittin and the antibodies were used to identify a
mammalian protein (in murine smooth muscle line BC3Hq) with similar
functions and antigenic properties. This protein (28kDa) was termed
'phospholipase A2 - activating protein' and selectively stimulated
PLA2 activity in cell-free sonicates of the smooth muscle cell line,
but had no effect on PLC or on pancreatic or snake venom PLA2.
Clark, Conway, Shorr and Crooke (1987) also found the phospholipase A2
- activating protein in the bovine endothelial cell line CPAE, the
human monocytic cell line U937, and the murine T-cell line E24.
Clark, Chen, Crooke and Bomalski (1988) demonstrated that tumour
necrosis factor induced [^H]-arachidonic acid metabolite release from
bovine endothelial CPAE cells, an effect apparently mediated by a
transient increase in PLA2 activity. This action was prevented by
eyeloheximide (100^ig/ml) and actinomycin D (10/ig/ml) treatment showing
that protein and RNA synthesis is required for PLA2 activation. They
also showed that the amount of the phospholipase A2 - activating
protein increased following administration of tumour necrosis factor
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treatment, and that the time-course of induction of the phospholipase
A2 - activating protein correlated with the induction of PLA2
activity. Clearly, this protein with phospholipase A2 stimulatory
activity may be found in many different cells, and PLA2 activity may
not only be inhibited but also stimulated by regulatory proteins. It
is also interesting to speculate whether the phospholipase A2
activating protein stimulates the release of Ca^+ from intracellular
stores like melittin, and whether a "phospholipase A2 -activating
protein-like factor" is involved in the stimulation of PGF2Q
production by the guinea-pig endometrium towards the end of the
oestrous cycle.
One of the main mechanisms by which hormones and
neurotransmitters elicit an intracellular reponse is by binding to a
cell surface receptor linked to membrane-bound, GTP-binding proteins
(G-proteins). These G-proteins transduce the "ligand-receptor
binding signals" to membrane associated effector systems that produce
second messengers which control the required intracellular action.
G-proteins transduce receptor-mediated signals for a variety of
effector systems, including cyclic nucleotide phosphodiesterases,
adenylate cyclase, phospholipase C and ion channels (Gilman, 1987).
Recently, G-proteins have also been implicated in the activation of
PLA2. For example, in the rod outer segments of bovine retina, light
activation of PLA2 l>as been demonstrated to occur by a transducin-
dependent mechanism, with transducin the major G-protein in this
preparation (Jelsema and Axelrod, 1987). G-proteins have also been
implicated in the activation of PLA2 anc^ i-n the release of arachidonic
acid in cells of the rat thyroid cell line FRTL5 in response to a\-
adrenergic stimulation (Burch, Luini and Axelrod, 1986). Burch and
Axelrod (1987) have proposed that stimulation of Swiss 3T3 fibroblasts
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results in arachidonic acid release by PLA2 anc* this response is
mediated via a G-protein. However, it appears unlikely that PLA2 in
the guinea-pig uterus is stimulated by G-proteins, since they are
primarily concerned with eliciting a rapid response mediated by a
membrane-bound receptor. Stimulation of uterine PG production in the
guinea-pig is controlled over several days in responses to
intracellular responses via nuclear steroid receptors which mediate
the synthesis of protein(s) which stimulates PLA2.
If pregnancy occurs, the luteolytic effect of the uterus must be
inhibited, because ovarian progesterone is required in the guinea-pig
for the maintenance of the first 4-5 weeks of pregnancy (Heap and
Deanesly, 1966; Csapo, Puri and Tarro, 1981). In the non-pregnant
guinea-pig, oestradiol output from the guinea-pig ovary increases
after 10 day of the cycle (Joshi, Watson and Labhsetwar, 1973), just
before the increase in uterine PGF2Q output measured in the utero-
ovarian venous plasma (Blatchley, Donovan, Horton and Poyser, 1972;
Earthy, Bishop and Flack, 1975). However, if the guinea-pig is
pregnant, the increase in ovarian oestradiol and uterine PGF2Q outputs
after day 10, as measured in the utero-ovarian plasma, do not occur
and plasma progesterone levels remain high (Blatchley, Maule Walker
and Poyser, 1975a, b; Antonini, Turner and Pauerstein, 1976).
Henderson, Scaramuzzi and Baird (1977) showed that PGE2 delayed luteal
regression caused by PGF2Q in sheep, and therefore PGE2 was proposed
as a putative luteotrophic factor. However, in the guinea-pig,
Antonini, Turner and Pauerstein (1977) demonstrated that PGE2 output
from the ovary was not increased during this early stage of pregnancy,
and this finding was confirmed by Poyser (1984b). Consequently, PGE2
is not involved in luteal maintenance in the guinea-pig.
In the sheep, the mechanism by which the conceptus prevents the
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luteolytic effect of PGF2Q is becoming clearer. A polypeptide of
17kDa has been isolated as the major secretory protein produced by the
conceptus between days 13 and 21 of pregnancy (Godkin, Bazer, Moffat,
Sessions and Roberts, 1982). This protein (ovine trophoblast protein
- one; oTP-1) bound to receptors present both in the endometrium and
in the corpus luteum (Godkin, Bazer, Thatcher and Roberts, 1984).
However, oTP-1 did not stimulate luteal progesterone production
(Godkin, Bazer and Roberts, 1984) and this suggested that oTP-1 was
eliciting its anti-luteolytic effect on the endometrium. Godkin,
Bazer and Roberts (1984) also observed that oTP-1 stimulated the
synthesis of several endometrial proteins. Proteins released by the
sheep conceptus in culture and injected into non-pregnant sheep
suppressed the induction of uterine PGF2Q release by oestradiol and
oxytocin (Fincher, Bazer, Hansen, Thatcher and Roberts, 1986).
Subsequently, Vallet, Bazer and Roberts (1987) showed that oTP-1
induced both an increase in secretion of some proteins and a decrease
in the secretion of other proteins by sheep endometrial explants.
The origin of these endometrial proteins was not determined, although
it was speculated that they were produced by surface and upper
glandular epithelial uterine layers, since oTP-1 receptors have been
localised in these layers by immunocytochemical techniques (Godkin,
Bazer and Roberts, 1984). These glandular epithelial sites are also
the sites of PGF2Q synthesis. The protein oTP-1 may induce the
production by the endometrium of a luteotrophic factor, as suggested
by Vallet, Bazer and Roberts (1987), but it may also inhibit the
production of a PLA2 stimulatory protein in the uterus that is
required for the increase in PGF2Q production at the end of the cycle.
A similar "oTP-1 like" protein is produced by the bovine conceptus and
is a major product released from these conceptuses between day 16-26
200
of pregnancy, during the critical period at which the corpus luteum
has to be protected from the luteolytic action of uterine PGF2Q
(Bartol, Roberts, Bazer, Lewis, Godkin and Thatcher, 1985). This
protein is produced at a similar stage of development of the conceptus
in the cow when compared to the sheep conceptus and is immunologically
related to oTP-1, and so it has been termed bovine trophoblast
protein-one (bTP-1; Helmer, Hansen, Anthony, Thatcher, Bazer and
Roberts, 1987). Therefore, the cow and sheep appear to have similar
mechanisms of preventing luteal regression. It may be speculated
that a trophoblast protein is secreted by the guinea-pig that has a
functionally similar role in the maternal recognition of pregnancy,
and may control the synthesis of endometrial proteins that regulate
PLA2 activity and hence PG synthesis. Certainly, there is much
evidence that the guinea-pig conceptuses secrete an antiluteolytic
factor which reduces endometrial PGF2a synthesis (Horton and Poyser,
1976; Poyser, 1984c).
Overall, the studies in this thesis have shown that PGF2Q
production in the guinea-pig endometrium is dependent on calcium and
protein synthesis. It is proposed that oestradiol acting on a
progesterone-primed uterus stimulates the synthesis of a protein(s)
which, with Ca^+ mediates the increased release of arachidonic acid by
PLA2 f°r the selective synthesis of PGF2Q by the guinea-pig
endometrium towards the end of the oestrous cycle. It is possible
that, during early pregnancy, a "trophoblast protein", secreted by the
guinea-pig conceptuses, prevents the synthesis of this PLA2-
stimulating protein. Increased PGF2Q synthesis is therefore
prevented and the corpora lutea are maintained.
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ABSTRACT
The effects of oestradiol, oxytocin, progesterone and
hydrocortisone in vitro on prostaglandin (PG) output from guinea-
pig endometrium, removed on days 7 and 15 of the oestrous cycle
and maintained in tissue culture for 3 days, have been
investigated. Oestradiol (3.7 to 3700nM) and oxytocin (2 to
200pM) did not stimulate endometrial PGF2a output, thus not
confirming the findings of a previous report (Leaver & Seawright,
1982), nor did they stimulate the outputs of PGE2 and 6-keto-PGF-] a.
In fact, oestradiol (3700nM) inhibited the outputs of PGF2a, PGE2
and, to a lesser extent, 6-keto-PGFi a. Progesterone (3.2 to
3200nM) inhibited the outputs of PGF2a and PGE2; hydrocortisone
(2.8 to 2800nM) had no effect on endometrial PG output. These
findings indicate that the inhibitory effect of progesterone on
endometrial PG synthesis and release in the guinea-pig is not due
to progesterone having a glucocorticoid-like action. Furthermore,
progesterone had no effect on 6-keto-PGF-] a output, suggesting that
the mechanisms controlling endometrial PGI2 synthesis (as reflected
by measuring 6-keto-PGF1a) are different from those controlling
endometrial PGF2a and PGE2 synthesis.
INTRODUCTION
Many studies indicate that prostaglandin (PG) F2a is the
uterine luteolytic hormone in non-primate mammalian species (see
1,2), including the guinea-pig (3). The output of PGF2a from the
guinea-pig uterus increases from day 11 of the oestrous cycle
(4,5,6). Oestradiol acting on a progesterone-primed uterus
appears responsible for this increase, since treatment of
ovariectomized guinea-pigs with these two steroid hormones causes a
large increase in uterine PGF2a output (7), and oestradiol output
from the guinea-pig ovary increases after day 10 of the cycle (8).
However, studies in several mammalian species have shown that the
maximum output of PGF2a from the uterus does not occur until after
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plasma progesterone levels have started to fall (see 1.2),
indicating that progesterone has inhibitory as well as facilitatory
effects on uterine PGF2a production. Indeed, basal and
oestradiol-stimulated outputs of PGF2a from human and guinea-pig
endometrium maintained in tissue culture, and from human
endometrial cells maintained in cell culture are inhibited by
progesterone treatment _in vitro (9,10,11,12). Glucocorticoid
hormones stimulate the production by many tissues of lipocortin, a
protein which inhibits phospholipase A2 [EC. 3-1-1activity and
thereby decreases PG synthesis and release by reducing the supply
of substrate (see 13). Consequently, the question is raised as to
whether progesterone inhibits PGF2a synthesis by the endometrium
due to a glucocorticoid-like action. The purpose of this study
was to compare the effects of progesterone and hydrocortisone, the
main glucocorticoid hormone in the guinea-pig (114), on basal PG
output and on the previously reported (15) stimulation of PGF2a
output by oestradiol and oxytocin from guinea-pig endometrium
maintained in tissue culture.
METHODS
Female, virgin guinea-pigs weighing between 650 and 950g were
examined daily and a vaginal smear was taken when the vaginal
membrane was open. The first day of the oestrous cycle was
designated as the day before the post-ovulatory influx of
leucocytes when cornification is at a maximum. All animals had
normal cycles before being killed, by stunning and incising the
neck, on day 7 or day 15 of the cycle. The uterus from each
guinea-pig was removed and placed in culture medium. The
endometrium was dissected away from the myometrium by cutting away
1 x 2mm pieces of endometrium, under sterile conditions.
Approximately 12mg endometrium was placed on a raised platform in a
Petri dish, which contained 4ml Medium 199 plus Earles's salts,
supplemented with glutamine and antibiotics (16). Eighteen Petri
dishes containing endometrial tissue were prepared from each
guinea-pig; 14 of the dishes contained "hormonal treatments"
(performed in duplicate) as outlined below and four dishes were
untreated (controls). The Petri dishes were placed in two
modified Kilner jars (nine dishes per jar) such that each set of
nine dishes contained one of the duplicate treatments and two
controls. The endometrium was cultured for 72h as described
previously, and the tissue remains viable during this period
(16,17). The culture medium was changed every 24h. The samples
of culture medium were stored at -20°C before radioimmunoassay,
without extraction, for PGF2a, PGE2 and 6-keto-PGF-| a. There were
5 animals per group which produced 10 samples per time point.
Hormonal Treatments
Experiment 1 Day 7 and day 15 guinea-pig endometrium (i.e.
endometrium removed from guinea-pigs on days 7 and 15 of the
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oestrous cycle respectively) was treated on day 2 (24 to 48h
period) of culture with the following compounds: oestradiol-176
(37, 370 and 3700nM); progesterone (32 and 320nM); oxytocin (20
and 200pM).
Experiment 2 a. Day 15 guinea-pig endometrium was treated on
all 3 days of culture with the following compounds: oestradiol-176
(3.7, 37, 370 and 3700nM); progesterone (3.2, 32, 320 and
3200nM); hydrocortisone (2.8, 28, 280 and 2800nM); oxytocin (2,
20 and 200pM).
b. Day 7 guinea-pig endometrium was treated on all 3 days of
culture with oestradiol-176; (3.7, 37, 370 and 3700nM).
Sources of Materials Culture medium, glutamine and antibiotics
were obtained from Flow Laboratories, Rickmansworth, Herts., U.K.;
sterile Petri dishes from Sterilin Ltd., Teddington, Middlesex,
U.K.; oestradiol-178, progesterone, hydrocortisone and oxytocin
from Sigma Chemical Co. Ltd., Poole, Dorset, U.K.
Details of Radioimmunoassay Prostaglandin F2a, PGE2 and 6-keto-
PGF-|a were measured using antibodies raised in this laboratory and
whose cross-reactivities have been reported elsewhere
(18,19,20,21). The only significant cross-reactivities are PGF-]a
(100?) with the PGF2a antiserum, and PGE-] (66?), PGA2 (25.5?) and
PGB2 (11.8?) with the PGE-] antiserum. Previous studies involving
analysis by gas chromatography and mass spectrometry have shown
that the guinea-pig uterus synthesises very little PGF-]a in
comparison to PGF2a, and that there is no detectable synthesis of
PGE-] , PGA2 and PGB2 (22). Therefore, it is likely that the PGF2a
and PGE2 antisera were measuring predominantly the PG to which they
had been raised. The inter-assay coefficients of variation were
8.2? (PGF2a), 8.6? (PGE2), and 6.6? (6-keto-PGF-] a). The intra-
assay coefficients of variation were 5.6? (PGF2a), 7.8? (PGE2), and
5.9? (6-keto-PGF-] a). The limits of detection were 30pg PGF2a,
40pg PGE2 and 30pg 6-keto-PGF-|a per assay tube.
Statistical tests Results were analysed by Student's t_-test.
RESULTS
The outputs of PGF2a, PGE2 and 6-keto-PGF-] a from day 7 and day
15 guinea-pig endometrium are shown in Figure 1. PGF2a is the
major PG released from day 15 guinea-pig endometrium, together with
lesser quantities of PGE2 and 6-keto-PGF-] a. On day 7, endometrial
PGF2a and 6-keto-PGF-] a outputs are similar while PGE2 output is
somewhat lower. The outputs of PGF2a, PGE2 and, to a limited
extent, 6-keto-PGF-] a are higher from day 15 than from day 7
endometrium, and the output of all 3 PGs falls during the 3-day
period of culture.
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FIGURE 1. Mean (± s.e.m., n = 10) outputs of prostaglandin (PG) F2a,
PGE2 and 6-keto-PGF-] a from guinea-pig endometrium, removed on days 7
and 15 of the oestrous cycle, on days 1, 2 and 3 of tissue culture.
* Significantly (_P < 0.05) higher than day 7 value for same PG on same
day of culture (Student's t-test).
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Experiment 1. The addition of oestradiol (37 to 3700nM) or
oxytocin (20 and 200pM) to the culture medium only on day 2 of
culture had no stimulatory effect on the outputs of PGF2a, PGE2 and
6-keto-PGF•] a from day 7 and day 15 guinea-pig endometrium (Tables
1, 2 and 3). In fact, oestradiol at the highest concentration
(3700nM) significantly (P < 0.05) inhibited the outputs of PGF2a,
PGE2 and 6-keto-PGF-|a from day 7 and, except for 6-keto-PGF; a, from
day 15 guinea-pig endometrium on day 3 of culture. Progesterone
(320nM) added to the culture medium only on day 2 of culture
significantly (£ < 0.05) reduced (i) PGF2a output from day 7
endometrium on day 2 of culture, (ii) PGF2a output from day 15
endometrium on day 3 of culture, and (iii) PGE2 output from day 7
and day 15 endometrium on day 2 of culture (Tables 1 and 2).
Progesterone (32nM) significantly (P_ < 0.05) reduced PGF2a output
from day 7 guinea-pig endometrium on day 2 of culture (Table 2).
The outputs of 6-keto-PGF;a were unaffected by progesterone
treatment (Table 3).
Experiment 2. The addition of oestradiol (3.7 to 3700nM) or
oxytocin (2 to 200pM) to the culture medium for all 3 days of
culture had no stimulatory effect on the outputs of PGF2a, PGE2 and
6-keto-PGF-j a from day 7 and day 15 guinea-pig endometrium (Tables
1, 5 and 6). At the highest concentration (3700nM), oestradiol
significantly (P < 0.05) reduced the output of PGF2a from day 7 and
day 15 endometrium on all 3 days of culture (Table 4). Similarly,
oestradiol (3700nM) significantly (P < 0.05) reduced the output of
PGE2 from day 15 endometrium on days 2 and 3 of culture, and from
day 7 endometrium on days 1 and 2 of culture (Table 5). (On day 3
of culture, the output of PGE2 from progesterone-treated day 7
endometrium was below the detection limit of 10pg/mg tissue/2ith,
and was therefore reduced). Oestradiol (3700nM) had no
significant inhibitory effect on 6-keto-PGF-] a output, although the
output of 6-keto-PGFia from day 15 endometrium tended to be reduced
on days 2 and 3 of culture by this treatment (Table 6).
The addition of progesterone (3.2 to 3200nM) to the culture
medium for 3 days significantly (P < 0.05) reduced the output of
PGF2a from day 15 endometrium on day 1 of culture (except for
3.2nM), on day 2 of culture, and on day 3 of culture (3200nM only;
Table M). The output of PGE2 from day 15 endometrium was
significantly (P < 0.05) reduced by progesterone (320nM) on day 2
of culture, and by progesterone (3200nM) on days 1 and 2 of culture
(Table 5). The output of 6-keto-PGF-] a from day 15 endometrium was
unaffected by progesterone treatment (Table 6).
Hydrocortisone (2.8 to 2800nM) had no effect on the outputs of
PGF2a, PGE2 and 6-keto-PGF]a from day 15 to guinea-pig endometrium
when present in the culture medium for all 3 days (Tables 4, 5 &
6).
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The amounts of PGs in the guinea-pig uterus are very low (23),
so the PG content of the culture medium reflects fresh PG synthesis
by the endometrium. The basal output of PGF2a from guinea-pig
endometrium maintained in culture was higher on day 15 than on day
7 of the oestrous cycle. This shows that the stimulation of
endometrial PGF2a synthesis and release, due to oestradiol acting
on a progesterone-primed uterus from day 11 of the oestrous cycle
in vivo (see Introduction), is maintained in tissue culture in the
absence of steroid hormones, particularly during the first day of
culture. PGF2a output falls during the next two days of culture,
especially output from day 15 endometrium. From the report of
Leaver & Seawright (11), it was expected that oestradiol (37 to
37O0nM) added to the culture medium on day 2 of culture would have
increased PGF2a output from day 7 and day 15 guinea-pig endometrium
on day 3 of culture. Similarly, oxytocin treatment on day 2 of
culture would have been expected to increase PGF2a output from day
15 guinea-pig endometrium on days 2 and 3 of culture. We found
that oestradiol and oxytocin had no such stimulatory activity.
Even when present for all 3 days of culture, oestradiol and
oxytocin had no stimulatory effect on the output of PGF2a. The
outputs of PGE2 and 6-keto-PGF-|a were also not stimulated by
oestradiol and oxytocin in both experiments. In fact, oestradiol
at the highest concentration used (3700nM) reduced the outputs of
PGF2a, PGE2 and, to a lesser extent, 6-keto-PGF-| a from day 7 and 15
guinea-pig endometrium.
Our findings do not support the conclusions of Leaver &
Seawright (11) that the _in vitro treatment with oestradiol and
oxytocin stimulates PGP2a output from guinea-pig endometrium
maintained in tissue culture. This lack of effect of oxytocin on
PG output is in agreement with the study of Poyser & Brydon (24) in
which the outputs of PGF2a, PGE2 and 6-keto-PGF-|a from the day 7
and day 15 guinea-pig uterus were not affected during a 30 min
superfusion with oxytocin. The failure of oxytocin in the present
study to stimulate PGF2tt release from the guinea-pig uterus is
consistent with the failure of oxytocin treatment of guinea-pigs in
vivo to shorten oestrous cycle length (25).
The lack of a stimulatory effect of oestradiol _in vitro on
PGF2a output from the guinea-pig endometrium maintained in tissue
culture is in contrast to the well-documented increase in PGF2a
output from human endometrium, maintained in tissue or cell
culture, by oestradiol treatment in vitro (10,12,15,26). Although
the treatment of guinea-pig endometrium in vitro with oestradiol
does not stimulate PGF2a output, the iui vivo treatment of guinea-
pigs with physiological doses of oestradiol leads to an increase in
uterine PGF2a output when measured i_n vivo or in vitro (4,7,27).
However, the treatment of guinea-pigs with large, non-physiological
doses of oestradiol prevents luteolysis due, in part, to an anti-
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luteolytic action (28). The findings in the present study that a
high concentration of oestradiol reduces PGF2a output from guinea-
pig endometrium in culture provides a possible explanation for this
anti-luteolytic effect.
Since oestradiol and oxytocin failed to stimulate PG output
from guinea-pig endometrium in culture, it was not possible to
investigate the effects of progesterone and hydrocortisone on
hormonally-stimulated increases in endometrial PGF2a synthesis and
release. However, progesterone inhibited the basal outputs of
PGF2a and PGE2 but not of 6-keto-PGF-| a. This inhibitory effect of
progesterone on PGF2a output is in agreement with similar studies
performed on the guinea-pig (11) and human uterus (9,10,26).
Studies on human endometrium indicated that progesterone inhibits
PG synthesis by preventing the release of arachidonic acid from
phospholipids due to it having an indirect inhibitory action on
phospholipase activity (29). Since glucocorticoids inhibit
phospholipase A2 activity (and, hence, arachidonic acid release)
indirectly by causing the synthesis of lipocortin (see 13) and
since glucocorticoids also inhibit PGF2a output from the human
endometrium (15,25,29), progesterone may inhibit endometrial PGF2a
synthesis and release due to it cross-reacting with the
glucocorticoid receptor and causing the synthesis of lipocortin.
However, in the present study hydrocortisone, over a wide
concentration range, had no effect on the outputs of PGF2a, PGE2
and 6-keto-PGF-| a from guinea-pig endometrium in culture. In a
previous study (30), hydrocortisone had no inhibitory effect on the
basal and A23187-stimulated outputs of PGF2a, PGE2 and 6-keto-PGF-| a
from the day 15 guinea-pig uterus superfused for 3h in vitro.
Consequently, hydrocortisone has no effect on PGF2a synthesis by
the guinea-pig endometrium during short-term or long-term treatment
with the hormone. Therefore, it is unlikely that the inhibitory
effect of progesterone on endometrial PGF2a and PGE2 outputs is due
to a glucocorticoid-like action. This conclusion is in agreement
with the study of Schatz, Markiewicz & Gurpide (31) who found that,
while dexamethasone and progesterone both reduce PGF2a from human
endometrium maintained in tissue culture, dexamethasone increased
while progesterone decreased lipocortin output, indicating that
progesterone and the glucocorticoid hormones inhibit PGF2a output
from human endometrium by different mechanisms.
Progesterone inhibited the outputs of PGF2a and PGE2 from day
7 and 15 guinea-pig endometrium without affecting the output of 6-
keto-PGFia. This finding indicates that the intracellular
processes controlling PGI2 synthesis (as reflected by measuring 6-
keto-PGFia output) are different from those controlling the
synthesis of PGF2a and PGE2. It will be interesting to see if
progesterone has a differential effect on endometrial PG synthesis
in other species. The inhibitory effect of a large concentration
of oestradiol may be due to it having a progesterone-like action.
However oestradiol, in contrast to progesterone, tended to reduce
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endometrial 6-keto-PGF-) a output. Also, oestradiol (37yM) but not
progesterone (32yM) inhibited the A23197-induced and arachidonic
acid-induced increases in outputs of PGF2a, PGE2 and 6-keto-PGF-|a
from the day 7 and day 15 guinea-pig uterus superfused in vitro
(30). All these findings suggest that the inhibitory actions of
oestradiol and progesterone are different.
Overall, these studies have failed to confirm a previous
report (11) that oestradiol and oxytocin treatment _in vitro
stimulates PGF2a output from guinea-pig endometrium maintained in
tissue culture. The inhibitory effect of progesterone on
endometrial PGF2a and PGE2 outputs appears not to be due to a
glucocorticoid-like action.
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EFFECT OF ACTINOMYCIN D ON PROSTAGLANDIN SYNTHESIS
BY AND OUTPUT FROM THE GUINEA-PIG UTERUS






(reprint requests to N.L. Poyser)
ABSTRACT
The intra-uterine administration of actinomycin D on Day 10 reduced
the output of prostaglandin (PG) F^a (the major PG released) from the
Day 15 guinea-pig uterus _in vitro by 80 to 85?. PGE2 output was
reduced by 50?, while 6-keto^PGF-]a output was unaffected. Plasma
progesterone levels were high (3 to 15 ng/ml) on Day 15 due to the
reduction in uterine PGF2a output. Endometrial PGF2a synthesizing
capacity was reduced by 50? by actinomycin D treatment, while
endometrial PGE2 and 6-keto-PGF-|a synthesizing capacities were
unaffected. Oestradiol treatment Ln vivo did not reverse the
inhibitory effects of actinomycin D on uterine PG production. A23187
increased uterine PGF2a, 6-keto-PGF-|a and PGE2 outputs irrespective of
treatment, indicating that substrate supply was always rate limiting.
Actinomycin D inhibited the uterotrophic action of oestradiol indicating
that fresh protein synthesis had been inhibited. Overall, this study
suggests that increased protein synthesis is involved in stimulating
endometrial PGF2a synthesis and release. Previous studies have shown
that increases in enzyme activities induced by oestradiol are only
secondary events in the stimulation of endometrial PGF2a production.
We propose that oestradiol induces the synthesis of a protein
('lipostimulin') which, acting on a progesterone-primed uterus,
"switches on" endometrial PGF2a synthesis and release by causing the
activation of endometrial phospholipase A2.
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INTRODUCTION
The life-span of the corpus luteum, and hence oestrous cycle
length, in the guinea-pig, as in several other non-primate mammalian
species, is controlled by prostaglandin (PG) F2ct released from the
uterus (1,2). Oestradiol acting on a progesterone-primed uterus is
probably the physiological stimulus in guinea-pigs for the increase in
PGF2a production by the uterus during the last one*-third of the cycle
(3,4). Oestradiol output from the ovary (5) increases just before the
increase in PGF2a output from the uterus (6, 7, 8). It is generally
recognised that many actions of oestradiol are mediated by increased
protein synthesis which in turn is dependent upon the stimulation of
DNA-dependent RNA synthesis. A previous study (9) showed that
actinomycin D, an inhibitor of DNA-dependent RNA synthesis, administered
directly into the uterine lumen prevented the increase in uterine PGF2a
synthesizing capacity which normally occurs towards the end of the
oestrous cycle, and prolonged the life-span of the corpus luteum as
indicated by plasma progesterone Levels and oestrous cycle length. It
was presumed in that study that actinomycin D had prevented the increase
in PGF2a output from the uterus, thus resulting in luteal maintenance.
Consequently, in the present study, PG output from and endometrial PG
synthesizing capacity by the guinea-pig uterus have been measured
following the intra-uterine administration of actinomycin D and
following A23187 treatment Ln vitro, so as to gain further insight into
the intracellular processes controlling endometrial PGF2a synthesis and
release.
METHODS
Virgin, female guinea-pigs weighing 650-950 g were examined daily
and a vaginal smear was taken when the vagina was perforate. Day 1 of
the cycle was taken as the day preceding the post-ovulatory influx of
leucocytes when cornification was at a maximum. All guinea-pigs used
had exhibited cycles of normal length before being used in the following
experiments. After receiving the appropriate treatment, each guinea-
pig was killed on Day 15 of the cycle by stunning and incising the neck.
A blood sample was collected into a heparinized (20 U/ml) syringe, and
was centrifuged at 2500 g. The plasma was withdrawn and stored at
- 20°C before being assayed for progesterone.
Experiment 1. The uteri from 5 Day-15 guinea-pigs were removed and
divided into their 2 uterine horns. Each uterine horn was "opened" by
cutting longitudinally. The endometrium and myometrium forming one
uterine horn from each animal were separated by cutting pieces of
endometrium away from the myometrium with a pair of fine scissors (10).
Each tissue type was weighed, homogenized separately in 10 ml Krebs
solution (for composition, see 11), and incubated for 60 min at 37°C in
an atmosphere of 5% C02 and 95% O2.
The other uterine horn from each animal was weighed, suspended in an
organ bath and attached to an isotonic lever under a load of 2 g. This
uterine horn was superfused (5 ml/min) with Krebs solution at 37°C and
which had been pre-gassed with 5% CO2 and 95% 02- Samples of
superfusate were collected for 10-min periods consecutively over the
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first 70 min of superfusion (i.e. 7 samples). Immediately after the
superfusion, the endometrium and myometrium were separated, weighed,
homogenized and incubated as above. The amounts of PGF2a, PGE2 and
6-keto-PGF-|a in the incubates and superfusates were measured by
radioimmunoassay (RIA).
Experiment 2. Ten Day-10 guinea-pigs were anaesthetized i.p. with
fentanyl citrate (0.^7 mg/Kg) and fluanisone (15 mg/Kg; "Hypnorm",
Crown Chemical Co. Ltd., Lamberhurst, Kent), plus midazolam (3 mg/Kg;
"Hypnovel", Roche Products Ltd., Welwyn Garden City). An incision was
made in the abdomen of each guinea-pig, the junction of the 2 uterine
horns was exposed, and 0.5 ml of sterile NaCl solution (9 g/1;
"Steriflex", Boots Company Ltd., Nottingham) was injected into each
uterine horn. For 5 of the guinea-pigs the NaCl solution contained
20 yg of actinomycin D (Sigma Chemical Co. Ltd., Poole, Dorset). The
body wall and skin were stitched and each guinea-pig received s.c. 0.4
mg naloxone ("Narcan", Du Pont (UK) Ltd., Stevenage, Herts.) to quicken
recovery from the anaesthetic. None of the animals subsequently showed
any adverse effects.
The uterus from each guinea-pig was removed on Day 15. The two
uterine horns were separated, "opened" by cutting longitudinally and
treated as in Exp. 1, except that only 2 samples of superfusate were
collected. These samples were obtained between 0-10 min and 60-70 min,
0 min being the start of the period of superfusion. The amounts of
PGF2a, PGE2 and 6-keto-PGFia present in the Superfusates and incubates
were measured by RIA.
This whole procedure was repeated on a further 10 guinea-pigs with,
additionally, each animal receiving s.c. 10 yg oestradiol benzoate
(Sigma Chemical Co. Ltd., Poole, Dorset) in 0.5 ml arachis oil daily
between Days 11 and 14.
Experiment 3. Ten Day-10 guinea-pigs were anaesthetized and received
intra-uterine NaCl solution (9 g/1) with or without actinomycin D (5
animals of each), as in Exp. 2. The uterine horns were removed on Day
15, weighed, "opened" by cutting longitudinally, and both horns
superfused with Krebs solution using the same conditions as in Exp. 1 .
After a settling period of 60 min, samples of superfusate were collected
from each uterine horn for 10-min periods consecutively over the next 90
min (i.e. 9 samples/uterine horn). During the superfusion of one
uterine horn from each animal, A23187 (Sigma Chemical Co. Ltd., Poole,
Dorset) was present in the Krebs solution (1 yg/ml) during the
collection of samples 4, 5 and 6. Immediately after the end of the
superfusion period, the endometrium and myometrium forming each uterine
horn were separated, weighed, homogenized and incubated as in Exp. 1.
The amounts of PGF2a, PGE2 and 6-keto-PGF-|a present in the superfusates
and incubates were measured by RIA.
This whole procedure was repeated on a further 10 guinea-pigs with,
additionally, each guinea-pig receiving s.c. 10 yg oestradiol benzoate
in 0.5 ml arachis oil daily between Days 11 and 14.
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Table 1. Mean (± s.e.m., n = 5) amounts (ng/100 mg tissue) of
prostaglandins (PGs) synthesized by homogenates of endometrium and
myometrium from Day-15 guinea-pigs.
Endometrium Myometrium
Time
0 min 70 min 0 min 70 min
PGF2a 82.1± 8.7 55.1± 8.0 * 17.1± 1.2 19.5+ 8.7
PGF2 13.1+ 0.9 8.3+ 0.1 * 8.0 ± 1.3 8.7± 0.3
6-keto-PGF-|a 31.1± 9.1 21.1± 1 .7 58. 7±11 .8 56.0± 5.1
* significantly lower (£ < 0.05) than corresponding value at 0 min for






Figure 1. Mean (± s.e.m., n = 5) outputs of prostaglandins (PGs) from
Day-15 guinea-pig uterine horns superfused in vitro.




Solvent extraction. The pH of the superfusates and incubates was
adjusted to 4.0 with HC1. Each sample was extracted twice by shaking
with 2 volumes of ethyl acetate. The two ethyl acetate fractions were
combined and evaporated to dryness at 45°C on a rotary evaporator.
Each dried extract was redissolved in 5 ml (incubates) and 10 ml
(superfusates) ethyl acetate and stored at -20°C before being assayed.
The recoveries of PGF2a and PGEg are > 90?, and the recovery of 6~keto~
PGFia is > 80? by this method (12, 13). The results are not corrected
for recoveries.
Radioimmunoassays. PGF2a, PGE2 and 6-keto-PGF-|a were measured
using antibodies raised in rabbits and tested in this laboratory (12,
14, 15, 16). The only significant cross-reactivities are PGFia (100?)
with the PGF2a antiserum, and PGE-| (94?), PGB2 (73?) and PGA2 (24?) with
the PGE2 antiserum. Previous studies involving analysis by gas
chromatography and mass spectrometry have shown that the guinea-pig
uterus synthesizes very little PGF-|a in comparison to PGF2a, and that
there is no detectable synthesis of PGE-| , PGB2 or PGA2 (17).
Consequently, the PGF2a and PGE2 antisera were measuring predominantly
the PG to which they had been raised. The intra-assay coefficients of
variation, calculated from the variation between the duplicates results
obtained for each sample were 5.6? (PGF2a), 7.8? (PGE2) and 5.9?
(6-keto-PGF-|a). The inter-assay coefficients of variation, calculated
from the results obtained by incorporating a known amount of the
appropriate PG into each assay, were 9.3? (PGF2a), 8.6? (PGE2) and 6.6?
(6-keto-PGF-] a). The limits of detection were 30 pg PGF2a, 40 pg PGE2
and 30 pg 6-keto-PGF-|a per assay tube for the respective assays.
Progesterone was measured as described previously (17), using an
antibody raised in this laboratory and whose cross-reactivities have
been reported elsewhere (18, 19). The intra-assay and inter-assay
coefficients of variation (calculated as for the PGs) were 10.8? and
10.1?, respectively. The detection limit was 30 pg progesterone per
assay tube.
Statistical Tests. Changes in the output of a PG with time during the
superfusion experiments were analyzed by Duncan's multiple-range test.
Other comparisons were made by using Student's _t test (which was used in
a modified form if the variances were unequal by the variance F ratio
test), or by using the paired t test, as appropriate.
RESULTS
Results are expressed as the mean (_+ s.e.m., n = 5 unless otherwise
stated).
Experiment 1 . The outputs of PGF2a, PGE2 and 6-keto-PGF-] a from the Day
15 superfused uterine horns were initially high during the first 10-min
period of superfusion, but then significantly fell (£ < 0.05) to values
which were 50 - 80? lower than the initial values. The outputs of the
3 PGs did not vary significantly with time over the next 60-min period





























































































































































































































































































































































Control Ac tin. 0
2. With Qestradioi Treatment
Control Actin. D
Figure 2. Mean (± s.e.ra., n = 5) outputs of prostaglandins (PGs) from
the uterine horns superfused in vitro of Day—15 guinea-pigs receiving
intra-uterine NaCl solution (9 g/1) on Day 10 not containing (Control)
or containing (Actin.D.) 20 yg actinomycin D, (1) not treated or (2)
treated with 10 yg oestradiol benzoate s.c. daily from Days 11-14, and
not treated (broken line) or treated (solid line) with A23187 (1 yg/ml)
as indicated.
tsignificantly higher (P < 0.05) than corresponding values for the
same PG before treatment with A23187.
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6-keto-PGF-|a, synthesized by the endometrium significantly fell (P <
0.05) between 0 and 70 min. The amounts of the 3 PGs synthesized by
the myometrium did not differ significantly between the 2 times studied
(Table 1). Plasma progesterone levels in this group of Day-15 guinea-
pigs were 0.27 0.05 ng/ml.
Experiment 2. The outputs of PGF2a, PGE2 and 6~keto^PGF-|a from all
uterine horns, with or without actinomycin D treatment, were
significantly lower (P < 0.05) at 70 min than at 10 min (Table 2). The
outputs of PGF2a and of PGE2, but not of 6~keto-PGF-| a, were
significantly lower from the actinomycin D-treated uterine horns than
from the control uterine horns, at both times studied (Table 2). A
similar profile of PG outputs was found in those guinea-pigs which had
additionally received oestradiol benzoate between Days 11 and 1 -4, except
that PGE2 output from the actinomycin D-treated uterine horns was only
significantly (P < 0.05) lower at 70 min (Table 2).
The amounts of PGF2a, PGE2 and 6-keto~PGF-|a synthesized by the
endometrium of control, but not of actinomycin D-treated, uterine horns
significantly decreased (£ < 0.05) between 0 and 70 min in those guinea-
pigs which did not receive oestradiol benzoate, but did not change
significantly in those control guinea-pigs which received oestradiol
benzoate between Days 11 and 14. The amounts of PGF2a, PGE2 and
6-keto-PGF-]a synthesized by the myometrium did not change with time in
either group of guinea-pigs (Table 3).
In guinea-pigs which did not receive exogenous oestradiol, intra¬
uterine actinomycin D significantly (JP < 0.05) reduced the amounts of
PGF2a, but not of PGE2 and 5-keto-PGF-] a, synthesized by the endometrium
whereas in those guinea-pigs which received oestradiol, the amounts of
PGF2a, PGE2 and 6-keto<-PGF-| a synthesized by the endometrium were all
significantly (P < 0.05) reduced by actinomycin D treatment, at both
times studied (Table 3). Actinomycin D did not affect PG synthesis by
the myometrium in either group at either time (Table 3).
Plasma progesterone levels were high in those guinea-pigs which had
received intra-uterine actinomycin D, with or without oestradiol
treatment, and were typically low in the control Day-15 guinea-pigs
(Table 2). The increase in uterine horn weights induced by oestradiol
was significantly reduced (P < 0.05) by actinomycin D (Table 2).
Experiment 3. A23187 caused a significant (£ < 0.05) stimulation in
the outputs of PGF2a, 6-keto-PGF-] a and, to lesser extent, PGE2 from the
guinea-pig uterus irrespective of the treatment they had received in
vivo (Fig. 2). The maximum output of PGF2a was significantly lower (P
< 0.05) from the actinomycin D-treated uterine horns, with or without
oestradiol treatment (Fig. 2). However, if the difference in the basal
outputs of PGF2a are taken into account, A23187 caused an approximate 3~
fold stimulation of uterine PGF2a output from control and actinomycin D-
treated uterine horns, with or without oestradiol treatment.
A23187 treatment had no significant effect on the amounts of PGF2a,
PGE2 and G'-keto^PGFia synthesized by homogenates of the endometrium or
myometrium at the end of the superfusion period. In guinea-pigs which
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*significantlylower(P<0.05)thancorresponding"Control"v luef rmPGrsti srec ivi similartreat ent.
did not receive oestradiol treatment, the amounts of PGF2a, but not of
PGE2 or 6~keto-PGF-| a, synthesized by the endometrium and myometrium were
significantly lower (P < 0.05) in the actinomycin D-treated than in
control guinea-pigs (Table it). Plasma progesterone levels were 4.13 ±
0.52 and 0.21 ± 0.04 ng/ml in the actinomycin D-treated and control
guinea-pigs, respectively. In the oestradiol-treated guinea-pigs, the
amounts of PGF2a, PGE2 and 6-keto-PGF-|a synthesized by the endometrium,
but not by the myometrium, were significantly lower (P < 0.05) in the
actinomycin D-treated than in the control guinea-pigs (Table 4).
Plasma progesterone levels were 3-31 ± 0.80 and 0.11 ± 0.02 ng/ml in
these 2 groups of guinea-pigs, respectively. The increase in uterine
horn weight produced by oestradiol was significantly inhibited (P <
0.05) by actinomycin D treatment (910 ± 43 v. 596 ± 24 mg, respectively,
n = 10).
DISCUSSION
The output of PGF2a from the superfused guinea-pig uterus in vitro
increases 22-fold between Days 7 and 15 of the cycle (20). The release
rates of PGF2a from the uterus observed in vitro are similar to those
observed in vivo (21). The intra-uterine, but not systemic
administration, of 40 pg actinomycin D extends oestrous cycle length 2-
fold, due to an extended life-span of the corpus luteum as indicated by
plasma progesterone levels (9). The present study has shown that the
intra-uterine administration of actinomycin D causes a 80-85? reduction
in the output of PGF2a from the Day 15 guinea-pig uterus. Plasma
progesterone levels were consequently high (for Day 15) in these guinea-
pigs treated with actinomycin D. Oestradiol treatment did not overcome
the inhibitory effect of intra-uterine actinomycin D on uterine PGF2a
output and the resultant maintenance of luteal function.
The outputs of PGE2 and 6-keto-PGF-| a (which reflects PGI2
production) from the superfused uterus of Day-15 guinea-pigs which did
not receive actinomycin D were considerably lower than the output of
PGF2a, as reported previously (20). Actinomycin D significantly
reduced the output of PGE2, but not of 6-keto-PGF-| a, irrespective of
whether or not the guinea-pigs were treated with oestradiol. These
findings show that actinomycin D is showing selectivity of action
towards PGF2a and PGE2.
The PGF2a synthesizing capacity of the guinea-pig endometrium
increases 2.5-fold between Days 7 and 15 of the cycle (18). Intra¬
uterine actinomycin D treatment prevented this increase in endometrial
synthesizing capacity without affecting myometrial PGF2a synthesizing
capacity, and without affecting endometrial and myometrial PGE2 and
6-keto-PGFia synthesizing capacities. This shows that the inhibition
of PGF2a synthesizing capacity by actinomycin D in homogenates of whole
guinea-pig uterus (9) is due to a specific action of actinomycin D on
the endometrium. Furthermore, this previous study (9) showed that the
reduction of PGF2a synthesis in uterine homogenates by actinomycin D was
not due to lack of available substrate or to increased PGF2a metabolism.
Thus, the stimulation of endometrial PG synthetase levels (probably the
cyclo-oxygenase component) by oestradiol (18) was prevented by the
intra-uterine administration of actinomycin D, indicating that fresh
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protein synthesis had been inhibited. Oestradiol treatment did not
overcome this inhibitory effect of actinomycin D and, in fact,
actinomycin D significantly reduced the endometrial, but not myometrial,
PGF2a, PGE2 and 6-keto-PGF-] a synthesizing capacities in oestradiol-
treated guinea-pigs.
It might be supposed that the reduced output of PGF2a from the
guinea-pig uterus following actinomycin D treatment is due to the
reduction in endometrial PGF2a synthesizing capacity. This would mean
that the amount of enzyme and not the amount of free substrate is rate
limiting in the synthesis of PGF2a by the endometrium. In control
guinea-pigs which did not receive actinomycin D or oestradiol,
endometrial PGF2a synthesizing capacity fell by 40? between 0 and 70 min
(Table 3), and fell by another 50? between 70 and 150 min (cf. Tables 3
& 4). The endometrial synthesizing capacities of PGE-|a and 6-keto-
PGF-|a also fell between 0 and 70 min, but did not decrease further
between 70 and 150 min. However, after the initial high outputs of
PGF2a, PGE2 and 6-keto-PGF-|a during the first 10-min period of
superfusion (probably due to the trauma of setting up the tissue), the
basal outputs of PGF2a, PGE2 and 6-keto-PGF1a remained steady over the
subsequent periods of superfusion (Figs 1 & 2), in spite of the
reduction in endometrial PG synthesizing capacity. In addition,
previous studies on ovariectomized guinea-pigs have shown that
oestradiol causes the maximum increase in endometrial PGF2a
synthesizing capacity, an effect which is reduced by progesterone (18).
However, oestradiol acting on a progesterone-primed uterus causes a
larger increase in PGF2a output from the uterus when compared to
oestradiol acting alone (4). Also, although PGF2a is the major PG
synthesized by homogenates of Day 7 guinea-pig endometrium, the output
of PGF2a from the Day 7 superfused guinea-pig uterus is less than the
outputs of PGE2, 6-keto-PGF-] a, and thromboxane B2 (18, 20). These
studies show that uterine PGF2a output is not controlled by endometrial
PGF2a synthesizing capacity and that changes in endometrial PGF2a
synthesizing capacity are not the direct cause of changes in uterine
PGF2a output. Interestingly, oestradiol treatment prevented the
decline in endometrial PG synthesizing capacity with time (Tables 3 &
4).
A23187 caused a 3~fold increase in uterine PGF2a output from all
uterine horns, irrespective of treatment. The outputs of 6-keto-PGF-|a
and, to a lesser extent, PGE2 were also increased. These increases are
due to an influx of extracellular Ca2+ by A23187 (22) which presumably
stimulates phospholipase A2 (PLA2; EC 3-1.1.4) to release more
arachidonic acid for increased PG synthesis, since PLA2 is a calcium-
requiring enzyme (23). Actinomycin D did not inhibit this process,
initiated by A23187. The studies with A23187 indicate that the amount
of available substrate and not the amount of enzyme is therefore the
rate-limiting factor in controlling uterine PGF2a output (and the
outputs of the other PGs), although the maximum amount of PGF2a
synthesized would appear to depend to some extent on the amount of
cyclo-oxygenase present in the endometrium. PLA2 activity in guinea-
pig endometrium increases 1.5-fold between Days 7 and 16 of the cycle.
However, optimum endometrial PLA2 activity is more than adequate to
account for the amounts of PGF2a released from the uterus at both stages
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of the cycle (23). It was considered, therefore, that activation of
endometrial PLA2 by raising the intracellular free Ca2+ concentration,
rather than changes in absolute PLA2 activity, was the more important in
the process by which oestradiol acting on a progesterone-primed uterus
"switches on" endometrial PGF2a synthesis and release after Day 11 of
the cycle in vivo.
In the present study, actinomycin D prevented this "switching on"
process, and this inhibition was not overcome by oestradiol
administration in a dose which normally stimulates uterine PGF2a
synthesis and release (3, 11, 6). Actinomycin D also prevented fresh
protein synthesis as indicated by the inhibition of the uterotrophic
effect of oestradiol and the lack of increase in endometrial PG
synthetase levels. Since many actions of oestradiol are mediated by
increased protein synthesis, we propose, therefore, that oestradiol
causes the synthesis by the endometrium of a protein ('lipostimulin')
which acts in a progesterone-primed uterus to raise the endometrial
intracellular free Ca?+ concentration. This calcium combines with
calmodulin (2H, 25) which then activates PLA2 (26) to release
arachidonic acid from endometrial phospholipids, predominantly from
phosphatidylcholine and phosphatidylethanolamine (10, 27), for increased
PG synthesis. The increases in PLA2 and cyclo-oxygenase activities are
secondary events which ensure that, following stimulation of PLA2 by
lipostimulin, a greater amount of arachidonic acid is released and a
greater proportion of that free arachidonic acid is converted into PGH2
than would have occurred if the amounts of these enzymes present in the
endometrium had not changed. The PGH2 formed is predominantly directed
in some way into the PGF2a~forming pathway. Whether such a
lipostimulin exists requires further investigation.
Actinomycin D or cycloheximide administered to ovariectomized rats
failed to prevent oestradiol treatment from stimulating uterine PG
synthesis (28). From these findings, it was suggested (28) that
oestrogen-stimulated uterine PG synthesis does not require protein
synthesis in the uterus. This suggestion does not agree with our
proposal. However, the protein synthesis inhibitors were administered
to rats systemically and, in a previous study (9), it was shown that the
systemic administration of actinomycin D to guinea-pigs had no effect on
uterine PG synthesizing capacity and oestrous cycle length. It was
found necessary to administer the actinomycin D directly into the
guinea-pig uterus in order to prevent the stimulation of uterine PG
production. Consequently, the study on rats needs repeating but with
the protein synthesis inhibitors being administered by the intra-uterine
route.
Actinomycin D and the anti-luteolytic factor secreted by the guinea-
pig conceptuses (21) exert the same effects on the guinea-pig uterus
after Day 11, i.e. prevent increases in uterine PGF2a output and
endometrial PGF2a synthesizing capacity. Oestradiol treatment does not
overcome these inhibitory effects in actinomycin D'-treated guinea-pigs
and in a majority (75?) of the pregnant guinea-pigs (19). Also, the
uterotrophic action of oestradiol is prevented by actinomycin D and by
the presence of the conceptuses. It appears that the anti-luteolytic
factor, like actinomycin D, prevents oestradiol-induced fresh protein
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synthesis from occurring in the endometrium, particularly the synthesis
of the postulated lipostimulin. Whether the anti-luteolytic factor
prevents oestradiol from combining with its receptor, or blocks the
subsequent transcription on translation processes involved in protein
synthesis, requires further study. In addition, it will also be
interesting to see whether proteins secreted by the sheep and cow
conceptus and which inhibit uterine PGF2a output induced by oestradiol
(29, 30) also act by inhibiting the formation of uterine proteins
required for the stimulation of endometrial PGF2a synthesis and release
in these species. As in the guinea-pig, the intra-uterine
administration of actinomycin D in sheep prolongs luteal function (31)
indicating that fresh protein synthesis is normally required for the
stimulation of uterine PGF2a production in the sheep.
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Prostaglandin production by the guinea-pig endometrium: is
calcium necessary?
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ABSTRACT
The output of prostaglandin (PG) F2a from guinea-pig
endometrium obtained on day 15 of the oestrous cycle
and maintained in tissue culture was significantly
(P<005) reduced by the use of Ca2+-depleted
medium, EGTA (a Ca2+ chelator), 8-(N,N-diethyl-
amino)octyl-3,4,5-trimethoxybenzoate hydrochloride
(TMB-8; an intracellular Ca2+ antagonist), trifluo¬
perazine (TFP) and N-(6-aminohexyl)-5-chloro-l-
naphthalenesulphonamide (W-7; both calmodulin
antagonists). Nifedipine inhibited PGF2a output at a
concentration (100pmol/l) much greater than that
usually required to block Ca2+ channels. Verapamil
had a small but significant (P<005) inhibitory effect
on PGF2a output at 10-100 pmol/l. The outputs of
PGE2 and, to a lesser extent, 6-keto-PGFla (the
hydrated product of PGI2) were also reduced by using
Ca2+-depleted medium. EGTA reduced the outputs
of PGE2 and 6-keto-PGFla on day 1 of culture, but
stimulated 6-keto-PGFlo output on day 3 of culture.
The outputs of PGE2 and 6-keto-PGFIa were
increased by TMB-8 (100 pmol/1) on day 3 of culture
and by TFP and, to a smaller extent, by W-7 on all 3
days of culture. Nifedipine (100pmol/l by not 1 or
10pmol/l) reduced the outputs of PGE2 and 6-keto-
PGF1o on all 3 days of culture, whereas verapamil
(100 pmol/1 but not 1 or 10 pmol/1) increased the out¬
puts of these two prostaglandins on days 2 and 3 of
culture. Phorbol 12-myristate 13-acetate (an activator
of protein kinase C) had no effect on the outputs of
PGF2a, PGE2 and 6-keto-PGFla from cultured guinea-
pig endometrium obtained on days 7 and 15 of the
oestrous cycle. It is concluded that extracellular Ca2+
is necessary for the high output of PGF2a from the
guinea-pig uterus after day 11 of the oestrous cycle,
and that the action of Ca2+ is not potentiated by the
activation of protein kinase C.
J. Endocr. (1987) 113, 463-471
INTRODUCTION
The uterine luteolytic hormone in non-primate mam¬
malian species has been identified as prostaglandin
(PG) F2a (see Horton & Poyser, 1976; Poyser, 1981).
In the guinea-pig, increased PGF2a output from the
uterus occurs from day 11 of the cycle (Blatchley,
Donovan, Horton & Poyser, 1972; Earthy, Bishop &
Flack, 1975; Antonini, Turner & Pauerstein, 1976).
Studies on the superfused guinea-pig uterus in vitro
have shown that the outputs of PGF2a, PGE2 and
6-keto-PGFla increase 21 -9-, 1-8- and 2-9-fold respect¬
ively between days 7 and 15 of the cycle (Poyser &
Brydon, 1983), and that oestradiol acting on a pro¬
gesterone-primed uterus in vivo is responsible for this
relatively specific increase in PGF2q output in vitro
(Poyser, 1983a). Oestradiol output from the guinea-
pig ovary increases after day 10 (Joshi, Watson &
Labhsetwar, 1973), and this is consistent with oestra¬
diol being responsible for the increase in uterine
PGF2o output from day 11. Phosphatidylcholine (PC)
and phosphatidylethanolamine (PE) appear to be the
source of arachidonic acid for increased PGF2a syn¬
thesis by the guinea-pig endometrium (Leaver &
Poyser, 1981; Ning, Leaver & Poyser, 1983; Ning &
Poyser, 1984).
The calcium ionophore A23187 stimulates PG
output from the guinea-pig uterus (Poyser &
Brydon, 1983), an action dependent upon extracellu¬
lar Ca2+ (Poyser, 1984). It has been proposed,
therefore, that oestradiol acts upon a progesterone-
primed uterus to increase the endometrial intra¬
cellular free Ca2+ concentration which, in turn, acti¬
vates phospholipase (PL) A2 (EC 3.1.1.4; a calcium-
requiring enzyme) to release arachidonic acid from
PC and PE for PGF2a synthesis (Downing & Poyser,
1983). This study investigated whether Ca2+ is
necessary for the high output of PGF2a from guinea-
pig endometrium towards the end of the oestrous
cycle.
J. Endocr. (1987) 113, 463—171 © 1987 Journal of Endocrinology Ltd Printed in Great Britain
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MATERIALS AND METHODS
Virgin female guinea-pigs, weighing between 600 and
950 g, were examined daily and a vaginal smear was
taken when the vaginal membrane was open. The first
day of the oestrous cycle was taken as the day before
the post-ovulatory influx of leucocytes when cornifi-
cation is at a maximum. All animals had normal
cycles before being used. Each guinea-pig was killed
by stunning and incising the neck on day 7 or day 15
of the cycle. The uterus was removed and placed in
culture medium. The endometrium was dissected
away from the myometrium under sterile conditions
at room temperature by cutting away 1 x 2 mm pieces
of endometrium. Approximately 12mg endometrium
was placed on a raised platform in a Petri dish
containing 4 ml Medium 199 plus Earle's salts or
Ca2 + -depleted Medium 199 plus Earle's salts (the
Ca2+-containing salts having been omitted during
preparation by the manufacturers), supplemented
with glutamine and antibiotics (Ning et al. 1983).
Eighteen Petri dishes containing endometrial tissue
were prepared from the uterus of each guinea-pig; 14
of the dishes contained 'treatments' (performed in
duplicate) as outlined below and four dishes were
untreated (controls). The Petri dishes were equally
divided between two Kilner jars (i.e. nine dishes per
jar); each set of nine dishes consisted of one dish from
each of the duplicate treatments and two untreated
control dishes. The endometrium was cultured for
72 h as described previously, and the tissue remained
viable during this period (Ning et al. 1983; Ning &
Poyser, 1984). The culture medium was changed every
24 h. The samples of culture medium were stored at
— 20 °C before radioimmunoassay, without extrac¬
tion, for PGF2a, PGE, and 6-keto-PGFla.
Experimental treatments
Using Ca2+-containing medium
Endometrium removed from guinea-pigs on day 15 of
the oestrous cycle (day-15 guinea-pig endometrium)
was treated with the following compounds: EGTA (a
calcium chelator; 2 mmol/1), 8-(N,N-diethylamino)-
octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-
8; an intracellular Ca2 + antagonist; 30 and 100 pmol/1;
Chiou & Malagodi, 1975), trifluoperazine (TFP; a
calmodulin antagonist; 100 and 200pmol/l; Levin
& Weiss, 1977), N-(6-aminohexyl)-5-chloro-l-naph-
thalenesulphonamide (W-7; a calmodulin antagonist;
150 and 300 pmol/1; Hidaka, Asano, Iwadare et al.
1978), nifedipine (1,10 and 100 pmol/1) and verapamil
(1, 10, 50 and 100pmol/l) (voltage-dependent Ca2+
channel blockers) and phorbol 12-myristate 13-acetate
(TPA; a stimulator of protein kinase C; 1-6, 81 and
40-5 nmol/1; Castagna, Takai, Kaibuchi et al. 1982).
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The preparation and dispensing of solutions contain¬
ing nifedipine and verapamil were performed under
sodium light.
Endometrium removed on day 7 of the oestrous
cycle (day-7 guinea-pig endometrium) was cultured in
medium containing TPA (1-6, 81 and 40-5 nmol/1).
Using Ca2+-depletedmedium
Day-15 guinea-pig endometrium was cultured
with EGTA (2 mmol/1), TMB-8 (100pmol/l), W-7
(150pmol/l), nifedipine (100pmol/l) and verapamil
(100 pmol/1).
Sources of materials
Culture medium (Ca2+-containing and Ca2+-
depleted), glutamine and antibiotics were obtained
from Flow Laboratories, Rickmansworth, Herts;
Petri dishes from Sterilin Ltd, Teddington, Middx;
EGTA and TPA from Sigma Chemical Co. Ltd,
Poole, Dorset; TFP from Smith, Kline & French
Laboratories, Welwyn Garden City, Herts; W-7 from
Beecham-Wulfring, Gronau (Leine), F.R.G.; TMB-8
from Aldrich Chemical Co. Ltd, Gillingham, Kent;
nifedipine from Bayer U.K. Ltd, Newbury, Berks and
verapamil from Knoll AG, Ludwigshafen, F.R.G.
Details of radioimmunoassay
Prostaglandin F2a, PGE2 and 6-keto-PGF10 were
measured using antibodies raised in this laboratory
and whose cross-reactivities have been reported else¬
where (Dighe, Emslie, Henderson et al. 1975;
Poyser, 1980; Poyser & Scott, 1980; Lytton & Poyser,
1982). The only significant cross-reactivities were
PGEj (66%), PGA2 (25-5%) and PGB2 (11-8%) with
the PGE2 antiserum, and PGFla (100%) with the
PGF2a antiserum. Previous studies involving analysis
by gas chromatography and mass spectrometry have
shown that the guinea-pig uterus synthesizes very little
PGFla in comparison with PGF2a, and that there is no
detectable synthesis of PGE,, PGB2, and PGA2
(Poyser, 1983Z?). It is likely, therefore, that the PGF2a
and PGE2 antibodies were measuring predominantly
the PG to which they had been raised. The intra-assay
coefficients of variation were 5-6% (PGF2q), 7-8%
(PGE2) and 5-9% (6-keto-PGFla). The interassay
coefficients of variation were 8-2% (PGF2a), 8-6%
(PGE2) and 6-6% (6-keto-PGFla). The limits of detec¬
tion were 0 09 pmol PGF2a, 0-11 pmol PGE2 and
0-08 pmol 6-keto-PGFla per assay tube for the
respective assays.
Statistical tests
Results were analysed by the one- or two-tailed
Student's t-test, as appropriate.
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RESULTS
Using Ca -containing medium
Basal PG output from day-7 and day-15 guinea-pig
endometrium in culture
The outputs of PGF2a, PGE2 and 6-keto-PGF1(1 from
day-7 and day-15 guinea-pig endometrium declined
from day 1 to day 3 of culture (Fig. 1). Comparing
day-15 with day-7 tissue, the ratios of the mean out¬
puts on days 1, 2 and 3 of culture for PGF2a were
7-2:10, 3-3:1-0 and 2-1:1-0 respectively, for PGE2 they
were 3-3:1-0, 2-4:10 and 1-3:1-0 respectively, and for
6-keto-PGFla they were 1-2:1-0, 1-3:1-0 and 1-2:1-0
respectively. Output of PGF2o from day-15 endome¬
trium was significantly (P<0-05) higher than from
day-7 endometrium on all 3 days of culture. Output of
PGE2 was significantly (PcO-05) higher from day-15
endometrium on days 1 and 2 of culture, and 6-keto-
PGFl0 output was significantly (PcO-05) higher from
day-15 endometrium only on day 2 of culture. The
ratios of the mean outputs of PGF2a, 6-keto-PGFla
and PGE2 on days 1, 2 and 3 of culture for day-7
endometrium were 7-3:11-0:1 -0, 9-8:4-8:1-0 and
6-7:4-3:1-0 respectively on the successive days of
culture, and for day-15 endometrium they were
13-9:3-4:1-0, 13-4:2-6:1-0 and 8-2:3-2:1 -0 respectively
on the successive days of culture. PGF2a and 6-keto-
PGFla were released in similar quantities from day-7
endometrium, with lesser quantities of PGE2. PGF2a
was the major PG released from day-15 endometrium,
with lesser quantities of PGE2 and 6-keto-PGFla.
Effect of various treatments on PG output
The results for day-15 guinea-pig endometrium are
shown in Tables 1 (PGF2a), 2 (PGE2) and 3 (6-keto-
PGFla). EGTA (2mmol/l) significantly (PcO-05)
reduced the outputs of PGF2a, PGE2 and 6-keto-
PGFla on day 1 of culture, and of PGF2a on day 2 of
culture. The output of 6-keto-PGFla was significantly
(P<0 05) increased on day 3 of culture by EGTA.
TMB-8 (30 and 100pmol/l) significantly (PC0-05)
reduced the output of PGF2a on days 1, 2 and 3 of
culture. TMB-8 (30pmol/l) significantly reduced
PGE2 output on day 2 of culture, and lOOpmol
TMB-8/1 significantly (P<005) increased PGE2 and
6-keto-PGFla outputs on day 3 of culture.
The output of PGF2a was significantly (P<005)
reduced by TFP (200 pmol/1 on day 1 of culture,
100 pmol/1 on day 2 of culture and 100 and 200 pmol/1
on day 3 of culture). The outputs of PGE2 and 6-keto-
PGFla were significantly (PcO-05) increased by TFP
(100 and 200 pmol/1) on all 3 days of culture. W-7 (150
and 300pmol/l) significantly (P<0-05) inhibited
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figure 1. Mean (± s.e.m., n = 10) outputs ofprostaglandin
(PG) F2a, PGE2 and 6-keto-PGFla from guinea-pig endome¬
trium, removed on day 7 (solid bars) and day 15 (open bars)
of the oestrous cycle, on days 1,2 and 3 of tissue culture.
*Significantly higher (P< 0 -05) compared with day 7 value
for same PG on same day ofculture (Student's f-test, or
modified /-test if variances were unequal by variance ratio
P-test).
PGE2 was significantly (P<0-05) increased by W-7
(150 and 300 pmol/1) on all 3 days of culture except at
150 pmol/1 on day 1. The output of 6-keto-PGFla was
significantly (P<0-05) increased by W-7 (150 and
300 pmol/1) on day 2 of culture, and by W-7
(150 pmol/1) on day 3 of culture.
Nifedipine (1 and 10pmol/l) had no significant
effect on the outputs ofPGF2a, PGE2 and 6-keto-PGFla
on all 3 days of culture. Nifedipine (100pmol/l) sig¬
nificantly (P<0 05) inhibited the outputs of PGF2a,
PGE2 and 6-keto-PGFla on days 1 and 2 of culture,
and PGF2a output on day 3 of culture. Verapamil
(1 pmol/1) had no effect on the outputs of PGF2a,
PGE2 and 6-keto-PGFla on the 3 days of culture. The
output of PGF2a was significantly (PcO-05) reduced
by verapamil (10 and 100 pmol/1) on day 1 of culture,
and by verapamil (10 pmol/1) on day 2 of culture. The
outputs of PGE2 and 6-keto-PGFlo were significantly
(P<0-05) increased by verapamil (100pmol/l) on
days 2 and 3 of culture, and 6-keto-PGFla output
was significantly (P<0-05) increased by verapamil
(50 pmol/1) on day 3 of culture.
The outputs ofPGF2a, PGE2 and 6-keto-PGFla from
day-15 and day-7 endometrium were not affected by
TPA (1 -6-40-5 nmol/1) on any day of culture.
J. Endocr. (1987) 113, 463^471
466 s. C. Riley and n. l. poyser • Co1 + and uterine PGproduction
table 1. Mean (+ s.e.m., n = 10) output of prostaglandin (PG) F2o (expressed as % of day 1 control (C) output) from guinea-
pig endometrium removed on day 15 of the oestrous cycle (unless otherwise stated) and cultured in the absence (C) or presence
(T) of EGTA, TMB-8, trifluoperazine (TFP), W-7, nifedipine (nifed), verapamil (verap) and phorbol 12-myristate 13-acetate
(TPA)
Output of PGF2ll (% of control on day 1 of culture)
Day 1 Day 2 Day 3
C T C T C T
Treatment
EGTA 2 mmol/1 100 65-3 + 11-2* 40-6 + 4-2 24-6 + 6-2* 14-3 + 1-8 12-1+2-0
TMB-8 30 pmol/1 100 66-3 + 5 0* 32-8 + 4-2 18-6 + 3-7* 8-7+1-7 4-3 + 0-7*
100 pmol/1 56-3 + 5-7* 12-2+1-6* 4-6 + 0-8*
TFP 100 pmol/1 100 83-2 + 8-4 40-8 + 5-7 20-4 + 3-2* 20-7 + 5-5 3-4 + 0-7*
200 pmol/1 76-4 + 9-4* 27-4 + 4-9 4-6+1-3*
W-7 150 pmol/1 100 36-2 + 3-1* 34-8 ±3-2 13-1 + 1-6* 8-8 + 1-2 4-1+0-4*
300 pmol/1 35-9 + 3-5* 9-9 + 2-2* 1-7 + 0-5*
Nifed 1 pmol/1 100 111-2 + 8-4 29-2 + 1-8 34-6 + 3-6 9-0 + 2-0 12-3 + 5-1
10 pmol/1 98-5 + 8-4 30-8 + 3-5 8-3 + 1-4
100 pmol/1 57-5 + 1-5* 10-7+1-8* 3-4+1-5*
Verap 1 pmol/1 96-2 + 11-4 26-0 + 2-3 8-6 + 3-0
10 pmol/1 79-3 + 8-0* 23-3 + 2-0* 6-0+ 0-5
50 pmol/1 82-7 + 7-7 25-9 + 2-9 9-1 + 1-3
100 pmol/1 76-2 + 5-1* 35-3 + 3-2 9-6 + 0-7
TPA 1-6 nmol/1 100 102-2+10-7 28-4 + 3-1 32-3 + 5-1 6-8+1-1 7-0+1-1
8T nmol/1 98-2+10-9 33-1 + 5-9 7-7+1-7
40-5 nmol/1 104-5 + 10-2 37-0 + 5-6 6-7+1-7
TPA 1-6 nmol/1 100 107-4 + 7-6 70-2 ±11-6 75-5+16-9 29-9 + 5-5 27-2 + 7-7
Day 7 8 1 nmol/1 108-6+12-1 73-1 + 11-7 31-5 + 5-0
40-5 nmol/1 114-4+14-7 76-0+11-2 30-5 + 8-2
*Significantly lower (/*< 0-05) compared with corresponding control value for the same day (Student's one- or two-tailed /-test, as appropriate).
Effect of using Ca2 +-depleted medium
The basal outputs of PGF2a, PGE, and 6-keto-PGFla
from day-15 guinea-pig endometrium in Ca2+-
depleted medium compared with Ca2+-containing
medium are shown in Fig. 2. On days 1 and 2 of tissue
culture, the outputs of PGF2a and PGE2 were signifi¬
cantly (PC0-05) reduced by 48 and 39% respectively
in Ca2+-depleted medium. The output of 6-keto-
PGFl0 was significantly (P<0 05) reduced by 14% in
Ca2+-depleted medium on day 1 of culture.
The output of PGF2a in Ca2 +-depleted medium was
further and significantly (P<0-05) reduced by EGTA
(2mmol/l), TMB-8 (100 pmol/l), W-7 (150 pmol/1),
nifedipine (100 pmol/1) and verapamil (100 pmol/1) on
day 1 of culture, and by EGTA (2mmol/l), TMB-8
(100 pmol/1) and nifedipine (100 pmol/1) on day 2 of
culture. The output of PGE2 in Ca2+-depleted
medium was significantly (.P<0-05) reduced by
nifedipine (100 pmol/1) and significantly increased by
TMB-8 (100 pmol/1), W-7 (150 pmol/1) and EGTA
(100 pmol/1) on days 2 or 3 of culture. The output of
6-keto-PGFla in Ca2+-free medium was significantly
(.P<0-05) reduced by EGTA (2mmol/l) and nifedi¬
pine (100 pmol/1) on day 1 of culture and signifi¬
cantly (P<005) stimulated by EGTA (2mmol/l),
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TMB-8 (100 pmol/1), W-7 (150 pmol/1) and verapamil
(100 pmol/1) on days 2 and 3 of culture (Table 4).
DISCUSSION
The basal outputs of PGF2a and, to a much lesser
extent, PGE2 and 6-keto-PGFla from guinea-pig
endometrium maintained in culture were higher on
day 15 than on day 7 of the oestrous cycle. This shows
that a preferential stimulation of endometrial PGF2q
output occurred in vivo between days 7 and 15 of the
cycle, and that this stimulation is maintained in tissue
culture, particularly during the first 24 h of culture, in
the absence of the steroid hormones (i.e. oestradiol
and progesterone) responsible for this stimulation
(Poyser, 1983a). These findings are in agreement
with similar studies performed on the superfused
guinea-pig uterus (Poyser & Brydon, 1983).
Prostaglandin output from the superfused day-15
guinea-pig uterus is stimulated further by the calcium
ionophore A23187 (Poyser & Brydon, 1983), an
action which is dependent upon extracellular Ca2+
(Poyser, 1984). Raising the intracellular free Ca2+
concentration therefore stimulates PGF2a synthesis
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table 2. Mean (+ s.e.m., n = 10 unless otherwise indicated) output ofprostaglandin (PG) E2 (expressed as % ofday 1 control
(C) output) from guinea-pig endometrium removed on day 15 of the oestrous cycle (unless otherwise stated) and cultured in
the absence (C) or presence (T) of EGTA, TMB-8, trifluoperazine (TFP),W-7, nifedipine (nifed), verapamil (verap) and
phorbol 12-myristate 13-acetate (TPA)
Output of PGE2 (% ofcontrol on day 1 of culture)
Day 1 Day 2 Day 3
C T C T C T
Treatment
EGTA 2 mmol/1 100 474 + 6-0* 38-0 + 3-7 27-2 + 5-0 21-0 + 4-7 25-1 + 7-1
TMB-8 30 pmol/1 100 100-1+9-8 42-4+ 5-7 24-7 + 4-4* 16-0 + 2-9 12-6 + 2-5
100 pmol/1 119-9 + 13-0 47-5 + 6-3 37-5 + 6-0
TFP 100 pmol/1 100 231-0 + 37-7f 48-6 + 5-6 204-5 ±46-6t 28-7 ±5-1 87-5+ 15 9t
200 pmol/1 283-6 + 42-5t 207-4+ 25-3f 108-0+19-3t
W-7 150 pmol/1 100 109-4 + 7-3 37-5 + 5-9 87-3 + 9-5f 16-7 + 3-1 46-7 + 6-3t
300 pmol/1 180-4 + 20-2t 121-3 + 20-6f 27-6 + 3-lf
Nifed 1 pmol/1 100 112-3 + 9-8 39-2±3-0 43-5 + 4-7 20-5 + 3-3 16-8 + 3-8
10 pmol/1 86-1+7-3 31-5 + 4-6 18-2 + 3-4
100 pmol/1 48-7 + 9-0* 17-1+4-9* 13-0 + 2-7
Verap 1 pmol/1 96-2 + 9-9 35-7 + 4-1 12-0 + 3-0
10 pmol/1 88-2 + 9-1 32-9 + 3-1 15-3+1-8
50 pmol/1 102-2+10-5 39-8 + 5-8 35-6 + 6-9
100 pmol/1 111-2+10-0 67-5 + 7-6t 54-0+ 10-9+
TPA 1-6 nmol/1 114 0 + 9-4 33-7±2-2 37-6 + 3-5 11-1 + 1-8 12-0 + 2-2
8-1 nmol/1 116-8 + 10-2 39-8 + 4-9 10-5 + 1-3
40-5 nmol/1 106-4 + 7-9 41-2 + 4-1 8-5 + 1-2
TPA 1-6 nmol/1 100 91-0 + 8-6 48-6+ 16-Of 55-0+ 10-2} 25-8 + 7-6J 18-4 + 11-4$
(Day 7) 8-1 nmol/1 113-9 +15-6 52-4+ 10-5J 23-0 + 9-7J
40-5 nmol/1 110-7 + 8-9 53-0+ 16-2J 26-0 + 6-8J
Significantly (/><0 05) *lower or thigher than corresponding control (C) value for the same day (Student's one- or two-tailed f-test, as appropriate).
JMean (± s.e.m.) of four to six values. Other values were below the limit ofdetection (003 pmol/mg tissue per 24 h), and these values were obtained for control
and the corresponding treated samples.
by, and release from, the guinea-pig uterus. However,
the high basal output of PGF2o from the day-15
guinea-pig uterus is not reduced during a 2-5 h super-
fusion with Ca2+-free medium (Poyser, 1984), or
during a 30-min superfusion with the intracellular cal¬
cium antagonist TMB-8 (Poyser, 1985a). These find¬
ings raised the question of whether Ca2+ is necessary
for the increase in endometrial PGF2a production
which occurs after day 11 of the cycle. The present
study showed that EGTA and TMB-8 in Ca~+-con-
taining medium significantly reduced basal PGF2a
output from day-15 guinea-pig endometrium main¬
tained for 3 days in tissue culture. The use of Ca2+-
depleted medium had the same effect. TMB-8 and
EGTA also caused a further small reduction in endo¬
metrial PGF2a output in Ca2+-depleted medium,
suggesting that EGTA acts intracellular!y as well as
extracellularly. Alternatively, the inhibitory action of
EGTA may be due to it chelating residual Ca2+ in the
Ca2+-depleted medium. These findings indicate that
Ca2+, primarily of extracellular origin, is necessary for
the high output of PGF2o from day-15 guinea-pig
endometrium. Similar findings have been reported for
PGE2 output from human amnion cells (Olson,
Opavsky & Challis, 1983). However, the possibility
cannot be excluded that endometrial PGF2a synthesis
is dependent upon the mobilization of Ca2+ from
intracellular stores, and that the extracellular Ca2+ is
necessary solely to replenish these stores. Neverthe¬
less, previous studies (Poyser, 1984, 1985a) have
shown that PGF2a output from day-15 guinea-pig
uterus superfused for short periods can be maintained
in the absence of extracellular and non-bound intra¬
cellular Ca2+.
The high basal output ofPGF2a from day-15 guinea-
pig endometrium was reduced by the calmodulin
inhibitors W-7 and, to a lesser extent, TFP. These
findings are consistent with these compounds prevent¬
ing A23187-stimulated increases in uterine PGF2a out¬
put (Poyser, 1985a,&), and suggest that calmodulin is
involved in the process by which an increase in the
intracellular free Ca2+ concentration stimulates PLA2
activity. However, there is some debate as to whether
PLA2 is a calmodulin-dependent enzyme (Withnall &
Brown, 1982; Moskowitz, Andres, Silva et al. 1985).
The activity of platelet PLA2 is stimulated by acidic
phospholipids (such as phosphatidic acid and phos-
phatidylserine), but not by calmodulin, in a Ca2+-
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table 3. Mean (± s.e.m., n = 10) output of 6-keto-prostaglandin (PG) Fla (expressed as % of day 1 control (C) output) from
guinea-pig endometrium removed on day 15 of the oestrous cycle (unless otherwise stated) and cultured in the absence (C) or
presence (T) of EGTA, TMB-8, trifluoperazine (TFP), W-7, nifedipine (nifed), verapamil (verap) and phorbol 12-myristate
13-acetate (TPA)
Output of6-keto-PGFla (% of control on day 1 of culture)
Day 1 Day 2 Day 3
C T C T C T
Treatment
EGTA 2 mmol/1 100 72-1+ 10-7* 35-3 + 3-0 38-0 + 6-9 14-9+1-6 29-1 + 4-7f
TMB-8 30 pmol/l 100 106-8 + 5-5 27-8 + 2-7 25-4 + 2-1 12-3 + 2-2 12-9 + 2-5
100 pmol/l 114-7 + 8-5 37-1+4-0 30-9 + 3-5f
TFP 100 pmol/l 100 163-2 + 15-3f 33-3 + 3-6 73-9+ 100t 19-5 + 4-4 29-9 + 4-9
200 pmol/l 179-2 + 20-2+ 76-1 +8-4+ 36-9 + 6-4f
W-7 150 pmol/l 100 108-1+6-8 27-6+1-8 52-1 ±5-5f 14-4 + 2-0 40-6 + 5-0f
300 pmol/l 134-4+18-8 53-2 + 6-2t 13-4 + 3-0
Nifed 1 pmol/l 100 99 1 +6-8 27-9+1-8 29-0 + 2-5 14-0+1-0 12-9+1-5
10 pmol/l 87-8+7-2 23-6+ 2-5 13-9+1-7
100 pmol/l 74-4 + 4-7* 21-7 + 2-2* 13-5+1-0
Verap 1 pmol/l 95-3 + 6-3 28-2+1-7 13-1 + 1-2
10 pmol/l 93-6 + 9-7 28-9 + 2-1 12-6 + 1-0
50 pmol/l 104-0 + 6-8 28-6 + 2-5 19-6+l-9t
100 pmol/l 112-7 + 10-9 36-6+l-9f 23-0 + 2-4t
TPA 1-6 nmol/1 100 106-4 + 6-0 31-0+ 2-3 30-5 + 2-9 10-2 + 0-9 11-5+1-3
8 1 nmol/1 114-7 + 8-3 37-4 + 5-3 10-1+0-9
40-5 nmol/1 106-6 + 8-0 31-7 + 3-2 9-8 + 0-9
TPA 1-6 nmol/1 100 98-7 + 6-4 24-9+1-7 23-4+1-9 13-4+1-4 12-4+1-1
(Day 7) 8-1 nmol/1 105-2 + 10-6 37-4 + 5-3 15-2 + 2-1
40-5 nmol/1 107-8+4-0 31-7 + 3-2 13-8 + 1-6
Significantly (P < 0-05) *lower or fhigher than corresponding control value for the same day (Student's one- or two-tailed /-test, as appropriate).
dependent manner. The calmodulin inhibitors TFP
and W-7 inhibit this stimulation of PLA2 by prevent¬
ing the binding of Ca2+ to the acidic phospholipids
(Watanabe, Hashimoto, Teramoto et al. 1986).
Whether calmodulin or acidic phospholipids mediate
the intracellular action of Ca2+ in guinea-pig endome¬
trium merits further investigation, but the reduction
in PGF2a output from day-15 guinea-pig endome¬
trium by TFP and W-7 is further evidence that Ca2+
is necessary for increased PGF2a production by the
guinea-pig uterus from day 11 of the cycle.
Nifedipine in concentrations (1 and lOpmol/1)
which normally block calcium channels had no effect
on endometrial PGF,a output. Verapamil (1 pmol/l)
also had no effect. However, nifedipine (100 pmol/l)
had a marked inhibitory effect on PGF2o output,
whereas verapamil (10-100 pmol/l) had a small, some¬
times significant, inhibitory action on PGF2a produc¬
tion. The inhibitory effect of both drugs was still
present in Ca2+-depleted medium. Nifedipine and the
verapamil derivative, D-600, inhibit calmodulin
(Andersson, Drakenberg, Thulin & Forsen, 1983;
Minocherhomjee & Roufogalis, 1984), so nifedipine
and verapamil may be inhibiting PGF2a synthesis in a
manner similar to that of TFP and W-7. Also, nifedi¬
pine (100 pmol/l) and verapamil (100 pmol/l) inhibit
PGI2 output from rabbit mesothelial cells (Van de
Day 1 Day 2 Day 3
figure 2. Mean ( + s.e.m., n= 10) outputs ofprostaglandin
(PG) F,a, PGE, and 6-keto-PGF,a from guinea-pig endo¬
metrium, removed on day 15 of the oestrous cycle, in the
presence (solid bars) and absence (open bars) of Ca2+ on
days 1,2 and 3 ofculture. *Significantly lower (P< 0-05)
than the value in the presence ofCa2+ for the same PG on
the same day of culture (Student's t-test).
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table 4. Mean (+ s.e.m., n = 10) output of prostaglandin (PG) F2a, PGE2 and 6-keto-PGFla (expressed as % of day 1 control
(C) output for the same PG) from guinea-pig endometrium removed on day 15 of the oestrous cycle and cultured in the
absence (C) or presence (T) of EGTA, TMB-8, W-7, nifedipine (nifed) and verapamil (verap) using Ca2+-depleted medium
Output ofPGs (% ofcontrol on day 1 ofculture)
Day 1 Day 2 Day 3
PG and treatment
pgf2a
2 mmol/1 EGTA 100 70-4+10-9* 26-8+1-4 15-8+1-5* 11-0+ 0-9 8-8 + 0-7
100 pmol/1 TMB-8 82-5 + 6-7* 20-4+1-9* 6-8+1-0
150 pmol/1W-7 71-2 + 6-6* 30-5 + 3-8 9-1 + 1-5
100 pmol/1 nifed 66-3 + 7-6* 15-5 + 1-7* 9-4+1-2
100 pmol/1 verap 82-6 + 7-1* 33-7 + 3-5 14-5 + 2-6
pge2
2 mmol/1 EGTA 100 88-5 + 7-9 36-3 + 4-4 42-1+3-6 22-8 + 4-5 33-7 + 4-7
100 gmol/1 TMB-8 124-8+9-1+ 59-5±7-3f 36-9 + 5-6
150 gmol/1 W-7 135-9+13-2+ 111-3+ 19-2+ 53-9±9-4f
100 gmol/1 nifed 22-0 + 4-0* 12-6 + 3-2* 7-7+1-8*
100 pmol/1 verap 106-5 + 3-6 71-2+10-3 47-5±100t
6-keto-PGFla
2 mmol/1 EGTA 100 84-7 + 5-7* 24-5+1-8 62-9 + 4-Of 11-9+1-1 37-9 + 3-Of
100 pmol/1 TMB-8 94-9 + 6-2 36-2±2-7t 20-5 + 2-Ot
150 pmol/1 W-7 108-6 + 5-3 44-l±4-2t 24-6±3-6t
100 pmol/1 nifed 83-4 + 6-4* 24-5 + 2-3 13-1 + 1-5
100 pmol/1 verap 103-9 + 6-5 35-5±3-6f 20-l±3-8t
Significantly (P< 0-05) *lower or thigher than corresponding control value for the same PG on the same day (Student's one- or two-tailed r-test, as appropriate).
Velde, Van den Bossche, Bult & Herman, 1986). It is
concluded that extracellular Ca2+ required for the
stimulation of PLA2 activity, and hence PGF2a
synthesis, does not enter the endometrium by voltage-
dependent channels, and that the inhibitory effect
of nifedipine and verapamil on endometrial PGF2a
synthesis is due to an intracellular action.
The inhibitory effects of removal of extracellular
Ca2+ on outputs of PGE2 and 6-keto-PGFla from the
day-15 guinea-pig endometrium in culture were less
marked than on PGF2a output. This is probably due
to the outputs of PGE2 and 6-keto-PGFlo being lower
than the output of PGF2a, particularly at the start of
the culture period (i.e. compared with day-7 endome¬
trium, the basal outputs of PGE2 and 6-keto-PGFla
from day-15 endometrium had not been stimulated to
the same extent as the basal output of PGF2a and thus
there was less scope for inhibition to occur). Paradoxi¬
cally, TMB-8, TFP, W-7, verapamil and, to a lesser
extent, EGTA stimulated the outputs of PGE2 and
6-keto-PGFla. Previous studies have shown that while
TMB-8, TFP and W-7 prevent the increases in PG
output from the superfused guinea-pig uterus induced
by A23187, on their own these compounds cause a
small stimulation in the outputs of PGF2a, PGE2 and
6-keto-PGFla (Poyser, 1985a,b). Thus TMB-8, TFP
and W-7 have opposing actions as regards PG pro¬
duction. In the present study, it is clear that the inhibi¬
tory effect predominates as regards PGF2a output, and
that the stimulatory effect predominates as regards
PGE2 and 6-keto-PGFla outputs. Verapamil and
EGTA, but not nifedipine, have similar opposing
actions. The stimulatory effect is present in Ca -free
medium suggesting that it is an intracellular process,
possibly due to a direct interaction with the mem¬
branes of the endoplasmic reticulum, the main site
of PLA2 and PG-synthesizing enzymes (DeWitt,
Rollins, Day et al. 1981; Lagarde, Menashi &
Crawford, 1981; Carey, Menashi & Crawford, 1982).
Trifluoperazine had a greater stimulatory effect on PG
output than the other compounds, which probably
accounts for its weaker inhibitory effect on PGF2a
output.
In platelets, protein kinase C catalyses phosphory¬
lation of a lipocortin-like protein thus rendering it
inactive (Touqui, Rothhut, Shaw et al. 1986), and
thereby potentiates platelet thromboxane synthesis, in
response to appropriate stimuli (Mobley & Tai, 1985),
due to the consequent enhancement of PLA2 activity.
TPA, an activator of protein kinase C, had no effect
on PGF2o production by day-7 and day-15 guinea-pig
endometrium. Protein kinase C is normally activated
by diglyceride formed by the action of phospholipase
C (PLC) on phosphatidylinositol (PI) or polyphos¬
phoinositides (PIP and PIP2; see Berridge & Irvine,
1984). The present findings are consistent with a pre¬
vious study (Ning & Poyser, 1984) which showed that
the turnovers of PI, PIP and PIP2 in guinea-pig endo¬
metrium were not increased on day 15 (a day of stimu¬
lated endometrial PGF2a output) compared with day
J. Endocr. (1987) 113, 463-471
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7 (a day of low endometrial PGF2a output) of the
cycle. Thus, these investigations show that there is no
stimulation of the PI cycle at the time of increased
PGF2a synthesis in the guinea-pig endometrium, and
that endometrial PLA2 activity in the guinea-pig is
not normally restrained by a protein kinase C-inacti-
vated lipocortin. TPA stimulates PGF2o synthesis
by cultured human endometrial cells (Skinner,
Liggins, Wilson & Neale, 1984), indicating that
differences exist in the intracellular mechanisms con¬
trolling PGF2o synthesis by human and guinea-pig
endometrium.
Overall, these studies indicate that Ca2+, mainly of
extracellular origin, is necessary for increased PGF2a
production by the guinea-pig endometrium from day
11 of the oestrous cycle. A previous study has shown
that this increased output of PGF2a is prevented by
the protein synthesis inhibitor, actinomycin D (Poyser
& Riley, 1985, 1987). We propose, therefore, that
oestradiol stimulates the synthesis of a protein which,
on a progesterone-primed uterus, causes an increase
in the endometrial free intracellular Ca2+ concen¬
tration and thereby activates PLA2 to release arachi-
donic acid from phospholipids for PGF2a synthesis.
The release of arachidonic acid for PGE2 synthesis by
transformed mouse fibroblasts in response to serum,
thrombin and bradykinin (Pong, Hong & Levine,
1977), for PGE2 synthesis by skeletal muscle
(Turinsky, 1985), and for the stimulation of PGI2
synthesis in endothelial cells by bradykinin and leuko-
trienes (Clark, Littlejohn, Mong & Crooke, 1986), is
also dependent upon increased protein synthesis.
Furthermore, increased PGI2 production in endo¬
thelial cells by bradykinin is dependent upon extracel¬
lular Ca2+, but is not dependent upon the opening of
voltage-dependent Ca2+ channels (Whorton, Willis,
Kent & Young, 1984). Our findings using the guinea-
pig endometrium are therefore consistent with find¬
ings in other tissues that the release of arachidonic
acid, the rate-limiting step for PG synthesis (Vogt,
1978), is dependent upon increased protein synthesis
and extracellular Ca2+.
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